Effects of light and caffeine on human sleepiness and alertness: A simulated driving experiment by Shekari Soleimanloo, Shamsi
 EFFECTS OF LIGHT AND CAFFEINE ON 
HUMAN SLEEPINESS AND ALERTNESS: A 
SIMULATED DRIVING EXPERIMENT  
Shamsi Shekari Soleimanloo 
BSc Occupational Health, MSc Occupational Health  
 
 
Submitted in fulfilment of the requirements for the degree of 
 Doctor of Philosophy (Research) 
 
Centre for Accident Research and Road Safety – Queensland (CARRS-Q) 
Faculty of Health 









Chronic partial sleep loss, 
 
Countermeasures for sleepiness, 
 
Models of sleep-wake regulation, 
 






Sleep-related road crash, 
 















Sleepiness remains a primary cause of road trauma, resulting in approximately 20% 
of the fatal crashes in Australia each year.  Young adults are overrepresented in 
sleep-related road crashes. Sleepiness is known to lead to neurobehavioral 
consequences such as decreased objective or subjective alertness, and impaired 
cognitive and driving performance. Sleep deprivation, arising from social or 
occupational obligations, is a major cause of sleepiness. Young adults are 
particularly sensitive to the adverse effects of sleep deprivation.   Drivers often rely 
on ineffective (e.g. opening the window, listening to music) or temporary (e.g. 
consumption of caffeine) countermeasures for sleepiness.  Finding more effective 
countermeasures for driver sleepiness is of great importance. Recent description of 
the acute alerting effects of light has raised the possibility of light as a novel 
countermeasure for sleepiness. However little is known about the effects of light on 
sleepy drivers, especially after naturalistic partial sleep restriction.  
This thesis aimed to understand the effect of blue-green light and caffeine on young 
drivers’ sleepiness and driving performance.   
Three reviews were conducted; firstly, a review of the mechanisms and models of 
human sleep-wake regulation, and the effects of sleep loss on a variety of human 
alertness and other contributors to sleepiness; secondly, a systematic review of the 
effects of sleep loss on young drivers’ sleepiness and driving performance using 
GRADE criteria to formally rate quality of evidence; and finally a review of the 
alerting effects of bright light and caffeine on drivers’ sleepiness. Based on the 
findings of these three reviews, a repeated-measures factorial design was adopted in 
an experimental study to investigate the alerting effects of light and caffeine, 
individually or combined together, on young drivers’ alertness and performance after 
chronic partial sleep deprivation. Prior to the experimental study, the sleep-wake 
times of 30 young participants (18-25 years) were monitored via Actigraphy, and 
their bedtimes were reduced from 8 hours to 7 hours gradually. In the last three days 
of Actigraphy, participants attended three test sessions involving two 30-minute 
simulated drives. The first drive was conducted under dim red light (Placebo 
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condition) and the second under each of three randomised interventional conditions, 
which presented caffeinated (100 mg caffeine) or placebo non-caffeinated gum, in 
conjunction with either blue-green light (520 nm dominant, 230 µW/cm²) or red light 
(< 2 lux). Light and caffeine were provided via commercial light glasses and 
caffeinated chewing gums respectively.  
Findings of the experimental study revealed that provision of all three interventional 
conditions decreased subjective sleepiness scores from “some signs of sleepiness” to 
“not sleepy” or even to “rather alert”. However, none of these conditions improved 
electroencephalographic or electrocardiographic indices of alertness. Light alone did 
not improve drivers’ psychomotor performance (reaction time indices of sleepiness), 
while caffeine alone and light and caffeine in combination both improved some of 
these indices. Each of the three conditions improved indices of driving performance, 
but to different extents. The absolute value of steering wheel angle found to be the 
most sensitive index of driving performance to sleep deprivation with a significant 
reduction under all three interventional conditions.  
Overall, data partly supported the alerting effect of administering the intervention 
when compared with the placebo condition. Data were also partly in agreement with 
the hypothesis of a greater alerting effects of light alone, caffeine alone or the 
combination of them than the Placebo condition. Additionally, data partly supported 
the hypothesis of a greater alerting effect of light and caffeine in combination than 
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Chapter 1: Introduction 
This chapter outlines the background (Section 1.1), context of the research (section 
1.2), and its purposes (Section 1.3). Finally, Section 1.4 describes the significance 
and scope of this research.  
 
1.1 BACKGROUND 
Driving is a complex task requiring optimal cognitive, perceptual, motor and 
decision making skills (Campagne, Pebayle, & Muzet, 2004). While receiving 
multiple stimuli simultaneously from the road scene (complex visual, auditory and 
tactile information), the driver needs to select and analyse stimuli, and to react 
rapidly based on the road situation, driving regulations, conditions of the vehicle, and 
on their previous driving experiences (Jackson, Croft, Kennedy, Owens, & Howard, 
2013). Functional magnetic resonance imaging (FMRI) has shown that different parts 
of human brain are involved in the driving task including the occipital, parietal, and 
cerebellar cortices (Spiers & Maguire, 2007). Figure 1.1 shows five human brain 
areas. The brain areas involved in different driving-related tasks (Spiers & Maguire, 
2007) are presented in Table 1.1. 
 
 
Figure 1.1 Human brain areas, (adopted from Camazine, 2008) 
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Table 1.1: Different brain areas activated during specific driving tasks (Spiers & Maguire, 2007) 
Action while 
driving 
Involved regions General function Related driving task  
Performing 
prepared actions 




starting to move mostly by the left lateral motor/premotor,  
turning corners, reversing and stopping, attention to visual 
motion,  
 cerebellum fine-control during 
movement execution 
prepared manoeuvres with the vehicle 
 medial and lateral occipital 
regions 
all the prepared actions visual change during all prepared actions, attention to 
visual motion and fixed landmarks 
Responding to 
driving hazards 
pre-SMA action planning choosing actions or making decisions for future actions 
 parietal cortex  future intentions, planning actions 
 lateral occipital cortex visual processing focusing on locations 
 posterior parietal cortex, 
pre-cuneus and lateral 
occipital cortex  
visual and attentive 
tracking moving objects 
monitoring traffic, 
Road traffic rules the right lateral **PFC and 
medial PFC 
rule retrieval and 
maintenance 
spontaneous processing of rules 
*Supplementary Motor Area, **Pre Frontal Cortex 
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Sleepiness is known to decrease brain activity and function primarily in the alertness 
and attention related areas such as the thalamus, the prefrontal cortex, and the 
posterior parietal cortices (Thomas et al., 2000), and to result in decreased cognitive 
performance, impaired concentration and perception, vision disturbances, slower 
reactions, more frequent ‘micro sleep’ episodes (Jackson et al., 2013; Martella, 
Casagrande, & Lupiáñez, 2011; Orzeł-Gryglewska, 2010), and other functions 
subserved by these distinct brain regions.   
Estimates of the prevalence of sleepy driving vary widely between countries (i.e. in 
Norway 10%, in Ontario, Canada 14.5%, and in the United States 32%), possibly due 
to geographical or cultural differences, and/or reflecting differences in the 
measurement and reporting of sleepiness (Phillips & Sagberg, 2013). Sleep-related 
crashes represent up to 20% of all crashes in developed countries (Connor et al., 
2002; Horne, J.A & Reyner, 1995; Sagaspe, P et al., 2010; Sagberg, 1999; 
Smolensky, Di Milia, Ohayon, & Philip, 2011; Vanlaar, Simpson, Mayhew, & 
Robertson, 2008). In spite of differences in the nature and quality of the studies 
reporting sleep-related crashes, a consensus has emerged that sleepiness is a 
particularly significant risk factor for severe and fatal crashes (Abe, Komada, 
Nishida, Hayashida, & Inoue, 2010; Horne, J.A & Reyner, 1995; McCartt, Ribner, 
Pack, & Hammer, 1996; Stutts, Wilkins, Osberg, & Vaughn, 2003). According to the 
report of the Parliament of the Commonwealth of Australia, driver sleepiness 
accounted for 6% of all crashes, 15% of fatal crashes, and 30% of fatal crashes on 
rural roads in 2000 (Papadelis et al., 2007). 
Road crashes caused by sleepy driving, or other reasons, impose a very large human 
and financial burden on society. In Australia, estimations by the Bureau of 
Infrastructure Transport and Regional Economics (Bureau of Infrastructure Transport 
and Regional Economics [BITRE], 2009), revealed a $17.85 billion (2006 dollars) 
social cost of road crashes, approximately $2.4 million per fatality for human losses, 
approximately $214,000 per injury (including disability-related costs) for a 
hospitalized injury, and $2200 per injury for non-hospitalized injury in 2006. Efforts 






Young drivers (those aged between 18 and 24 years) appear to be at higher overall 
risk for road crashes (Campagne et al., 2004; Horne, J.A & Reyner, 1995). In some 
studies the risk of being involved in a traffic crash among drivers younger than 24 
years has been estimated between 2 to 10 fold compared to other age groups 
(Åkerstedt, Kecklund, & Hörte, 2001; Sagaspe, P et al., 2010). During the last 10 
years in Australia, 17–25 year-olds comprised only 13% of the population, but had 
the highest rate (22%) of road-related fatalities (Bureau of Infrastructure Transport 
and Regional Economics (BITRE), 2013). Consistent with this figure, in 2012 more 
than 140 drivers out of 600 fatalities of drivers in Australian roads were in the 17–25 
age group (Bureau of Infrastructure Transport and Regional Economics (BITRE), 
2013).  
It remains possible that sleepiness-related crashes are even more common than 
generally reflected in these statistics. This may be due to the lack of an objective test 
for measuring sleepiness, and confusion or misattribution regarding the constructs of 
fatigue, inattention, and sleepiness. This confusion has been driven by a lack of 
specificity around these constructs, and interchangeable use of these terms in the 
literature. Sleepiness can be defined as a person’s inability to maintain wakefulness 
and their tendency to doze off or to fall asleep (Cluydts, De Valck, Verstraeten, & 
Theys, 2002). Fatigue can be considered as a gradual process of disinclination 
towards effort which may not be directly observable or measured, but eventually 
impairs performance on a range of cognitive and psychomotor tasks (Lal & Craig, 
2001(b); Philip et al., 2005(a); Williamson, A. et al., 2011), including tasks critical for 
safe driving. 
The higher risk of being involved in a crash among young drivers is partly due to a 
range of cohort-related factors, including being inexperienced in driving, increased 
social deviance and broader risk involvement (including increased use of alcohol and 
other drugs), peer influence, and even car preference (Smith, S., Horswill, Chambers, 
& Wetton, 2009(b)). However, even in that context, sleepiness remains a very 
substantial primary contributor to crashes (Åkerstedt et al., 2001; Cummings, 
Koepsell, MoVat, & Rivara, 2001; Lowden, Anund, Kecklund, Peters, & Åkerstedt, 
2009). There are a number of contributors to increased sleepiness among young 
23 
 
drivers including social factors (socialization and work patterns), disrupted sleep 
patterns, and driving when ordinarily asleep (particularly late at night and in the early 
morning (Smith, S. et al., 2009(b)). Some of the behaviours that lead to increased 
sleepiness interact with sleepiness as risk factors, and may be amplified by 
sleepiness, are subserved by neurophysiological processes specific to the late 
adolescent and young adult cohort. One such process is the maturation of the 
dorsolateral prefrontal cortex (DLPFC), a functional region associated with proper 
judgment and decision-making (Beeli, Koeneke, Gasser, & Jancke, 2008). 
While acute sleep deprivation has been shown to impact on driving skills, the effects 
of more naturalistic chronic sleep deprivation (i.e. long term partial sleep restriction 
or partial sleep disruption typical in this age cohort) is less well described. This 
naturalistic element may be important for linking laboratory research to the on-road, 
epidemiological, and crash-data based studies. 
There are two obvious solutions to sleepy driving; the first and the best solution for 
sleepiness is to control circadian rhythmicity and to not drive when sleepy 
(MacLean, Davies, & Thiele, 2003). However, drivers may often not be able to 
achieve sufficient sleep, may in any case underestimate their sleepiness, and may 
prefer to adopt countermeasures when sleepy due to commercial and social pressures 
(Anund, Kecklund, Peters, & ÅKerstedt, 2008(a); Horne, J.A & Reyner, 1996; 
Reyner, L. & Horne, 1998; Rogers, P.J et al., 2005(b); Van Dongen, Maislin, 
Mullington, & Dinges, 2003).  
The second solution is not to be sleepy when driving; one contemporary 
countermeasure for sleepiness is taking a nap. In one study, a nap was perceived as 
an effective countermeasure for sleepiness by 70% of drivers (Nordbakke & 
Sagberg, 2007). However, there are some flaws in taking the nap after sleep loss. A 
study among shift worker participants reported poor daytime sleep quality due to 
difficulty in falling asleep, sleep latency of about 20 minutes and early awakening 
after falling asleep (Garbarino, Nobili, Beelke, & Balestra, 2002). One important 
drawback of the nap is sleep inertia (a biological tendency to feel not fully awake) 
after the nap. For example in a 40-min simulated driving experiment in the early 
morning after one night sleep loss the objective evidence of sleep inertia was 
observed immediately after a 10-min nap as deteriorated PVT performance (Hilditch, 
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Dorrian, Centofanti, Van Dongen, & Banks, 2015). This means that drivers are not 
fully alert immediately after taking the nap, and for some time thereafter. 
Additionally, the existing regulation of maximum driving time only applies to 
professional drivers and there is no obligatory regulation for non-professional drivers 
to stop and take a nap (MacLean et al., 2003). 
Caffeine, another commonly used countermeasure, is cheap and readily accessible, 
has few harmful side effects and is socially acceptable. Caffeine has a very rapid oral 
absorption (Blanchard & Sawers, 1983) and has been shown to restore performance 
to baseline levels after sleep loss (Smith, A., 2002). 
Despite the potential effectiveness of caffeine, 20% of people do not habitually use 
caffeinated beverages (Heckman, Weil, Mejia, & Gonzalez, 2010; Mets, Baas, van 
Boven, Olivier, & Verster, 2012), or are genetically sensitive to caffeine (Landolt, 
2012). Additionally, the alerting effects of caffeine do not typically appear until 30 
minutes after consumption and last only for about one hour (Blanchard & Sawers, 
1983; O'connell & Zurzola, 1984).  
In Australia,  some televised educational campaigns have been launched, including  
“Join the drive, driving tired” (Department of Transport and Main Roads, 2015), 
“Ride to live”, “Stop revive survive”, “Driver reviver” (NSW Centre for Road 
Safety, 2015). Additionally, in the state of New South Wales (NSW) a downloadable 
map of rest areas in major roads has been provided (NSW Centre for Road Safety, 
2015). Nevertheless, there are no data available to show that these population-level 
interventions are efficacious, and the rates of sleep-related crashes remain very high 
despite these campaigns. There remains a need to look for other alternatives to 
improve the ‘armoury’ available to solve this problem. 
Recently, the possible alerting effects of light have received increasing attention 
(Cajochen, C., 2007; Kaida, Takahashi, & Haratani, 2006(b)). Light can affect brain 
function and cognition by activating alertness-related pathways in subcortical 
structures and mood-related pathways in the limbic areas, followed by modulation of 
cortical area activities (Chellappa et al., 2011; Smolders, de Kort, & Cluitmans, 
2012; Vandewalle, Maquet, & Dijk, 2009). Light directly elicits instantaneous 
changes in physiological arousal (Smolders et al., 2012; Stephenson, Schroder, 
Bertschy, & Bourgin, 2012; Thessing, Anch, Muehlbach, Schweitzer, & Walsh, 
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1994), improvement of both subjective and objective alertness at night and during the 
day (Figueiro, M.G, Bullough, & Rea, 2007a; Horowitz, Cade, Wolfe, & Czeisler, 
2001; Lockley et al., 2006; Revell, Arendt, Fogg, & Skene, 2006; Rüger, Gordijn, 
Beersma, De Vries, & Daan, 2006), reduction of sleepiness (Figueiro, M.G et al., 
2007a; Horowitz et al., 2001; Rüger et al., 2006; Vandewalle et al., 2009), 
improvement of mood (Rüger et al., 2006; Stephenson et al., 2012), enhancement of 
cognitive performance (Rüger et al., 2006; Stephenson et al., 2012; Thessing et al., 
1994), particularly psychomotor vigilance reaction times (Lockley et al., 2006), 
reduction of attention failures (as measured by EOG slow rolling eye movements), 
and suppression of EEG alpha-theta (α+θ; 5-9 Hz) activity, regarded as markers of 
sleepiness in the waking electroencephalogram (Lockley et al., 2006). While all these 
studies strongly suggest that light acts as an alerting agent when sleepy, they do not 
clearly show that the light has alerting effects on drivers who are chronically sleep 
restricted. These studies do not demonstrate that light is efficacious for all driving-
related tasks (Table 4.2).  
Acute sleep deprivation remains the dominant experimental manipulation of sleep, 
but it is becoming clear that the effects (on metabolism, cognition and safety) of 
chronic sleep deprivation might differ from those exposed by acute deprivation. This 
has been demonstrated in both animal and human models. It is expected that 
performance after chronic sleep deprivation may differ from after acute deprivation, 
but may better reflect the ‘real world’ experience of young adults (Novati, Hulshof, 
Granic, & Meerlo, 2012; Philip et al., 2012). Taking the limitations of existing 
studies of sleepy driving in the vulnerable young adult population into account, there 
is a critical need to assess the potential of light as a novel countermeasure for 
sleepiness in this context, either alone or combined with existing strategies such as 
caffeine. 
 
1.3 PURPOSE OF THIS RESEARCH 
In general, this program of research aimed to investigate the nature and magnitude of 
any alerting effect of light among young drivers when sleepy. A number of light 
delivery systems have now been commercialized and are widely available. These 
devices are primarily marketed as therapies for circadian rhythm disorders or for 
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seasonal affective disorders. Similarly, new modes of caffeine delivery (specifically 
caffeinated gums) are now widely available, and promoted as alerting agents. An 
overarching pragmatic aim of this research program was to determine the potential 
benefit of these types of contemporary interventions for driver safety when sleepy. 
To address this aim, the program of research was developed as a four-part research 
protocol.  
Firstly, in order to address the consequences of sleep loss, a primary literature review 
was performed to understand the concepts of sleepiness and alertness and the 
relationship between them, mechanisms of sleepiness, models of sleep-wake 
regulations, the contributors to sleepiness and the adverse effects of sleep deprivation 
on drivers of all levels including objective sleepiness, subjective sleepiness and 
driving performance.  
Secondly, a systematic review was conducted to explore the specific effects of 
chronic sleep loss on young drivers’ daytime driving performance and to evaluate the 
quality of the available body of evidence.  
Thirdly, a literature review of the alerting effects of light and caffeine on driver’s 
sleepiness was undertaken. This review highlighted some known and unknown facts 
about the alerting effects of light and caffeine which were of importance to the main 
study (experimental study).  
Finally, an experimental study was undertaken to determine the alerting effects of a 
standardized ‘dose’ of light and caffeine when administered alone or in combination 
on young drivers’ daytime sleepiness after chronic partial sleep loss. For this purpose 
six primary research questions were posed (Table 1.2). Six specific hypotheses were 








Table 1.2: Research questions  
Research Question Description 
Research Q1 Does light have any alerting effect on drivers’ objective, subjective, cognitive performance or driving performance 
measures of sleepiness after chronic partial sleep loss? 
Research Q2 Do low levels of caffeine light have any alerting effect on drivers’ objective, subjective, cognitive performance or 
driving performance measures of sleepiness after chronic partial sleep loss? 
Research Q3 Does the combination of light and caffeine have any alerting effect on drivers’ objective, subjective, cognitive 
performance or driving performance measures of sleepiness after chronic partial sleep loss? 
Research Q4 Are there any significant differences between alerting effects of the combination of light and caffeine on objective, 
subjective, cognitive performance and driving performance measures of sleepiness as compared to those of light or 
caffeine? 
Research Q5 Is there any significant difference between alerting effects of light on objective, subjective, cognitive performance 
and driving performance measures of sleepiness as compared to those of caffeine? 
Research Q6 Is there any significant overall difference between objective, subjective, cognitive performance and driving 




Table 1.3:  Research hypotheses to answer the research questions 
Hypothesis Description 
Hypothesis 1 Light (condition 2) has an alerting effect relative to the Placebo condition (condition 4) 
Hypothesis 2 Caffeine (condition 3) has an alerting effect compared to the Placebo condition (condition 4) 
Hypothesis 3 Light and caffeine in combination (condition 1) has an alerting effect compared to the Placebo condition (condition 4) 
Hypothesis 4 Light and caffeine in combination (condition 1) has a greater alerting effect than either light or caffeine alone 
Hypothesis 5 Light alone has a greater alerting effect than caffeine alone 




1.4 SIGNIFICANCE, SCOPE AND DEFINITIONS 
This program of research was intended to contribute to new knowledge by 
addressing some key methodological limitations identified in existing research 
(including aspects of study design, sample characteristics, the quality and quantity of 
intervention, and control for confounders). All four components of this research are 
of importance. The first part, review of effects of sleep loss on drivers’ alertness and 
performance, identified the most sensitive outcome measures associated with 
sleepiness in all levels including objective and subjective sleepiness and driving 
performance. The second part, a systematic review of the effects of sleep loss on 
young drivers’ performance, highlighted the driving performance outcomes most 
sensitive to chronic sleep loss in young drivers during the daytime, and identified the 
existing gaps in this knowledge. The third part, review of the alerting effect of light 
and caffeine, addressed current knowledge on the alerting effects of bright light and 
caffeine in the driving context, particularly light and caffeine in combination. The 
outcomes of these three reviews informed the framework of the fourth part, the 
experimental study in terms of inclusion and exclusion criteria, the size and 
characteristics of the sample, study design, the doses and timing of administration of 
the light and caffeine, and the outcome measures of sleepiness. As a result, the 
experimental study included a number of specific aspects as follows: 
The design of the experimental study was a repeated-measures, within-subjects 
design. The repeated-measures facet of this study enabled the researchers to examine 
cumulative effects of sleep loss over a period of three days, while the within-subjects 
aspect eliminated most of inter-individual differences such as age, gender, driving 
experience, and individual sensitivity to sleep loss. The sample in the experimental 
study comprised 30 young non-professional and non-shift-worker drivers aged 18-25 
years. This age group represented the most vulnerable drivers to sleep loss (Smith, 
M. R., Fogg, & Eastman, 2009(a)), and the most involved drivers in sleepiness-related 
crashes. Regarding the quality of sleep loss as an intervention, gradual bedtime 
restriction was induced to examine the effects of chronic sleep loss over a week. The 
severity of total sleep loss was quite low, a one-hour reduction of time in bed, to 
examine the effects of naturalistic levels of sleep loss.  This study revealed some new 
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findings about the relative alerting effects of light and caffeine in the daytime after 




Chapter 2: Review of Effects of Sleep Loss 
on Drivers’ Alertness and 
Performance 
This chapter provides a review of the literature on the following topics: mechanisms 
and models of human sleep/wake regulation (Section 2.1), alertness (Section 2.2), 
characteristics of human arousal (Section 2.3), the adverse effects of sleep 
deprivation (Section 2.4), and other contributors to sleepiness (Section 2.5). Section 
2.6 provides a summary of the literature reviewed and explains the corresponding 
implications for the current research program. 
 
2.1 MECHANISMS AND MODELS OF HUMAN SLEEP/WAKE 
REGULATION  
Sleep is a state driven by a biological rhythm that is synchronized to the solar day, 
and responds to a need for recovery or recuperation (Beersma, D. G. M., 1998; 
Borbély, 1982).  Sleep can be characterized by its period (length of rhythm), phase 
(timing of rhythm), and amplitude (magnitude of rhythm).  The alternation between 
sleep and wake is driven by a very complex neurobiology (Van Dongen & Dinges, 
2005). Two primary factors appear to be vital for modulating sleepiness and alertness 
at any point of time; the homeostatic and circadian drives that interact but originate 
from distinct brain mechanisms and neurotransmitter systems. 
The circadian process is mediated by circadian pacemakers in the suprachiasmatic 
nucleus (SCN) of the anterior hypo-thalamus (Cluydts et al., 2002; Moore, 2006). 
The circadian pacemaker is actually a web of oscillator neurons which receives light-
dark information from the inner retina of the eye via photoreceptor peptides, 
melanopsin (Moore, 2006). Melanopsin contributes to the light response of 
intrinsically photosensitive retinal ganglion cells (ipRGCs) in the retina (Zele, Feigl, 
Smith, & Markwell, 2011). The ipRGCs are maximally sensitive to the ‘blue’ range 
of visible light, that is, light with wavelength around 460-480 nm (Appleman, 
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Figueiro, & Rea, 2013; Gooley et al., 2010; Lockley et al., 2006; Münch, Linhart, 
Borisuit, Jaeggi, & Scartezzini, 2012; Postolache & Oren, 2005; Revell et al., 2006; 
Stephenson et al., 2012; Zele et al., 2011). Light passes through the ganglion cell 
layer before reaching the rods (R) and cones (C), and elicits an intrinsic response in 
the IpRGCs (Figure 2.1). Additional light (indirect input) information is transferred 
from rods and cones to the ganglion cells (G) via the second-order bipolar cells (B) 
and complements the initial intrinsic response of IpRGCs (Vandewalle et al., 2009). 
That is, while the IpRGC’s are non-image-forming cells, they also transduce light 





Figure 2.1. Mechanism of non-visual effects of light including circadian rhythm of 
sleep-wake regulation, ‘A’ depicts retinal cells (adopted from Vandewalle et al., 
2009).  
 
Light information is transferred to the brain via the optic nerve and directly or 
indirectly innervates a range of neural sites associated with sleep-wake regulation 
including hypothalamic nuclei such as the supreachiasmatic nuclei (SCN; including 
the central circadian pacemaker), the ventro-lateral preoptic nucleus (VLPO), which 
contains sleep active neurons, the lateral hypothalamic area (LH) which regulates 
wakefulness, the olivary pretectal nuclei (OPN) involved in pupillary constriction 
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(and therefore the pupillary light response), the amygdala (MA) involved in emotion 
regulation, as well as areas typically involved in vision such as the thalamic lateral 
geniculate nuclei (LGv/d), and the brainstem superior colliculus (SC) (Vandewalle et 




Figure 2.2. Non-visual pathways of light in the brain of male Sprague Dawley rats in 
cross section, (adopted from Gronfier, 2013). The sagittal section, the bulb at the 
front is the eyeball. 
 
The homeostatic process however, is neither primarily modulated by time of day, nor 
by a single locus in the CNS, but reflects a cumulative process that increases with 
wake time, and involves several distinct but interacting neural systems such as 
monoamine, neuropeptide, and cytokine transmitters in the hypothalamus, basal 
forebrain, and brain stem nuclei (Toppila & Porkka-Heiskanen, 1999). As an 
example, in the basal forebrain, homeostatic processes are mediated by a progressive 
increase in adenosine levels after prolonged wakefulness, and by slow decrease 
during recovery sleep (Cluydts et al., 2002; Porkka-Heiskanen et al., 1997).  
A number of sleep regulation models have been developed to summarise 
observations of sleep processes. These models do not generally concentrate on 
sleepiness, but more on the dynamics of sleep-wake regulation. The basic 
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quantitative model of human sleep regulation, known as the ‘two-process’ model of 
sleep regulation, was proposed by Borbély (1982). Other models have also been 
developed by adding to or refining the two-process model, including the ultradian 
model, the three-process model of alertness regulation (Folkard & Åkerstedt, 1987), 
the two opponent-process model (Edgar, Dement, & Fuller, 1993), and the four-
process model of sleep-wake (Johns, Murray, 1998). These models each describe the 
basis of sleepiness and alertness in different ways, and are discussed in more detail as 
follows. 
 
2.1.1 The two-process model of human sleep regulation 
Two-process model delineates the processes involved in sleep-wake and stipulates 
that the timing of the alternation between human sleep and wake is regulated by an 
interaction between a circadian process and a homeostatic process (Bonnet, M.H & 
Arand, 1999; Cluydts et al., 2002).  
The term circadian refers to a near-24-hour cycle (Van Dongen & Dinges, 2005). 
The circadian process, in this group of models termed process C, is basically a clock-
like mechanism and is conceived as largely independent of prior sleep and wake. The 
relative phase position and skewed sine-wave shape of the circadian process in this 
model was initially derived from sleep duration data obtained at different times of 
day and night (Borbély & Achermann, 1992). The circadian process regulates the 
appropriate timing of sleep (Toppila & Porkka-Heiskanen, 1999), and seeks to 
constrain adult human wakefulness to the daytime hours, and sleep during the night 
time hours (Van Dongen & Dinges, 2005). The daily variations in the circadian 
process are exhibited in Figure 2.3 (left panel). 
The homeostatic process, also known as process S, refers to a build-up of 
homeostatic pressure (sleep propensity) for sleep during periods of wakefulness 
(Philip et al., 2005(a); Van Dongen & Dinges, 2005). The model suggests that the 
homeostatic pressure to sleep rises in a monotonically saturating way during 
wakefulness, over a period of about 18 hours, and then declines exponentially during 
subsequent sleep (Beersma, D. G., Daan, & Dijk, 1987; Borbély, 1982). Process S 
depends on the amount of prior wake and/or prior sleep, and accounts for the 
‘sufficiency’ of sleep (Toppila & Porkka-Heiskanen, 1999). As prior wake time 
35 
 
increases, and prior sleep time decreases, process S strengthens (Cluydts et al., 
2002). In addition to regulation of the time spent awake and asleep, this process acts 
to consolidate sleep towards the end of the sleep episode, and influences the 
distribution of sleep stages within the sleep episode (Duffy, Zeitzer, & Czeisler, 
2007). The time-course of the homeostatic process has been principally derived from 
power in slow-wave EEG frequencies delta (Achermann & Borbély, 1998; Borb & 
Achermann, 1999), and theta activity (Borbély & Achermann, 1992; Ferrara & De 
Gennaro, 2011). Based on the initial and final levels of process S during both normal 
sleep and recovery sleep after sleep loss, this model also suggests that during a 
daytime nap the homeostatic process decreases, hence slow wave activity declines in 
subsequent night time sleep (Borbély & Achermann, 1992). Figure 2.3 (left panel) 
shows the daily variations in the homeostatic process. 
The two-process model assumes that the timing of sleep-wake cycle is determined by 
an interaction between the homeostatic process and circadian process, such that the 
intersection of these two processes results in sleep or wake onset (Natesan, Cho, & 
Koshida, 2006), and non-linear variations in sleepiness across the day (Philip et al., 
2005(a)). The net effect of this interaction is a sustained period of wakefulness during 
the day. At night before falling asleep, circadian pressure for wakefulness gradually 
withdraws, whereas the homeostatic pressure for sleep continues to accumulate. 
Consequently, there is an increase in sleep propensity, and sleep is more likely to 
occur (Van Dongen & Dinges, 2005). Figure 2.3 (right panel) demonstrates the 







   
Figure 2.3. The homeostatic and circadian processes of sleep and their interaction; 
Left panel shows homeostatic and circadian processes during wake (W) and sleep 
(S), (adopted from Borbély & Achermann, 1992). Right panel shows the interaction 
of two processes. Process S rises during waking (white bars) and declines during 
sleep (black bars), (adopted from Achermann & Borbély, 1990). 
 
A variety of experiments have been undertaken to test the assumptions of the two-
process model. For instance, Åkerstedt (1986) confirmed the independency of 
homeostatic and circadian processes, as was assumed in the original model, by 
utilizing bright light to shift the circadian phase of process C without changing the 
time course of process S (determined by Slow Wave Activity, SWA).  The saturating 
function describing the increase in homeostatic pressure during wake time has also 
been confirmed by examining the time course of SWA during daytime naps after 
different waking times (Beersma, D. G. et al., 1987; Dijk, Beersma, & Daan, 1987) 
or during long sleep periods (Dijk, Brunner, & Borbély, 1990b). The decrease of 
SWA during sleep after daytime naps has been confirmed by Feinberg, et al.(1985),  
Daan, et al. (1988) and Knowles, et al. (1990) The observations of an increased SWA 
during daytime naps following one night partial sleep loss (Åkerstedt & Gillberg, 
1986; Gillberg & Åkerstedt, 1991) supports the assumption of the model that 
shortening sleep strengthens the SWA during subsequent sleep periods.   
Although the two process model has been most often adopted to predict the effects of 
acute sleep loss, it has also been used to predict SWA after chronic sleep loss.  
Brunner et al. (1990) reported that two nights of sleep restricted to the first 4 hours of 
the habitual bedtime period (without decreasing SWA) only induced a minor increase 
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in SWA during recovery sleep. The two-process model accurately predicted these 
findings.  
 
2.1.2 The ultradian process during sleep 
An ultradian rhythm of sleep (that is, cyclic rhythms within the NREM-REM cycle) 
was initially recognized by Dement and Kleitman (1957). However, Achermann 
(1990; 1993) elaborated the two-process model and included the regulation of 
NREM and REM sleep by “ultradian process”. Using this model, it is possible to 
predict the time course of SWA during normal sleep, and after manipulations of 
sleep such as partial sleep loss, after selective slow wave sleep loss, after a daytime 
nap, during prolonged sleep period, or during prolonged wakefulness (Achermann & 
Borbély, 1990; Borb & Achermann, 1999; Borbély & Achermann, 1992). 
Furthermore, the interaction of circadian and homeostatic processes in this model 
could predict timing of sleep-wake transitions as well as timing of daytime alertness 
(Borb & Achermann, 1999). 
Based on predictions from the ultradian model some researchers sought to examine 
the effect of selective sleep loss on human daytime performance. Findings of forced 
desynchrony (FD) protocols showed that no manipulations of Stage 1, Stage 2, or 
SWA sleep could elicit impairment in human cognitive performance when measured 
by a 5-min serial addition and subtraction (SAS) task and a digit symbol substitution 
(DSS) task. In contrast, specific reductions in REM sleep duration were associated 
with a poorer waking performance (Darwent et al., 2010). These findings imply that 
cognitive performance may be more sensitive to a reduction, disruption or restriction 
of REM sleep (a sleep architecture state more likely to occur later in the sleep 
episode) than from disruption of NREM/SWS sleep. The ultradian model identifies 
the importance of the type of sleep loss in manipulation of sleep. This has direct 
implications for the methodologies used in studies that restrict sleep. For example, 
sleep loss exerted by awakening participants earlier in the morning might impact on 
REM sleep duration, in contrast to extension of wake (staying up later) that might 




2.1.3 The three-process model of alertness  
This model was first introduced by Folkard & Åkerstedt (1987) to predict variations 
in alertness due to irregular sleep/wake patterns (Åkerstedt & Folkard, 1997). A third 
factor (process W) was added to the other two components (circadian and 
homeostatic processes) of the original two-process model (Figure 2.4). This 
additional process is known as sleep inertia, which is observed as a drop in alertness 
experienced immediately after awakening, and for up to a few hours thereafter 
(Åkerstedt & Folkard, 1995(b); Cluydts et al., 2002).  In this model S + C represents 
the predicted alertness during 24 hours wakefulness (i.e. one night total sleep loss). 
This condition induces a decline of alertness during the night, with a trough in the 
early morning. 
 
   
 
Figure 2.4. Parameters of the three-process model of alertness regulation; C = 
circadian component; S = homeostatic component; W = sleep inertia component 
(adopted from Åkerstedt, Gillberg, & Folkard, 1992). 
 
The outputs of this model, measured by changes in objective and subjective alertness 
due to altered sleep/wake patterns, have been validated against subjective sleepiness 
ratings (predominantly the Karolinska Sleepiness Scale, KSS), and EOG slow eye 
movements and alpha (α; 8-12 Hz) power density (Åkerstedt & Folkard, 1995(b)). 
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Comparison of the alertness scale (levels ranging from 1 to 16) and KSS scale 
revealed that there is some correspondence between the predicted performance and 
self-rated alertness (Åkerstedt & Folkard, 1995(b)). 
However, this original model was based on circumstances of acute sleep loss (e.g. 
one full night without sleep), and could not predict the effects of chronic partial sleep 
loss (a number of nights of restricted sleep) because of the high steepness of the 
modelled recovery function (Åkerstedt & Folkard, 1995(b)). In this model, at sleep 
onset, process S is reversed (called S′) and recovery occurs in an exponential rate 
such that, total recovery is usually accomplished in 8 hours. This steepness increases 
with increasing sleep loss, hence resulting in a rapid and unreasonable prediction of 
the recovery (Åkerstedt, Ingre, Kecklund, Folkard, & Axelsson, 2008). 
Åkerstedt & Folkard (1996(b)) elaborated this model by changing the exponential rise 
of S′ to a slower linear one, and published an alertness nomogram that describes the 
predicted alertness under conditions of chronic partial sleep loss. Although, this 
modified model exhibited a slow increase in sleepiness due to partial sleep loss and a 
slow decrease in sleepiness during the recovery days, it could not accurately describe 
the mechanisms behind the sleepiness. In this model a transitional state of lowered 
alertness upon awaking from sleep, termed process W, was introduced. Process W is 
related to the circadian and homeostatic processes and has been found to induce a 
detrimental effect on cognition up to 4 h after awakening depending on prior sleep 
duration (Cajochen, C., 2007). The three-process model has been also used to predict 
group means for duration of sleep (Åkerstedt & Folkard, 1996(a)) and to predict sleep 
latency associated with irregular sleep/wake patterns (Åkerstedt & Folkard, 1996(b)). 
The two and the three-process models of sleepiness-alertness share some common 
shortcomings: firstly, these models of sleep propensity are based on data drawn from 
studies of acute total sleep loss (Åkerstedt et al., 2008), hence there is not much 
evidence to support these models for prediction of the effects of accumulated 
sleepiness due to chronic partial sleep loss (Van Dongen, 2004(a)).  Secondly, the 
contribution of factors other than the model parameters to sleepiness is obvious. 
These include the influence of ultradian rhythms, which provoke afternoon 
sleepiness (Cluydts et al., 2002), environmental factors (including light), stress, sleep 
disorders, drugs (including both stimulants and sedatives), and general health status 
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(Åkerstedt & Folkard, 1995(b)). Thirdly, these models have been validated against 
group data, and generally are not able to predict individual-level effects (Åkerstedt & 
Folkard, 1995(b); Cluydts et al., 2002). Fourthly, although in these models the effect 
of contributing factors of sleepiness, processes S and C, seems plausible, the relative 
importance of each factor is not clear. In other words, the primary factor with the 
most decisive role has not been specified. There is some evidence that, under normal 
conditions, the circadian process has a more fundamental effect than does the 
homeostatic influence, but that the homeostatic process becomes more important in 
sleep-deprived conditions (Cluydts et al., 2002). Finally, these models exclusively 
emphasize the drive to sleep whereas there appears to be an important corollary role 
for the drive to wake (Cluydts et al., 2002).  
 
2.1.4 The two opponent processes of sleep–wake regulation 
The two opponent process of sleep-wake regulation contradicts the assumption of the 
independency of homeostatic and circadian drives described in the two-process 
model. The idea of two-opponent sleep-wake regulation was first stated by Edgar et 
al. (1993) when they found that disruption of the SCN in monkeys caused disruption 
of the circadian timing of sleep, increased duration of sleep, and decreased wake 
duration. These findings contradicted the prediction of the two-process model of 
sleep regulation about the independency of the homeostatic process and overall sleep 
duration from the circadian process (Schwartz & Roth, 2008).  
According to the two-opponent process model of sleep regulation, sleep and wake 
are not a simple continuum, but are competing states. The circadian process 
promotes waking by controlling the timing of the sleep-wake cycle and the offset of 
sleep.  Therefore, the circadian process opposes the homeostatic process which 
promotes sleep. In this model, circadian oscillations originate from SCN-dependent 
mechanisms and comprise part of the sleep drive. In contrast, the conventional two- 
process model assumes that circadian processes control sleep propensity to determine 




2.1.5 The four-process model of sleep and wakefulness 
Johns (1998) incorporated wake drive into the two-opponent model and named it the 
‘four-process model of sleep and wakefulness’. In this model Johns proposed that the 
relative strength, rather than the absolute strength of wake and sleep drives controls 
falling asleep, sleepiness, hypo-vigilance, and the physiological signs of sleepiness 
(Cluydts et al., 2002; Johns, Murray, 1998). Moreover, Johns emphasized the 
importance of sleep-inducing effects of environmental contributors to the wake drive, 
contributions that had been largely ignored previously (Cluydts et al., 2002). In this 
model, the primary components subserving the sleep and wake drives originate from 
different neuronal groups within the central nervous system and are defined as 
follows: 
1. The primary wake drive corresponds to process C in the two-process 
model. This is an intrinsic circadian rhythm, generated in the central 
nervous system, which ordinarily peaks at 7 to 9 p.m. and drops at 4 to 5 
am in ‘normal’ night sleepers. Environmental and behavioural factors can 
shift the phase of the circadian rhythm, and change the levels of circadian 
indicators such as core temperature, cortisol secretion, melatonin secretion, 
and REM sleep.  
2. The secondary wake drive mainly originates from postural factors such as 
movement and position of muscles, joints, and other factors such as audio-
visual inputs. This secondary wake drive can be controlled voluntarily. 
3. The primary sleep drive originates from intrinsic activity in various 
neuronal centres promoting NREM sleep with maximum activity between 
10 p.m. and midnight. This drive is associated with the secretion of thyroid 
stimulating hormone, and could explain the reappearance of delta-waves in 
the latter part of sleep or inter-individual difference in delta-wave activity. 
4. The secondary sleep drive corresponds to process S (in the two-process 
model) with a progressive rise during wakefulness and a drop during 
NREM sleep. 
The four-process model suggests a way to combine the disparate aspects of the three-
process model and the two opponent processes model, and incorporates a role for 
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exogenous factors. However, this ‘model’ has not been explicitly tested against data, 
and has no computational form (i.e. it exists as a schematic only). 
 
2.2 ALERTNESS 
Alertness is part of the attention system. Posner & Petersen (1990) proposed a three- 
network model for the attention system. This system comprises three specialized 
neural networks of alerting, orienting and executive control.  The alerting network 
refers to two components of phasic and tonic alertness. In the alerting network, 
phasic alertness is defined as activation of the cognitive system and increased 
readiness to response to an external stimulus, while tonic alertness (also known as 
intrinsic alertness, vigilance, or sustained attention) refers to the maintenance of 
activity of the cognitive system (wakefulness and arousal). In this thesis the term 
“alertness” refers to tonic alertness. The orienting network refers to the selection of 
information from numerous sensory inputs. This selective function directs attention 
towards a visual area or object. Finally, an executive control function is associated 
with more complex mental activities while detecting and resolving conﬂicts between 
computations in the brain (Fan et al., 2009; Martella et al., 2011; Posner, Michael I & 
Fan, 2004; Posner, Michael I. & Petersen, 1990).   
Alertness and sleepiness are strongly correlated with each other so that different 
aspects of attention have been measured by some correlates of sleepiness including 
1) different subjective sleepiness scales; 2) physiologic correlates of sleepiness (e.g., 
electroencephalogram EEG, sleep latencies, pupillometric parameters); and 3) 
cognitive performance tests (Kraemer et al., 2000).  Despite this physiological and 
functional interplay between mechanisms of sleep-wake and those of alertness, 
sleepiness and alertness are not reciprocal constructs (Moller, Devins, Shen, & 
Shapiro, 2006). There is not a straightforward slope from one to the other instead 
there is a lurch in the variation of alertness. The time-of-day variation in tonic 
alertness has a close relationship with the circadian rhythm as observed in core body 
temperature. The circadian rhythm of alertness is a normal physiological 
phenomenon, but it may have a synergistic effect on sleepiness during certain times 
of day (Vakulin et al., 2007; Vandewalle et al., 2009; Weeb et al., 1998). Figure 2.5 
shows the time-of-day alterations of sleepiness and alertness. The alertness level is 
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typically highest at two times of the day - around 10 a.m. and 9 p.m.  There are two 
main periods of decreased alertness; in the early morning at the minimum core body 
temperature (the temperature nadir) when circadian drive for sleep is greatest 
(Cluydts et al., 2002), usually between 1 and 6 a.m. (Campagne et al., 2004; Lenné, 
M. G, Triggs, & et al., 1997; Lowden et al., 2009; Otmani, Pebayle, Roge, & Muzet, 
2005; Reimer, D'Ambrosio, & Coughlin, 2007), and again between 1 and 4 p.m. 
(Campagne et al., 2004; Lenné, M. G et al., 1997; Otmani et al., 2005) because of 




Figure 2.5. Circadian rhythm of sleepiness and alertness (adopted from Shahali & 
Amirabadi Farahani, 2013). 
 
Apart from the circadian rhythm of alertness, sleep deprivation causes instability in 
alertness. Of all the components of the attention system, tonic alertness (vigilance) is 
the component most sensitive to sleep deprivation (Lim & Dinges, 2008). Acute total 
sleep loss could reduce brain activity, particularly in the cortico-thalamic networks 
involved in cognitive performance and alertness (Thomas et al., 2000). Extended 
wake times of more than 16 hours (providing high homeostatic sleep pressure), and 
sleep inertia (i.e. upon awaking from sleep) also impair human alertness (Cajochen, 
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C., 2007). Chronic partial sleep deprivation leads to cumulative performance deficits 
similar to those observed after total sleep deprivation (Van Dongen & Dinges, 2005).  
Before moving to the effects of sleep loss on indicators of sleepiness and alertness, it 
is necessary to understand characteristics of human alertness in various states of 
wake, sleepiness, and sleep. 
 
2.3 CHARACTERISTICS OF HUMAN STATES OF ALERTNESS  
Variations in brain activity reflect various states of alertness from wake to sleepiness 
or to sleep. In the human brain a complex interaction between cortical neurons and 
sub cortical ‘pacemakers’ underlies synchronization of postsynaptic potentials and 
hence rhythmic activity (Tononi, 2004). The Electroencephalogram (EEG) represents 
variations in the accumulation of postsynaptic potentials of cortical nerve cells 
measured at the scalp via electrodes (Olejniczak, 2006). The EEG is known to be one 
of the most predictive and reliable physiological indicators of sleepiness and 
alertness, and can reflect various states of brain activity from alert to sleepy, to being 
fast asleep. In fact, the EEG is often regarded as the “gold standard” to identify these 
states of arousal (Cluydts et al., 2002; Johnson et al., 2011; Lal & Craig, 2001(b); 
Papadelis et al., 2007). The periodic rhythms in EEG are conventionally described by 
their frequency (Hz or cycles/sec) and their amplitude (μV, microvolts). 
A range of EEG frequencies from 0.3 Hz to 70 Hz, have been measured in 
psychophysiological studies (Niedermeyer, 2005). Sleep-related EEG activity is 
typically observed between 0.1 and 30 Hz (Colrain, 2011). Four frequency 
components are conventionally obtained from EEG recordings, because they can be 
visually determined from the electroencephalogram and because they correspond to 
shifts in underlying brain state; delta (δ; 0-4 Hz, 20-200 μV), theta (θ; 4– 8 Hz, 10 
μV), alpha (α; 8–13 Hz, 20-200 μV), and beta (β; 13–30 Hz, 5-10 μV) (Colrain, 
2011; Jap, Lal, Fischer, & Bekiaris, 2009; Lal & Craig, 2001(a); Niedermeyer, 2005). 
Of these frequency bands, alpha and beta are known as ‘fast wave’ activities, while 
theta and delta are ‘slow wave’ activities (SWA) (Colrain, 2011; Lal & Craig, 
2001(a)). Alpha EEG is recognized in the electroencephalogram as a rounded or 
sinusoidal wave with amplitude of less than 50 microvolt which occur predominantly 
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over the posterior regions (occipital cortex) of the scalp during relaxed wakefulness 
and during early sleep onset (Berger, 1929; Lal & Craig, 2001(b); Niedermeyer, 
2005). The EEG beta is associated with increased alertness and arousal (Eoh, Chung, 
& Kim, 2005), and attenuates during sleepiness (Jap et al., 2009; Lal & Craig, 
2001(a)). The EEG sigma band, in the range of alpha and beta activities, is an 
additional band representing the discrete EEG morphology known as sleep spindles 
(Colrain, 2011). Sleep spindles are defined as a group of rhythmic waves in the 12–
14 Hz range that progressively ‘grow’ in amplitude before gradually decreasing in 
amplitude (a waxing and waning of the amplitudes) across a period of 0.5 to 3 s (De 
Gennaro & Ferrara, 2003; Dijk, 1995; Himanen, Virkkala, Huhtala, & Hasan, 2002). 
The K-Complex wave, a very distinctive negative sharp waveform followed by a 
positive wave for total duration of more than 0.5 s, is another discrete EEG feature 
indicative of sleep onset (De Gennaro & Ferrara, 2003).  
The EEG frequencies change from low amplitude high frequency activity to high 
amplitude low frequency activity during progression from wakefulness to deep sleep. 
In other words, EEG follows a characteristic progression from alpha to theta, K 
complexes, spindles and slow-wave activity (SWA) respectively. EEG frequencies 
are presented in Figure 2.6. This progression is mostly about “Sleep EEG” with less 
known about the distinct features of “Wake EEG” associated with increasing (or 
decreasing) sleepiness in the same way as Sleep EEG. The wake EEG spectrum 








 Figure 2.6. EEG frequencies (adopted from McGrath, 2010) . 
 
The interpretation of the EEG spectrum is conventionally conducted by two methods; 
visual scoring (typically used in clinical diagnostic environments) and spectral 
analysis.  
The first application of visual scoring of polysomnography (PSG; simultaneous 
measurement of electroencephalogram, electro-oculogram and electromyogram) to 
identify sleep states dates back to the 1930s (Silber et al., 2007). The current method 
of visual scoring (R&K), was published by Rechtschaffen & Kales (1968) to 
interpret human EEG sleep. Since then the R&K visual scoring criteria have been 
extensively used in sleep research as the standard classification of the arousal states 
that differentiate from wake from sleep, and differentiate the stages within sleep. 
According to the original R&K method, the major ‘stages’ of sleep include 
wakefulness, Non Rapid Eye Movement (NREM) sleep and Rapid Eye Movement 
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Sleep (REM).  NREM sleep includes four sleep stages (1, 2, 3, and 4), while REM 
sleep comprises tonic REM and phasic REM states.  In 2004, the American Academy 
of Sleep Medicine (AASM) commissioned the AASM Visual Scoring Task Force to 
review the R&K scoring system. This review resulted in several changes. As an 
example, the AASM renamed Stage 1 as N1, Stage 2 as N2, Stages 3 and 4 as N3 
and REM sleep as R. The most significant change was the combination of Stages 3 
and 4 into Stage N3 (these two stages were previously differentiated only by the 
proportion of observed ‘slow waves’ within each 30 s epoch of sleep). The revised 
scoring was published in 2007 as The AASM Manual for the Scoring of Sleep and 
Associated Events (Colrain, 2011; Iber, Ancoli-Israel, Chesson, & Quan, 2007). 
Visual scoring of the EEG depends strongly on the personal experience, training and 
calibration of the scorer (with typically poor inter-rater and within-rate reliability) 
and is also time-consuming.  
The R&K and the AASM visual scoring systems have both been developed for 
clinical purposes to characterize human wakefulness and sleep. However, both 
systems have important conceptual gaps in terms of characterizing sleep onset. In 
particular, this approach poorly characterizes the transition from wakefulness, to 
drowsiness, and then to sleep (the sleep onset period).   
Power spectral analysis (PSA) is an alternative quantitative approach to the 
description and interpretation of EEG data. This method is based on signal 
processing approaches (Welch, 1967). The Fast Fourier Transform (FFT) identifies 
signal amplitude for each frequency during 30 s epochs and quantifies the overall 
power trends in the EEG data (Ktonas & Gosalia, 1981). Using FFT the absolute 
power (μV2), relative power (%), and mean frequency (Hz) within each frequency 
component in a given time domain (30 s epochs) can be determined. The absolute 
power of an EEG frequency band is the integral of all of the power values within its 
frequency range, while the relative power (RP) is the percentage of the absolute 
power in each frequency band relative to the sum of absolute powers of the four 
frequency bands (Yuvaraj et al., 2014). The different stages of sleep have been 





NREM sleep typically comprises 75-80% of the total sleep time of healthy sleepers 
(with some changes in proportion across the lifespan). Stage 2 comprises 45-60% of 
the total sleep time, and typically starts after 10-12 min of Stage 1 sleep. During 
Stage 2 (N2) the maximum spindle frequency activity (SFA), power has been 
observed in 12-15 Hz which may intermittently co-appear with K-complex waves 
(De Gennaro & Ferrara, 2003). Small numbers of delta waves (0.5-4 Hz) may appear 
in the EEG, but eye movements (EOG) and muscle activity (EOG) decline (Natesan 
et al., 2006).  
Stages 3 and 4 (N3), also known as delta sleep, slow wave sleep (SWS), or deep 
sleep, account for 15-20% of total sleep time (Natesan et al., 2006). Increased power 
density in the delta frequency, often known as slow wave activity (SWA), is a 
prominent feature of slow wave sleep (Dijk, 1995; Lal & Craig, 2001(b)).  SWA, 
known as a hallmark of sleep intensity (Achermann & Borbély, 1998; Kecklund & 
ÅKerstedt, 1992), has a homeostatic regulation (Aeschbach & Borbely, 1993; 
Colrain, 2011; Ferrara & De Gennaro, 2011). 
Rapid Eye Movement (REM) sleep compromises 20-25% of sleep duration 
(Aeschbach & Borbely, 1993; Natesan et al., 2006; Rosenthal, 2006).The first REM 
sleep typically starts 60-90 min after onset of NREM sleep (Natesan et al., 2006; 
Rosenthal, 2006), with cyclic episodes of REM sleep becoming more frequent later 
in the sleep period. Differentiating human Stage 1 sleep from REM sleep can be 
difficult due to similar amplitudes of occipital alpha power in the EEG during both 
sleep states (15–20 µV) (Cantero & Atienza, 2000). However, during REM sleep 
alpha activity in frequencies from 7.8 to 8.6 Hz yields higher power values and beta 
activity is lower as opposed to wakefulness and Stage 1 sleep (Cantero & Atienza, 
2000; Jap et al., 2009). Figure 2.7 illustrates the EEG during different sleep stages. 
Characteristics of these sleep stages as defined by the two standard methods (R&K 






Figure 2.7. Human arousal states from awake to REM sleep (adopted from Ternopil 












Table 2.1 Comparison of characteristics of sleep stages as defined by two standard methods proposed by Rechtschaffen and Kales and AASM 
Sleep scoring 
method 
Sleep/wake stage EEG EOG 





Alpha activity (8-13 Hz) and/or a mixed frequency activity with low 
voltage 
 
Rapid eye movement and 






Diminished alpha activity, appearance of low voltage mixed 




AASM N1 Intrusion of theta rhythm into an EEG epoch 
 





Appearance of sleep spindles and K-complexes. Occasional 
appearance of delta waves (0.5-4 Hz)  
 
Lack of SEMs 





Slow wave sleep 
(SWS) 
NREM sleep Stage3: 
Moderate amount (> 20% but < 50% of a 30 s period) of high 
amplitude (> 75 microwatts), slow wave activity (0.5-2 Hz) 
 
Lack of SEMs 
NREM sleep Stage 4: 
Large amount (> 50% of 30 s period) of high amplitude (> 75 
microwatts), slow wave activity (0.5-2 Hz) 













Desynchronized EEG (Low-voltage, mixed frequency activity with 
slow alpha, 1-2 Hz less than alpha activity in wakefulness) with small 




Low-voltage, mixed frequency activity with slow alpha (1-2 Hz less 
than alpha activity in wakefulness) and theta 
 
Fast eye movement in all 
directions 
AASM R Mixed frequency, theta and beta EEG activity Rapid eye movements 
 




Wake is an arousal state associated with desynchronized low voltage mixed 
frequency (predominantly beta) activity and synchronized alpha activity (8-13 Hz), 
rapid eye movement and blinks, and high muscle tonus levels (Colrain, 2011; 
Natesan et al., 2006; Rosenthal, 2006). Alpha activity varies during wakefulness 
among well-rested individuals, and between eyes open or eyes closed conditions. 
During resting wakefulness with eyes closed, alpha typically shows higher activity 
while during active wakefulness with eyes open and resting position, alpha usually 
shows low levels of activity (Cote, Milner, Osip, Baker, & Cuthbert, 2008; Ferreira 
et al., 2006). 
 
2.3.3 Sleepiness 
The conventional ‘stages’ of sleep (described above) are not always necessary, nor 
sufficient, to describe the state or presence of sleepiness (Eoh et al., 2005; Lal & 
Craig, 2001(b)). Sleepiness is mostly induced by conditions such as sleep loss, 
delayed or advanced bedtime (circadian disturbance or circadian desynchrony), sleep 
fragmentation (Otmani et al., 2005), variations in sleep quality, individual state and 
trait differences in sleep propensity, together with interacting factors that impact on 
arousal such as alcohol, drugs and other medication (Lowden et al., 2009). 
Sleepiness, at one extreme, can correspond to the onset of Stage 1 sleep. Stage 1 
comprises 3-8% of overall sleep time and mostly occurs during the transition from 
wakefulness to NREM sleep, and sometimes during transitions from arousals to other 
stages of sleep (Natesan et al., 2006; Rosenthal, 2006).  These transitions are not as 
gradual as perceived subjectively (Trinder, J, Waloszek, Woods, & Jordan, 2012). 
Characteristics of Stage 1 are repeated alternation between alpha activity (relaxed 
wakefulness) and low voltage mixed frequency activity with the highest activity in 
theta frequencies (4-8 Hz) indicative of early sleep onset (Gora, Colrain, & Trinder, 
1999), the occurrence of slow rolling eye movements, the reduction in tonic EMG, 
the appearance of vertex sharp waves (50-200 milliseconds) at the end of Stage 1 
(Natesan et al., 2006; Rosenthal, 2006), and finally the emergence of sleep spindles 
which initially are accompanied by vertex waves (Yeo, Li, & Wilder-Smith, 2007). 
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There are some inconsistencies in the description of alpha activity during sleepiness 
between researchers. Various studies have found that in the early sleepiness state 
alpha activity increases when compared with the lower alpha activity observed 
during alert wakefulness with the participant’s eyes open (Åkerstedt & Gillberg, 
1990; Eoh et al., 2005; Liu, Hosking, & Lenné, 2009; Niedermeyer, 2005; Otmani et 
al., 2005; Torsvall & ÅKerstedt, 1987). Lal & Craig (2001(a)) reported that, at the 
beginning of sleepiness, alpha rhythm may attenuate for a few seconds, reappear 
again, and continue this fluctuation for a few minutes until these ‘trains’ of alpha 
waves finally disappear. In contrast, Santamaria (1987) and Jap (2009) reported a 
decrease in the amplitude of the occipital alpha rhythm. In spite of these 
discrepancies, it is generally believed that sleepiness is characterized by the 
disappearance of alpha activity (Lal & Craig, 2001(b)). 
Theta activity, observed as distinctly slower EEG waves, provides another index of 
vigilance level in the waking electroencephalography similar to alpha activity 
(Campagne et al., 2004). The EEG theta activity can occur during a variety of mental 
states including sleep onset (Lal & Craig, 2001(b)), and Stage 1 sleep (Eoh et al., 
2005). Progressive increase in spectral power in the theta frequency band is related to 
the presence of sleepiness (Åkerstedt & Gillberg, 1990; Lal & Craig, 2001(b); Otmani 
et al., 2005). However, Liu et al. (2009), were of the opinion that theta activity is 
associated only with more ‘severe’ sleepiness. Increments of theta also correlate with 
some deficits in subjective sleepiness and alertness such as impaired concentration, 
distracted thoughts, and longer lapses (Orzeł-Gryglewska, 2010). 
Vertex sharp waves are unique to sleepiness and appear at the end of Stage 1 and the 
beginning of Stage 2 sleep, either as an isolated phasic event or as repetitive sharp 
waves (De Gennaro & Ferrara, 2003; Yeo et al., 2007). Vertex sharp waves are 
indicators of inhibitory mechanisms preventing the processing of sensory stimuli 
during sleep onset (Peszka & Harsh, 2002), and facilitate the initiation and 
maintenance of sleep (Yeo et al., 2007).  
Some researchers have introduced different staging criteria to describe sleepiness. 
Santamaria & Chiappa (1987) classified the EEG of sleepiness into four distinct 
phases as follows: 
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1. A transitional phase: between awake and absence of alpha, this 
phase contains microsleeps (Lal & Craig, 2002),  
2. A combination of transitional and post-transitional phases, with 
characteristics of either transitional or post-transitional phases, 
3. A post-transitional phase (immediate EEG epochs after 
disappearance of alpha, early Stage 1 of sleep, this phase contains 
microsleeps as well (Lal & Craig, 2002),  
4. An arousal phase (awakening from sleepiness).  
Hori et al. (1991; 2001) and Tanaka et al. (1996) followed this classification with the 
introduction of a broader concept known as the sleep onset period (SOP). The SOP 
refers to the transition phase from sleepy wakefulness (sleepiness) to unresponsive 
sleep. In this understanding, the SOP contains the whole Stage1 sleep, but overlaps 
into both wakefulness and Stage 2 sleep by R&K criteria (Tanaka, H, Hayashi, & 
Hori, 2000; Yeo et al., 2007). The classification of different stages of SOP is shown 
in Table 2.2. The EEG Stages 1 and 2 in this classification are equivalent to Stage W 
(wakefulness) in R&K criteria.  The EEG stages 3 to 8 correspond to Stage 1 sleep 
and EEG stage 9 in this classification is equivalent to Stage 2 sleep in the R&K 
criteria.  The latter researchers also defined some new criteria to identify EEG stages 






Table 2.2 Characteristics of different stages of sleep onset period (Tanaka, H et al., 2000) 
Stage of sleepiness  Characteristics 
EEG stage1(alpha wave train) Appearance of a chain of alpha activity with amplitude of 20 *µV 
EEG stage 2 (alpha wave 
intermittent,  A) 
Attenuation of alpha to a train comprising at least 50% alpha activity with a minimal amplitude of 
20 µV 
EEG stage 3 (alpha wave 
intermittent, B) 
Progressive alpha attenuation to a train comprising less than 50% alpha activity with minimal 
amplitude of 20 µV 
EEG stage 4 (EEG flattening) Progressive suppression of  alpha activity even at amplitudes less than 20 µV 
EEG stage 5 (Ripples) Suppression of low voltage theta wave burst, between 20 µV and 50 µV in the absence of vertex 
sharp wave 
EEG stage 6 (Vertex sharp wave 
solitary) 
Appearance of the first well-defined vertex sharp wave 
EEG stage 7 (Vertex sharp wave 
train or burst) 
Presence of at least two well-defined vertex sharp waves  
EEG stage 8 (Vertex sharp wave and 
incomplete spindle) 
Simultaneous presence of at least one well-defined vertex sharp wave and one incomplete spindle 
with 0.5 s duration and amplitude between 10 µV and 20 µV 




Some studies have reported high correlations between subjective sleepiness and EEG 
Alpha and Theta activities, and have confirmed that drivers can be aware of their 
sleepiness prior to critical driving events (Horne, James A & Baulk, 2004; Howard et 
al., 2014; Williamson, Ann, Friswell, Olivier, & Grzebieta, 2014). However, these 
studies have not reported if changes in Alpha and Theta EEG activities occurred 
prior to drivers’ perceived sleepiness. According to the aforementioned sleepiness 
classification (Tanaka, H et al., 2000), Delta activity together with vertex sharp 
waves, which are related to behavioural changes and a subjective feeling of 
‘‘vagueness’’,  start to appear at the late part of sleep onset from stage 6 onwards (the 
end of Stage 1 sleep; (Finelli, Achermann, & Borbély, 2001; Hori, T et al., 1991; 
Tanaka, H et al., 2000; Yeo et al., 2007). This implies that changes in Alpha and 
Theta activities could represent the start point of sleepiness, and that subjective 
sleepiness appears at some point after primary EEG changes in Alpha and Theta 
activities. The point at which drivers perceive their sleepiness is of great importance 
in that they mostly rely on their feeling of sleepiness before taking measures to 
combat their sleepiness.  
Overall, sleep and sleep onset, are not simple, homogenous, or monotonous 
processes. Instead, the processes are continuous, very dynamic, and complex. 
Therefore, superficial (visual) features of sleepiness need to be considered along with 
‘deeper’ facets such as changes in spectral power in the EEG bands. 
Electrophysiological methods can be used to objectively and reliably measure a shift 
in alertness and sleepiness, and may provide some indices of relevance to driving 
skills. More specifically, these findings suggest that alpha and theta activity could be 
hallmarks of sleepiness (and of sleep onset) during driving studies. It could be 
expected that a dominance of alpha EEG activity during driving would be replaced 
by theta EEG dominance at the onset of sleep and that this change in EEG would 
appear earlier than subjective perceptions of sleepiness.  
The next sections explain the main sources of sleepiness particularly sleep loss, and 




2.4 SLEEP DEPRIVATION 
Sleep deprivation is the main reason for driver’s sleepiness and in this context refers 
to insufficient sleep periods (totally or partially) due to early morning awakening, 
extended wake, and sleep fragmentation. Early wakeup is more prevalent among 
shift workers who drive in the early morning (Smith, S. et al., 2009(b)) while 
extended wake is a behaviour often observed in samples of long-haul and heavy 
vehicle drivers (Horne, J.A & Reyner, 2001). 
A study among more than 1500 non-professional drivers revealed that 30% of non-
professional drivers were habitually sleep deprived for 1 hour and 25% of them have 
a sleep debt of 2 hours (Carter, Ulfberg, Nyström, & Edling, 2003). Additionally, 
drivers are more confronted with chronic partial sleep deprivation than just one night 
total sleep loss (Otmani et al., 2005). 
Both acute total sleep deprivation and chronic partial sleep deprivation impact on 
neurobehavioral function during subsequent wake time. Chronic partial sleep 
deprivation (e.g. consecutive nights of insufficient or limited sleep) may cause 
greater deﬁcits than that of short term acute sleep loss. This appears to be related to 
the accumulative aspects of sleep debt. One explanation for this effect was provided 
by Cote et al. (2008), such that the brain may be able to compensate for the effects of 
short periods of extreme sleep loss (e.g. 24 h), but be unable to sustain that 
compensation for longer durations. Data on sleep-related crashes is consistent with 
an impact of chronic-partial sleep loss on safety.  In some studies, the sleep-related 
crash rates were found to be 3 to 5 fold higher among drivers habitually sleeping less 
than 5 hours per night (Connor et al., 2002; Stutts et al., 2003). In another study 
(Otmani et al., 2005), there was no change in the crash rate after one night of partial 
sleep deprivation (3 h) but from the second night to the fifth night of partial 
deprivation, this rate significantly increased. (Matthews et al., 2012(b)) in a 28-h 
daytime forced desynchrony protocol for one week, regardless of time of day or 
amount of time awake, found that chronic moderate or severe sleep restriction 
significantly increased the standard deviation of lateral position (F2,1923 = 95.81, p < 
0.001). 
Attempts have been made to specify the minimum sleep time necessary for 
preventing chronic sleep related performance deficits. One week partial sleep 
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restriction to 5 hours per night was found to linearly increase sleepiness, impairment 
of mood and performance “lapses” (Dinges et al., 1997). A minimum 6 hours sleep 
per night was subsequently identified as an adaptable sleep threshold (Cote et al., 
2008; Drake et al., 2001).  
Contrary to Drakes’s  (2001) statement of a minimum sleep threshold of 6 hours and 
contrary to the core sleep theory (Van Dongen et al., 2003), some researchers have 
reported that maintaining sleep time at 6 hours per night over several days may 
decrease performance . Similarly, progressively impaired psychomotor vigilance 
performance, impaired working-memory performance, and impaired cognitive 
throughout performance in both 4-h and 6-h (time in bed per night) conditions has 
been observed, although in both conditions slow wave activity was conserved (Orzeł-
Gryglewska, 2010; Van Dongen & Dinges, 2005; Van Dongen et al., 2003). These 
deficits were comparable to those found after 1 to 2 days of total sleep deprivation. 
The latter authors proposed that approximately 8 hours of sleep was the minimum 
sleep necessary for unaffected performance (15.84 ± 0.73 h wake time per day).  
In addition to the amount of sleep deprivation, the stage of the restricted sleep is 
important. Based on the core sleep theory, it was primarily believed that if slow 
wave sleep (Stages 3 and 4 of NREM sleep) remained uninterrupted, chronic sleep 
deprivation would not affect performance (Van Dongen et al., 2003). In contrast, 
Karni et al. (1994) found that selective deprivation of REM sleep impaired 
performance on a visual discrimination task, whereas selective deprivation of SWS 
did not impair the performance on this task. 
Currently, it is well established that chronic sleep loss or fragmentation of sleep 
results in impaired performance, mainly in cognitive functions, attention and 
working memory, comparable to those of short-time total sleep deprivation (Orzeł-
Gryglewska, 2010). Current peak consensus for the sleep needs of an adult suggest 





2.4.1 Effects of sleep loss on objective outcomes of sleepiness 
Waking electroencephalogram (EEG) 
Sleep deprivation appears to exert local effects on the brain, rather than global effects 
(Ferreira et al., 2006). According to the local use dependent theory, the pre-frontal 
cortex (PFC) is the most active region of brain during wakefulness. Sleep is a crucial 
recovery opportunity for this region. Therefore, it is not surprising that the pre-
frontal cortex is more vulnerable to sleep deprivation than are other brain areas 
(Couyoumdjian et al., 2010; Ferreira et al., 2006). Reduction of brain activity in pre-
frontal cortex has consistently been shown following total sleep deprivation (Cote et 
al., 2008). 
Increased activity in EEG measures of alpha (Gillberg, Kecklund, Göransson, & 
Åkerstedt, 2003; Lowden et al., 2009), or both alpha and theta bands have been 
validated against increased sleepiness and are known as indicators of sleepiness 
(Åkerstedt & Gillberg, 1990; Horne, J.A & Reyner, 1996; Kecklund & Åkerstedt, 
1993; Torsvall & ÅKerstedt, 1987). Studies of EEG characteristics among drivers are 
limited and have been mostly concerned with alterations in alpha and theta bands 
(Papadelis et al., 2007). Alpha and theta activities have been studied as absolute or 
relative power. The relative band ratio is a unit-less value between 0 and 1 and 
represents the relative ratio of the power of each frequency band against the total 
frequency power for the EEG frequency bands (delta: 0.5–4 Hz, theta: 4–8 Hz, alpha: 
8–12 Hz, beta: 12–30 Hz, and gamma: 30–40 Hz) (Papadelis et al., 2007).   
In a daytime 1.5 hour simulated driving task in non-sleep-deprived participants, 
increased activities in relative alpha and theta power were observed at the end of 
driving task with increasing driver sleepiness (Zhao, Zhao, Liu, & Zheng, 2012).   
In a morning (8 a.m) 50 min simulated driving task, after a night of sleep deprivation 
and a dose of caffeine, EEG alpha (α: 8–13 Hz), EEG theta (θ: 4–8 Hz) and EEG 
(α+θ)/β; increased gradually during the drive, while EEG beta (β: 13–22 Hz) and β/α 
decreased. Additionally, index β (13–22 Hz) increased immediately after crashes 
(losing the control of the car) and gradually decreased over time (Eoh et al., 2005).  
In an on-road nocturnal driving task for one hour followed by one night total sleep 
loss an increase in relative powers in the delta and alpha bands, but a decrease in the 
relative power in beta and gamma frequency bands (in central and parietal areas) 
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were observed (Papadelis et al., 2007). Additionally, the extended wake periods 
exerted an increasing effect on EEG alpha activity, reflecting decreased cortical 
arousal (Lal & Craig, 2001(b)). 
 
Waking electrocardiogram (ECG) 
The electrocardiogram (ECG) describes the electrical activity of heart activity. Heart 
activity is continually modulated by the sympathetic and parasympathetic nervous 
systems.  The most obvious index of heart activity is the heart rate. The reciprocal of 
the heart rate is called inter-beat interval, which is time interval between individual 
beats (typically between successive R waves in the QRS complex (Tarvainen, 
Niskanen, Lipponen, Ranta-Aho, & Karjalainen, 2014).) observed in the ECG. This 
interval is also called as inter-beat interval, beat-to-beat interval, or R-R interval. The 
term Heart Rate Variability (HRV) refers to changes in the inter-beat intervals, 
indicating changes in the balance between sympathetic and parasympathetic activity 
(Michail, Kokonozi, Chouvarda, & Maglaveras, 2008). 
HRV is commonly calculated from R-R intervals by two methods: frequency domain 
(Power spectral analysis) and time domain (statistical operations) (Ergün, Demirci, 
Nurlu, & Komürcü, 2008). Power spectral analysis of HRV is commonly used to 
calculate the sympathetic and parasympathetic activity of the autonomous nervous 
system (Schaffer, Hensel, Weigand, Schüttler, & Jeleazcov, 2014). In this method the 
R-R interval is converted to sum of sinusoidal functions of frequencies and 
amplitudes using the Fast Fourier Transform (FFT) (Ergün et al., 2008). The power 
spectrum represents the amplitude of heart rate variability in three forms of LF, HF, 
and LF/HF (Ergün et al., 2008). The LF is the low-frequency (slow rhythm, from 
0.04 to 0.15 Hz) heart rate variability, and is understood to be controlled by both 
sympathetic and parasympathetic nervous systems. The LF heart rate variability 
represents wakefulness characteristics such as higher sympathetic and/or lower vagal 
activity.  HF is the high-frequency (fast rhythm, 0.15 to 0.4 Hz) heart rate variability, 
and is primarily controlled by the parasympathetic system. HF HRV may provide an 
index associated with ‘sleepy’ characteristics, such as lower sympathetic and/or 
higher parasympathetic and vagal activity (Baharav et al., 1995; Michail et al., 2008). 
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The sympathovagal balance between these two components is defined as LF/HF ratio 
(Baharav et al., 1995).   
Sleep-related studies in driving settings have found inconsistent changes in ECG 
measures. For instance, there was no significant alteration of heart rate variability 
during a one hour on-road trip after one night of total sleep loss (Papadelis et al., 
2007). However, in another study sleep deprived drivers showed a lower LF/HF and 
lower LF values (Michail et al., 2008). In a 2-hour simulated drive during daytime 
increasing heart rate was positively correlated to increased sleepiness, but there was 
no change in HRV indices of sleepiness during the drive (Wijesuriya, Tran, & Craig, 
2007). In a daytime driving experiment a 1.5-hour simulated drive resulted in a 
decreased LF HRV and an increased HF HRV (Zhao et al., 2012). 
Studies show that mean RR during wake period is lower than sleep episodes and 
during SWS is greater than wakefulness before sleep onset. (Boudreau, Yeh, 
Dumont, & Boivin, 2013)  
Heart rate (beat/minute) decreases during sleepy driving (Borghini, Astolfi, 
Vecchiato, Mattia, & Babiloni, 2014), particularly night time driving (Lal & Craig, 
2001(a)). For instance, in a long time night-time driving for 9.5 hours with total sleep 
loss, heart rate decreased (Riemersma, Sanders, Wildervanck, & Gaillard, 1977). In 
another simulated drive for 120 min, there was a decrease in heart rate during 
driver’s sleepiness (Liang, Yuan, Sun, & Lin, 2007).  Since these studies have been 
conducted during sleep deprivation the changes in heart rate might reflect circadian 
variation in HR not the effect of sleep loss alone. There was no significant alteration 
of heart rate variability during one hour on-road driving at night time after one night 
total sleep loss (Papadelis et al., 2007). 
 
 Cognitive performance 
Studies on the mechanism of impairments in cognitive performance have revealed 
that the cognitive functions subserved by the pre-frontal cortex (PFC) may be 
particularly sensitive to sleep loss (Couyoumdjian et al., 2010). During sleep loss 
attenuation in arousal extends to posterior region after rapid and progressive linear 
decreases in arousal in the pre-frontal cortex (Cote et al., 2008). In this stage some 
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behavioural deficiencies start to appear, such as impaired attention, inefficient 
information processing, reduced decision-making capability, impaired 
communication and language skills, divergent thinking, as well as impaired memory, 
motor function, mood and wake status (Couyoumdjian et al., 2010; Drake et al., 
2001; Jones & Harrison, 2001; Papadelis et al., 2007; Smith, S. et al., 2009(b)). 
The magnitude of impairment in cognitive performance from sleep loss seems to be 
dependent on some factors such as the type of task performed, the type of 
performance test (Cluydts et al., 2002; Horne, J.A & Wilkinson, 1985), and the 
severity of sleep restriction (Otmani et al., 2005).     
The majority of performance tests, including simple task performance tests (such as 
the Psychomotor Vigilance Task; PVT), and complex task performance tests (e.g. 
executive function), are sensitive to sleep loss (Cluydts et al., 2002; Couyoumdjian et 
al., 2010; De Gennaro et al., 2007; Smith, S. et al., 2009(b)). The PVT (visual or 
auditory) appears to be a sensitive performance test, in that the tonic alertness 
(vigilance or sustained attention) is the component of the attention network most 
affected by sleep loss when compared to the other components of cognition (Lim & 
Dinges, 2008; Papadelis et al., 2007).  
In the PPVT, reaction times are sorted into the following categories:  
Type 1: representing false responses (responses made prior to stimulus presentation)   
(Tarvainen et al., 2014), Type 2: correct responses (Tarvainen et al., 2014), Type 3: 
lapses representing the responses slower than 500 milliseconds after the stimulus 
onset on the PVT (Arnedt, Geddes, & MacLean, 2005; Kim et al., 2001; Lim & 
Dinges, 2008; Martella et al., 2011; Papadelis et al., 2007; Smith, S. et al., 2009(b)), 
and Type 4: very slow responses.  
Some other variables are typically extracted from PPVT data including, mean 
reaction time, standard deviation of reaction time from correct responses (as measure 
of performance variability); and percentage of false responses (as measures of 
performance accuracy) (Loh, Lamond, Dorrian, Roach, & Dawson, 2004; Sforza, 
Haba-Rubio, De Bilbao, Rochat, & Ibanez, 2004), and mean reciprocals of reaction 
times (1/RTs, seconds 
-1
) as the reaction speed (Sforza et al., 2004). These variables 
are listed in Table 5.3. It should be noted that attention lapses are discrete 
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phenomena from prolonged lapses (most often understood to reflect microsleeps). 
There are some differences between these two types of lapses. Firstly, attention 
lapses can wax and wane in seconds, more frequently than prior assumptions of 
fluctuations over minutes or hours, while prolonged lapses last longer than attention 
lapses (3-15 s) (Lim & Dinges, 2008). The fact that sometimes sleepy drivers have 
had a crash during wakefulness with open eyes(Jackson et al., 2013), confirms that 
changes in human vigilance level can be very rapid. Secondly, attention lapses are 
not only modulated by sleep loss (homeostatic drive), but also by circadian drive 
(Dinges et al., 1997; Martella et al., 2011; Ting, Hwang, Doong, & Jeng, 2008; Van 
Dongen & Dinges, 2005), and most frequently occur across the circadian nadir (Lim 
& Dinges, 2008; Van Dongen & Dinges, 2005), while prolonged lapses are only seen 
in sleep-deprived participants and not among well-rested individuals (Welsh, 
Thomas, & Thome, 1998). 
Sleep loss has been found to elicit significant impairments on both visual and 
auditory PVTs including increased attention lapses and prolonged lapses. 
In a study involving a severe sleep loss (62 hours of continuous wakefulness) an 
increasing effect of hours of wakefulness was observed on the number of lapses and 
mean reciprocals of reaction time (Lamond et al., 2008). 
The relationship between attention lapses (measured by PVT) and higher crash risk 
rates has been repeatedly demonstrated (Arnedt et al., 2005). For instance, attention 
lapses from sleep loss have been found to be associated with both lane drifting 
(Jackson et al., 2013; Philip et al., 2005(a)) and road crashes on a driving simulator 
(Dinges et al., 1997; Ting et al., 2008). 
 
2.4.2 Effects of sleep loss on subjective outcomes of sleepiness  
All forms of sleep loss (acute or chronic partial sleep loss) have been shown to lead 
to an increased subjective sleepiness (Cluydts et al., 2002; De Gennaro et al., 2007; 
Otmani et al., 2005; Van Dongen et al., 2003; Zhou et al., 2012).  Liu, et al. (2009) 
reported that an increase in sleepiness score (on the KSS) from a rating of 5 (neither 
alert nor sleepy) to a rating of 9 (very sleepy, great effort to stay awake), 
dramatically raised the risk for a major lane departure. Nevertheless, subjective 
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perception of sleepiness has been typically found to be less sensitive to sleep loss 
than are the corresponding neurocognitive measures (Finelli et al., 2001; Hori, T et 
al., 1991; Tanaka, H et al., 2000; Yeo et al., 2007). A larger gap between subjective 
and objective sleepiness at higher levels of sleepiness has been observed (Cluydts et 
al., 2002; Dinges et al., 1997; Drake et al., 2001; Zhou et al., 2012). For instance, 
Van Dongen, et al. (2003) observed that at the end of 14 days of chronic sleep 
limitation, the participants reported that they only felt slightly sleepy, while in 
contrast their PVT scores were far more deteriorated.  
 
2.4.3 Effects of sleep loss on driving performance measures of sleepiness 
A variety of driving performance outcome measures, mostly a combination of 
several variables have been used to measure driver performance when sleepy. These 
measures include lane departures (lane excursion or inappropriate lane crossing), the 
standard deviation of lane position (SDLP), the standard deviation of lateral position, 
the minimum time to lane crossing (TLC), the number of line edge crossings, mean 
amplitude of steering wheel movements (SWM), the standard deviation of steering 
wheel angle (SDSWA), steering wheel movements count, mean speed, standard 
deviation of speed, and other metrics. 
Lane keeping behaviour (ability of drivers to maintain a stable lane position (Atchley 
& Chan, 2011) is measured by mean lane position, the standard deviation of lane 
position (SDLP), the total number of centre line crossings and total number of road 
edge excursions. 
Lateral position, or the driver's ability to track the lane centre, reflects road tracking 
errors or ‘weaving’ and has also been found to be very sensitive to sleepiness.  
Sleepy drivers have repeatedly exhibited larger variations in lateral position (Arnedt 
et al., 2005; Arnedt, Wilde, Munt, & MacLean, 2001; Lenné, M.G, Triggs, & 
Redman, 1998).  
The standard deviation of lane position (SDLP), refers to the driver's ability to 
maintain a straight path (driver precision), although not necessarily a specific 
position relative to the lane centre (Boyle, Tippin, Paul, & Rizzo, 2008). This 
variable is the most frequently studied outcome measure of driving performance 
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(Sandberg, D., Akerstedt, Anund, Kecklund, & Wahde, 2011(a)). Sleepiness has 
shown to increases deviation from the average position of the vehicle (Atchley & 
Chan, 2011; Desmond & Matthews, 1997; Liu et al., 2009). Increase in the standard 
deviation of lateral lane has been repeatedly reported in nocturnal simulated driving 
tasks with total sleep loss (Phipps‐Nelson, Redman, & Rajaratnam, 2011) or 
extended wakefulness (Anund et al., 2008(a)) as well as in daytime studies with 
partial sleep loss (De Valck & Cluydts, 2001). 
Lane departure or inappropriate lane crossing (ILC) could vary from minor incidents 
(e.g. part of the car crossing a lane boundary) to major incidents (e.g. the entire car 
crossing a lane boundary). According to epidemiological findings, 65% of sleep-
related crashes occur after an inappropriate lane crossing (Sagberg, 1999). Minor 
departures occur more than major ones (Sagberg, 1999), but both types of departures 
appeared to be important indicators of driver impairment (Liu et al., 2009). For 
example, in a randomized cross-over study the total number of inappropriate line 
crossings increased by 8 cases after sleep restriction (Philip et al., 2005(a)). Regarding 
specific types of lane departure, if any part of the tyre straddles the road way centre 
line a centre line crossing is counted. If the tyres leave the road edge line in the 
driver’s direction (left edge line) a road edge excursion is counted (NCSU Human 
Factors and Ergonomics (HFE) Area, 2011). Increase in the number of lane 
infractions is an indicator of impaired attention (Liu et al., 2009) or fatigue (Atchley 
& Chan, 2011; Oron-Gilad & Shinar, 2000). 
Variations in the mean vehicle speed appear to reflect the ability of the driver to 
control their speed during microsleep episodes (Boyle et al., 2008; Risser, Ware, & 
Freeman, 2000). However, speed choices also reflect other aspects of driving 
behaviour, road type, and traffic characteristics (Sandberg, D. et al., 2011(a)). Many 
drivers tend to slow down when experiencing sleepiness or impaired vigilance, 
particularly at night time (Lenné, M. G et al., 1997). An increase in speed 
fluctuations (deviation from the posted speed limit) seems to be a common feature 
across studies (Arnedt et al., 2001; Brookhuis, Waard, & Fairclough, 2003; 
Campagne et al., 2004; Lenné, M. G et al., 1997). Higher speed deviations in driving 
after sleep loss have been more specifically associated with the driver’s inability to 
pay attention to both the road scene and the speedometer simultaneously (Jackson et 
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al., 2013). Accordingly the number of speeding errors (speed exceedance) could be 
one marker of sleepiness (Campagne et al., 2004). 
Gravitational forces (G-forces) are important outcome measures of driving 
performance and are measures of variation in vehicle acceleration from delayed 
braking, fast starts and hard right-hand or left-hand turns (Simons-Morton, Zhang, 
Jackson, & Albert, 2012). These sudden accelerations increase the risk of losing 
control of vehicle, decrease the available time for both the driver and other road users 
to react to the hazardous situations in time (Bagdadi & Várhelyi, 2011). A correlation 
of 0.6 has been observed between G-Force event rate and crashes and near crashes 
rate among teenage drivers over a period of three years (Simons-Morton et al., 2012). 
Despite the importance of these indices, G-forces are mainly known as physical 
facets of driving and the effects of sleep loss on the nature and magnitude of changes 
in G-forces are not well known yet, particularly in car drivers. 
Steering wheel related outcome measures have also examined by sleep deprivation. 
Normally drivers maintain a steady course on the road by make minor steering 
adjustments. Both number and amplitude of steering wheel movements (SWM) 
increase during sleepiness (Brown, I. D., 1997; Lal & Craig, 2001(a)). Sleepy drivers 
fail to correct their vehicle heading, and consequently make larger and more rapid 
movements of the wheel to keep the trajectory bring it back onto the lane. Therefore, 
large SWM’s (6–10°) or extremely large SWM’s (more than 10°) have been 
associated with increased driver sleepiness (Atchley & Chan, 2011; Brown, J. D., 
1994; Thiffault & Bergeron, 2003(b)). 
In a night-time simulated drive for 2 hours following a 4-hour sleep loss the 
preceding night, there were no significant effects of sleep deprivation on either mean 
amplitude of small steering wheel angle (between 0.5° and 5°) or frequency per 
minute of small steering wheel angle. In this study smaller angles indicated higher 
sleepiness levels (Otmani et al., 2005). Additionally, a greater standard deviation of 
steering wheel angle shows increased fatigue (Atchley & Chan, 2011). 
In the most comprehensive study of driver performance by Forsman et al. (2013) the 
researchers drew 87 different metrics of driving performance from the literature and 
examined those variables in two simulated driving studies on 41 subjects. They 
found that of the 87 metrics just two - steering variability and lane variability - 
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captured most of the variance in performance. Lane variability in particular was 
correlated with night-time subjective sleepiness.  
Lane position outcome measures have also been examined in combination with 
steering-based variables to acquire complementary information about sleepy drivers 
(Friedrichs & Yang, 2010). Berglund (2007) in a study on 22 participants on a truck 
simulator found that of 17 driving performance outcome measures a linear 
combination of steering wheel direction reversals (the number of cases the driver 
changed the direction of the steering wheel over a time interval), vehicle path 
deviations (the area of the vehicle deviation) and standard deviation of lateral 
position showed the highest sensitivity to sleepiness (Cluydts et al., 2002). 
 
2.5 OTHER CONTRIBUTORS TO SLEEPINESS 
2.5.1 Circadian pressure for sleep 
Based on the two-process model of sleep-wake regulation, the neurobehavioral 
impairment from sleep loss (homeostatic drive) accumulates throughout the day 
based on the circadian drive. Therefore, sleepiness is more severe at certain times of 
day after sleep deprivation (Vakulin et al., 2007). For instance, driving performance 
on measures such as steering movement, speed, standard deviation of speed, and 
reaction time, are poorer during nights and the afternoons (Lenné, M. G et al., 1997; 
Reimer et al., 2007). 
The interactions between circadian rhythm and homeostatic drive for sleepiness have 
been studied in forced desynchrony protocols through de-coupling the circadian 
phase from sleep times by enforcing non-24 hour ‘days’. Under these conditions, the 
clock times of sleep and wake change over consecutive days, and the phase 
relationship between sleep episodes and the circadian rhythm also vary. This 
approach allows researchers to examine driver performance at different combinations 
of prior wake and circadian phase (Zhou et al., 2012). It is important to consider the 
impairment in alertness and driving performance from the circadian drive in 





The time-on-task effect refers to attenuation of performance across the course of a 
task. According to the report of  Horne & Reyner (1995), all the early morning sleep-
related crashes involving truck drivers occur within the first two hours of driving 
(Horne, J.A & Reyner, 2001). Borb (1999) also found that an increase of just 10 
minutes in driving duration, in conjunction with short prior nocturnal sleep (< 6 h), 
was associated not only with increased rear-end collisions but also with increased 
single-car crashes.  
A variety of studies, have examined the effect of driving duration, sometimes 
combined with sleep loss, on driver objective outcome measures of sleepiness. 
Simulated driving studies have shown that increased driving duration results in 
increased EEG activity in both alpha (Eoh et al., 2005; Schier, 2000), and theta band 
(Kecklund & Åkerstedt, 1993), higher numbers of short (1 s) alpha bursts (Boyle et 
al., 2008; Eoh et al., 2005; Kecklund & Åkerstedt, 1993), and higher numbers of 
short theta bursts (Kecklund & Åkerstedt, 1993). Otmani et al (2005) also reported 
that during simulated driving both alpha and theta EEG power increased in response 
to increased driving duration. Extended driving time has resulted in higher eye blink 
rates and slower eye blink in other studies (Papadelis et al., 2007; Sandberg, D et al., 
2011(b)). 
Simulated driving studies have shown that increased driving duration results in 
higher ratings of subjective sleepiness (Arnedt et al., 2005; Kecklund & Åkerstedt, 
1993; Lowden et al., 2009; Sandberg, D et al., 2011(b); Ting et al., 2008).  Moreover, 
time-on-task effects can be observed in increased impairment of driver’s cognitive 
performance. In a simulated driving study, median brake reaction times during the 
last 10-minute period of a 90-minute session were found to be 0.31 s longer than 
those in the ﬁrst 10 minutes. This difference equates to an additional 8 metres in 
stopping distance when travelling at 100 km/h (Schmidt et al., 2009).  
Some studies have examined the effect of driving duration on driving performance 
specifically (Arnedt et al., 2005). For instance, a study by Thiffault & Bergeron 
(2003(b)), demonstrated that as driving duration increased drivers made fewer small 
steering wheel movements (1-5 
o
), but made a greater number of larger steering 
wheel movements (6-10 
o
). Thiffault and Bergeron (2003(b)) attributed this difference 
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to the inability of the drowsy driver to detect small lane deviations due to sleepiness. 
A similar relationship between steering wheel movements and time-on-task was 
reported by Otmani et al. (2005). Additionally extended time of driving increases the 
standard deviation of the lateral position (Otmani et al., 2005; Sandberg, D et al., 
2011(b); Ting et al., 2008), higher rates of edge line crossings (Otmani et al., 2005), 
increases in vehicle speed, decreased driver awareness of pedestrians (Ranney, 
Simmons, & Masalonis, 1999), and decreased steering performance (Van der Hulst, 
Meijman, & Rothengatter, 2001). 
Consistent with some of the data above and contrary to the general belief that long 
driving hours affect driver performance. Philip, et al. (2005(a)), could not find any 
substantial effect of the duration of driving on performance and sleepiness. They 
attributed this discrepancy to the brief ‘active breaks’ that they had included within 
their paradigm, and so their findings may not apply to sustained driving without such 
breaks.  
There is no consensus on the start point of significant time-on-task effects. In spite of 
previous thoughts that time-on-task effects only appears after a minimum task 
duration of 30 minutes, it has been confirmed that sleep-deprived subjects may 
exhibit time-on-task effects after just a few minutes of performance (Lim & Dinges, 
2008). This may particularly be the case in simulated driving studies, during which 
sleepiness generally appears faster than real on-road driving conditions (Arnedt et al., 
2005), perhaps due to differences in motivation or other factors. In an attempt to 
provide general guidance for drivers, some researchers have scored the performance 
of drivers in different durations of driving, and reported that the optimum duration of 
safe highway driving is approximately 80 min at a constant speed of 60 km/h 
(Nilsson, Nelson, & Carlson, 1997; Ting et al., 2008). However, there is no good 
evidence to support this recommendation. 
 
2.5.3 Fatigue from work demands  
Fatigue from work demands such as multiple jobs or long work shifts, contributes to 
sleepiness among 50% of drivers (Di Milia, 2006). Long shift lengths not only result 
in higher fatigue from the workload per se, but also result in extended wakefulness. 
The frequency of sleep-related crashes among shift-workers engaging in more than 
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60 hours of work per week is more than 3.7 times more than other workers (Stutts et 
al., 2003). Barger et al (2005) found an increased rate of sleep-related crashes 
amongst medical interns working with extended work shifts of more than 80 hours 
per week in the hospital. They reported that motor vehicle crashes and near-miss 
incidents after an extended shift were respectively 2.3 and 6 times higher when 
compared with a non-extended shift.  These findings are consistent with data from a 
previous survey by Heslegrave et al. (2000) on the driving behaviour of miners 
changing from 9-hour to 12.5-hour shifts with a 30-min commute. They pointed out 
that a switch to a 12.5-hour shift resulted in more drivers falling asleep at the wheel 
and greater likelihood of having near misses when compared with the former 9-hour 
shift (Di Milia & Bowden, 2007). 
 
2.5.1 Individual differences in vulnerability to sleep loss 
There appears to be great inter-individual difference in resistance to some sleep-
related deficits such as sleepiness and mood alterations (Åkerstedt et al., 2002(b); 
Ohayon, Smolensky, & Roth, 2010; Otmani et al., 2005), decrements in vigilance, 
disturbance of working memory, and impairment of executive function(Van Dongen, 
Baynard, Maislin, & Dinges, 2004(b)). A study on sleep-related crashes highlighted 
that only 5% of truck drivers account for 26% of sleep-related crashes. Indeed 20% 
of them were involved in 60% of crashes (Hanowski, Wierwille, & Dingus, 2003). 
These differences are known to be associated with individual variations in  EEG 
activity patterns during waking, personality traits(Van Dongen et al., 2004(b)), such 
as extroverted and tension-prone personality (Lal & Craig, 2001(a); Thiffault & 
Bergeron, 2003(a); Verwey & Zaidel, 2000), sensation seeking  (Martin, S. B. et al., 
2007; Thiffault & Bergeron, 2003(a)), external locus of control (Verwey & Zaidel), 
eveningness, neuroticism, rigid sleeping habits, difficulty in overcoming drowsiness, 
proneness to internal desynchronization (Costa, 2003), and some negative mood 
states including anger, anxiety, confusion and low levels of vigour (Lal & Craig, 
2001(a)). 
Considerable variations have been revealed between individuals on their waking 
EEG. Studies have shown that the alpha and sigma frequency activities can be 
considered individual trait-like characteristics. Additionally, during sleep and 
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NREM-REM-NREM sleep transitions, there are large regional frequency-specific 
EEG differences between people. These regional EEG differences are reliably unique 
for each person and allow individuals to be distinguished from each other with a high 
probability (92%). The uniqueness of these EEG patterns is one of the genetically-
determined traits of human beings (Ferrara & De Gennaro, 2011). 
Likewise, the magnitude of psychomotor performance impairment after 36 h sleep 
loss varies substantially between individuals, but the performance profile is known to 
be stable for each person (Van Dongen & Dinges, 2005). Inter-individual differences 
have also been observed in working memory performance, but to a lesser extent than 
the differences seen in psychomotor vigilance performance (Van Dongen & Dinges, 
2005).  
The most common personality trait studied in vigilance tasks such as driving is 
related to the extroversion–introversion dimension (Thiffault & Bergeron, 2003(a); 
Verwey & Zaidel, 2000). 
Extroverts are ‘stimulus-hungry’, and make more compensatory effort when 
confronted with low levels of stimuli. Hence they tend to demonstrate a poorer 
performance on monotonous driving tasks (Brocke, Tasche, & Beauducel, 1997; 
Thiffault & Bergeron, 2003(a)). Sensation seeking is general term for individuals with 
some personality dimensions such as a tendency to do risky or adventurous tasks, 
experience seeking (ES; seeking of arousing experiences and novel environmental 
stimuli), disinhibition (DIS; behaviours of nonconformity through social and sexual 
experiences) and boredom susceptibility, an aversion to monotonous and repetitive 
experiences (Martin, S. B. et al., 2007; Pintrich & Maehr, 2004; Thiffault & 
Bergeron, 2003(a)).  
The implications of personality traits on different performance measures of drivers 
have been already examined. For instance, extroversion and boredom personalities 
had an increasing effect on departure from the road due to falling asleep, whereas  
disinhibited-honest subjects were more likely to cross solid lane markings even 
without falling  asleep (Verwey & Zaidel, 2000). Another study revealed that 
sensation seeking, particularly the experience seeking (ES) dimension, may be an 
indicator of increased variance in steering wheel movements (in monotonous roads). 
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This study indicated a higher prevalence of falling asleep at the wheel among high 
sensation seekers (Thiffault & Bergeron, 2003(a)). 
Given the importance of the individual differences, they need to be quantified, 
controlled, or manipulated in future studies. 
 
2.5.2 Monotonous conditions  
Monotonous and boring tasks such as driving appear to be more impaired by sleep 
loss than are other types of task (Papadelis et al., 2007). Most studies regarding the 
effects of sleep loss on driving performance have been undertaken in driving 
simulators. The simulator environment appears to induce an earlier and more 
pronounced decline in driver performance when compared with real driving 
environment (Cluydts et al., 2002), mainly due to the more monotonous or 
predictable driving conditions. Monotony refers to a situation with constant or highly 
repetitive stimulus (Thiffault & Bergeron, 2003(b)). Monotonous driving on long and 
straight roads with little visual stimulation intensifies, or unmasks, drowsiness (Gilad 
& Ronen, 2008).  Motorway routes, highways and rural roads, roads with few turns 
and no road signs or stop lights, may be more monotonous than urban routes in 
simulated driving (Arnedt et al., 2005; Boyle et al., 2008; Reimer et al., 2007). 
According to the findings of Thiffault (2003(b)) driver sleepiness is clearly observable 
in the first 20 minutes of driving under monotonous conditions. Some of the 
symptoms observed included increased number of lane departures (Arnedt et al., 
2005; Gilad & Ronen, 2008), longer minimum times taken to lane crossing (TLC) 
(Boyle et al., 2008), and higher standard deviations of vehicle speed (Arnedt et al., 
2005; Reimer et al., 2007). 
 
2.5.3 Age of drivers 
There is a large variability across the spectrum of drivers in terms of their perceptual, 
cognitive, and physical abilities (Horberry & Inwood, 2010). Some of these 




Older drivers have shown to get less sleepy than younger drivers at night (Lowden et 
al., 2009; Philip, 1999). This could partly be explained by differences in activation of 
the hypothalamic–pituitary–adrenal (HPA) axis which results in higher mean 
nocturnal cortisol levels among older adults. Cortisol underlies increased brain 
activity in the sigma and beta EEG bands, and activity in these bands is associated 
with higher vigilance level and shorter sleep (Lowden et al., 2009; Van Cauter, 
1996). Another reason for differences in sleepiness could be the lack of high alpha 
activity (representing higher sleepiness) among older people (Lowden et al., 2009). 
Findings of a night time simulated driving (Campagne et al., 2004) revealed 
increased alpha activity among both the young and middle aged group, but not the 
elderly group (60–70 years). Therefore, they could not find any significant 
correlation between alpha activity and incidents of running off the road among older 
drivers. Instead, driving errors in this group was observed during severe sleepiness 
(during increased EEG theta spectral power). This could be a neurophysiological 
change (less EEG alpha generated) or a measurement issue (less EEG alpha 
observed). 
There are some differences in cognitive performance in response to sleepiness 
between younger and older drivers. Sleep restricted to 4 or 6 hours of nocturnal sleep 
has shown cumulative deficits in neurobehavioral performance among younger 
drivers (Van Dongen et al., 2003). Younger drivers (less than 25 years) although 
demonstrating faster simple reaction times after normal sleep (Philip, 1999; Philip et 
al., 2004; Quimby, Maycock, Carter, Dixon, & Wall, 1984; Smith, S. et al., 2009(b)), 
show slower reaction times than do older drivers after 8 h of driving (Philip, 1999), 
or when driving after sleep loss (Philip et al., 2004; Smith, S. et al., 2009(b)). In spite 
of demonstrating faster simple reaction times, novice drivers normally exhibit slower 
hazard perception latencies (reaction time to a potential hazard) than do more 
experienced drivers, and this difference increases with increased age (Smith, S. et al., 
2009(b)). Faster or more efficient hazard perception by older drivers may contribute 
to higher resistance to sleepiness (Smith, S. et al., 2009(b)). 
The adverse effects of sleep loss on young drivers’ performance are discussed in a 




2.5.4 Health status 
A number of health-related factors can also impact on individual’s trait sleepiness, 
and on the responses to sleep loss, restriction or disruption. For example, people 
experiencing a range of psychiatric disorders may exhibit reduced heart rate 
variability. At the same time, many psychoactive medications themselves reduce 
heart rate variability. This has implications for the utility of HRV-based indices of 
sleepiness (or arousal) in these populations. Other medical diseases may raise the risk 
of sleepiness (Craig & Hancock, 1996; Wijesuriya et al., 2007). Some health 
problems such as obstructive sleep apnea syndrome (Boyle et al., 2008), some 
medical disorders, large body mass indices (BMI) more than 30 kg/m² (Smith, M. R., 
Cullnan, & Eastman, 2008), and use of medicines and illicit drugs, are each known to 
contribute to driver sleepiness.  
Generally, exogenous and endogenous contributors to sleepiness are rarely isolated 
and tend to co-occur while driving. The major underpinning factors include sleep 
loss (acute or chronic sleep loss due to early morning wake up, extended wakefulness 
or sleep disturbances), mistiming of sleep-wake with circadian rhythm (shift work, 
international travel (jetlag), social choices (social jetlag) and phase delay in 
adolescence), time-on-task fatigue from work demands, age, environmental 
conditions, health status, and individual differences in vulnerability to sleepiness. 
These factors induce microsleep episodes and result in decreased neurobehavioral 
and cognitive performance in both on-road and simulated driving tasks (Jackson et 
al., 2013; Martella et al., 2011). Therefore, development of an efficient 
countermeasure for sleepiness while driving is of great importance in transportation 
safety. 
 
2.6 SUMMARY AND IMPLICATIONS 
2.6.1 Summary of findings of the literature review 
The literature review was conducted with the purpose of understanding sleepiness as 
part of human sleep-wake regulation, problems of sleepy driving, effects of sleep 
deprivation on driver sleepiness, other contributors to driver sleepiness, the gaps in 
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the existing knowledge of the effects of sleepiness on driving, particularly in young 
drivers.  
The available literature suggests that human sleep and wake are part of arousal states 
that could be predicted by a number of sleep regulation models. Although these 
models are not directly concerned with human sleepiness, they are of great 
importance in understanding the factors involved in the regulation of sleep-wake and 
hence sleepiness. According to the basic model, the two-process model of sleep-wake 
regulation, the interaction between homeostatic and circadian drives results in human 
sleep and wake, with the homeostatic drive increasing after 16 hours of wake period 
and the circadian drive regulated by time of day (as an indirect effect of light), with 
minimum effect around 10 a.m. Based on the ultradian-process of sleep-wake 
regulation, a cyclic rhythm (ultradian rhythm) within the NREM and REM sleeps is 
regulating these two stages. Based on this model the selective sleep loss leads to 
elimination of different stages of sleep. The waking up earlier than usual (REM-sleep 
deprivation) seems to impair performance more than extended wake (reduction of 
NREM sleep). Based on the three-process model of human sleep-wake regulation, 
there is a third drive to sleep, sleep inertia that is a lower alertness level after 
awakening persisting for a few hours (up to 4 hours).  
The literature review revealed some important facts about the type and severity of 
sleep deprivation among drivers. Practically, drivers experiencing chronic partial 
sleep deprivation over more than one are more affected than those with acute sleep 
deprivation. A considerable proportion of non-professional drivers (33%) suffer from 
one hour sleep deprivation (7 hours of sleep) (Carter et al., 2003), while a minimum 
8 hours sleep per night is needed to prevent degradation of performance due to 
sleepiness. Drivers younger than 24 years old are more sensitive to sleep loss than 
older drivers, partly due to their physiological differences and are over represented in 
sleepiness-related crashes.  
Based on the reviewed studies, monitoring sleep-wake time is crucial to ensure 
compliance of participants with sleep deprivation regime. The best and the most 
reliable method is Actigraphy. Most studies have monitored sleep-wake times for 1 
to 2 weeks.  
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In addition to the abovementioned findings, the review pointed out some factors that 
are not included in sleep-wake regulation models but are contributing to sleepiness. 
These factors had some major implications in the protocol of this research program 
with the experimental study designed to manipulate or eliminate them. 
The literature highlights the need for taking a multidimensional approach to measure 
sleepiness, in that sleepiness might affect a variety of neurobehavioral outcomes to 
different extents. This is important in that sleep deprivation might degrade subjective 
sleepiness to a lesser extent than objective levels. The literature also shows that 
subjective perception of sleepiness (increasing EEG delta activity) occurs after 
starting objective sleepiness (increasing alpha and theta activity). These findings 
highlight that subjective outcomes of sleepiness are not reliable alone and all types of 
subjective and objective sleepiness and driving performance outcome measures need 
to be measured together. 
In-vehicle outcomes, comprising large numbers of outcomes, could be measured via 
on-road experiments or by simulated driving experiments.  On-road studies involve 
more limitations in that they have more difficulties in measuring EEG-related 
outcome measures and are not as accurate as simulated experiments. 
 
2.6.2 Implications of the literature review  
Factors that could be manipulated 
Since sleepiness is part of the same sleep-wake cycle in the two-process model of 
sleep-wake regulation the same two drives for sleep are inducing sleepiness while 
transitioning from wake to sleep. The sleep loss, whether from a long wake period or 
from sleep restriction, strengthens the homeostatic pressure for sleep and increases 
sleepiness. This indicates that in order to measure daytime sleepiness from sleep loss 
alone, the homeostatic part of sleepiness should be included (i.e. by reducing time in 
bed) and the sleepiness from the circadian drive should be excluded by measuring 




Taking the ultradian model of sleep-wake regulation to induce as much sleepiness as 
possible, it is best to restrict sleep time to the NREM stage only and eliminate the 
REM sleep by awakening participants in early morning.  
Based on the three-process model of sleep-wake regulation and in order to avoid the 
confounding effect of the sleep inertia, a minimum time of 4 hours needs to be 
considered between the wake-up time and the time of measuring sleepiness.  
Considering the effects of these three models, an early morning wake-up time no 
later than 6 am seemed to meet all the considerations of homeostatic and circadian 
drives for sleepiness, sleep inertia, and selective REM sleep deprivation.  
Based on mechanisms of regulating the circadian rhythm of human sleep-wake by 
light, it is important to let the participants be exposed to daylight at the interval 
between the wake-up time and measurement of sleepiness. This insures that daylight 
attenuates the circadian drive for sleepiness to its minimum levels by the time of 
measuring sleepiness from homeostatic drive alone.  
Based on the two-process model of sleep-wake regulation the length of sleep loss is 
of importance and determines the severity of sleepiness from the homeostatic drive. 
Since one-third of non-professional drivers are experiencing sleep debt of 1 hour, a 
minimum 1 hour of sleep deprivation (awakening 1 hour earlier) was determined to 
induce the realistic mild sleepiness and a minimum of four consecutive days were 
considered to induce the chronic sleep deprivation.  
Considering the higher sensitivity of young drivers to sleepiness, drivers between 18 
to 25 years were selected as the sampling group for the experimental study. 
 
Factors that could not be manipulated 
The literature showed that there are other contributors to sleepiness that are not 
included in the computational models of human sleep-wake or alertness regulation.  
These models only apply to mean group data and generally are not able to predict 
individual-level effects (Åkerstedt & Folkard, 1995(b); Cluydts et al., 2002; Van 
Dongen, 2004(a)). Some of these factors such as monotony, stress, drugs and 
participant health status (Åkerstedt & Folkard, 1995(b))could be identified and be 
eliminated by setting some relevant exclusion criteria. However, some of them, 
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particularly inter-individual differences (age, driving experience, personality) could 
not be easily traced. Therefore, the contribution of these factors to driver’s sleepiness 
could be eliminated by using a repeated-measures study design.  
 
2.6.3 Gaps in the knowledge of effects of sleep loss on drivers’ alertness and 
performance  
Even though chronic sleep loss is more realistic and the more often experienced type 
of sleep loss in drivers’ daily lives, most studies have examined the implications of 
acute total or acute partial sleep loss on human sleepiness, alertness and 
performance. In particular, the effects of sleep loss on young drivers’ performance 
are not well understood. Current computational models predicting sleepiness from 
sleep loss are also predominantly based on data from studies of acute total sleep loss 
(Åkerstedt et al., 2008). As a result, the broader effects of sleepiness conferred by 
chronic partial sleep loss (Van Dongen, 2004(a)) are less predictable. Therefore, a 
systematic review of the effects of sleep loss (including chronic sleep loss) on young 
drivers’ performance was conducted and is presented in Chapter 3:. 
This literature review (Chapter 2) did not include the alerting effects of light and 
caffeine. A review of the alerting effects of light and caffeine on sleepy drivers in the 
driving context was conducted and is presented in Chapter 4.  
The literature also revealed no evidence of the effect of commercially available light 
and caffeine on young drivers’ alertness and performance after chronic partial sleep 
loss. Therefore, those effects were examined in an experimental study (presented in 
Chapter 5:).   
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Chapter 3: A Systematic Review and the 
GRADE Rating Analyses of the 
Evidence on the Effects of Sleep 
Loss on Young Drivers’ 
Performance  
The effects of sleep on young drivers’ performance are systematically reviewed and 
the quality of the body of evidence is graded in this chapter. As a systematic review 
can be regarded as scientific investigation in itself (Mulrow, 1994), it has been 
presented here as a separate chapter.  
This chapter begins with a definition and description of the benefits of systematic 
reviews and meta-analyses (Section 3.1). The rationale for conducting this specific 
systematic review is provided in Section 3.2. The methods of conducting the 
systematic review in this research, the GRADE rating analysis, and the results of the 
review and GRADE analysis are explained in Section 3.3 and Section 3.4, 
respectively. Finally, the conclusions are provided in Section 3.5.   
 
3.1 DEFINITION AND BENEFITS OF SYSTEMATIC REVIEWS AND 
THE GRADE RATING ANALYSIS 
Systematic reviews are a rigorous type of literature review  (Mallett, Hagen-Zanker, 
Slater, & Duvendack, 2012) driven by the principles of evidence-based medicine, 
and particularly by the methods developed and promoted by the Cochrane 
Collaboration (Higgins & Green, 2008). Based on the Cochrane Collaboration 
definition, a systematic review is “a review of a clearly formulated question that uses 
systematic and explicit methods to identify, select, and critically appraise relevant 
research, and to collect and analyse data from the studies that are included in the 
review” (Fineout-Overholt, Melnyk, Stillwell, & Williamson, 2010). 
Systematic reviews have evolved to identify, critically assess, and synthesise the 
research already conducted in a field, with particular emphasis on the inclusion of 
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high-quality quantitative and/or qualitative evidence. This can be done to make the 
results from a sometimes large and diverse literature available in a reliable, succinct 
and usable format (Fineout-Overholt et al., 2010; Korhonen, Hakulinen‐Viitanen, 
Jylhä, & Holopainen, 2013; Mallett et al., 2012). 
While traditional narrative reviews are subject to the bias and impressions of the 
individual reviewers (Mulrow, 1994), the values and benefits of systematic reviews 
are now well-established. This approach enables the researcher to capture all the 
available literature, addresses systematic errors of bias and increases the reliability, 
accuracy and confidence in conclusions across the body of evidence addressing a 
specific question (Fineout-Overholt et al., 2010). It is typical in the literature for 
there to be inconsistencies in the direction and magnitude of effects between studies 
(Mulrow, 1994). Such inconsistencies can arise from different study designs, 
different eligibility criteria for participants, different definitions and measurement 
methods for exposure, and different interventions. This approach is now recognized 
beyond the Cochrane Collaboration, with many journals either dedicated to, or 
accepting of, systematic reviews. 
A meta‐analysis is the statistical combination of results from at least two studies to 
generate estimates of the effect of the intervention with greater precision (Korhonen 
et al., 2013; Mulrow, 1994). Meta-analysis is not always included in a systematic 
review (Fineout-Overholt et al., 2010), but systematic reviews of randomised 
controlled trials (RCTs) which have adopted a meta-analysis of results, are regarded 
as the best (level 1) evidence (Korhonen et al., 2013). It should be noted that because 
of insufficient studies of sleep deprivation paradigms and driving tasks with shared 
outcome measures and methodological differences in sample size, it was not possible 
to conduct a meta-analysis in this study. Therefore, only the directions of findings 
were compared, followed by a GRADE rating analysis of quality of the body of 
evidence. 
 
3.2 RATIONALE FOR CONDUCTING A SYSTEMATIC REVIEW 
Young drivers appear to be at a higher risk of road crashes than are older drivers 
(Campagne et al., 2004; Horne, J.A & Reyner, 1995; McCartt et al., 1996; Ting et 
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al., 2008). The increased risk of being involved in a traffic crash for drivers younger 
than 24 years has been estimated to be 2 to 10 fold higher when compared to other 
age groups (Åkerstedt et al., 2001; Sagaspe, P et al., 2010). Young drivers also 
comprise a greater proportion of driver fatalities. For example, young drivers 
comprise only 13% of the Australian population, but comprise 22% of driver 
fatalities (Bureau of Infrastructure Transport and Regional Economics (BITRE), 
2013). The quantification of the effects of sleep deprivation on young drivers’ 
performance has important implications for determining the potential benefit of the 
alerting effects of countermeasures, such as exposure to light. For this purpose, it is 
crucial to understand the effects of sleep loss on young drivers’ performance. There 
are currently about 150 papers published on the effects of sleep loss on drivers’ 
sleepiness outcomes. A small proportion of the existing literature has examined the 
effects of sleep loss on young drivers’ performance-related outcomes specifically. 
There are also substantial inconsistencies between findings in the existing literature 
due to different study designs, different sleep deprivation regimens, different 
outcome measures, different definitions of similar outcome measures of driver 
performance, and variable measurement methodologies. These discrepancies have 
made it difficult to draw reliable conclusions about the directions and magnitude of 
the above-mentioned effects. To the best of the researcher’s knowledge there is only 
one systematic review, published in 2001, examining the effect of driver sleepiness 
on crash rates (Connor, Whitlock, Norton, & Jackson, 2001). To date there are no 
narrative reviews or systematic reviews available on the effects of sleep loss on 
drivers’ performance, particularly on the performance of young drivers.  
Given the higher sensitivity of young drivers to sleep loss, and current uncertainty 
about the nature, directions and magnitude of the effects of sleep loss on young 
drivers’ performance, a systematic review and GRADE rating analysis on the effects 
of sleep loss on young driver’s performance were undertaken. 
 
3.3 METHOD OF SYSTEMATIC REVIEW 
Different methods for the conduct and transparent reporting of systematic reviews 
have been recommended since QUOROM (Quality Of Reporting Of Meta-analysis; 
(Moher et al., 1999), the first guidelines for reporting meta-analyses, were developed 
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in 1999. The PRISMA statement (Preferred Reporting Items for Systematic reviews 
and Meta-Analysis; (Moher, Liberati, Tetzlaff, & Altman, 2009) was introduced in 
2005 as an evolved version of the QUOROM guidelines. The PRISMA statement 
comprises a checklist of 27 items that should be reported in systematic reviews to 
reflect the findings of the review explicitly, following a four-phase flowchart from 
identification to inclusion of studies in the review. A novel series of statements, the 
GRADE (Grading of Recommendations Assessment, Development and Evaluation) 
guidelines, were introduced from 2011 to 2013 in a series of 15 papers published in 
the Journal of Clinical Epidemiology (Andrews et al., 2013(1); Andrews et al., 2013(2); 
Balshem et al., 2011; Brunetti et al., 2013; Guyatt et al., 2011(1); Guyatt et al., 2011 
(2); Guyatt et al., 2011(5); Guyatt et al., 2011(7); Guyatt et al., 2011(6); Guyatt et al., 
2011(4); Guyatt et al., 2013(2); Guyatt et al., 2011(8); Guyatt et al., 2011(3); Guyatt 
et al., 2013 (3)). These guidelines can be adopted as part of systematic reviews to 
assist in summarising the findings, to grade the quality of evidence provided by the 
findings, and to summarise the magnitude of the effects of interventions (Guyatt et 
al., 2011(1)). A wide range of potential clinical applications were considered in 
developing the GRADE guidelines and this approach is used to guide reviews in 
public health (Dijkers, 2009). Because of its wide range of applications, the GRADE 
approach was chosen to inform the approach of this review. GRADE provides 
guidelines to develop a research question, to select the important outcome measures 
in terms of their benefits for consumers, and to evaluate the quality of evidence for 
those outcome measures. This system is applicable for grading both high quality and 
low quality evidence (and is the first approach that downgrades or upgrades the 
quality of evidence (Dijkers, 2009). The primary literature review (Chapter 2:) 
identified diversity in study approaches and probable quality in the literature, so this 
framework was used to formalize that impression.   
The current systematic review was undertaken according to the PRISMA and 
GRADE guidelines. Based on these guidelines, a review protocol was developed that 
included the following explicit steps: 
1. Development of the research question 
2. Definition of scope, inclusion and exclusion criteria  
3. Systematic search for information  
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4. Screening and selection of eligible studies based on PRISMA flowchart 
5. Review of selected reports based on the GRADE guidelines 
6. Grading the quality of the body of evidence using the GRADE criteria 
7. Summarising effect sizes using GRADE guidelines 
 
3.3.1 Research question 
The research question was first developed using the PICOS approach described in 
the PRISMA guidelines (Moher et al., 2009). In this approach, the research question 
is ideally constructed after consideration of Population, Intervention, Comparator 
(control), Outcomes and Study design elements.  The research question that evolved 
from the PICOS approach was: 
What are the effects of sleep loss on young drivers’ performance outcomes? 
Young drivers in this review were considered to be adults aged from 18 to 24 years. 
Selection of this age range was based on conventional classification of young adults 
in sleep and circadian studies. The term ‘sleepiness’ refers to the term ‘fatigue’ as 
well. Fatigue in this review refers to an undistinguishable feeling of sleepiness and 
tiredness due to a long drive or monotonous driving conditions (Phillips, 2015). 
However, due to the lack of a standard definition for sleepiness and fatigue, we have 
used them interchangeably to address the need for sleep. All forms of sleepiness or 
fatigue, induced by acute or chronic sleep loss, including extended wake duration, 
early morning wakeup (sleep limitation), sleep fragmentation or sleep disturbance 
were included in the review. Driver performance outcomes of interest included both 
cognitive and in-vehicle performance outcomes in real on-road or simulated driving 
experiments. All forms of study design including Randomised Control Trials 
(RTCs), observational studies such as longitudinal, quasi-experimental, correlational 
experiments, and cross-sectional studies, were reviewed. Only peer-reviewed original 
research papers were included in the review to ensure the quality of the body of 
evidence.  Since all study designs were included in the review, the study design was 
not reflected in the research question. This research question dictated the search 
strategy to be taken. 
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3.3.2 Scope of review 
The review included only peer-reviewed papers of any design published from 2004 
to 2014 that examined the effects of any type of sleep loss on young drivers’ 
cognitive and driving performance outcome measures from any on-road or simulated 
driving paradigm (see Section 3.2). Only papers published in English were 
considered because translation of information from other languages may increase the 
risk of bias (Patil & Davies, 2014). Additionally, exclusion of non-English literature 
has little effect on estimation of effects (Jüni, Holenstein, Sterne, Bartlett, & Egger, 
2002). 
 
3.3.3 Inclusion criteria 
Papers were eligible for review if they met all criteria as described in Table 3.1.  
 
3.3.4 Systematic search for information  
A comprehensive Boolean/Phrase search was conducted from 27 July 2014 to 12 
August 2014 for papers within electronic data bases including: PsycINFO (via 
EBSCOhost), PsycARTICLES (via EBSCOhost), MEDLINE (via EBSCOhost), 
Science Direct, ProQuest Psychology journals database, Web of Science, Scopus, 
Ergonomic Abstracts (via EBSCOhost), PubMed (via NCBI), Trip, CINAHAL (via 
EBSCOhost), Transportation Research Information Database, The Cochrane Library 
and EMBASE. 
The following key words were included in the search statement: [(“sleep depriv*” 
OR “sleep loss” OR “sleep limitation” Or “sleep restriction”) AND (“sleepiness” OR 
drows* OR hypersomnol* OR “sleep onset” OR “excessive sleep*” OR “sleep 
propensity” OR fatigue* OR microsleep* OR alert* OR vigilance OR hypovigilan*) 
AND (driver OR simulator OR vehicle OR “commercial drivers” OR “professional 
driver” OR “driver performance” OR “truck driver” OR “bus driver”)].  
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Table 3.1. Criteria for inclusion of papers in the systematic review 
No Inclusion Criterion Description 
1 Young participants Participants were young (18-24 years old), healthy, non-professional and non-shift working car 
drivers who were free from sleep disorders 
2 Sleepiness caused by 
sleep loss 
Sleepiness was induced by sleep deprivation. This means that studies examining other forms 
of sleepiness without any prior sleep deprivation (e.g. time-on task fatigue or usual daytime 
sleepiness) were excluded from the study. However, studies that could not distinguish 
sleepiness caused by sleep loss from sleepiness (fatigue) from time-on task were included. 
3 All forms of sleep loss All forms of sleep loss acute or chronic sleep loss, including extended wake duration, early 
morning wakeup (sleep limitation), sleep fragmentation or sleep disturbance were identified as 
eligible. 
4 Sleep loss as exposure Sleep deprivation was the main exposure; studies examining the effect of other agents (e.g. 
light, Modafinil, caffeine, nap, rest, exercise, etc.) on sleep deprived subjects were excluded, 
5 Driving performance as 
primary outcome 
measures 
The primary outcome measures of interest were driver performance on either a driving 
simulator or real road; studies measuring driving performance in all forms along with other 
objective and subjective determinants of sleepiness were included. Studies on prevalence of 
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No Inclusion Criterion Description 
sleepy driving were excluded 
6 Published in the last 10 
years 
Published between 1 January 2004 and 30 December 2014 
7 All types of study design There was no study design limitation to this systematic review. Therefore, all types of study 
design including  RCTs, experiments, cross-sectional and observational studies were included 
8 Only peer-reviewed Only papers published in peer-reviewed journals were included 






Some data bases such as the Transportation Research Information Database, The 
Cochrane library and EMBASE do not utilise asterisk (*) within their search 
strategy. Therefore, the complete wordings of key words were substituted for 
searches within these databases.  
From 7/12/2014 to 14/12/2014 all searches were updated to find all new papers 
published from 1/08/2014 to 31/12/2014. The precise search statements and limiters 
are presented in the Table 3.3. 
Using filters in some databases, the findings were narrowed to only peer-reviewed 
papers published between 2004 and 2014. In some cases the journal websites were 
checked directly for verification of their peer-review processes. Search alerts were 
activated in some databases to automatically update the records. Bibliographic 
records of all identified papers were also examined to identify additional potential 
papers for inclusion. 
 
3.3.5  Screening and selection of eligible studies  
The selection of papers for review was undertaken as described by the search flow 
diagram in the PRISMA statement. Firstly, all studies retrieved from the databases or 
from examining the references were included. Secondly, after aggregating all records 
and removing duplicates, the title and abstracts of all papers were checked against 
the inclusion criteria. In the next phase, the full-text prints of the selected papers 
were assessed against the eligibility criteria, and the reasons for inclusion/exclusion 
of papers were documented. Finally, papers were selected after a discussion with 
other members of the research team, and a consensus method was used to make a 
decision in case of any discrepancy. Whenever possible, further information was 
sought from authors of the selected papers about their study.  
 
3.3.6 Review of selected reports using the GRADE 
Summarising the papers 
Once the selection was completed, the important elements of studies were 
summarised and sorted by the outcome measures of interest. It should be noted that 
all items specified in GRADE (developed primarily for review of health and medical 
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literature) were not applicable to studies on road safety. Therefore, some important 
aspects of studies such as study design, sample size, participants’ age range, sleep 
deprivation regime, driving conditions, and findings were considered for each 
outcome measure. In the next step, the important strengths and potential flaws of 
studies underlying the quality of each outcome were extracted and documented to 
assess the quality of the ‘body of evidence’. 
 
Grading the quality of body of evidence 
In order to grade the quality of individual papers using the GRADE guidelines 
(Balshem et al., 2011), the applicable factors for downgrading or upgrading the 
quality score were identified as the grading criteria. Since GRADE is flexible and 
relies to some extent upon the judgment of the researcher, some other important 
downgrading and upgrading factors specific to the available data and sleep studies 
were also considered and added to these criteria. In the next step, based on the 
GRADE guidelines, a multi-step approach was used to grade the quality of the ‘body 
of evidence’ for each specific outcome. First the quality of each individual paper, and 
then then the quality of the body of evidence (all available papers), was determined 
for each given outcome.  
 
Grading the quality of each individual paper 
Firstly, it should be clarified that GRADE is an outcomes-based guideline. This 
means that the GRADE approach rates the quality of each paper, and then the whole 
body of evidence for a single outcome measure. The quality of each paper for a given 
outcome measure was assessed by adopting some GRADE criteria (downgrading and 
upgrading factors). This process involved deducting one point for downgrading 
factors and then by adding one point for upgrading factors as follows: 
Firstly, the quality of papers was scored for their study design. Randomised control 
trials (RTCs) initially scored a rating of ‘high-quality’ while observational studies 
using longitudinal, quasi-experimental and correlational designs and cross-sectional 
studies were initially assigned a ‘low-quality’ score. Studies were then downgraded 
for the quality of findings for each outcome measure in light of factors such as study 
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limitations (risk of bias), imprecision (i.e. broad confidence intervals), inconsistency 
of results between studies, indirectness (caused by findings from similar population 
i.e. stroke instead of traumatic brain injury), and likelihood of publication bias (not 
publishing the study at all due to null or contrary findings). Risk of bias is considered 
a major factor for downgrading the quality of papers. Risk of bias refers to problems 
with “validity” or “internal validity” of the study. Different causes of risk of bias 
have been identified for RTCs and observational studies. Important contributors to 
risk of bias in observational studies include inappropriate inclusion/exclusion criteria 
for participants, flawed measurement of both exposure and outcome, and 
inappropriate control for confounders (Guyatt et al., 2011(1)). 
Secondly, the quality of papers were upgraded if a large magnitude of effect on the 
outcome was reported, a dose response relationship was described, or some 
confounders were involved which acted to minimise the effects of the independent 
variable. A single quality score for each outcome measure for each paper was 
generated by adding all assigned points.  
Finally, an Overall Grade Score (OGS) across the body of evidence (all papers 
reporting the same outcome measure) was derived (Guyatt et al., 2011(1)).  The 
overall score was not simply an average of scores for each outcome across papers,  
but was based on the contribution of each paper to the quality of the body of 
evidence. For example, studies with larger sample sizes had a greater impact on the 
overall quality score (Guyatt et al., 2011(1)). Therefore, a special algorithm was 
developed to estimate the OGS of the body of evidence. This algorithm is explained 
in Section 3.4.7. 
 
3.3.7 Estimate of effect size 
Effect size refers to either of the strength of relationships or to the magnitude of 
differences described in the studies. The correlation coefficient (r) or regression 
coefficient (R), commonly reported as indices of association, are in fact measures of 
effect sizes. These coefficients can show the whole range of positive, zero, or 
negative relationships in a precise way, and are also coefficients that are independent 
of sample size. Most publications identified in this review reported effect sizes in an 
unstandardized way, for example, as a measure of difference in the original units (i.e. 
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a 0.4 second increase in reaction time after sleep loss). This is a measure of effect 
giving the actual difference; however, does not give any idea whether the difference 
represents a big, medium, or small effect. Ideally, these actual differences should be 
accompanied by standardised effect size measures to allow comparison of effects 
between studies. The standardized effect sizes are independent of what is being 
measured (measuring units) and are calculated by the same scale for all types of 
effect (Walker, 2008). 
According to Cohen’s rules of thumb for interpreting effect sizes (Cohen, 2013), a 
“small” effect size refers to a real effect observable through careful study. A “large” 
effect size is a substantial effect (big enough, and/or consistent enough) which can be 
easily observed. As an example, r = 0.1 conventionally represents a 'small' effect 
size, while r = 0.3 and r = 0.5 refer to a 'medium' and a 'large' effect size, respectively 
(Walker, 2008).   
Table 3.2 represents some conventions for the description of different standardised 
effect sizes (Watson et al., 2015). Each paper was searched for estimates of effect 
size reported in any of these ways (Table 3.2). The reported effect sizes are presented 
in Table 3.7. 
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Table 3.2 Standardised effect sizes and their magnitudes (adopted from Watson et al., 
2015) 
Effect Size Metric  Use  Small  Medium  Large  
r Correlation 0.1  0.3  0.5  
η2 one-way Anova (regression)  0.01  0.06  0.14  
η2 Anova  0.02  0.13  0.26  
omega-squared  Anova  0.01  0.06  0.14  
Multivariate eta-squared  one-way MANOVA  0.01  0.06  0.14  
Cohen's f  one-way an(c)ova (regression)  0.10  0.25  0.40  
η2 Multiple regression  0.02  0.13  0.26  
κ2 Mediation analysis  0.01  0.09  0.25  
Cohen's f  Multiple Regression  0.14  0.39  0.59  
Cohen's d  t-tests  0.2  0.5  0.8  
Cohen's ω  chi-square  0.1  0.3  0.5  
Odds Ratios  2 by 2 tables  1.5  3.5  9.0  




3.4  RESULTS 
3.4.1 Database search and data extraction 
Overall 369 records were found through the initial database search. One relevant 
paper was later identified by searching the references of selected papers.  
Of the initial 370 records, 240 duplicates were removed.  The titles and abstracts of 
the 132 remaining papers were then screened.  Using the inclusion/exclusion criteria 
described in Table 3.1, a further 53 studies were excluded. The seasons for exclusion 
were: studies of professional drivers or shift workers (criterion 1), published in non-
peer-reviewed journals (criterion 9), or review papers on the prevalence of sleepy 
drivers (criterion 5). From the 79 remaining records, 69 papers were excluded after 
assessing their full text, due to a primary focus on independent variables other than 
sleep deprivation (criterion 4), having participants with age range outside of 18-24 
years (criterion 1), and for not including driver performance as dependent variables 
(criterion 5).  The 10 remaining papers were included in the systematic review.  
Table 3.3 illustrates the search statement terms and limiters, and the number of 
papers initially identified for inclusion in the review. Figure 3.1 presents the data 
extraction flowchart. 
  
Table 3.3 Search statements and limiters 



































Statement (a)  
Publication date from Jan/2004 to 
Aug/2014 
 
132 111 56  
 
 
7/12/2014 3 3 59 





Statement (b) Published Date: 20140108-
20141231; Scholarly (Peer Reviewed) 
Journals; Age Groups: Adulthood (18 yrs 
& older), Young Adulthood (18-29 yrs), 
Thirties (30-39 yrs), Middle Age (40-64 
yrs), Aged (65 yrs & older), Very Old (85 




48  8/12/2014  6 5 53 
3 PsycARTICLES 




Statement (b) Published Date: 20040101-
20140731; Scholarly (Peer Reviewed) 
Journals; Age Groups: Adulthood (18 yrs 
& older), Young Adulthood (18-29 yrs), 
Thirties (30-39 yrs), Middle Age (40-64 
yrs), Aged (65 yrs & older), Very Old (85 
yrs & older)  
80 
 
0 0 8/12/2014 0 0 0 
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Statement (b) Date of Publication: 
20040101-20140731; Human; Age 
Related: Young Adult: 19-24 years, Adult: 
19-44 years, Middle Aged: 45-64 years, 
Middle Aged + Aged: 45 + years, Aged: 
65+ years, Aged, 80 and over, All Adult: 





45 9/12/2014 0 0 45 




Statement (b)  
In Psychology, Neurosciences and social 
sciences 
















Statement (b)  
Date: From 01 January 2004 to 31 July 
2014 
Age group: Adult (19-44 years), Aged (65+ 
years), Aged (80+ years), Middle aged (45-
64 years) 
Source type: Books, Dissertations & 




17 2  
 
9/12/14 0 0 2 




Statement (b)  




10 6  
 
9/12/14 22 4 10 
  































Statement (b)  





169  81  
 








Statement (b) using smart search 






13  14/12/2014 4 4 17 




Statement (b) in NBCI homepage 
Additional filters: publication date from 
1/01/2004 to 31/08/2014, 
Age 19+ years 
 
84 52 24  14/12/2014 0 0 24 





Statement (a)   






1 0 14/12/2014 0 0 1 










23 10  14/12/2014 
 
0 0 10 
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61 39  
 
14/12/2014 6 3 42 





Statement (b)  
Published Date: 20040101-20140831; Peer 
Reviewed; Human; Age Groups: Adult: 
19-44 years, Middle Aged: 45-64 years, 




9 1 14/12/2014 0 0 1 
Search statements: (driver or simulator or vehicle or "commercial driver" or "Professional driver" or "driver performance" or "truck driver" or "bus driver") and (sleepiness or 
drowsiness or hypersomnolence or "sleep onset" or "excessive sleepiness" or "sleep propensity" or fatigue or microsleep or alertness or vigilance or hypovigilance) and 
("sleep deprivation" or "sleep loss" or "sleep limitation" or "sleep restriction") 
 (“sleep depriv*” OR “sleep loss” OR “sleep limitation” Or “sleep restriction”) AND TX (“sleepiness” OR drows* OR hypersomnol* OR “sleep onset” OR “excessive 
sleep*” OR “sleep propensity” OR fatigue* OR microsleep* OR alert* OR vigilance OR hypovigilan*) AND TX (driver OR simulator OR vehicle OR “commercial drivers” 















3.4.2 Summary of reviewed papers  
Study design and sample size 
There was no available randomised control trial within the body of evidence. Instead, 
there was a homogenous group of quasi-experimental studies including cross-over (n 
= 3), between-groups (n = 4) and within-group (n = 3) designs. All papers reported 
on more than one outcome measure. The sample sizes ranged from 8 to 41 
participants, with less than 15 subjects for five papers, between 20 to 26 subjects for 
three papers and 40 to 41 participants for two papers. Most studies recruited only 
male participants, with only three reports including female participants (Contardi, 
Pizza, Sancisi, Mondini, & Cirignotta, 2004; Lowden et al., 2009; Pizza, Contardi, 
Mostacci, Mondini, & Cirignotta, 2004; Rupp, Arnedt, Acebo, & Carskadon, 2004). 
The study designs, sample sizes, and age ranges of participants are presented in 
Table 3.4. Table 3.5 provides sleep deprivation regimes in the reviewed papers and 
Table 3.6 shows the driving settings across the reviewed studies. 
The driving tasks differed in terms of time of driving, coincidence with sleep 
deprivation time, the frequency of driving, and the duration of the drives. For 
instance, driving time (time-on-task) ranged from 10 min to 8 hours, with five studies 
examining durations of 1.5 to 2 hours, and four studies using short drives of either 30 
minutes or 10 minutes. Only one study adopted a long driving protocol of 4 and 8 
hours. These significant differences in sample size, the sleep deprivation paradigms 
and driving tasks presented challenges for comparing the findings and for assessing 
the generalisability of the findings. 
  
Table 3.4 Study designs, sample sizes and age range of participants in the reviewed papers 
Study design  Sample size and age range 
N < 16 20 < N < 27 39 < N < 42 
Cross over (Philip et al., 2005(b)) (12 men; 19-24 yrs.),  
 (14 men; 21–25 yrs.)  
(Philip et al., 2005(a)) (22 men; 18-
24 yrs.),  
 
Between-groups  (Lowden et al., 2009) (5 young 
men, 5 young women; 18–24 yrs.), 
(5 old men, 5 old women; 55–64 
yrs.) 
(Matthews et al., 2012(b)) (41 men: mean 
21.8 (± 3.8) yrs.),  
(Filtness, Reyner, & Horne, 2012) (20 
young men; 20–26 yrs., 20 old men; 52–
74 yrs.) 
Within-groups (Anderson & Horne, 2013) (8 men; 20-26 
yrs.), 
(Matthews et al., 2012(a)) (14 men; mean 
21.8 (± 3.8) yrs.) 
  
Not reported explicitly (Pizza et al., 2004) (10 men, 10 women; 
mean 24.9 (± 0.6) yrs.) 
(Rupp et al., 2004) (13 men, 13 








Duration  Acute sleep loss   Chronic sleep loss Extended wake 
  Moderate Severe Total Moderate to severe  
Simulator 10 min    (Matthews et al., 2012(a)), 
(Matthews et al., 2012(b)) 
 
 30 min (Rupp et al., 
2004) 
(Rupp et al., 
2004) 
(Pizza et al., 2004)   
 1.5 
hours 
    (Lowden et al., 2009), 
 2 hours     (Anderson & Horne, 2013), 
(Filtness et al., 2012) 
On-road 4 hours     (Sagaspe, P et al., 2008), 
(Verster, Taillard, Sagaspe, 
Olivier, & Philip, 2011) 
 8 hours     (Sagaspe, P et al., 





 (Philip et al., 
2005(a); Philip et 
al., 2005(b)) 
   
  
Table 3.6 Driving setting in the reviewed papers 
 
Author Type of driving setting 
*(Sagaspe, P et al., 2008), 
(Verster et al., 2011) 
Two- lane highway 
 
(Anderson & Horne, 2013) Immobile car with a computer generated road projection 
  
(Philip et al., 2005(b)) Divided Attention Steering Simulator (Stowood Scientific Instruments, Oxford, UK) 
 
*(Pizza et al., 2004), (Contardi 
et al., 2004) 
STISIM 300 Driving Simulator, System Technology Incorporated, Hawthorne, USA 
 
(Matthews et al., 2012(a)) York Driving Simulator (YDS; DriveSim 3.00; York Computer Technologies, Kingstone, Ontario, Canada 
 
(Matthews et al., 2012(b)) York Driving Simulator (YDS; DriveSim 3.00; York Computer Technologies, Kingstone, Ontario, Canada 
 
(Philip et al., 2005(a)) Open Highway 
 
(Lowden et al., 2009) Hi-Fi moving base simulator (Volvo 850, Volvo Personbilar Sweden AB, Gothenburg, Sweden) 
 
(Filtness et al., 2012) Immobile car with a computer generated road projection 
*One study published in two papers
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3.4.3 Magnitudes of effects (effect sizes) 
Table 3.7 provides a summary of the magnitude of findings arranged by outcome 
measures. Of the 10 papers reviewed in this study, nine lacked any report of effect 
sizes such as partial eta square, Cohen’s d, coefficient of correlation (r), or 
coefficient of determination (r
2
) in their results.  Only one paper (Rupp et al., 2004), 
reported the effect sizes as Cohen’s d. Most studies reported unstandardized effect 
sizes (the differences in outcome variables reported in the actual units of that 















Time of day Outcome magnitude/effect size 
Lateral 
position  
(Philip et al., 
2005(b)), France 
Car distance from lateral lanes, 
Cross-over study comparing 6 times 
real and simulated driving after 
habitual sleep (8 h) or only sleep for 
2 hours, from 11p.m. to 1 a.m.) 
 
Sleep for 2 
h, from 
11p.m. to 1 
a.m.) 
1.5 h 6 times/ day 
from 9 a.m. to 
9:30 p.m. 
This variable was not a primary interest outcome, 
but was prerequisite of other outcomes. 
(Philip et al., 
2005(a)), France 
Car distance from lateral lanes, 
Cross-over study comparing 5 times 
real driving after habitual sleep (8 h) 
or only sleep for 2 hours, from 11 
p.m. to 1 a.m.) 
 
Sleep for 2 
hours, from 
11 p.m. to 1 
a.m.) 
1.5 h 5 times/ day 
from 9 a.m. to 
7:30 p.m. 
This variable was not a primary interest outcome, 




Distance from centre of the car to the 
left lane marker, 
Between-participant comparison, 
comparison of control group and 
medium and severe sleep deprived 
groups 
Chronic 
sleep loss in 
two doses: 1 
h sleep loss, 
and 3 h 
sleep loss  
 
10 min 8-9 times/day, 







This variable was not a primary interest outcome, 




Distance from centre of the car to the 
left lane marker, 
Within-participant comparison of 
each participant after normal sleep 
with chronic moderate sleep 
Chronic 
sleep loss, 3 
h sleep loss 
(5 h sleep) 
10 min 9 times/day, 















Time of day Outcome magnitude/effect size 
deprivation by 7 periods of forced 
desynchronized with 23.33 h of wake 




(Pizza et al., 
2004), Italy 
Distance from the car to the left lane 
marker, within-participant 
comparison of each participant after 




loss for one 
night 




This variable was not a primary interest outcome, 
but was prerequisite of other outcomes. 
(Lowden et al., 
2009), Sweden 
Perpendicular distance between the 
right side of the right front wheel and 
the left side of the right-hand lane 
boarder, between-participant 
comparison of performance of young 
and elderly participant after normal 
sleep with extended wakefulness 
 
5.5 h sleep 
loss 
(extended 
wake) and 2 
h sleep 
1.5 h Dual drives in 
afternoon and 
night time 
This variable was not a primary interest outcome, 
but was prerequisite of other outcomes. 
(Philip et al., 
2005(b)), France 
Mean lateral deviation from centre of 
the road, 
Cross-over study comparing 6 times 
real and simulated driving after 
habitual sleep (8 h) or only sleep for 
2 hours, from 11 p.m. to 1 a.m.) 
 
Sleep for 2 
h, from 11 
p.m. to 1 
a.m.) 
1.5 h 6 times/ day 
from 9 a.m. to 
9:30 p.m. 
This variable was not a primary interest outcome, 
but was prerequisite of other outcomes. 
(Pizza et al., 
2004), Italy 
Deviation in road position from lane 
centre, 
Total sleep 
loss for one 
30 min Between 
morning and 
Mean lane position did not show any significant 










Time of day Outcome magnitude/effect size 
Within-participant comparison of 
each participant after normal sleep 
with after sleep deprivation 
 
night afternoon 0.99) 
 (Rupp et al., 
2004),  Brown 
University 
Moderate Sleep loss (5 h sleep) 
for restricted group (n = 13), 
Severe Sleep loss (3 h sleep) 
for restricted group (n = 13) 
 
Sleep loss 
for 3 h, 
Sleep for 5 
hours 
30 min  between 1a.m 
and 9 a.m., 
between 3 a.m. 
and 9 a.m. 
No significant main effects or interactions 




(Pizza et al., 
2004), Italy 
Lateral position: distance from the 
car to the midline, 
Within-participant comparison of 
each participant after normal sleep 
with after sleep deprivation 
Total sleep 
loss for one 
night 
30 min Between 
morning and 
afternoon 
The lane position variability had a significant 
increase with the highest increase of 0.20 from 
basal condition (0.32) to sleep deprived condition 
(0.52) at 2 p.m. (χ2 = 0.003, p<0.05). Effects size 





Lateral position: distance from centre 
of the car to the left lane marker. 
 Between-participant comparison, 
comparison of control group and 
medium and severe sleep deprived 
groups 
Chronic 
sleep loss, 1 
h sleep loss 
(7 h sleep), 
3 h sleep 
loss (5 h 
sleep) 
10 min 8-9 times/day 






Sleep dose of either moderate or severe sleep 
restriction significantly increased SD of lateral 
position (F2,1923 = 95.81, p < 0.001). 
Significant effect of chronic sleep debt (day) only in 
moderate sleep restriction (F6,1923 = 7.96, p < 0.001); 
The standard deviation of lateral position increased 
from -0.02 m on day 1 to -0.05 m on day 7. 
A significant effect of times of day (F5,1923 = 17.96, 
p < 0.001); in moderately sleep restricted group SD 
of lateral position increased from -0.0.75 m at 180° 












Time of day Outcome magnitude/effect size 
A significant effect of prior wake (F8,1923 = 4.33, p < 
0.001); moderate sleep restriction SD of lateral 
position increase from -0.075 m after 2 hours of 
prior wake to 0.05 m after 20 hours of prior wake, 
an increase of 0.125 m 
 
(Lowden et al., 
2009), Sweden 
Lateral position: perpendicular 
distance between the right side of the 
right front wheel and the left side of 
the right-hand lane boarder, 
 Between-participant comparison of 
performance of young and elderly 
participant after normal sleep with 
extended wakefulness 
 




) and 2 h 
sleep 
1.5 h Dual drives in 
afternoon and 
night time 
From 30th minutes of drive onwards the standard 
deviation of lateral position increased from 0.17 in 
the early evening drive to 0.3 in the night time 




Lateral position: distance from centre 
of the car to the left lane marker, 
 Within-participant comparison of 
each participant after normal sleep 
with chronic moderate sleep 
deprivation by 7 forced 
desynchronized periods of 23.33 h of 




for 3 hours, 
Sleep for 5 
hours 
10 min Midnight The standard deviation of lane position (m) after 
sleep loss was significantly higher at different times 
of day (p < 0.001) or various prior wake times (p = 
0.005) or different days with growing sleep debt (p 
= 0.008), with the highest difference of 0.065 m and 
0.05 m at 60° after nadir and after 22 hours of prior 
wake respectively. Effects size has not been 
reported 
(Rupp et al., 
2004), Brown 
Lateral position: deviation from 
centre of the road, 
Sleep loss 
for 3 h, 
30 min between 1a.m. 
and 9 a.m., 
A significant interaction of group and task type: 










Time of day Outcome magnitude/effect size 
University  Between-group comparison group 
after normal sleep, moderate and 
severe Sleep deprivation  
 
Sleep for 5 h between 3 a.m. 
and 9 a.m. 
group for the dual driving and subtraction task 
versus the single driving task (medium effect size, 
Cohen’s d = 0.79), 
A significant interaction of group and session: lane 
variability was greater among sleep deprived group 
than the control group, 






(Sagaspe, P et 
al., 2008), 
France 
Inappropriate line crossing (ILC) car 
crosses one of lateral lane markers, 
Cross-over design comparison of 
each participant the effect of 2, 4 and 
8 h night time driving (extended 
wakefulness) on every participant  
Sleep loss 
for 6 h 
(extended 
wake), 





the wake time 
Compared to the reference session (9–10 p.m.), the 
incidence rate ratios of inappropriate line crossings 
were 6.0 (95% CI, 2.3 to 15.5; P,.001), 15.4 (CI, 4.6 
to 51.5; P,.001) and 24.3 (CI, 7.4 to 79.5; P,.001), 
respectively, for the three different durations of 





Driving incidents characterise d by at 
least two wheels of the vehicle 
leaving the carriageway, 
 Within-participant comparison of 
each participant after normal sleep 
with extended wakefulness 
Sleep loss 
for 3 h, 
Sleep for 5 h 
2 h Afternoon at 2 
p.m. 
There was a positive correlation between number of 
distractions and number of lane crossings under 
sleep restriction (large effect size r = 0.74), such 
that from 2308 distractions under sleep deprivation 
474 distraction directly resulted in incidents (t = 





Lane violation (crash): centre of the 
car leaves the road or car hits the 
adjacent car, 
Within-participant comparison of 
each participant after normal sleep 
Sleep loss 
for 3 h, 
Sleep for 5 h 
10 min Midnight The number of line crossings (lane violations), after 
sleep loss was significantly higher at different times 
of day (p < 0.001) or various prior wake times (p < 
0.001) or different days of experiment (p < 0.001), 











Time of day Outcome magnitude/effect size 
with chronic moderate sleep 
deprivation by 7 periods of forced 
desynchronized with 23.33 h of wake 
followed by 4.67 h of time in bed 
 
difference of 0.32 count and 0.30 count at 60° after 
nadir and after 22 hours of prior wake respectively. 
Effects size has not been reported 
(Philip et al., 
2005(b)), France 
Line crossings: car crosses one of 
lane markers, 
Cross-over study comparing 6 times 
real and simulated driving after 
habitual sleep (8 h) or only sleep for 
2 hours, from 11 p.m. to 1 a.m.) 
Sleep loss 
for 7 h, 




morning Not reported explicitly,  
a significant main effect of sleep deprivation on 
inappropriate line crossings (F1,10 = 60.013, P < 
.001) increase from 50 in rested condition to 190 
times in sleep- deprived condition, 
a significant increase of 8 times from zero in rested 
condition to 8 in sleep-deprived condition, 
Time of day in this study had no main effect on lane 
crossing (F5,50 = 1.274, P = 0.301), 
Effects size has not been reported 
  
(Philip et al., 
2005(a)), France 
Line crossings: car crosses one of 
lane markers, 
Cross-over study comparing 5 times 
real driving after habitual sleep (8 h) 
or only sleep for 2 hours, from 11 
p.m. to 1 a.m.) 
Sleep loss 
for 7 h, 
Sleep for 2 h 
1.5 h daytime Total crossings increased after sleep restriction (535 
crossings in the sleep-restricted condition versus 66 
after non-restricted sleep (incidence rate ratio 
(IRR): 8.1(95% CI): 3.2–20.5; p < 0.001)), from the 
first driving session, 
Effects size has not been reported 
 
(Rupp et al., 
2004), Brown 
University 
Line crossings: car crosses one of 
lane markers, 
Between-group comparison group 
after normal sleep, moderate and 
Sleep loss 
for 3 h, 
Sleep for 5 h 




Mean lane crossing increase by 1.4 (from 2.1 after 
normal sleep to 3.5 after sleep loss) for single 
driving task and by 1.6 (from 2.4 after normal sleep 










Time of day Outcome magnitude/effect size 
severe sleep deprivation task. This study reported a significant interaction of 
sleep condition (rested vs restricted) and 
experimental session on lane crossing (large effect 
size; Cohen’s d = 0.98). 
 
 (Filtness et al., 
2012), UK 
All four wheels came out of the 
driving lane (lane departure), 
Repeated measures between-group 
design comparing two conditions of a 
normal prior night’s sleep and sleep 
restricted to 5 h (extended 




for 3 h 
(extended 
wake, sleep 
for 5 h) 
1.5 h afternoon A significant condition by group interaction showed 
an increase in incidence of lane crossing in the last 
30 minutes of a 1.5 h drive in both young and old 
drivers [F1,38 =27.67, p = 0.000, ɛ = 1], the number 
of incidents in old drivers rose from zero to 2 while 
young drivers were more impaired [F1,38 = 9.92, p = 
0.003, ɛ = 1] with increase of incidents from 4 to 8. 
Effects size has not been reported. 
(Pizza et al., 
2004), Italy 
Number of crashes: it is not defined 
in the paper 
Within-participant comparison of 
each participant after normal sleep 
with after sleep deprivation 
 
Total sleep 
loss for one 
night 
30 min Between 
morning and 
afternoon 
The number of crashes had a significant increase 
with the highest increase of 0.8 from basal 
condition (0.00) to sleep deprived condition (0.8) at 





(Pizza et al., 
2004), Italy 
Within-participant comparison of 
each participant after normal sleep 
with after sleep deprivation 
 
Total sleep 
loss for one 
night 
30 min Between 
morning and 
afternoon 
No significant, worsening of mean speed (χ2 = 0.98, 
p > 0.05) and the standard deviation of speed (χ2 = 
0.21, p > 0.05) after sleep deprivation.   
(Lowden et al., 
2009), Sweden 
Between-participant comparison of 
performance of young and elderly 
participant after normal sleep with 
5.5 h sleep 
loss 
(extended 














Time of day Outcome magnitude/effect size 
extended wakefulness 
 
wake; 2 h 
sleep) 
 
 (Matthews et 
al., 2012(a)), 
Australia 
Within-participant comparison of 
each participant after normal sleep 
with chronic moderate sleep 
deprivation by 7 forced 
desynchronized periods of 23.33 h of 
wake followed by 4.67 h of time in 
bed 
Sleep loss 
for 3 h, 
Sleep for 5 h 
10 min Midnight Mean speed (p = 0.016) were both different after 
sleep deprivation over different days. The standard 
deviation of speed (km/h) after sleep loss was 
significantly higher at different times of day (p < 
0.006), and on different days (p = 0.010), but not at 
various prior wake times (p > 0.05).  The highest 
difference of 0.55 km/h in the standard deviation of 
speed was recorded at 60° after nadir under sleep 





(Contardi et al., 
2004), Italy 
Frequency of exceeding the speed 
limit 120km/h,  
Within-participant comparison of 
each participant after normal sleep 
with after sleep deprivation 
 
Total sleep 
loss for one 
night 
30 min Between 
morning and 
afternoon 
A significant change from 3.8 to 10.5 during 
daytime drive, an increase of 6.7 (χ2 = 0.018, p < 





Mean deviation from speed limit (80 
and (80 and 100 km/h), 
Within-participant comparison of 
each participant after normal sleep 
with chronic moderate sleep 
deprivation by 7 forced 
desynchronized periods of 23.33 h of 
wake 
Sleep loss 
for 3 h, 
Sleep for 5 h 
10 min Midnight The ‘Day’ variable, capturing the growing sleep 
debt through the protocol, had also significant 










Time of day Outcome magnitude/effect size 
followed by 4.67 h of time in bed 
(Rupp et al., 
2004), Brown 
University 
Between-group comparison group 
after normal sleep, moderate and 
severe Sleep deprivation 
 
Sleep loss 
for 3 h, 
Sleep for 5 h 





No effect on mean deviation from speed limit (F = 






SD of deviation from speed limit (80 
and (80 and 100 km/h), (speed 
variability), 
Within-participant comparison of 
each participant after normal sleep 
with chronic moderate sleep 
deprivation by 7 forced 
desynchronized periods of 23.33 h of 




for 3 h, 
Sleep for 5 h 
10 min Midnight Not reported explicitly, according to the figure 
speed variability increased from -0. 1 at circadian 
180 degrees after nadir to 0.55 at circadian phase 60 
degree, 
Effects size was not reported 
(Rupp et al., 
2004), Brown 
University 
Between-group comparison group 
after normal sleep, moderate and 
severe Sleep deprivation. 
Sleep loss 
for 3 h, 
sleep for 5 h 





No effect on the standard deviation of deviation 




al., 2012(a)),  
Australia 
Speed violation: cumulative time that 
speed was 5 km/h more than speed 
limit (80 and 100 km/h), 
Within-participant comparison of 
each participant after normal sleep 
Sleep loss 
for 3 h, 
sleep for 5 h 
10 min Midnight The ‘Day’ variable, capturing the growing sleep 
debt through the protocol, had also significant 
effect. The magnitude of effect has not been 











Time of day Outcome magnitude/effect size 
with chronic moderate sleep 
deprivation by 7 forced 
desynchronized periods of 23.33 h of 





(Pizza et al., 
2004), Italy 
Mean reaction time from divided 
attention test on the simulator, 
Within-participant comparison of 
each participant after normal sleep 
with after sleep deprivation. 
Total sleep 
loss for one 
night 
30 min Between 
morning and 
afternoon 
The mean reaction time had a significant increase 
with the highest increase of 0.58 s from basal 
condition (1.34) to sleep deprived condition (1.92) 
at 2 pm, a rise of o.58 s (χ2 = 0.004, p < 0.05).  
Effects size has not been reported. 
 
(Philip et al., 
2005(a)), France 
Reaction time from PALM personal 
organizer, 
Cross-over study comparing 5 times 
real driving after habitual sleep (8 h) 
or only sleep for 2 hours, from 11 
p.m. to 1 a.m.). 
 
Sleep loss 
for 7 h, 
sleep for 2 h 
1.5 h daytime A significant main effect for time of day and 
condition and the interaction between the two 
factors was observed (F1,21 = 20.447; P < 0.001).  





(Philip et al., 
2005(b)), France 
10% slowest reaction time from 
visual task on the simulator, 
Cross-over study comparing 6 times 
real and simulated driving after 
habitual sleep (8 h) or only sleep for 
2 hours, from 11 p.m. to 1 a.m.). 
Sleep loss 
for 7 h, 




morning The mean 10% slowest reaction time had a 
significant increase of 137 milliseconds during 
simulated driving (670 milliseconds vs 533 
milliseconds), (F1,11 = 13.083, p = 0.004). 
The mean 10% slowest reaction time had a 
significant increase of 223 milliseconds after sleep 
deprivation (713 milliseconds vs 490 milliseconds), 


















(Rupp et al., 
2004), Brown 
University 
Reaction time from subtraction task 
for 1 sec and dual driving and 
subtraction task, 
Between-group comparison group 
after normal sleep, moderate and 
severe Sleep deprivation. 
 
Sleep loss 
for 3 h, 
sleep for 5 h 




Main effect of task type on reaction time with 
longer reaction times on the dual task than on the 
single subtraction task (large effect size; Cohen’s d 
= 1.51).  
. 
Distraction (Anderson & 
Horne, 2013), 
UK 
Distraction: looking away from the 
main road way for >3 s, 
Within-participant comparison of 
each participant after normal sleep 
with extended wakefulness. 
 
Sleep loss 
for 3 h, 
sleep for 5 h 
2 h Afternoon at 2 
p.m. 
Curtailed sleep on the night prior to an afternoon 
drive led to a fourfold increase in long distractions. 
Effects size has not been reported. 





Inappropriate line crossing has been defined variously as crossing one lateral lane 
marker, running off the road at least by two wheels, and leaving the road by all four 
wheels.  
Of the 10 studies, eight papers reported findings of lane crossing. In three studies 
(Philip et al., 2005(a); Philip et al., 2005(b); Sagaspe, P et al., 2008), drivers’ sleep was 
severely restricted to only two hours sleep, and they drove for durations between 1.5 
to 2 hours. In one study (Philip et al., 2005(b)), sleep deprivation increased the total 
number of inappropriate line crossings in simulation by 140 events, from 50 cases in 
rested condition and up to 190 cases after sleep loss. The latter authors found 
considerably lower line crossing in on-road driving, but there was still a significant 
increase of 8 events in this variable after sleep deprivation when compared with no 
occurrence of line crossing in rested condition. In another study (Sagaspe, P et al., 
2008), the number of inappropriate line crossings in the last hour of 3 nocturnal 
driving sessions were 6, 15, and 24-fold greater than those of the reference driving 
session (9–10 p.m.), respectively. In another study (Philip et al., 2005(a)), after 6 
hours sleep deprivation (2 hours sleep) and 10 hours (5 x 90 minutes) on-road 
driving, the cumulative number of inappropriate line crossing per person rose from 
469 events from 66 cases in rested condition to 536 cases after sleep loss. The 
maximum increase of 120 events (8-fold) occurred in the last 1.5 hour driving 
session in the late afternoon, probably due to cumulative fatigue from long driving 
time.    
In a study with moderate sleep loss of three hours (Filtness et al., 2012), sleep 
deprivation increased the incidence of lane crossing in the last 30 minutes of a 1.5 
hour drive in both young and old drivers by 2 and 4 cases, respectively. In the study 
by Rupp et al. (2004), after a similar degree of sleep loss (3 hours), but during shorter 
drives of 30 minutes, sleep deprivation led to an increase of 1.4 in mean lane 
crossings for single driving task, and by 1.6 on dual driving and subtracting tasks.  
 
Lateral position variables 
Mean lateral position was not the primary outcome in most studies and was measured 
to determine other variables, mostly standard deviation of lateral position. Therefore 
  
the effects of sleep loss on this variable was not reported except in two studies (Pizza 
et al., 2004), and (Rupp et al., 2004), with no effect of sleep loss on this outcome. 
Variability in lane positioning, typically described by the standard deviation of 
lateral position in the reviewed studies, was defined as the distance from a certain 
point on the car (i.e. the centre of the car, right side of the right front wheel) to some 
reference point on the road (i.e. roadway midline, one of lane markers, left lane 
marker). Larger and more frequent deviations represented a higher risk of running off 
the road (line crossing) or hitting adjacent cars. The standard deviation of lateral 
position was reported in five of the reviewed papers (Lowden et al., 2009; Matthews 
et al., 2012(a); Matthews et al., 2012(b); Pizza et al., 2004; Rupp et al., 2004). 
A 1.5-hour night time simulated driving during an extended wake from 5 and 7 hours 
(Lowden et al., 2009) could increase the standard deviation of lateral position by 1.2 
after the 30
th
 minute of driving compared to driving in the rested condition.  
Total sleep loss in the study by Pizza et al. (2004) resulted in an increase of 0.20 in 
standard deviation of lateral position after a 30-min drive in daytime. 
There was no main effect of sleep loss on the standard deviation of lateral position in 
the study by Rupp et al. (2004) after sleep loss of 3 to 5 hours.  
An important point to consider is the interaction between sleep loss and the time of 
day (of either the loss or the subsequent testing). Matthews et al. in two studies with 
similar protocol but different doses of sleep loss (2012(a); 2012(b)), enforced a 28-h 
day compared to usual 24-h circadian day for one week. A 3-hour sleep deprivation 
condition with short drive of 10 minutes occurring at 2.5 hour intervals after waking 
was included within this forced desynchrony protocol. After sleep loss the number of 
line crossings (lane violations) (Matthews et al., 2012(a)) and the standard deviation 
of lane position were higher after either circadian nadir (early morning), after 22 
hours of prior wake (Matthews et al., 2012(a)).   
 
Speed variables 
A variety of speed variables were reported in three studies (Matthews et al., 2012(a); 
Pizza et al., 2004; Rupp et al., 2004). Mean speed and standard deviation of speed in 
the study of Pizza et al. (2004) had no significant change during a 30-minute drive 
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after one night total sleep loss. The frequency of speeding (during which the driver 
exceeded the speed limit) also showed a significant increase of 6.7 during daytime 
driving. However, no estimate of the effect sizes was reported. In the study of  Rupp 
et al. (2004) neither mean deviation, nor the standard deviation from speed limit 
showed a significant change during a 30-minute drive after sleep loss of either 3 
hours or 5 hours when compared to the rested group. 
 
Cognitive performance 
In the study by Philip et al. (2005(a)), a 7-hour sleep loss resulted in a significant 
main effect for differences in reaction time. Similarly, these authors in another study 
(Philip et al., 2005(b)), found a significant main effect of sleep loss on mean 10% 
slowest reaction time, with an increase of 223 milliseconds in the mean 10% slowest 
reaction after one week chronic sleep loss. 
In another study by Pizza et al. (2004) mean reaction time during a daytime drive 
showed a rise of 0.58 second after one night total sleep loss.  
 
3.4.4 Direction of effects 
The possibility of conducting a formal meta-analysis to statistically combine the 
quantitative results was explored. However, due to the lack of reported standardised 
effect sizes, as well as the insufficiency, inconsistency, and non-comparability of the 
unstandardized reported effects, it was impossible to combine the data and obtain a 
single pooled estimated effect size for each outcome. The only possible analysis was 
to determine and summarise the direction of effects of sleep loss on each outcome 
measure. This approach has been taken recently in other sleep-related systematic 
reviews (Thorpe et al., 2015). 
The numbers of papers reporting outcome measures and direction of effect have been 
represented in Figure 3.2. Of the in-vehicle performance outcomes, lane crossing, 
standard deviation of lateral position, and mean reaction time were the three most-
often reported outcomes. Lateral position was not reported in most studies, and was 
only monitored to obtain lane crossing or standard deviation of lateral position. The 
standard deviation of lateral position, line crossing, and distraction were each 
  
consistently reported to be impaired by sleep loss, while there were inconsistencies in 





Figure 3.2. Direction of effects of sleep deprivation on outcome measures,  
The X and Y axes reflect the number of papers and the outcome measures, respectively. These papers are not mutually exclusive. 
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3.4.5 Methodological and reporting characteristics of studies 
In order to develop some GRADE criteria for rating the quality of individual papers, 
the methodological and reporting facets of the papers were closely investigated. It 
should be noted that some of these papers might be excellent in other ways, and the 
‘flaws’ are about fitting to these criteria specifically. The methodological flaws and 
reporting faults of the papers, affecting the quality of findings, are presented in Table 
3.8. 
Some of important flaws were considered in the development of the GRADE criteria 
for quality grading. Within the 10 reviewed papers, the most common factor 
affecting the quality of papers was the lack of wake EEG measurements to confirm 
sleepiness of the participants during the driving tasks (eight papers did not measure 
wake EEG). Seven papers did not report their methods for controlling distraction 
sources as possible confounding factors. Methods of controlling for other 
confounders such as the consumption of caffeine, alcohol, or other stimulants/ 
sedatives prior to or during the experiments were not reported in five papers. Only 
two studies (Anderson & Horne, 2013; Filtness et al., 2012) monitored the effects of 
distraction (by split filming of the driver’s face) and sleep deprivation (via 
Actigraphy beforehand, and by recording wake EEG during the experiment). 
Estimation of effect sizes were reported in only two studies as noted above, albeit not 
for all outcomes, and the remaining eight studies only reported unstandardized 
magnitudes of effects.  
It is acknowledged that authors may actually have dealt with some of these 
methodological and reporting factors (e.g. a standardized lab environment). 
However, they have not explicitly reported them in the papers.  
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Table 3.8 Methodological elements of papers considered for quality rating  
Paper Methodological strengths and flaws Factors considered for quality rating 
(Philip et al., 
2005(b)) 
a. The reference point for measuring lateral position 
(centre or lateral side of the car etc.) was not reported, 
b. No measurement for possible distraction sources 
(confounders), 
c. No wake EEG measurement for confirming sleepiness, 
d. Not known if participants were professional drivers, 
shift workers, or had experienced recent time-zone travel, 
e. Consumption of caffeine, alcohol, and other 
stimulants/sedatives was not reported, 
f. Only males were included without any clear rationale 
for that, 
g. No criterion for quantifying driver experience (just 
yearly driving distance is given),  
h. Small sample size 
 
a. No wake EEG measurement for 
confirming sleepiness, 
b. Small sample size 
(Philip et al., 
2005(a)) 
a. The reference point for measuring lateral position (centre or 
lateral side of the car etc.) was not reported, 
b. No measurement for possible distraction sources (confounder), 
c. No wake EEG measurement for confirming sleepiness, 
a. No wake EEG measurement for 
confirming sleepiness, 
b. Small sample size, 
  
Paper Methodological strengths and flaws Factors considered for quality rating 
d. Not known if participants were professional drivers, shift 
workers, or had experienced recent time-zone travel, 
e. Consumption of caffeine, alcohol, and other 
stimulants/sedatives was not reported, 
f.  Only males were included without any clear rationale for that, 
g. No criterion for quantifying driver experience (just yearly 
driving distance is given),   




a. Only males were included without any clear rationale for that, 
b. No measurement for possible distraction sources (confounder), 
c. No wake EEG measurement for confirming sleepiness, 
d. Consumption of caffeine, alcohol, and other 
stimulants/sedatives was not reported, 
e. No criterion for quantifying driver experience (just yearly 
driving distance is given),   
f. Large sample size, 
g. Presence of learning effect for lane deviation in the control 
condition,  
 
a. No wake EEG measurement for 
confirming sleepiness, 
b. Big sample size, 
c. Presence of learning effect for lane 
deviation in the control condition, 
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Paper Methodological strengths and flaws Factors considered for quality rating 
(Matthews et 
al., 2012(a)) 
a. Only males were included without any clear rationale for that, 
 
b. No measurement for possible distraction sources (confounder), 
c. No wake EEG measurement for confirming sleepiness, 
d. No criterion for quantifying driver experience (just yearly 
driving distance is given),   
e. Consumption of caffeine, alcohol, and other 
stimulants/sedatives was not reported, 
f. Small sample size, 
 
a. No wake EEG measurement for 
confirming sleepiness, 
b. Small sample size 
(Pizza et al., 
2004) 
a. The study design is not reported (within-participant design), 
b. The reference point (centre or lateral side of the car etc.,) has 
not been reported, 
c.  Age range is not specified and method of control for age is 
unknown, 
d. No criterion for quantifying driver experience (just yearly 
driving distance is given),   
e. No measurement for possible distraction sources (confounder), 
f. No wake EEG measurement for confirming sleepiness, 
g. Small sample size, 
a. No wake EEG measurement for 
confirming sleepiness, 
b. Small sample size 
  
Paper Methodological strengths and flaws Factors considered for quality rating 
 
(Lowden et al., 
2009) 
a. Small sample size, 
b. Good control for confounders, 
c. Wake EEG, EOG measurement for confirming sleepiness, 
a. Small sample size, 
b. Good control for confounders, 
c. Wake EEG, EOG measurement for 
confirming sleepiness, 
(Rupp et al., 
2004) 
a. The study design is not reported (between-participant design), 
b. No criterion for quantifying driver experience (just yearly 
driving distance is given),   
c. Good control for sleep deprivation, 
d. No wake EEG measurement for confirming sleepiness, 
e. No measurement for possible distraction sources (confounder), 
 
a. Good control for sleep deprivation, 
b. No wake EEG measurement for 
confirming sleepiness, 
(Sagaspe, P et 
al., 2008) 
a. Type of lane crossing, partial (one wheel) or total (two wheel), 
was not reported, 
b. Good control for sleep deprivation before and during study, 
c. No wake EEG measurement for confirming sleepiness, 
d. No measurement for possible distraction sources (confounder), 
e. Results of the simulator might not be generalizable to real-life 
driving, except perhaps on a group level, 
f. Not known if participants were professional drivers, shift 
a. Good control for sleep deprivation 
before and during study, 
b. No measurement for possible 
distraction sources (confounder), 
c. Results of the simulator may not be 
generalized to real-life driving, 
except perhaps on a group level,  
d. Small sample size 
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Paper Methodological strengths and flaws Factors considered for quality rating 
workers, or had experienced recent time-zone travel, 
g. Consumption of caffeine, alcohol, and other 
stimulants/sedatives was not reported, 
h. Only males were included without any clear rationale for that, 




a. The side of the road to drive was not mentioned, 
b. The study design was not mentioned properly, 
c. Control for driver experience, 
d. Small sample size, 
e. Good control for distraction, 
f. Good control for sleep deprivation, 
g. No wake EEG for confirming sleepiness, 
a. Small sample size, 
b. Good control for distraction, 
c. Good control for sleep deprivation, 
  
Paper Methodological strengths and flaws Factors considered for quality rating 
(Filtness et al., 
2012) 
a. Good sample size, 
b. Control for driving experience, 
c. The rationale for choosing only males was mentioned, 
d. Good control of driver sleep deprivation before and during test, 
e. Control for distraction by filming driver face, 
f. Wake EEG and EOG, 
a. Good sample size,  
b. Good control of driver sleep 
deprivation before and during test, 
c. Control for distraction by filming 
driver face, 
d. Wake EEG and EOG, 
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3.4.6 GRADE criteria 
In this systematic review some grading criteria were developed based on both the 
GRADE guidelines and the important flaws and strengths of the 10 reviewed papers. 
These criteria were utilized to downgrade and upgrade the quality of papers and are 
presented in Table 3.9. The study design criteria were adopted from the GRADE 
statement. Additionally, from the potential downgrading factors described in the 
GRADE statement (risk of bias, inconsistency, indirectness, imprecision, and 
publication bias) only “risk of bias” and “imprecision” criteria were adoptable, and 
from the upgrading factors only large effect size was applicable. From downgrading 
or upgrading factors specific to the reviewed papers, the factors listed in the column 
“factors considered for quality rating” in Table 3.8 were considered.  
At the first stage of developing the grading criteria, the initial scores of 4, 2, 1 and 0 
were first assigned to studies with RCT, longitudinal, quasi experimental and ‘other’ 
designs, respectively. Quasi-experimental designs that manipulated sleep and 
longitudinal studies that provided detail of the cumulative effects of chronic sleep 
deprivation have potential to show the magnitude and direction of effects of sleep 
loss on drivers’ performance. Therefore, the GRADE scores were modified by 
adding 1 point to studies applying either of these two designs.  As can be seen in 
Table 3.8, “risk of bias” was the major reason for decreasing the quality ratings for 
the papers, and this risk included inappropriate eligibility criteria, inadequate control 
for confounders, reporting bias, conflict of interest, and flaws in measuring 
sleepiness and outcome. Upgrading factors were categorised into three groups, 
including good control for exposure and inclusion criteria, some control for 
confounders, and increased precision (certainty) in statistical reporting. The presence 
of a downgrading factor led to deduction of one point from the initial rating 
attributed to the study, and each upgrading factor resulted in the addition of one 
point. The deduction of one point for every single downgrading factor would result 
in a negative quality score for a number of the studies, a status which has not been 
defined in GRADE (limited to a score of 0). Therefore, those factors with the highest 
impact on the quality of a given outcome were selected as follows: 
a. From risk of bias: inadequate monitoring of sleepiness during test and 
practice effect. 
  
b. From imprecision: not generalizable findings and small sample size.  
c. From control for exposure and inclusion criteria: Strong control of sleep loss 
before test. 
 
d. From certainty: large effect size, large sample size, objectively confirming 
sleepiness by EEG (for simulated drives) and control for distraction by 



























Downgrading factors (1 score deducted) Upgrading factors (1 score added) 
High RTCs, score 4 
 
Risk of bias: 
Inappropriate eligibility 
criteria 
Includes people with: 
Shift-work., professional 
driving, travel to different 




Habitual heavy caffeine 
consumption, 
Caffeine avoidance, 
Alcohol abuse (more than 
two standard drinks per day), 
Inclusion of people from a 
specific place only (e.g. 
university students only) 
Control for exposure and inclusion 
criteria: 
Strong control of sleep loss before 
test, 
Strong inclusion criteria, 
 
Confounders: 
Residual confounders decreasing the 
estimated effect size, 
Strong control for confounders, 
 
Certainty: 
Large effect size, 
Large sample size, 
Confirming sleepiness with wake 
EEG, 





Downgrading factors (1 score deducted) Upgrading factors (1 score added) 
 
Low Observational study: 
Experimental or 




Other designs, score 0 





Inter-individual differences in 
sensitivity to sleep loss, 
 




  Conflict of interest Study being funded by an 
organisation or industry 




  Flaws in measuring 
sleepiness and outcome 
Inadequate monitoring sleep-
wake before test, 
Inadequate control for 
stimulants before (sleep-wake 







Downgrading factors (1 score deducted) Upgrading factors (1 score added) 
test, 
Inadequate monitoring of 
sleepiness during test (no 
wake EEG) 
Practice effect 
Unclear definition of outcome 
Inappropriate measurement of 
the outcome, 
 
  Imprecision 
(Uncertainty) 
Small sample size affecting 
generalisability 











3.4.7 Quality of outcomes for individual papers and across the body of evidence 
The distribution of GRADE criteria and various downgrading and upgrading factors 
are provided in Table 3.10. Downgrading factors and upgrading factors are 
highlighted by yellow and green colours, respectively.  
Based on these criteria, an Overall GRADE Score (OGS) was calculated for a given 
outcome in an individual paper. For instance, in Paper code 7, overall GRADE score 
for lateral position was calculated as: 
OGS = (Quasi- experiment) + (Inadequate monitoring of sleepiness during test) + 
Large sample size 
OGS = +2 - 1 + 1 = 2 
As can be seen from Table 3.10, any individual paper could be assigned different 
quality scores for different outcome measures.  
The last column of Table 3.10 represents the OGS for the body of evidence (that is, 
across all of the papers using the same outcome measure). To calculate the OGS, the 
magnitude of the contribution of each paper towards the quality of the body of 
evidence was taken into account. In the GRADE statement, papers with large sample 
sizes or more ‘events’ have a larger impact on the quality of evidence. However, 
there are no formal guidelines on how to include these two contributors in the quality 
context. The number of ‘events’ was not applicable in this review. There was no 
precedent for including the effect of sample size on the overall quality of the body of 
evidence. Therefore, a novel algorithm was developed for this literature as follows:  
 
Overall Grade Score for the body of evidence (OGS) =  
∑(𝐺𝑅𝐴𝐷𝐸 𝑠𝑐𝑜𝑟𝑒 𝑓𝑜𝑟 𝑝𝑎𝑝𝑒𝑟∗ 𝑆𝑎𝑚𝑝𝑙𝑒 𝑠𝑖𝑧𝑒 𝑜𝑓 𝑝𝑎𝑝𝑒𝑟)
𝑇𝑜𝑡𝑎𝑙 𝑠𝑎𝑚𝑝𝑙𝑒 𝑠𝑖𝑧𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑏𝑜𝑑𝑦 𝑜𝑓 𝑒𝑣𝑖𝑑𝑒𝑛𝑐𝑒
 
 
OGSs < 1.5 were approximated to 1,  
1.5 < OGSs < 2.5 were approximated to 2,  
2.5 < OGS < 3 were approximated to 3. 
132 
 
For example, to calculate the OGS for lateral position, the sample sizes for all 
relevant papers were extracted from Table 3.4. 
Using the above-mentioned algorithm, the OGS was calculated as follows: 
OGS = (Zuzewicz et al.)/ (12 + 22 + 41 + 14 + 20 + 20) = 1.10 ~ 1 
 










Downgrading factors for study design, risk of bias (limitations in execution) and imprecision Upgrading factors 
Overall GRADE 
Score 
Study design Risk of bias for other 
limitations 














































































































































































































































































































































































































































































(Philip et al., 
2005(b)) 
 
  * * * *    *  *  *   *      0 1 
(Philip et al., 
2005(a)) 
 

















  *  *  *   *    *   *      0 
(Pizza et al., 
2004) 
 








of the road 
(Philip et al., 
2005(b)) 
 




 *   *      0 1.4 
(Pizza et al., 
2004) 
 
  *  *     *  *  *   *      0 
(Rupp et al., 
2004) 
 




(Philip et al., 
2005(b)) 
 




 *   *      0 1.5 
 
(Pizza et al., 
2004) 
 




















Downgrading factors for study design, risk of bias (limitations in execution) and imprecision Upgrading factors 
Overall GRADE 
Score 
(Rupp et al., 
2004) 
 




et al., 2008) 
 












  *  *  *   * *         *   1 
(Philip et al., 
2005(b)) 
 




 *   *      0 
(Philip et al., 
2005(a)) 
 




  *   * *       *    *   *  3 
(Rupp et al., 
2004) 
 




  *            * *     * * * * * * 6 
(Pizza et al., 
2004) 
 












(Pizza et al., 
2004) 
 








(Pizza et al., 
2004) 
 




  *  *  *   *    *   *      0 
(Rupp et al., 
2004) 
 
  *  *     *     * *  *      2 
Speed 
variability  
(Rupp et al., 
2004) 
 













(Pizza et al., 
2004) 
 




  *  * * *   *    *   *      0 
(Philip et al., 
2005(b)) 








Downgrading factors for study design, risk of bias (limitations in execution) and imprecision Upgrading factors 
Overall GRADE 
Score 
 *  
(Rupp et al., 
2004) 
 
  *  *     *     * *  *      2 
(Philip et al., 
2005(a)) 
 




(Pizza et al., 
2004) 
  *  *     *  *  *   *      0 0 
Distraction (Anderson & 
Horne, 2013) 





  *   * *       *    *   *  3 *NR 




3.4.8 Levels of the quality of the body of evidence for outcomes 
The GRADE statement classifies the quality of a body of evidence as high, medium, 
low, and very low quality. These levels reflect the confidence in assuming that the 
estimated effect is close to the true effect (Balshem et al., 2011).  These levels are 
defined as follows: 
a. High quality: high confidence that the true effect lies close to the estimated 
effect 
b. Medium: moderate confidence the true effect lies close to the estimated effect 
c. Low: limited confidence that the true effect lies close to the estimated effect 
d. Very low:  very little confidence that the true effect lies close to the estimated 
effect  
The GRADE guidelines do not directly map onto the OGS for the body of evidence 
at the above-mentioned levels. Therefore, based on judgment, four ranges of OSG 
scores were assigned to each of these four quality levels. High quality evidence 
included all OGSs greater than or equal to 3, while scores between 2 and 3 
corresponded to medium quality. Scores between 1 and 2, and scores between 0 and 
1, were attributed low and very low quality body of evidence ratings, respectively. 
Table 3.11 represents the quality levels of the body of evidence for the outcomes.  
  
Table 3.11  The levels of the quality of body of evidence for outcomes 









Lateral deviation from centre of the road  *   
*SD of lateral position  *   
Lane crossing   *  
Deviation from speed limit *    
Speed variability  *   
Mean reaction time *    







It is clear that there are few studies available that describe the specific effects of 
sleep deprivation on young driver’s performance. Over the last 10 years only 10 
peer-reviewed original papers on this issue have been published. It is acknowledged 
that there are other sleepiness-related studies within the same age group as this 
systematic review. Based on the inclusion criteria (Section 3.3.3) these studies were 
not included since the sleep loss was not the main exposure (Watling, Smith, & 
Horswill, 2014), the outcome measures did not include driving performance (Smith, 
S., Horswill, Chambers, & Wetton, 2009(a)) and participants had different age ranges 
(Forsman et al., 2013).  
The PRISMA-based systematic search for information revealed that there are no 
previous reviews and particularly, no systematic reviews, available to summarise the 
findings of sleep loss on driving performance of young drivers.  
The review of selected papers based on the GRADE guidelines revealed some 
important facts in the available literature as follows: 
1. There is a lack of high-quality evidence provided by the available studies, 
with no randomized control trials (RTCs), very strong experimental designs, 
or large-scale studies. Most of the studies did adopt otherwise robust quasi-
experimental cross-over, within-groups, or between-groups repeated 
measures designs.  
2. There is considerable inconsistency in the available evidence due to major 
differences between the studies in factors such as sample sizes, the method of 
sleep deprivation, control for confounding factors, definition and 
measurement of outcomes, and the magnitudes of effects. There were also 
consistent flaws or omissions in the reporting of methodologies and findings.  
3. Samples are often limited, with 50% of the papers including samples of fewer 
than 15 participants. The limited sample sizes used in these studies, and the 
inclusion of only male participants in 70% of studies, raise questions about 





4. There are differences between studies in the definition of outcomes, and some 
definitions were not reported. The most inconsistent definition was that for 
lateral position. 50% of the papers utilised this parameter, but each of them 
defined this parameter in a different way. This resulted in different definitions 
for mean lateral position, and for the standard deviation of lateral position 
variables. Line crossing was reported in 70% of papers, but with less 
inconsistency in its definition. In 40% of papers a comparable definition of 
crossing one of the lane markers or lines has been assumed.  There were 
flaws in reporting the precise definitions of outcomes across studies, with 
50% of studies providing poor definitions of these outcome variables. 
5. Sleep deprivation paradigms also differed between the studies. In 80% of the 
studies, acute sleep loss was induced (but in different doses), and only 20% of 
papers attempted to induce a state of chronic sleep deprivation.  
6. The time of day for sleep restriction in 80% of the studies was consistent 
(restriction occurred at the same times of circadian days), while in 20% of the 
studies sleep loss happened in different times of day due to the application of 
forced desynchrony protocols.  
7. Driving conditions varied very much across the studies. 90% of studies were 
undertaken on a driving simulator of different types, each with various 
scenarios and driving tasks, while 30% of studies included on-road 
experiments in their protocol as well.   
8. Time-of-day when driving also differed between the studies. In 50% of 
studies, drives were undertaken during the night time hours (Lowden et al., 
2009; Matthews et al., 2012(a); Matthews et al., 2012(b); Rupp et al., 2004; 
Sagaspe, P et al., 2008). 
9. The durations of drives differed, with 50% of drives between 1.5 to 2 hours, 
and 40% of studies with shorter durations of 10 to 30 minutes.   
10. The outcomes reported in these studies were lane related variables (90% of 
studies), speed-related outcomes (20%), and cognitive performance outcomes 
(50%).  
11. From lane position related outcomes, the standard deviation of lateral position 
was studied by 50% of papers and found to increase with sleep loss in each of 





is sensitive to time of day, prior wake period, and the day of sleep deprivation 
(Matthews et al., 2012(a)). A severe or total sleep loss can increase STD of 
lateral position by at least 1.5 fold. It should be noted that there is limited 
confidence in the accuracy of these findings due to the low quality of 
findings. No evidence was available on the effects of chronic mild sleep loss 
on this outcome. 
12. Findings of lane crossing were reported in 80% of the studies. These data 
suggest an increase of between 1.5 and 6 fold in line crossing. This effect was 
supported by a medium-quality body of evidence, suggesting moderate 
confidence in the validity of the estimated effect (and with only one measure 
of effect size available). 
13. In 30% of reviewed papers (Matthews et al., 2012(a); Pizza et al., 2004; Rupp 
et al., 2004) after one night total sleep loss the number of speed exceedance 
events increased in daytime drives, however, the magnitude of speed 
exceedance and speed variability after partial sleep loss did not change (Rupp 
et al., 2004).  
14. Mean reaction time (Pizza et al., 2004) and mean 10% slowest reaction time 
(Philip et al., 2005(b)) both increased after acute total or chronic partial sleep 
loss, respectively. There is very low confidence in the findings of reaction 
time and their proximity to the real effect (very low quality).  
15. In the reviewed papers the steering wheel variables have not been studied, but 
the findings of lateral position in the reviewed papers are in agreement with 
the findings of (Forsman et al., 2013), that standard deviation of lateral 
position and steering wheel are currently the most sensitive outcomes to 
driver’s sleepiness and can result in lane crossings or hitting adjacent cars.  
 
Based on the GRADE criteria developed in this systematic review, the two 
predominant groups of degrading factors for the quality of papers were the “risk of 
bias” and, to a much lower extent, the “imprecision” (uncertainty). From the group of 
risk of bias, the quality of papers suffered from flaws in measuring sleepiness and 
outcome measures, particularly from two sub-factors of inadequate monitoring of 
sleepiness while conducting the experiment and from practice effect. The small 
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sample size of papers was the most common degrading factor from the imprecision 
group. The quality of papers benefited from two upgrading factors; firstly, from 
“control for exposure and inclusion criteria” (mainly from strong control of sleep 
loss before test), and secondly from “certainty” (in particular recording the wake 
EEG during test and control for distraction of drivers by filming their faces). 
The Overall GRADE Scores of the body of evidence for the most commonly studied 
variables were assigned very low-quality levels for mean reaction time and deviation 
from speed limit, to low-quality levels for standard deviation of lateral position, 
speed variability and lateral variation from centre of the road, and to medium-quality 
level only for lane crossing. None of the outcome measures was reported by a high- 
quality body of evidence.  
In summary, in order to draw an explicit conclusion about the effects of sleep loss on 
young drivers’ performance it is crucial to obtain more reliable data. This could be 
done by adopting common protocols and consistent metrics, ensuring adequate 
power in the studies, using better quality experimental designs such as RCTs for 
interventions, and by adopting better epidemiological methods. Additionally, the 
circadian and homeostatic contributors to sleepiness should be considered in 
developing methodologies, and certainly in understanding the variation in outcomes 
from published studies in which these factors vary. It is crucial to enhance the quality 
of studies on drivers’ sleepiness by considering the GRADE criteria, as well as to 








Chapter 4: Review of Alerting Effects of the 
Light and Caffeine   
This chapter provides a review of the effects of light and caffeine on driver alertness 
and performance. A brief overview of countermeasures for driver sleepiness is 
provided in Section 4.1. Section 4.2 provides a detailed review of non-visual effects 
of light, followed by the instantaneous alerting effects of light (Section 4.3) and the 
alerting effects of caffeine in Section 4.4. In Section 4.5 the alerting effects of light 
and caffeine are compared. Finally, a summary of the findings and their implications 
on this research program is provided in Section 4.6.  
 
4.1 COUNTERMEASURES FOR SLEEPINESS 
Drivers vary in their preference for using common countermeasures of sleepiness 
(Anund et al., 2008(a)) such as opening the window, stopping and taking a walk, 
listening to the radio or a passenger, napping and taking caffeine (Maycock, 1996). 
The three first strategies are regarded as ineffective (Heatherley, 2011; Horne, J.A & 
Reyner, 1996; Reyner, L. & Horne, 1998). Napping, while potentially effective, may 
cause “sleep inertia” upon awakening, observed as difficulty in arousing and “thick 
headedness” (Horne, J.A & Reyner, 1996, 2001; Phipps-Nelson, Redman, 
Schlangen, & Rajaratnam, 2009; Reyner, L. & Horne, 1998). Caffeine is regarded as 
a more feasible intervention (Dunwiddie & Masino, 2001; Fredholm, Bättig, 
Holmén, Nehlig, & Zvartau, 1999; Horne, J.A & Reyner, 1996; Mets et al., 2012; 
Reyner, L. & Horne, 1997; Reyner, L.  & Horne, 2000). Recently, some researchers 
have examined the effects of night or daytime exposure to light on driving tasks as a 
potential countermeasure for driver sleepiness (Phipps-Nelson, Redman, Dijk, & 
Rajaratnam, 2003). The effects of light and caffeine as two more effective 




4.2 NON-VISUAL EFFECTS OF LIGHT  
Light has been found to elicit direct and indirect neurobiological effects beyond 
vision. Light has some indirect long-term (phase shifting) effects on human circadian 
rhythms and hence, some human psycho physiological functions regulated by 
circadian rhythms such as sleep-wake cycle, core body temperature, melatonin 
secretion, alertness and performance (Figueiro, M.G et al., 2007a; Stephenson et al., 
2012). The mechanisms of human circadian sleep/wake and alertness were described 
in Chapter 2. Apart from these long term effects, light also directly elicits some 
instantaneous changes in physiological arousal and performance (Smolders et al., 
2012; Stephenson et al., 2012; Thessing et al., 1994). Phase-shifting effects and 
immediate effects of light on alertness and performance are explained here. 
 
4.2.1 Circadian phase-shifting effects of light 
Light exerts indirect physiological effects on the circadian rhythm via temporal phase 
shifting of the circadian clock (An, Huang, Shimomura, & Katsuura, 2009; Figueiro, 
M.G et al., 2007a; Lockley et al., 2006; Revell et al., 2006; Rüger et al., 2006; 
Stephenson et al., 2012; Thessing et al., 1994). Body temperature and melatonin 
levels are common markers of circadian rhythm. The endogenous rhythm of body 
temperature represents the circadian component of sleepiness, with maximum 
sleepiness occurring 1-2 h after the minimum of body temperature (Leproult, Van 
Reeth, Byrne, Sturis, & Van Cauter, 1997). The phase-shifting effect of light can 
only be detected in the longer term (i.e. in the next circadian cycle) (Vandewalle et 
al., 2009). 
Light is capable of resetting the phase of the circadian pacemaker and synchronising 
the intrinsic period of the human circadian pacemaker to a 24 h day (Klerman, Dijk, 
Kronauer, & Czeisler, 1996). Depending upon the precise time of exposure to light, 
circadian phase of melatonin production or minimum core body temperature will be 
altered. Light exposure before minimum core body temperature induces phase delays 
(e.g. minimum CBT occurs at a later times) and after minimum CBT causes phase 
advances in the pacemaker (e.g. minimum CBT occurs at an earlier time) (Appleman 
et al., 2013; Cajochen, Christian, Brunner, Kräuchi, Graw, & Wirz-Justice, 2000; 





(weak phase shift) PRCs, light exposure at the time of minimum CBT, even in 
consecutive days, does not change circadian phase, but attenuates amplitude of the 
circadian pacemaker (Klerman et al., 1996; Postolache & Oren, 2005). However, the 
type 0 PRCs (strong phase shift) may be established by consecutive light exposure, 
with the first exposure suppressing the amplitude and making the circadian rhythm 
more sensitive to the second exposure (Postolache & Oren, 2005). In type 0 PRC, 
phase shifts as large as 12 hours have been reported when light is centred at the time 
of minimum temperature (Czeisler et al., 1989; Postolache & Oren, 2005).  
The phase shifting capability of light has been utilised to shift the circadian phase of 
shift workers to help them cope with work hours. The phase delaying effects of a 
single-beam bright light are dependent on the duration of exposure. For instance, a 4-
h night time exposure to bright light at more than 9000 lux was able to reduce 
objective sleepiness (Multiple Sleep Latency Test) and performance (Simulated 
Assembly Line Task) for a considerable time, even during subsequent nights, while a 
2-hour exposure to the same amount of light does not produce the same effects 
(Thessing et al., 1994). Therefore, in simulated night-work studies some researchers 
have confirmed that precise timing of bright light/dark, and/or combination of bright 
light during night shifts and the scheduled daytime sleep/dark could result in 
approximately 7 h phase delays in circadian rhythms of shift workers (Horowitz et 
al., 2001; Smith, M. R. et al., 2009(a)). Some even incorporate days off in light dark 
schedule (Smith, M. R. et al., 2008). There are however, some practical issues 
regarding application of these schedules in real life, in that most permanent night-
shift workers (e.g. commercial drivers) are not interested in changing their normal 
day-oriented circadian rhythm to a night-oriented rhythm, particularly on days off 
due to their social and family lives (Figueiro, M.G et al., 2007a; Smith, M. R. et al., 
2008). Additionally, long time control of strict light/dark and sleep schedules is not 
plausible (Figueiro, M.G et al., 2007a). As a result, consideration of the acute direct 
alerting effects of light appear more reasonable (Figueiro, M.G et al., 2007a; 




4.3 INSTANTANEOUS ALERTING EFFECTS OF LIGHT 
Apart from light phase shifting properties, exposure to bright light has a direct 
alerting effect in humans (Phipps-Nelson et al., 2003).  
Figure 4.1 shows brain areas involved in the alerting effects of light. A network of 
areas around the pulvinars (red) mediates the effects of light on alertness and 
cognition. Light can affect brain function and cognition by activating alertness-
related pathways in sub cortical structures (e.g. hypothalamus, brainstem, pulvinars).  
Light rapidly affects the hypothalamus (blue) and pulvinars (green) and after the first 
little seconds the brainstem (yellow) starts to respond to light. The hypothalamus, 
amygdala, and the temporal cortex are mood-related pathways in limbic areas and are 
responsible for emotional changes from exposure to light. The cortical areas involved 





Figure 4.1. Different brain areas instantaneously responding to light (adopted from 
Vandewalle et al., 2009). 
 
Regardless of the time of day, the magnitude of alerting effects of bright light 
depends on dose (illuminance levels), wavelength , duration of lighting, level of prior 
exposure to light (Chang, Scheer, Czeisler, & Aeschbach, 2013), and endocrine and 
electrophysiological variations of alertness (Leger, Philip, Jarriault, Metlaine, & 
Choudat, 2009). Higher intensities, longer durations, and shorter wavelengths (blue) 
of light have more alerting effects (Chellappa et al., 2011; Smolders et al., 2012; 





In humans, intrinsically photosensitive retinal ganglion cells (ipRGCs) are 
responsible for the nonvisual alerting effects of light. The ipRGCs have peak 
sensitivity to 480 nm light (perceived as blue light, see Figure 4.2). This wavelength 
is shorter than peak sensitivity of most other photoreceptors in the retina, with the 
rods (R), S cones, M cones, and L cones having their peak sensitivities at ∼500 nm, 
∼420 nm, ∼530 nm and ∼560 nm, respectively (Hatori & Panda, 2010).  Other 
wavelengths can also drive ipRGCs, just at higher intensities as indicated by the 
distribution of their spectral response curve (Zele et al., 2011).  
 
Figure 4.2. Spectral sensitivity of rod, cones (S, M & L) and ipRGCs; dashed line 
indicates 520 nm light provided by the RE-Timer devices (modified version adopted 
from Hatori & Panda, 2010).  
 
 
Analysis of lighting conditions adopted in both night time and daytime studies 
suggests that blue light has been used mostly in the frequency range of 450-470 nm, 
in low levels from 1 to 40 lux, whereas white light (broad spectrum) has been used in 
high levels (up to 10000 lux). Red light has been mostly adopted in the frequency 
range of 630-640 nm, with approximately the same level as blue light (1- 40 lux).  
Light experiments vary in light intensities, duration of exposure, wavelength, timing 
of administration and target study group. In line with the research questions of this 
study and the associated hypotheses, the alerting effects of light in relation to 
objective, subjective, cognitive performance and driving performance outcomes of 




4.3.1 Alerting effects of the light on objective sleepiness outcome measures 
Effects of the light on EEG-related outcome measures 
Evidence shows that objective outcomes of sleepiness such as EEG and ECG related 
outcomes are sensitive to light. Alerting effects of light on different human 
sleepiness indicators have been mostly examined during the night to provide the 
greatest declines in alertness in both the circadian and homeostatic drives. Very few 
of these studies have examined the alerting effects of light in the driving context.   
Figueiro et al. (2009) reported that a 45-minute nocturnal exposure to diffused blue 
light (470 nm) at two irradiances of 40 μw/cm2 (40 lux) and 10 μw/ cm2 (at 10 lux) 
could significantly decrease the EEG relative alpha power and increase relative beta 
power when compared with dim red light (< 1 lux), with a larger effect of 40 lux blue 
light. Decreases in the EEG alpha power and increase in beta power suggest an 
alerting effect of blue light. Figueiro et al. (2009) also reported that low levels of 
blue light (40 lux) could increase heart rate variability. 
Cajochen (2000), reported that in the last 90 min of 6.5-h night time exposure to 
light, EEG alpha-theta frequencies (5-9 Hz) showed greater decreases under 106 lux 
and 9100 lux than under 3-lux light (P < 0.002). They concluded a steep dose-
response relationship between light level and EEG alpha-theta power density. 
Phipps-Nelson (2009) in a simulated night-time driving experiment compared the 
effects of 5 h (from 23:55 to 05:30) exposure to three counterbalanced lighting 
conditions with 2 h ambient light conditions from 20:40 to 23:30. Lighting 
conditions included blue light (460 nm, 2 m W/cm
2
, with 1.12 to 1.15 lux in the 
horizontal angle of gaze in the driving cabin), red light (620 nm, 1.13 to 1.18 lux) 
and ambient light (430 nm and 620 nm, 0.5 m W/cm
2
, 0.02 to 0.20 lux). Light 
condition had a significant effect on theta activity (F2,12 = 9.76, p = 0.003), but not on 
alpha activity. Blue light reduced theta activity both during (p = 0.031) and after light 
exposure (p = 0.030) when compared to ambient light. 
Some studies have reported the dependence of alerting effects of light on time of day 





In a constant routine study, Badia, et al. (1991) examined the effects of both night 
time and daytime exposure to bright white light (ranging from 5000 to 10,000 lux at 
the cornea) on EEG activity in alpha, beta and theta frequencies. The study involved 
four experiments with different groups of participants: 1) night time alternating 
bright light-dim light conditions in which participants were exposed to 90-min blocks 
of alternate bright light (5000 lux to 10,000 lux) or dim light (50 lux), 2) daytime 
alternating bright light-dim light condition as the control condition in which 
participants received two 90-min blocks of alternating bright light and dim light, 3) 
night time continuous bright light conditions in which participants were randomly 
exposed to only one bright light condition - either continuous night time bright light 
(5000 to 10,000 lux) or continuous night time dim light (50 lux) condition, and 4) 
night time continuous dim light condition. Comparison of the effects of night time 
bright light and dim light in participants exposed to alternating bright light (5000 lux 
to 10,000 lux white light) and dim light (50 lux) conditions revealed that bright light 
increased the log power density of EEG beta, but not power of alpha and theta bands, 
indicating alerting effect of bright light. A similar pattern in EEG differences was 
observed among the daytime alternate condition (control) group; however, the 
differences were not significant. This study implies that night time alternating bright 
light-dim light conditions exert more alerting effects in terms of EEG frequencies 
than daytime alternate bright light-dim light or daytime continuous bright light 
conditions.  
Rüger, et al. (2006), examined the effects of daytime and night time bright light 
exposure on heart rate using the results of three experiments involving a 4 h exposure 
to different light intensities (<10, 100 and 5000 lux), at various times (midnight till 
4:00 a.m. versus noon till 4:00 p.m.), and at different retinal areas exposed to the 
light (whole retinal versus partial retinal exposure). Participants were classified into 
two groups based on time of exposure (daytime experiment or night time 
experiment). During the daytime experiment participants were exposed to bright light 
(5000 lux) or dim light (10 lux) from noon until 4:00 pm. During the night time 
experiment participants were exposed to either bright light (5000 lux) or dim light 
(10 lux) from midnight until 4:00 a.m. They found that regardless of whole or partial 
retinal exposure to bright light, heart rate increased under night time bright light F1,11 
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= 22.9, p = 0.001, compared to daytime exposure with no such an effect F1,11 = 0.2,   
p = 0.604. The increase in heart rate is associated with increased alertness levels. 
An, et al. (2009) compared the time-of-day (daytime or night time) dependent effects 
of two monochromatic lights (with different wavelengths at 458 nm or 550 nm), but 
the same irradiance density (9.8 m W/cm
2
 at eye level) on human EEG activity and 
visual PPVT reaction time (RT). Monochromatic lights were delivered at two times 
(daytime and night time), 12 h out of phase with each other with day time exposure 9 
h after awakening. Findings of this study showed that the Alpha Attenuation 
Coefficient (AAC) at night was higher than in the daytime (F1,11 = 10.89, p < 0.01), 
suggesting that the participant levels of arousal at night time were higher than in the 
daytime.  
Few studies have been conducted in the daytime. Recently Okamoto et al. (2014) in a 
daytime study investigated the alerting effects of 48 min exposure to either blue light 
or red light or darkness on nine individuals after one-night sleep loss for 1.5 h in the 
early morning. They did not find any significant effects of light condition on EEG 
alpha and theta power densities. However, the EEG alpha power was lower under 
both blue and red lights when compared to the placebo (darkness) conditions 30, 40 
and 50 min after starting the experiment. In contrast, a main effect of time interval 
was found for theta with the EEG theta power being larger at 30, 50 and 60 min after 
starting the experiment. These findings show that both blue and red light could 
improve alertness by reduction of alpha activity after 30 min. The increase in theta 
activity shows increased sleepiness and the ineffectiveness of these two lights on this 
indicator of sleepiness. 
Overall, the alerting effect of light on objective sleepiness outcome measures have 
been shown by decreased alpha and theta activities, increased beta activity and heart 
rates. The findings also imply that the alerting effects of light exposure on human 
objective sleepiness depend on the wavelength and level of light, in that shorter 
wavelengths of light elicit more stimulating effects and need lower intensities to 
exert their alerting effects. Finally, the alerting effect of light depends on time of day 






Alerting effects of light on PPVT outcome measures of sleepiness 
Many studies have reported the sensitivity of the psychomotor vigilance task (PPVT) 
to the alerting effects of light.  
In a between-participant experiment, Lafrance et al. (1998) examined the stimulating 
effects of daytime exposure to white bright light on daytime vigilance (during and 
after exposure to light) among 14 participants (10 women, 4 men; 19–24 years old).  
Participants were involved in the experiment for four days at home and 4 days/6 
nights in the laboratory. Participants were given two nights of 4 h sleep restriction 
before being exposed to a 4.5 h bright light (a white light of about 10,000 lux at eye 
level) or red dim light (a red light of about 100 lux) during the late morning on two 
consecutive days. Findings of this study showed that two nights of sleep restriction 
did not affect their performance due to a high practice effect. A significant day effect 
on mean reaction time was observed only in the bright light group (p < 0.0001). 
There was a significant decrease of RTs from the pre-light day to day 1 and day 2 of 
light exposure (p < 0.05). There was also a significant day effect on percentage of 
errors in the bright light group (p = 0.01) but in a different direction. There was a 
significant increase in percentage of errors from the pre-light day to day 1 and day 2 
of light exposure (p < 0.05).  The authors concluded that daytime bright light and red 
dim light could improve global performance, but changed the method of performing 
PPVT (seen as faster reaction times and increased percentage of errors in bright 
light).  
Phipps-Nelson (2003) found a significant main effect of 5 h daytime exposure to 
bright light (1000 lux) on PPVT mean reaction times after two nights of 3 h sleep 
loss (F1,13 = 5.014, p < 0.05). Bright light reduced the mean reaction times, but dim 
light (< 5 lux) increased mean RTs. They also confirmed that PPVT reaction time 
improved immediately after exposure to light. A later study by Phipps-Nelson (2009) 
reported a significant effect of light conditions on PPVT reaction times (F2,14 = 4.42, 
p = 0.032), and PPVT lapses (F2,14 = 3.89, p = 0.048). They reported that mean 
reaction time was faster under 5 h exposure to blue light (2 mW/cm
2
, from 1.12 to 
1.15 lux) than ambient light (0.5 mW/cm
2
 from 0.02 to 0.20 lux) both during (p = 
0.038) and after light exposure (p = 0.048). In contrast, they reported an increase in 
PPVT lapses under all light conditions (F3,21 = 3.89, p = 0.048). 
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Smolders et al. (2012) examined the alerting and vitalizing effect of daytime 
exposure to bright light under natural conditions (no sleep loss or pre-experiment 
dim light). Participants had a short (> 30 min) exposure to less than 1000 lux white 
light with colour temperature of 4000 k during two experimental sessions (morning 
and afternoon sessions, each session lasting for 90 min). During a 30 min baseline 
phase, when participants were exposed to 200 lux (4000 k) at work level, two 
cognitive performance tests were measured including a 5 min auditory PPVT (mean 
reaction time, 10% slowest responses and 10% fastest responses), and a Necker cube 
pattern control task (number of errors and percentage correct). During a 1 h 
experimental phase (four 15 min blocks of counterbalanced light exposure to either 
200 lux or 1000 lux at eye level) all measurements of the baseline phase were 
repeated (except the second performance test). During blocks 1, 2, and 3, letter digit 
substitution tests (LDST, the number of correctly substituted digits) were undertaken 
followed by an auditory PPVT. Exposure to 1000 lux bright light shortened reaction 
times (PPVT) when compared with light of 200 lux. The effects of light on PPVT 
were modulated by time of day and duration of the experiment. The most 
pronounced effect of illuminance on PPVT was observed in the morning and/or 
towards the end of the experiment. In this study, light exerted alerting effects even 
during the daytime. Therefore, the authors hypothesised that in addition to the 
circadian system, alerting and vitalizing effects of light might be elicited by other 
mechanisms through the activation and modulation of alertness-related (e.g. 
brainstem, thalamus) and mood-related pathways (e.g. amygdale, hippocampus).   
These findings suggest that all outcomes of cognitive performance do not 
consistently respond to light. The effects of light on performance depend on the type 
of test with some performance tests, such as PPVT, being more sensitive to bright 
light.  
 
4.3.2 Alerting effects of the light on subjective sleepiness outcome measures 
Subjective sleepiness normally shows sensitivity to the alerting effects of light. 
Cajochen, et al. (2000) found an immediate improvement in subjective sleepiness in 
9100 lux compared to 106-lux and 3-lux lights. They suggested a dose-response 





was less deteriorated during 6.5 h night time exposure to 9100 lux and 106 lux than 
dim light (3 lux). They also reported that subjective sleepiness in the high (9100 lux) 
and mid-light-level (106-lux) groups deteriorated during the 2 h after exposure to 
light and reached the sleepiness level of the low-light-level group. 
Lockley et al. (2006) in a between-groups study, randomly assigned participants to a 
6.5 h 460 nm (n = 8) or 555 nm (n = 7) monochromatic light starting 9.25 hours 
before their respective wake time. They found no significant difference in KSS 
scores between the two groups (460 nm, n = 8; 555 nm, n = 7) at the onset and 
during light exposures and for up to 1 h after exposure ended. However, sleepiness 
increased in both groups after that time coinciding with the circadian nadir in 
alertness. 
Phipps-Nelson (2003) compared the alerting effects of 5 h daytime (from noon to 5 
p.m.) exposure to 1000 lux bright light with dim light on two groups of participants 
after two nights of 5 h sleep (delayed bed times). They found a significant main 
effect of light group on subjective sleepiness (KSS) (F1,13 = 6.258, p < 0.05), with 
subjective sleepiness decreasing under bright light and increasing under dim light. 
Interestingly, they did not observe the improvement of KSS immediately after 
exposure to light, but one hour after receiving bright light.  
Findings of the study by Rüger et al. (2006) showed improving effects of bright light 
(5000 lux at the whole retina) on subjective sleepiness (KSS), both in the daytime 
and at night. This study found an interaction effect between light condition and 
retinal exposure (F 1,22 = 16.8, p < 0.001). They suggested that regardless of time of 
exposure (night time vs. daytime), whole retina exposure to bright light (5000 lux) 
can decrease subjective sleepiness (KSS). 
A study conducted by Figueiro et al. (2009) found that light could not improve 
subjective sleepiness. The researchers reported that in their study involving a 45 min 
counterbalanced night time exposure to one of four lighting conditions of blue or red 
light at two levels (40 lux, 10 lux), subjective sleepiness (KSS) was not significantly 
changed when 30 min measured after exposure to these light conditions. In the study 
of Phipps-Nelson (2009)a significant increase in subjective sleepiness was observed 
during 6 h night time exposure to blue light (460 nm, 2 mW/cm
2
, from 1.12 to 1.15 
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lux) when compared to ambient light (430 nm and 620 nm, 0.5 mW/cm
2
 from 0.02 to 
0.20 lux)  (F2,14 = 20.13, p < 0.001). 
These findings suggest that bright light generally decreases subjective sleepiness 
during both night and daytimes.  
 
4.3.3 Alerting effects of light on driving performance outcome measures 
There is little evidence available regarding the alerting effects of light on driving 
performance of sleep-deprived drivers. One of the available study is the simulated 
driving study of Phipps-Nelson (2009) examining the alerting effects of 6 h night 
time exposure to counterbalanced blue light (460 nm, 2 mW/cm
2
, 1.12- 1.15 lux), red 
light (620 nm, 1.13-1.18 lux) and ambient light (430 nm and 620 nm, 0.5 mW/cm
2
, 
0.02 to 0.20 lux) on driving performance outcomes. They found that unlike the 
alerting effects of light on objective measures (theta activity) and mean reaction 
times, there was no main effect of light conditions on driving simulator performance 
(lateral lane deviations) (F2,14 = 17.10, p < 0.001). Instead, lateral lane deviations 
became progressively worse across the night under all light conditions. 
Two studies have compared the alerting effects of light and caffeine on different 
outcomes including driving performance outcomes. In one of these studies, night 
time administration of the combination of bright light (10000 lux) and 200 mg of 
caffeine decreased lane drifting by sleep-deprived participants during simulated night 
time driving (Hartley et al., 2013). In the other study, the effect of the administration 
of light on driver performance was compared to the effect of caffeine. Continuous 
nocturnal blue light (468 nm) improved on-road driving performance more than 200 
mg of caffeine or the caffeine placebo (Taillard et al., 2012). These two studies are 
explained in more detail in Section 4.5. 
 
4.4 CAFFEINE 
Caffeine (1, 3, 7-trimethylxanthine), reaches its maximum plasma concentration 
within 15 to 120 min (Arnaud, 1987), or an average of 30 minutes after consumption 





completely by the body after around 45 min (Blanchard & Sawers, 1983). Studies 
have revealed complex alerting and stimulating effects for caffeine depending on 
dosages, participants and experimental conditions (Lorist & Tops, 2003). Generally, 
caffeine has been shown to restore performance to initial levels during circadian dips 
in alertness or after sleep loss (Nehlig, 2010; Smith, A., 2002). The stimulating 
action mechanism of caffeine is generally regarded as an antagonism of a mediator of 
sleep, adenosine, particularly by blocking adenosine A1 and A2A (Fredholm et al., 
1999). 
According to Denaro (1990), 4 mg/kg/day (e.g. 240 mg/day for a 60 kg individual) 
and 12 mg/kg/day are regarded as low-dose and high-dose caffeine levels, 
respectively. Several driving experiments have demonstrated that taking 100–300 
mg, found in 1-3 average cups of coffee or two cans of “energy” drinks such as “Red 
Bull”, can enhance performance and reduce subjective sleepiness in both driving 
simulators (De Valck & Cluydts, 2001; Horne, J.A & Reyner, 1996; Reyner, L. & 
Horne, 1997; Reyner, L.  & Horne, 2000), and on-road studies (Philip et al., 2006; 
Sagaspe, Patricia et al., 2007) among sleep deprived participants. Similarly, lower 
doses of caffeine (one cup containing 80 mg caffeine), as predominantly consumed 
in real life, appear to (1) enhance driving performance as measured by the standard 
deviation of lateral position (SDLP) and the standard deviation of speed, and (2) 
reduce mental effort and subjective sleepiness in a prolonged simulated highway 
driving among non-sleep deprived individuals (Mets et al., 2012). A recent case-
control study among long-distance commercial drivers also revealed that drivers who 
had consumed caffeinated beverages such as tea, coffee, and energy drinks were 
about 63% less likely to have a  crash compared with non-consumers of caffeine 
(Sharwood et al., 2013). These alerting effects of caffeine mostly appear 30 min after 
consumption and last for an hour or so depending on the level of sleepiness 
(Blanchard & Sawers, 1983; Horne, J.A & Reyner, 2001; O'connell & Zurzola, 
1984). Some other forms of caffeine, such as caffeinated gum, have been used by 
Snel & Lorist (2011). These authors found that after oral ingestion of caffeine, 99% 
of it was absorbed from the gastrointestinal tract into the bloodstream with maximum 
levels reached between 45 and 80 min post-administration. There is discrepancy 
about the washout period of caffeine. Some researchers considered a period of 12 h 
(Brunyé, Mahoney, Lieberman, Giles, & Taylor, 2010). Others have considered a 3 
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day washout for caffeine (Giles et al., 2012). Caffeine plasma half-lives also found to 
vary from 2.7 to 9.9 h due to substantial inter-individual differences in its elimination 
(Blanchard & Sawers, 1983). 
In most studies participants were under acute caffeine withdrawal before starting the 
experiment. Hence, some researchers attribute the alerting effects of caffeine to 
withdrawal reversal rather than a net beneficial effect of caffeine (Heatherley, 2011; 
Rogers, P.J et al., 2005(b)). In one study researchers included a one-week washout 
period to eliminate any effects of caffeine withdrawal. They found that even 
individuals who were withdrawn for a week showed alerting effects of caffeine 
(Smith, A., Sutherland, & Christopher, 2005). 
Overall, the literature supports the alerting effects of caffeine. Nevertheless, it is not 
a reliable countermeasure since it has a temporary effect and its consumption 
depends on personal preferences. Additionally, caffeine has some side effects on the 
upcoming recovery sleep after sleep loss such as increased sleep onset latency 
(Carrier et al., 2007), decreased sleep efficiency, decreased sleep duration and REM 
sleep (Carrier et al., 2007). Table 4.1 shows the characteristics of light/caffeine 
interventions in some related studies. Table 4.2 represents a summary of the 






Table 4.1 Characteristics of light/caffeine interventions in some related studies 
Authors Light colour / 
wavelength  
Caffeine dose 
Timing and duration of exposure/caffeine 
consumption 
Light irradiance/illuminance Placebo 
condition 







blue light at 
468 nm ± 8 nm, 
Caffeine 200 
mg, 
Caffeine or placebo of caffeine intake, 2 h 
driving under blue light, caffeine or caffeine 
placebo intake during 15 min break, 2 h 

























30 min counterbalanced exposure to caffeine 
plus bright light, caffeine plus bright light 
placebo, caffeine placebo plus bright light, 
and caffeine placebo plus bright light 
placebo, 
Bright light 10,000 lux at eye level, placebo white 
light, 









retinal light  
Diffused blue 
light, 470 nm 
Diffused red 
light, 630 nm, 
45 min in dim red light (darkness) before a 
45 min counterbalanced exposure to one of 4 
lighting conditions - blue or red light at 40 
lux and 10 lux.  
Exposure to both levels of the same 
spectrum in each session, 
Two light boxes (0.6 x 0.6 x 0.6 m) 
with light-emitting diodes (LEDs) 
distributing blue light peaked at 470 
nm (40 μw/cm2 at 40 lux, 10 μw/ cm2 
at 10 lux), 
Two boxes emitted red light peaked at 
630 nm (19 μw/cm2 at 40 lux and 4.7 
μw/cm2 at 10 lux),  
Light illuminances and irradiances 
Dim red light 
(< 1 lux), 
Very close to light 
box, ensuring 




Authors Light colour / 
wavelength  
Caffeine dose 
Timing and duration of exposure/caffeine 
consumption 
Light irradiance/illuminance Placebo 
condition 
Distance from the 
eye 




Night time  




A fixed gaze for 90 min in the light before a 
free gaze for 10 min 6.5 h, 
Blue light 12.1 µW/cm
2
 photon 







Yellow light at 10.0 µW/cm
2
 and 










blue light, 460 
nm, 





6 h night time exposure to counterbalanced 
blue, white or red light included in the 9 h 
test session at night time, 
Blue light with spectral peak of 460 
nm, 2 mW/cm
2
, from 1.12 to 1.15 lux 
in the horizontal angle of gaze in the 
driving cabin,  
Red light with spectral peak of 620 
nm ranged from 1.13 to 1.18 lux in 
the driving cabin, 
Ambient light with spectral peaks at 
430 nm and 620 nm, 0.5 mW/cm
2
 





The ambient light 
in the driving cabin 
produced by 
projector,  




across the simulator 
dashboard display, 





Blue light, 458 
nm 
Counterbalanced monochromatic light 
exposure either at blue or yellow light for 
daytime and night-time, with 12 h out of 
phase with each other, 
Blue light at 9.8 m w/cm
2
 (at eye 
level), 






Authors Light colour / 
wavelength  
Caffeine dose 
Timing and duration of exposure/caffeine 
consumption 
Light irradiance/illuminance Placebo 
condition 














The timing of light exposure was determined 
by an on-line core temperature assessment, 
participants were randomly exposed to a 6.5 
h single illuminance, ranging from 3 to 9100 
lux, being cantered 3.5 h before their 
expected CBT minimum (23:00-5:30) and 
ending 0.25 h before their expected CBT 
minimum, 
Single illuminance ranging from 3 to 
9100 lux, 











Blue light, 470 
nm, 
Red light, 630 
nm 
Three test sessions at one week intervals, 
In each session first darkness for 12 min, 
exposure to one of 3 counterbalanced light 
conditions (blue, red or no light) for 48 min 
(from 7 to 8 a.m.), 
Two light boxes (0.6 x 0.6 x 0.6 m) 
with light-emitting diodes (LEDs) 
distributing blue light peaked at 470 
nm (40 μw/cm2 at 40 lux) and red 




Very close to light 
box, ensuring 







8 participants were exposed to dim light 
from 9 a.m. to noon, bright light from noon 
till 5 p.m., dim light from 5 to 9 p.m.  
The bright light (mean = 1,056 lux, 
range = 1,000, lux - 1,100 lux) 
presented by 6 fluorescent tubes, 
Dim light <5 
lux, 





Authors Light colour / 
wavelength  
Caffeine dose 
Timing and duration of exposure/caffeine 
consumption 
Light irradiance/illuminance Placebo 
condition 





8 participants were only exposed to dim 
light for the entire day, 
 
Dim light, provided by standard 
lamps with 40-watt incandescent, 
Bright light (1.5 m 
in front of 
participant at eye),  
 








4 groups with 4 lighting conditions: 3 groups 
at night under 9 h constant routine and one 
group in day as control group: 
Night time counterbalanced alternating BL-
DL condition:  six 90 min blocks of 
alternating bright light (5K lux to 10K lux) 
and dim light (50 lux), 
Night time continuous bright light: six 90 
min blocks of bright light  
Night time continuous dim light: six 90 min 
blocks of dim light 
Daytime alternating BL-DL condition, 
starting at 1 p.m.: two 90 min blocks of 
alternating bright light and dim light, 
 
Fluorescent 40 W cool white lamps to 
produce bright light 5000-10000 lux, 





Lights were placed 
in front of the 
participant 46 cm 
from the face, 






Randomized assignment of participants in 
two groups for two times of exposure to 4 h 
of bright light: one group between noon and 
4:00 p.m. (daytime experiment) and another 
Bright light boxes delivering 5,000 
lux in the direction of gaze at eye 
level,  
Dim light emitted from the personal 







Authors Light colour / 
wavelength  
Caffeine dose 
Timing and duration of exposure/caffeine 
consumption 
Light irradiance/illuminance Placebo 
condition 






group between night and 4:00 a.m. (night 
time experiment), with 1-3 washouts 
between two sessions, 
computer without the lamps being 
turned on (<10 lux), 








light 480 nm, 
Monochromatic 
light 550 nm, 
Monochromatic light exposure for two times 
(daytime and night time), 12 h out of phase 
with each other with day time exposure 9 h 
after awakening,  
Each test session: 5 min exposure to 
standard light (19 lux on vertical surface and   
96 lux on horizontal surface at eye level), 
dark adaptation (<1 lux) for 5 min followed 
by counterbalanced light exposure either at 
458 nm or 550 nm,  
 
Monochromatic light generated by a 
variable voltage (0–100) halogen 
lamp 30 cm away from the eye, and 
filtered by interference filters in to 
458 nm or 550 nm with irradiance of 
9.8 m w/cm
2 
at eye level, 
NA Monochromatic 
light 30 cm away 






light 460 nm, 
Monochromatic 
light 555 nm, 
During three baseline days ambient light was 
190 lux,  
From midday of the third day of baseline 
period ambient light < 2 lux till the end of 
study, 
randomly assignment of participants to 6.5 h 
either 460 nm (n = 8) or 555 nm (n = 8) 
monochromatic light (±10 nm half-peak 






 for 555 nm and 460 
nm, respectively, generating an equal 
photon density of 2.8 x 1013  






Authors Light colour / 
wavelength  
Caffeine dose 
Timing and duration of exposure/caffeine 
consumption 
Light irradiance/illuminance Placebo 
condition 
Distance from the 
eye 
bandwidth), starting 9.25 hours before their 
respective wake time (approximately 6.75 h 










dim red light, 
 
Expose the participants to a 4.5 h either 
bright light (10,000 lux at eye level) or dim 
red light (100 lux) on 2 consecutive days (in 
the late morning with no effects on 
melatonin secretion or on the circadian 
phase) after 2 nights of sleep restriction,  
Bright white light (mean 12000 lux),  
Dim red light (mean 100 lx),  
The room light intensity below 50 lux 
at all other times, 
NA Three panels 62 x 
61 cm delivered 
bright white light 
over the entire 
visual field at 
participant eye 
level,  
Dim red light was 
distributed by red 
filters, 





Table 4.2 Summary studies of alerting effects of light 









Timing of recording of 
outcomes 
Results 















subjective   



























A battery of 
three 












first 45 min inactivity in 
darkness, 
In the last 15 min of data 
collection (EEG, Performance 
and saliva melatonin, 
45 min either 40 lux or 10 lux of 
either blue or red light, 
 
One time: 
45 min inactivity in darkness 
(dim red light), 
The last 15 minutes of darkness 
data collection (EEG, 
Performance and saliva 
melatonin), 
 
Effect of blue and lights on relative the 
EEG the EEG alpha power F 7,91= 2.15, 
p = 0.046 and on beta power F7,91=3.91, 
p < 0.0009 as opposed to dim light, 
A significant decreasing impact of both 
10 lux and 40 lux blue light and only 10 
lux red light on relative the EEG the 
EEG alpha power, 
A significant increasing impact of both 
10 lux and 40 lux blue light and only 10 
lux red light on relative beta power, 
A dose-response relationship between 
blue light illuminance and changes in 
relative alpha and beta powers, 
A significant increase in heart rate by 
higher level (40 lux) of both blue and 
red light compared to ineffective lower 
level (10 lux) of the two spectra, 
No significant effect of all spectra and 
intensities of light conditions on 
performance measures (PPVT) and KSS, 
164 
 







































































Each test session lasted for 9 h 
during night, 
From 20:40 to 23:30 pre-light 
test battery under ambient white 
light condition including Saliva, 
PPVT, KDT, KSS,  
2 h night time simulated driving 
task (speed limit 80 km/hr), 
 Saliva, KSS, PPVT, KDT, 30-
min break, 
From 23:55 to 05:30 two times 
of test battery under one of 3 
counterbalanced light treatments 
including blue light, red light 
and ambient white light, test 
battery included KSS,  
2 h simulated drive,  
Saliva, KSS, PPVT, KDT, 30-
min break, 
A significant effect of light conditions 
on PPVT reaction times and lapses, 
Mean reaction time was faster under 
blue light than ambient light both during 
(p = 0.038) and after light exposure (p = 
0.048), 
PPVT lapses increased significantly 
under all light conditions, 
No significant difference between red 
(placebo) and ambient light, 
No main effect of light conditions on 
subjective sleepiness, 
A significant increase in subjective 
sleepiness in night  
No main effect of light conditions on 
driving simulator performance (lateral 
lane deviations) F2,14 = 17.10, p< 0.001 
Lateral lane deviations became 



































From 5:55 to 8:30 the post-light 
test battery under ambient white 
light condition included KSS,  
2 h simulated drive, Saliva, 
KSS, PPVT, KDT,  
A minimum 4 weeks wash out 
period between three 
counterbalanced lighting 
sessions, 
Using red light as the Placebo 
condition with light intensity 
equated in photopic lux (1.1 lux) 
to blue light, rather than equal 
photon density, so the light 
sources were perceived to be of 
similar intensity, 
 
all light conditions, 
A decrease in the SEMs (slow eye 
movements) by placebo red light as 
compared to ambient, 
Significant effect of light condition on 
theta activity found (F2,12 =9.76, p = 
0.003). Blue light reduced theta activity.  
Planned contrast showed that blue light 
compared to ambient light reduced theta 
activity both during (p = 0.031) and after 
light exposure (p = 0.030), 
No effect of light condition on alpha 
activity.  
Alerting effect by blue light via 
mechanisms other than melatonin since 
the nocturnal exposure blue light could 
offset the homeostatic sleep drive 
induced by sleep loss but did not 
suppressed melatonin 












(n = 22) and 
female (n = 1) 
volunteers  
50 h constant 
routine 
without sleep 







A 9-day protocol consisting 3 
days laboratorial regular sleep-
wake time and a 50 h constant 
routine (awake, semi recumbent 
under dim light of 10 lux at eye 
Dependence of subjective sleepiness 
(KSS), plasma melatonin and core body 
temperature on luminance level such 
that KSS was less deteriorated under 
9100 lux and 106 lux than 3 lux, 
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sleep of 8 h, 
going to bed 
again starting 

























level) to assess initial phase of 
core body  temperature,  
An 8h recovery sleep starting 
4.5 h after the CBT minimum 
(23:00 – 05:30) under 3 lux 
ambient light levels, 
participants were randomly 
exposed to a 6.5 h single 
illuminance, ranging from 3 to 
9100 lux, being cantered 3.5 h  
before their expected CBT 
minimum and ending 0.25 h 
before their expected CBT 
minimum, 
A second constant routine of 30 
h duration to assess the effects 
of the experimental light pulse 
on the circadian phase, 
Assessment of subjective 
sleepiness (Karolinska   
sleepiness scale, KSS), plasma 
melatonin and objective 
alertness (Karolinska drowsiness 
test, KDT) in 30 min, 30 min 
A rapid improvement in subjective 
sleepiness in 9100 lux compared to low 
intensities, 
A significantly lower plasma melatonin 
level under entire 6.5 h exposure to high 
intensity group than low light levels, 
A stable level of both alertness and 
plasma melatonin in both groups 
exposed to high intensity and low 
intensity after 2 h exposure, 
A higher mean core body temperature 
during exposure to the high intensity 
light, 
Mid and high illuminance decreased 
EEG alpha-theta frequencies (5-9 Hz) in 
the last 90 min more than low intensities 
(P < 0.002) 
A steep dose-response relationship 
between light intensity and subjective 
alertness, SEMs and EEG theta–alpha 
activity such that half of maximal 
alertness in 9100 lux can be induced by 
100 lux and SEMs and EEG theta–alpha 














Timing of recording of 
outcomes 
Results 
and 1 h intervals after 
awakening. respectively, 
Classification of light intensities 
into 3 classes: first 33
rd
 
percentile (3 lx), second 33
rd
 
percentile (106 lx) and third 33
rd 
percentile of the illuminance 
range (9100 lx). 
 
than those in 180 lux and 90 lux  


















(5 men, 4 
women) aged 
between 22 













Three times recording EEG with 
one week intervals, 
EEG was recorded in 2.5 min 
periods, in the last 2.5 min of 
darkness, and 6 times during 
light conditions (for 2.5 min at 5 
min intervals) 
 
No main effect of light condition for 
EEG alpha and theta was found, 
The EEG alpha power was lower under 
both blue and red lights as opposed to 
placebo (darkness) conditions in the 30, 
40 and 50 min after starting the 
experiment, 
A main effect of time interval for theta 
was found with the EEG theta power 
being larger 30, 50 and 60 min after 
starting the experiment. 
 










Participant randomly fixated to 
either 1000 lx bright light or 5 
A significant main effect of light group 
F1,13 = 6.258, p <0.05 (attenuated 
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and 35 years 




(from 1 a.m. 









On day 11 
sleep from 1 
a.m. to 6 



























lux dim light (from 12.30 p.m. 
to 5 p.m., every 10 min), 
On day 12, from 9 a.m. to noon 
exposure to dim light and hourly 
measuring of KSS, PPVT, 4 min 
KDT, saliva, 
From 12:30 to 5 p.m. one group 
exposure to bright light every 10 
min, one group to dim light and 
every 30 min recording KSS and 
PPVT, 4 min KDT, saliva, 
From 5 p.m. to 9 p.m. exposure 
to dim light and hourly 
measuring KSS and PPVT, 4 
min KDT, saliva 
 
subjective sleepiness under bright light 
from 1 p.m. onward, but increased KSS 
under dim light),  
 A significant main effect of light group 
on PPVT: F1,13 = 5.014, p < 0.05, bright 
light reduced mean reaction times but 
dim light increased mean RTs, reduced 
the percentage of KDT epochs 
containing SEMs,  
Independency of the effects of bright 
light on sleepiness and performance 
from suppression of salivary melatonin,  
Immediate improvement of PPVT 
performance after the onset of bright 
light exposure, whereas KSS improved 
after 1 h exposure, 
A significant correlation between PPVT 
performance and subjective sleepiness 

























Badia et al. 
(1991),  










(5000  to 
10,000 lux 
at the 
cornea)  on 
core body 
temperature






























After each block the following 
fixed order of tests was 
conducted: 
Temperature, free-time, snack, 
temperature, first battery of 
performance, temperature, EEG, 
MWT, temperature, 
Assessment of performance by a 
battery of different 
computerized tasks including 
digit recall, logical reasoning, 
two-letter search, two-column 
addition, serial addition-
subtraction, and a continuous 
performance task in each block, 
Performing a maintenance of 
wakefulness test for 15 min at 
Alternating BL and DL group:  
Increase in the log power density of 
beta, but not power of alpha and theta 
bands by night time bright light, 
indicating alerting effect of bright light, 
A significant increase in log power 
density of theta across blocks of bright 
light F2,28 = 5.9, p < 0.05, 
A similar pattern of EEG differences by 
daytime alternate condition (control 
group), however the differences were 
not significant. 
Small differences in sleepiness (MWT) 
during first two blocks of night time 
continuous bright or dim light, but a 






















the end of each block Both night-time and  
daytime alternating condition:  
Improvement of performance on all 
tasks by bright light, more significantly 
on Digit Recall, Two Letter Search, and 
Serial Add/Sub, 
Dim light could not offset deterioration 
of performance over night,  
An insignificant worsened performance 
during alternating daytime exposure, 
Continuous BL--DL condition: 
Insignificant, but similar to night time 
alternating condition improvements of 
performance on all tasks during 
continuous BL--DL condition, 
 

















23.1 ±1.5 yr), 




first test from 
6 p.m. till 
midnight (4 
a.m.), second 
test from 8 









Experiment A (day time):  The 
first testing battery (testing 1) 
from 6:00 p.m. on day 0, with 
hourly measurements 6 min 
wake-EEG, ECG recording, 
salivary cortisol concentration, 
The second testing (testing 2): 
From 8:00 a.m. until midnight. 
Similar effect of light on subjective 
sleepiness (the KSS) and on subjective 
fatigue (the VAS-F) and energy level for 
the daytime and night time bright light 
exposure independently from the time of 
day. Interaction effect for the factors 























sleepiness   
experiment 
(mean age, 








wake from 6 
p.m. till 9 
a.m. and the 
second test 
from 6 pm 











Exposure to bright light or dim 
light from noon until 4:00 p.m.  
Experiment B (night-time 
exposure):  The first testing 
battery started at 6:00 p.m. on 
day 1 and lasted until 9:00 a.m. 
on day 2 during which the 
participants were exposed bright 
light or dim light from midnight 
until 4:00 a.m.  
The second testing: Lasted 
from 6 p.m. to 12:00 a.m. of the 
next day (day 3), 
 
Increased heart rate by night time 
exposure to bright light F1,11 = 22.9, p = 
0.001, 
and reduced circadian drop in core body 
temperature by night time bright light, 
  
No effect of daytime exposure to bright 
light on heart rate (F1,11 = 0.2, p = 0.604) 
and temperature  
 
 
An et al. (2009), 
Repeated 
measures within 










s of light, 





















al., 1982),  
Arousal level 
(Alpha 
Monochromatic light exposure 
for two times (daytime and night 
time), 12 h out of phase with 
each other with day time 
exposure 9 h after awakening, 
Collection of subjective 
alertness scores (the kwansei 
gakuin sleepiness scale) before 
each session,   
During monochromatic light 
A higher alpha attenuation coefficient 
(AAC) F1,11 = 10.89, p < 0.01, 
representing a higher level of arousal at 
night time than in the daytime, under 
both 458 nm or 550 nm light, 
No change of subjective sleepiness 
between day and night time F3,11 = 
0.717, p > 0.05, 
A considerable interaction among 
wavelength, time of day, and EEG 
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Timing of recording of 
outcomes 
Results 























exposure, performing an alpha 
attenuation test (AAT) for 6 
min, followed by an 
approximately 20 min oddball 
task to extract P300 event-
related potentials, 
electrode site such that, during 458 nm 
light exposure, participants paid more 
attention to perform the oddball task at 
night time than in the daytime, 
An increased P300 amplitude (higher 
cognitive function) after 458 nm light 
exposure more than 550 nm, 
Dependence of the time-of-day effects 
of monochromatic light exposure on 
human cognitive function to light 
wavelength. 
 



























Measurement of the KSS was 
presented every 10 to 20 min for 
the first 90 min awake, every 30 
to 60 min during the 16 h wake 
episode, including the start light 
exposure, and every 1 h after 
No significant difference in KSS scores, 
and in performance measures between 
two groups (460 nm, n = 8; 555 nm, n = 
7) at the onset of light exposure, 
No change in subjective sleepiness 



































(day 6-7), a 










































Measurement of performance 
every 30 to 90 min using an 
auditory 10 min test 
exposures for up to a 1 h after exposure 
ended. However, sleepiness increased in 
both groups after that time coinciding 
with the circadian nadir in alertness, 
Faster auditory reaction times and 
median reaction times throughout 
exposure to 460 nm light than during 
exposure to 555 nm monochromatic 
light, 
Reduction in auditory lapses, during 
exposure to 460 nm (< 4 per 10 min test) 
as compared with 555 nm light, 
 
Improvement of psychomotor 
performance parameters persisted for up 
to 1 h before deteriorating at circadian 
nadir, 
Reduction of EEG power densities delta-
theta and increase in the EEG the EEG 
alpha power densities during exposure to 
460 nm, 
No significant difference in cortisol 
levels during exposure to both 460 nm 
and 555 nm light, 
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(10 women, 4 







of 4 h sleep 
restriction 
from 4 a.m. 
















Matching the participants for 
gender, for age and for the mean 
daytime sleep latency for two 
groups and administration of 
two nights of 4 h sleep 
restriction, 
Assessment of daytime 
vigilance before, during, and 
after the two days of light 
exposure and sleep restriction, 
including physiological sleep 
tendency, subjective alertness, 
and performance, 
Assessment of subjective 
alertness (VAS) every 30 min 
A decrease in subjective alertness and 
daytime sleep latencies significantly by 
two nights of sleep restriction,  
No effect of two nights of sleep 
restriction on performance due to 
practice effect, 
A significant day effect only in bright 
light group on mean reaction time (p < 
0.0001); decrease of RTs from pre-light 
day to day 1 of light exposure and day 2 
of light exposure (p < 0.05), 
A significant day effect on percentage of 
errors only in bright light group (p = 
0.01); increase of percentage of errors 




























throughout all the time awake 
and every hour during the light 
exposure, 
Assessment of the performance 
by four-choice reaction time test 
(4-CH) every 2 h in all times 
except 1.5 h after the end of the 
light treatment, 
exposure and day 2 of light exposure (p 
< 0.05), 
 
No improved subjective alertness or 
increased sleep latencies or global 
performance by daytime bright light or 
dim red light,  
  
A change in the method of performing 
PPVT as faster reaction times and 
increased percentage of errors by bright 
light, 
No suppression of melatonin secretion 
or circadian phase shifts by bright light, 
 





crossover study  
Compariso



























(468 nm ± 8 
nm), 
delivered 
from a light 
source in the 
middle of the 
dashboard 
(approximate
Three randomized night-time 
driving sessions for all 
participants (from 1:00 a.m. to 
5:15 a.m.) with more than one 
weak washout between two 
sessions, 
Driving 400 km for 4 h with a 
15 min break in the middle of 
the session, either under 
A significant reduction in the number  of 
inappropriate line crossings and SD  of 
the lateral position by both blue light 
and caffeine, 
Effectiveness of blue light in short and 
long driving periods and throughout the 
night, even at the circadian trough, 
Nocturnal driving impairment under 
light exposure and caffeine intake 
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at the eye 






continuous blue light during 
driving or 2*200 mg of coffee or 
placebo of coffee (15 min before 
driving and at the beginning of 
the break), 
Actigraphy for 3 days after each 
session to track quality/quantity 
of sleep and the regularity of the 
sleep wake cycle. 
 
corresponds to a blood alcohol 
concentration (BAC) of 0.08%, less than 
blood alcohol concentration (BAC) of 
0.10% under placebo, 
No effect of age on driving performance, 
No effect of temporary continuous 
nocturnal blue light exposure on 
quantity and timing of subsequent sleep, 
Eye-related discomfort or visual 
problems among 17% of drivers, 
















12 males aged 
20 to 50 years 
EEG, 
Lane drifting 














at a distance 
of 30 cm 
Placebo light 
(< 50 lux), 
Exposure to one of four 
treatments at the beginning of 
each session (1 a.m.) with one 
week wash out between two 
sessions, 
Treatments: 
Caffeine (capsules containing 
200 mg) plus bright light 
(C+L+), caffeine plus bright 
light placebo (C+L—), caffeine 
placebo plus bright light (C—
L+), and caffeine placebo plus 
Increased in lane drifting, subjective 
fatigue and sleepiness (VAS), but 
decrease in reciprocal reaction time 1:30 
a.m. to 4 a.m. and 6 a.m. in the absence 
of caffeine or bright light (the placebo 
condition), 
A decrease in lane drifting, but not 
immediately by caffeine and bright light 
(C+L+): the ﬁrst effect of bright light 
was a decrease in speed deviation in the 
2 h after treatment, 



















of the vehicle 
crossed over 
the edge of 





















bright light placebo (C—L—), 
Each testing session included 
one 30 min treatment following 
by four 30 min randomized 




polysomnography at home 
followed by a recovery sleep, 
plus bright light (C+L+) as improved 
lane drifting and reciprocal reaction time 
at 6 a.m. 
No change in the quantity and quality of 
recovery sleep by treatments, 
A smaller lane drifting by caffeine plus 
light (C+L+) than placebo caffeine plus 
placebo light (C—L—), 
A smaller number of lapses by caffeine 
plus placebo light (C+L—) than placebo 
caffeine plus light (C—L+) or than 
placebo caffeine plus placebo light (C—
L—). Therefore, caffeine was more 
effective in decreasing the number of 
lapses, 
Higher effect of caffeine than light on 
decreasing subjective sleepiness, 
A worsened mean RRT by caffeine in 
the absence of light, 
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4.5 COMPARISON OF ALERTING EFFECTS OF LIGHT AND CAFFEINE 
In some studies, the alerting effects of light have been compared with those of 
caffeine. Table 4.3 represents the methodological analysis of two studies comparing 
the alerting effects of light and caffeine. 
In the first study Taillard et al. (2012) compared the effects of continuous exposure 
to 20 lux monochromatic blue light (spectral wavelength of 468 nm) with two doses 
of 200 mg coffee or caffeine placebo on three randomized 4 h night time on-road 
driving performance tests among young and middle-aged sleep-deprived participants.   
In the second study Hartley et al. (2013) used a randomized cross-over design to 
examine the effects of four interventions including caffeine (capsules containing 200 
mg) plus bright white light (10,000 lux), placebo of caffeine (50 mg) plus bright 
light, caffeine plus bright light and placebo of caffeine plus placebo of bright light 
(50 lux), on simulated night time driving among sleep-deprived individuals. Each 
testing session included one 30 min intervention following by four 30 min periods of 
simulated driving. In both studies there was a one-week washout period between 
each test session. These two studies revealed the following findings: 
In the absence of caffeine or bright light (the placebo condition) lane drifting and 
subjective vigilance (VAS) increased, but reciprocal reaction time decreased (Hartley 
et al., 2013). 
Blue light (40 lux) or caffeine (200 mg every 2 h) when administered individually 
could significantly reduce the number of inappropriate line crossings and standard 
deviation of the lateral position (Taillard et al., 2012). Similar effects were with 
bright white light (10000 lux) plus caffeine which signiﬁcantly decreased lane 
drifting and reciprocal reaction time. Moreover, bright white light on its own 
decreased variations of speed (Hartley et al., 2013).  
Blue light was effective in short and long driving periods and throughout the night, 
even in the circadian trough (Taillard et al., 2012), while the effects of white light on 
speed or effects of white light plus caffeine on lane drifting and reciprocal reaction 
time appeared at least 2 h after receiving light (Hartley et al., 2013). 
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The magnitude of effects of blue light or caffeine corresponds to a blood  alcohol 
concentration (BAC) of 0.08% which is far less than the BAC of 0.10% under the 
placebo caffeine (Taillard et al., 2012).  
Caffeine was more effective in decreasing the number of lapses and in reducing 






Table 4.3: Methodological analysis of two studies comparing alerting effects of light and caffeine 
Author Sleep-wake schedule Intervention type Intervention method Outcome measures 
Limitations/ gaps 
 
Hartley et al. (2013), 
Night time simulated 
driving 
15 days before starting 
study and throughout 3-
week study (from 9 p.m. 
to 6 a.m., or from 
midnight to 9 a.m.) 
Counterbalanced 
receiving treatments: 
white bright light 
(10000 lux), or placebo 
of white light (50 lux), 
PLUS caffeine (200 mg) 
or placebo (0 mg) 
From 1 a.m. to 1.30 
a.m. (30 min) only 
once-off exposure to 
treatment, followed 
by four times 30 min 
performing first 
KSS, VAS, and 
counterbalanced 












Vigilance (10-min PPVT): 
Mean reciprocal reaction 
time
4
, number of lapses
5
, 
visual analogue scale (VAS) 
score, Karolinska sleepiness 
score (KSS),  24 h EEG (four 
channel), EOG, ECG, EMG 
recording during all the study 
day and during 3 consecutive 
recovery sleeps.  
No study of daytime 
exposure to light, 
No chronic partial sleep 
loss, 
No specific study of blue 
or red light in low levels, 
Measurement of outcomes 
only after finishing 
treatments not during 
exposure to light, 
Short time exposure to 
light (30 min), 
Using high dose (200 mg) 
of caffeine, 
 
Taillard, et al (2012), 
Night time on-road 
driving 
 
Sleep from midnight ± 2 
h to 8 a.m. ± 2 h one 
week prior and during 




continues blue light 
(468 nm, 20 lux) or 2* 
200 mg caffeine or 
placebo (15 mg) before 
driving and during break 
 
From 1 am to 5:15 
a.m. 4 h with 15 min 
break in the middle 
of on-road driving 
session  
 






, SD  of the lateral 
position 
 
No study of daytime 
exposure to light,  
No chronic partial sleep 
loss, 
Using high dose (2*200 
mg) of caffeine, 
Limitation of outcome 
measures to in-vehicle 





1-Lane drifting: standard deviation from the middle of the road,  
2- Number of crash: frequency of crossing the centre of vehicle to the left or the right lane,  
3-Speed deviation: mean sum of differences between speed and posted speed limit,  
4- Mean reciprocal reaction time: 1/mean reaction time in seconds,  
5-Number of lapses: number of reaction times more than 500 milliseconds, 
6- An ILC was recorded when the car crossed a right or left lateral lane, whatever the duration and the amplitude of the crossing,  





4.6 SUMMARY AND IMPLICATIONS 
The literature review was conducted with the purpose of understanding the alerting 
effects of light and caffeine on driver alertness and performance and determining the 
types and doses of light and caffeine needed for the experimental study.  
Low doses of caffeine, less than 100 mg, were found to improve driving performance 
outcome measures. Caffeine in the form of gum was found to have a very high 
absorption rate. Therefore, a low dose of caffeine, preferably chewing gum, seemed 
suitable for the experimental study to address the alerting effects of minimum but 
routinely consumed caffeine by young drivers. 
Studies of alerting effects of light on sleepy drivers via both night time and daytime 
protocols have highlighted some conflicts about the positive effects of light on 
objective, subjective and performance outcomes of driver sleepiness. These 
discrepancies raised from differences in protocols utilized, physical characteristics of 
light (intensity, wavelength, pulse or continuous light), the timing of exposure, 
duration of exposure, sensitivity of outcome measures to light, inter-individual 
differences (age, gender, intolerance to bright light) and so on.  
Generally, night time studies suggest that some indices of alertness such as 
subjective sleepiness and EEG theta–alpha activity have a dose-response relationship 
with light, such that even ambient room light can enhance both objective and 
subjective alertness (Cajochen, C., 2007). EEG correlates of alertness appear to be 
more sensitive to light than behavioural measures of alertness (Figueiro, M.G et al., 
2009). Some of studies have found that shorter wavelengths of light (blue range) 
have more stimulating effects in the visible spectrum requiring lower intensities to 
elicit their alerting effects (An et al., 2009), such that blue light seems to elicit a 
greater decrease in waking EEG power density in the delta-theta frequency range 
(sleep related range), greater increase in  power density in the alpha range (relaxed 
wake), and greater enhancement of auditory performance (Lockley et al., 2006), 
particularly in reaction times and driver performance (Taillard et al., 2012). 
Daytime experiments revealed that bright light elicits some improvements in 
objective and subjective alertness measures, such as decreased eyes-open EEG alpha 
activity (Badia et al., 1991; Kaida et al., 2006(b)), attenuated subjective sleepiness 
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(Leger et al., 2009; Phipps-Nelson et al., 2003; Smolders et al., 2012), and improved 
psychomotor performance test (PPVT) (Phipps-Nelson et al., 2003). 
Based on these findings there was a need for taking a multidimensional approach to 
measure the alerting effects of light and caffeine to ensure that these stimulants elicit 
some alerting effect on subjective outcomes and induce a false sense of security 
among drivers but not improve driver performance outcomes to a considerable 
extent. Therefore, relying on one level of alertness to examine the alerting effects of 
light or caffeine would not be beneficial. 
 
4.7 GAPS IN THE EXISTING KNOWLEDGE  
This literature review revealed some important gaps in our current knowledge of the 
effects of light and caffeine on driver alertness and performance as follows: 
a. An alerting response to light appears to be a robust finding in laboratory 
studies, mostly observed after acute total or partial sleep loss, but little is 
known about alerting properties of light under chronic sleep loss.  
b. It is not still clear that how light can fit in the current computational models 
of sleep-wake or alertness regulation, because these models do not 
incorporate light as an input. 
c. The important light properties (e.g. optimum intensity, wavelength, and 
duration) to exert alerting effects are not known. 
d. The effectiveness of light in terms of sleep homeostatic and circadian factors 
is largely unknown.  
e. The effects of light on daytime human alertness and performance is not well 
understood, since most studies have been undertaken during night time to 
maximize decline in performance and alertness through coincidence of 
circadian and homeostatic drives for sleepiness. 
f. The studies of light and caffeine did not show a consensus on the washout 
period of light or caffeine in the driving context. Regarding light, minimum 
adaptation to darkness appeared to be necessary. For caffeine, maximum 





g. The literature supports the possibility of caffeine and light as 
countermeasures for sleepiness. However, the relative alerting effects of each 
as well as the effects of light and caffeine in combination on sleepiness 
outcomes have not been examined. 
Taking above-mentioned gaps in our knowledge into consideration, there was a need 
to adopt a chronic partial sleep loss paradigm to compare the effects of light and 
caffeine on objective, subjective and performance measures of sleepiness among 
young drivers. An experimental study was conducted to explore the possibility of 
light as a countermeasure for sleepiness either alone or combined with caffeine. 
Obviously, all existing gaps could not be addressed by one study. Therefore, some 
pragmatic approaches were considered to specifically bridge some of above-
mentioned gaps. A summary of existing gaps in the knowledge of alerting effects of 





Table 4.4 Existing gaps in the effect of light and caffeine on drivers’ alertness and 
performance 
Gap in the knowledge Approach to address the gap  
Most studies of alerting effects of light are 
based on acute total or acute partial sleep 
loss, not on chronic sleep loss, 
 
Adopt a chronic partial sleep loss 
paradigm, 
The effects of light in daytime on driver 
alertness is not well understood, since most 
of studies have been undertaken during 
night time to maximize driver’s sleepiness, 
 
Running the experiment during 
daytime, 
The nature of effects of light on driver 
alertness is not known, 
Utilizing broader ranges of outcome 
measures of sleepiness including 
objective, subjective and driver’s 
driving performance, 
 
The magnitude of alerting effects of light 
compared to current countermeasures such 
as caffeine alone has not been determined, 
 
Washout periods of light and caffeine are 
not known , 
Comparison of effects of light with 
those of caffeine by adopting a 
factorial design, 
 
Administration of dark adaptation 
before experiment to eliminate any 
potential remaining alerting effects of 
light, setting a maximum time for 








Chapter 5: Experimental Study  
This chapter describes the major experimental study conducted to address the aims 
and objectives stated in Section 1.3 of Chapter 1. Section 5.1 discusses the 
methodology used in the experimental study and the research design. Section 5.2 
details the participants and the study’s inclusion and exclusion criteria and sample 
size justification. Section 5.3 includes the list of all the instruments and the outcome 
measures used in the study. Section 5.4 describes the interventions adopted in this 
study. Section 5.5 outlines the procedure of the study from recruitment to test 
session. Section 5.6 discusses how the data was processed before explaining the 
analysis of data in Section 5.7. Finally, Section 5.8 discusses ethical and technical 
considerations raised by the study. 
 
5.1 METHODOLOGY AND RESEARCH DESIGN 
5.1.1 Methodology 
This study was a laboratory-based quantitative experiment. This approach was 
intended to compare the effects of light, caffeine and light and caffeine in 
combination on drivers’ performance when sleepy.  
 
5.1.2 Research Design 
The experimental study adopted a within-participant repeated measures factorial 
design. The independent variables comprised two levels of the Light Condition (blue-
green light and Placebo (red) light) and two levels of a Caffeine Condition 
(Caffeinated gum and Placebo (decaffeinated) gum).  
The interventional conditions presenting either caffeinated gum (Active Caffeine) or 
placebo non-caffeinated gum, in conjunction with either blue-green light (Active 




The four interventional conditions that were presented in a partial-counterbalanced 
order across three test sessions. Condition 4 (Placebo caffeine and placebo light) was 
presented first on each test session. 
 
Table 5.1 The interventional conditions 
 Active Light Placebo Light 
Active Caffeine 1 3 
Placebo Caffeine 2 4 
 
In this thesis the above mentioned four interventional conditions are referred to as 
follows: 
Condition 1 (Active light plus Active Caffeine): Light and caffeine in combination,  
Condition 2 (Active Light plus Placebo Caffeine): Light alone, 
Condition 3 (Placebo Light plus Active Caffeine): Caffeine alone, 
Condition 4 (Placebo Light plus Placebo Caffeine): Placebo condition 
 
The Active Light was 500 nm dominant wavelength UV-free light (perceptually 
blue-green) with an illuminance of 506 Lux (lm/m²) and irradiance of 230 (µW/cm²). 
The Placebo light was created by using the same emitter, but covering the LEDs with 
a Wratten neutral density red filter (SHEET 0.3ND). These filters specifically absorb 
blue-green light (Onley & Boynton, 1962) and provide a perceptually very dim red 
light output. This Placebo condition was intended to replicate all other aspects 
associated with wearing the Re-Timer glasses. The Placebo light was not intended to 
match the Active light in photon density or in spectral profile. While intensity-
matched long-wavelength (red) light may have some physiological impacts 
(Figueiro, M.G et al., 2009), these impacts have not been demonstrated at this low 





Due to the uncertainty in the washout period for caffeine (anywhere from 12 h 
(Brunyé et al., 2010) to 3 days (Giles et al., 2012), the conditions were partially 
counterbalanced using a Latin Squares sequence. Specifically, all participants were 
first exposed to Condition 4 (Placebo Light & Placebo Caffeine condition) then 
received one of other conditions (1, 2 and 3) in each test session. Each participant 
received every condition across the three test days. Therefore, there were six 
potential different condition sequences for each participant across three test days: 
123, 231, 312, 213, 321, and 132.   
The presentation of Condition 4 at the start of each test before administration of the 
other counterbalanced active conditions had three advantages: 
1. Receiving the placebo condition eliminated the need for including a washout 
period between the three test days.  
2. It reduced the overall time required for accomplishing the study. 
3. This approach accommodated day-to-day variations in alertness (Cajochen, 
C., 2007; Lenné, M. G et al., 1997) by effectively providing daily baselines. 
 
5.2 PARTICIPANTS 
5.2.1 Inclusion criteria  
In order to promote homogeneity in the participant group and to control for factors 
that might impact on either the independent variable (sleepiness manipulation) or on 
the dependent measures, some inclusion criteria were defined. Participants were 
required to meet the following criteria:  
1. Be capable of consent, 
2. Hold a driving license, with no physical restrictions to drive, 
3. Be young adults (age range of 18-25 years). This age group is known to be 
sensitive to sleepiness (Smith, S. et al., 2009(b)). Selection of this age group 
was based on conventional classification of young adults in sleep and 
circadian studies (Smith, S. et al., 2009(a); Smith, S. et al., 2009(b)), 
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4. Have self-reported normal vision or a corrected to normal vision (normal 
vision while using spectacles and or contact lenses). 
 
5.2.2 Exclusion criteria 
Exclusion criteria were intended to minimize potential confounding factors as 
previously discussed in Section 2.5. Visual criteria, based on participant self-reported 
eye diseases, their colour vision and corrected vision, ensured participants could see 
computerized tests properly, and could distinguish blue light from red light. Potential 






Table 5.2 Exclusion criteria  
Exclusion criterion Description 
Sleep disruption 




Score greater than 10 as sleepiness was measured by Epworth sleepiness scale (Boyle et al., 2008; Hartley et al., 
2013; Johns, M, 1991; Wijesuriya et al., 2007), 
Evening Chrono type 
Participants who normally go to sleep after 12 p.m. and score less than 30 on the Horne-Ostberg Morningness– 
Eveningness Questionnaire (Horne, J.A & Ostberg, 1976).  Studies have found that the extreme evening types 
have less exposure to daylight and are more sensitive to sleep loss than are intermediate/morning types (Martin, 
J. S., Hebert, Ledoux, Gaudreault, & Laberge, 2012), 
Significant health problems Scores above 20 on the Lifestyle Appraisal Questionnaire (LAQ) (Craig & Hancock, 1996), 
Acute illness or active 
confounding medical 
conditions 
Neurological diseases such as dementia, cardiovascular diseases (since cardiovascular diseases may change the 
heart rate variability), major psychiatric (mental) diseases that may be associated with reduced heart rate 
variability, vestibular diseases (balance problems)  
Large body mass index Body mass index more than 30 kg/m² (Smith, M. R. et al., 2008),  
Alcohol use Habitual consumption of more than 2 standard alcoholic drinks per day (a standard drink contains 10 grams of 
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Exclusion criterion Description 
alcohol),  
Illicit drug use 
Habitual use of opiates (Naturally extracted or semi synthetic drugs) such as opium, morphine, codeine and 
heroin, opioids (wholly synthetic products) such as methadone, pethidine and fentanyl, 
sedative-hypnotics such as Methaqualone (Dassanayake, Michie, Carter, & Jones, 2011), 
Stimulants such as cocaine hydrochloride and crack cocaine, amphetamine and amphetamine-type stimulants 
(ATS), MDA (3,4-methylenedioxy-amphetamine) and MDMA (3,4-methylenedioxy-methamphetaime or 
ecstasy), and cannabis; Marijuana and Hashish (Penning, Veldstra, Daamen, Olivier, & Verster, 2010), 
Prescription medication use  
Current use of beta blockers, melatonin, or melatonin agonists (Hartley et al., 2013), because of direct effects of 
these medications on sleep, 
Psychoactive medications. These medications might change the heart rate variability and include: 
Cocaine for treatment of narcolepsy (Penning et al., 2010),  
Antihistamines (Engeland, Skurtveit, & Mørland, 2007; Meltzer, 1990),  
Antidepressants (Dassanayake et al., 2011),  
Anxiolytics, anticonvulsants such as barbiturates,  non-barbiturate depressants (methaqualome) and 
benzodiazepines (diazepam or Valium) in the treatment of tension and anxiety, insomnia and some psychiatric 





Exclusion criterion Description 
Being a caffeine avoider, 
sensitive to caffeine or a 
heavy caffeine user 
Participants were required to be a normal caffeine user. Caffeine avoiders would feel uncomfortable after 
caffeine administration during the study. The relatively low levels of caffeine in this study (100 mg) may under-
dose heavy caffeine users (consumers of two or more cups of coffee or an equivalent amount of other 
caffeinated beverages daily). Furthermore, heavy caffeine users might not easily cope with the caffeine curfew 
prior this study and experience withdrawal effects (Juliano & Griffiths, 2004; Rogers, P., 2014), 
Eye and optic nerve 
diseases  
Suffering from retinopathy (Hartley et al., 2013), incompatible colour vision with the driving act (Otmani et al., 
2005), or diseases of the optic nerve, or ocular media (Figueiro, M. G., Rea, & Bullough, 2006),  
Photosensitivity 
Being sensitive to light or having epilepsy. Light has the potential to produce some side effects such as eye 
strain, headache, and nausea. Eye-related discomfort and/or visual problems among 17% of drivers have been 




5.2.3 Sample size justification 
According to the findings of the systematic review in Chapter 3: most studies of 
driving performance have adopted quasi-experimental designs with the number of 
participants in the range of 8 to 50 (Table 3.4). To estimate the minimum sample size 
for the current study, the primary dependent variable of lane crossing and Cohen's 
conventions (Cohen, 1992) for relative effect size were adopted (e.g. an effect size 
represented by Cohen’s D of 0.2 to 0.3 might be a "small" effect, around 0.5 a 
"medium" effect, and 0.8 to infinity, a "large" effect). The systematic review in 
Chapter 3 showed that the effect size for these performance outcomes has been 
reported in just one study (Rupp et al., 2004), with a large effect size (0.98) for lane 
crossing under moderate to severe sleep loss. However, this effect size may be 
optimistic (in the context of no later replication) and a smaller potential effect size 
under conditions of mild sleepiness has been assumed. Using statistical software 
(Swanson & Holton) for repeated measures MANOVA, and within-factors tests and 
considering statistical power of 0.85, six repeated measurements for lane crossing 
(overall 6 conditions), an expected ‘small’ size of the effect of sleepiness on lane 
crossing (Cohen’s D of 0.3), and an alpha level of 0.05, a minimum sample size of 
26 participants was estimated. Since all subjects were randomly assigned to one of 
three counterbalanced interventional conditions (1-3) in each test session, and there 
were six different orders of presentation for these three conditions, the sample size 
needed to be a multiple of 6 to secure the equal possibility for each subject to be 
assigned to one of these six orders of presentations. Therefore, a minimum sample 
size of 30 participants was determined to meet all requirements.  
 
5.3 MEASURES  
Instruments utilised in this study have been classified in two groups: those to assess 
eligibility of participants and those used for presenting the exposure and measuring 






5.3.1 Instruments for assessing eligibility of participants 
Phone screening questionnaire 
 A phone call screening questionnaire was developed as the first screening tool on 
the phone. This questionnaire comprised some questions on inclusion criteria (age, 
driving licence status and the exclusion criteria (Section 5.2.1). A sample phone call 
screening questionnaire is provided in Appendix A. 
 
Screening checklist 
A screening checklist was designed to assess the eligibility of the participants using 
responses to the questions asked during the phone call screening and the results of 
three above-mentioned questionnaires. A sample screening checklist is provided in 
Appendix B. 
 
Lifestyle Appraisal Questionnaire (LAQ) 
Health status was assessed by the Lifestyle Appraisal Questionnaire (LAQ; Craig & 
Hancock). This is a multi-factorial questionnaire for assessing health status, 
including items that assess the body mass index (BMI), alcohol intake, prescribed 
medications, cigarette intake, exercise, social support and so on. Scores above 20 on 
the LAQ suggest lower health status, which increases sleepiness risk (Craig & 
Hancock, 1996; Wijesuriya et al., 2007). This questionnaire is provided in Appendix 
C. 
 
Horne-Ostberg Morningness– Eveningness Questionnaire (MEQ) 
Individual chronotype was assessed by the Horne-Ostberg Morningness– 
Eveningness Questionnaire (MEQ; Horne, J. & Ostberg; Horne, J.A & Ostberg, 
1976). This questionnaire indicates whether the individual’s peak sleepiness falls 
during the morning, evening, or at an intermediate time of day. The MEQ consists of 
19 multiple-choice questions and four response options for each question, 
representing the preference of the respondent for sleep/wake time rather than their 
actual sleep/wake time. The sum of scores ranges from 16 to 86; scores of 41 and 
below represent "evening types", with extreme evening types scoring less than 30. 
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Scores from 42 to 58 indicate "intermediate types. Scores of 59 and above indicate 
"morning types", with extreme morning types scoring more than 70 (Horne, J. & 
Ostberg, 1975). This questionnaire is presented in Appendix D. 
 
The Epworth Sleepiness Scale (ESS) 
Excessive daytime sleepiness was assessed by the Epworth Sleepiness Scale (ESS; 
Johns, M, 1991). This scale, although intended as a measure of sleep propensity, has 
been widely used as a general measure of daytime sleepiness. The ESS comprises 
eight items reflecting the individual’s potential for falling asleep in different 
situations such as sitting and reading, sitting while talking to somebody, in a car, or 
while stopping in traffic. The score for each item varies from 0 = ‘never would doze’ 
to 3 = ‘high chance of dozing’. Each subject scores between 0-24. The ESS has 
showed a high test-retest reliability (r = 0.82, p < 0.001), and satisfactory internal 
consistency (Cronbach’s alpha = 0.88) among people with various sleep disorders 
(Johns, 1992). The validity of ESS is questionable, since it has shown associations 
with objective measures of sleepiness, such as the Multiple Sleep Latency test 
(MSLT) that range from moderate (Johns, M, 1991) to insignificant (Fong, Ho, & 
Wing, 2005). A sample ESS is presented in Appendix E. 
 
Pittsburgh Sleep Quality Index 
Sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI; Buysse, 
Reynolds, Monk, Berman, & Kupfer), a self-rated questionnaire to assess sleep 
quality and disturbances over a 1-month time interval. The questionnaire consists of 
19 self-rated questions which yield seven "component" scores: subjective sleep 
quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, 
use of sleeping medication, and daytime dysfunction. The sum of scores for these 
seven components yields one global score which has a range of 0-21. Any Score 
greater than 5 represents poor sleep qualities (Backhaus, Junghanns, Broocks, 
Riemann, & Hohagen, 2002). The PSQI has been used both in psychiatric clinical 
practice and research activities (Philip et al., 2005(b)). Backhaus (Backhaus et al., 
2002), found a correlation (r = 0.86, p < 0.001) between test and retest sessions. A 





5.3.2 Instruments for measuring the outcomes  
Compumedics Somté devices 
EEG and ECG activities were recorded by Compumedics Somté (V1) PSG devices 
(clinical laboratory quality polysomnography; PSG). These devices comprise a data 
recorder (to record EEG and ECG) and an electrode input box. The data recorder and 




Figure 5.1. Compumedics Somté devices for recording EEG and ECG activities, the 
data recorder is on the left and the patient input box on the right. 
 
The recordings of brain activities were undertaken by placement of EEG and ECG 
electrodes according to the International 10–20 System of Electrode Positioning.  In 
this method the EEG electrode are positioned in places determined by measurements 
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from landmarks on the head (Yueh Cheng & Te Hsu, 2011). Measurements were 
made from left to right at 10-20% of distance from inion to nasion (Harner & Sannit, 
1974). A schematic placement of EEG electrodes is provided in Figure 5.2.  
 
 
Figure 5.2. International 10–20 system of EEG electrode placement,  Fp1, Fp2: 
prefrontal,  F3, F4: frontal,  C3, C4: central, P3, P4: parietal, O1, O2: occipital, F7, 
F8: anterior temporal, N: Nasion, I: Inion, T3, T4: mid-temporal, T5, T6: posterior 
temporal, A1, A2: ear (or mastoid),  Fz: frontal midline, Cz: central vertex, Pz: 
parietal midline, (z = zero), adopted from (Yueh Cheng & Te Hsu, 2011). The red 
circles show positions of recording electrodes. 
 
EEG was recorded in all frequencies using gold cup electrodes (Compumedics, 180 
cm, 1.5 mm touch proof, 7000- 0044-00). EEG activity was recorded at a frequency 
of 256 HZ by placement of two electrodes at the central (C4), and occipital (O1) 








Figure 5.3. EEG electrode placement (adopted from Somté PSG user guide). 
 
ECG was recorded using two Snap-On electrode wires (Compumedics, 180 cm, 1.5 





 rib on the left side (Figure 5.4). In order to test for adequate 
impedance of all electrodes (less than 5 KΩ determined via UFI ‘Checktrode’ 1089 
MKIII) a ground reference electrode was attached under the left clavicle. After 
testing for impedance, all electrodes were connected to the corresponding leads in the 
patient input inbox (Figure 5.5). 
 
 






Figure 5.5. EEG, ECG and ground reference leads in Patient Input Box (adopted 
from Somté PSG user guide). 
 
PEBL Psychomotor Vigilance Task (PPVT) 
A specific aspect of the participant’s cognitive performance was assessed with a 
short computerized version (5-min) of the Psychology Experiment Building 
Language (PEBL) Psychomotor Vigilance Task (PPVT). The psychomotor vigilance 
task (PVT) is a standard probe widely used in sleep research (Dinges et al., 1997). 
The PPVT is a simple visual reaction time task in which a circle stimulus appears on 
a screen at intervals varying between 2 and 12 seconds (Figure 5.6). The participant 
must depress the spacebar as quickly as possible in response to the stimuli. This task 
has been found to be free of aptitude and learning effects, and is reliably sensitive to 
performance variations due to partial sleep loss and circadian rhythm (Cluydts et al., 








Figure 5.6. PEBL psychomotor vigilance test (PPVT). 
 
The STISIM Drive simulator 
In this study a desk-top based driving simulator, STISIM Drive
®
 (Systems 
Technology Inc. Model 100 Kit), was utilised to simulate the driving scenarios. The 
STISIM Drive simulator has been widely used in psychophysiological research (over 
1,000 studies identified in Google Scholar), including studies of sleepiness and 
vigilance in healthy subjects (Pizza et al., 2004).  
This simulator is capable of sampling up to 40 variables in one driving session. This 
system comprises a computer system (keyboard, mouse, monitor and a computer), 
sound system, roadway display device (32” high resolution and colour-calibrated 
LCD display) and force-feedback wheel and pedal set (Logitech G27). The scenarios 
are developed in a proprietary scripting language (STISIM Scenario Definition 
Language). Configuration files define different aspects of the simulation such as the 
nature of the roadway sections, driver cabin, sound effects, crash effects, and driver 
view parameters, etc. During a simulation run, the simulator combines predefined 
settings (configurations) and programs (scenario events) to create a desired graphic 
in each visual frame in response to driver control of the virtual car using the steering 
wheel, gas, and brake pedals. These data are processed in the simulation kernel and 







Figure 5.7. Mechanism of simulation by the STISIM Drive simulator, adopted from 
STISIM Drive Getting Started manual. 
Figure 5.8 represents a basic road way scene shown in a single simulation visual 
frame. The different road way sections (width of lanes, shoulders, fore slopes, etc.) 
are defined in a scenario event file and some features of those sections are configured 
in the configuration file (e.g. colour, texture, side of the road to drive, etc.). This 
platform allows the researchers to add unlimited elements such as vehicles, road 
signs and billboards, hills, buildings, bridges, rivers, and intersections to develop the 







Figure 5.8. Basic road way sections simulated by the STISIM Drive simulator, 
adopted from STISIM Drive Scenario Definition Language Events manuals. 
 
Three new driving scenario projects were developed for this study. The scenarios had 
identical physical structure (e.g. the distribution and dimensions of straights and 
curves in the roadway), but each had different roadway backgrounds (appearance of 
terrain, scenery, etc.). For this purpose, three different configuration and scenario 
event files were developed. The simulator measurement unit was set in Metric units. 
The roadway was a 50-km long four-lane rural roadway, two lanes on the left side 
(ongoing traffic) and two lanes on the right side (upcoming traffic) with defined 
median, centre line stripes, left edge and right lane markers, left and right edge lines, 
left and right shoulders, fore slopes and ground areas. The task was intended to 
replicate a monotonous drive on the road with mostly straight sections and some 
limited curves, residential areas, and gas stations on both sides of the road and a city 
area at the end of the drive. To reduce potentially alerting feedback, the crash visual 
effects, off-road sound effects, and traffic violation sound effects (violation of speed 
limit) were disabled. The speed limit on the straight sections of roadway was mostly 
110 km/h, while there were lower speed limits on the curves and in residential areas 
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(villages or city) at 80 and 60 km/h, respectively. Considering these speed limits the 
drive time was 30 minutes, a period intended to be long enough to be sensitive to 
sleepiness, but not so long as to induce time-on-task fatigue. The driving scenarios 
were counterbalanced across test sessions to eliminate the practice effect. At the 
beginning of the drive, participants found themselves on the left side of the roadway 
and were instructed to drive only on the left side for the entire drive (the standard in 
Australia). There were some cars and motorcycles on the right lane of ongoing traffic 
(driver’s side), but since drivers were driving on the left lane there was no need to 
overtake any vehicle. This strategy eliminated the lane deviation data from 
overtaking other cars. Additionally, in each test day in order to minimize the learning 
effect from first drives on the second drive on the same scenario, the random 
selection of immobile and mobile cars, pedestrians and buildings was included in the 
of scenario. Therefore, drivers could not remember the exact sequence of events in 
the second play of the same scenario. There were also no obstacles in the road, no 
cars pulling out onto the road, and no pedestrians or animals unexpectedly crossing 
the road. In addition to minimising learning effect, these features were intended to 
minimize the possibility of deviations in lane position of the car or large steering 
wheel movements while overtaking other cars or sudden reactions to an unexpected 
event. On the occurrence of collisions, the simulator did not stop and continued 
displaying roadway objects after the crash and did not reset speed or position of the 







Figure 5.9. A frame of simulated roadway by the STISIM Drive simulator as viewed 
by the participant 
 
The simulation image refresh rate for this study was set to 120 frames per second, 
resulting in a perceptually continuous and uninterrupted roadway scene. The 
simulator was set to sample the variables with a sampling frequency of 60 Hz. This 
means that the simulator sampled those variables repeatedly once every 0.016 
seconds. In order to enable the simulator to sample the desired variables, some data 
saving blocks (epochs) of 4 seconds were defined (Matthews et al., 2012(b)). 
Considering the maximum speed limit of 110 km/h, these blocks 4-second blocks 
were approximately equivalent to 125 m of the roadway.  
 
5.3.3 Outcome measures 
The dependent variables were comprised of a focussed set of outcome measures 
intended to assess the three primary constructs of interest; objective sleepiness, 
subjective sleepiness, and driving performance. Table 5.3 provides the outcome 
measures for each construct and their definitions in more detail. 
It should be noted that since driving performance was a key outcome it was 
important to understand sensitivity of specific indices of driving performance to the 
interventional conditions. Therefore, a broad range of relevant driving performance 
indices (25 variables) were sampled and primarily analysed. These variables were 
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measuring different aspects of driving tasks including velocity, acceleration, steering 
wheel angle, lateral lane position, minimum time to collision with other vehicles and 
pedestrians, minimum range of collision with other vehicles and pedestrians, road 
crashes with other vehicles and pedestrians, and variables related to line crossing 
including off road accidents, road edge excursion (inappropriate line crossing) and 
centreline crossing. Based on the findings of the three literature reviews of 
sleepiness, effects of sleep loss on young drivers and effects of light/caffeine, some 
sampled outcome measures (including driving performance outcomes) were selected 
as primary outcome measures of interest and were analysed further. These primary 
outcome measures of interest are shown in Table 5.4, followed by a brief rationale 





Table 5.3: The sleepiness outcome measures in the experimental study 
Construct Outcome measure Definition 
Objective alertness: 
EEG 
Mean Alpha Mean EEG absolute power (millivolts squared, mV
2
) in alpha range (α; 8–
13 Hz) 
SD Alpha Standard deviation of EEG absolute power (Volts-squared per Hz, V
2
/Hz) 
in alpha range (α; 8–13 Hz) 
Mean Theta  Mean EEG absolute power (Volts-squared per Hz, V
2
/Hz) in theta range 
(θ; 4– 8 Hz) 
SD Theta  Standard deviation of EEG absolute power (Volts-squared per Hz, V
2
/Hz) 




Mean RR Mean beat-to-beat (R-wave peak to R-wave peak) interval 
SD RR Standard deviation of the beat-to-beat interval 
Mean HR Mean heart rate 
SD HR Standard deviation of heart rate 
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Construct Outcome measure Definition 
LF (0.04-0.15) High-frequency heart rate variability (0.15 to 0.40 Hz) 
HF (0.15-0.4) Low-frequency heart rate variability (0.04 to 0.15 Hz) 





Lapse frequency  Number of responses longer than 500 milliseconds 
Mean RT calculated 
only from correct 
responses 
Mean Reaction Time (interval between stimulus onset and key pressure) 
RT variability 
calculated only from 
correct responses  
The standard deviation (SD) of the intra-individual RT 
Percentage of false 
response 
Percentage of false response; (number of false responses*100)/total trials 
Percentage of lapses The percentage of response times greater than or equal to 500 





Construct Outcome measure Definition 
Percentage of correct 
responses 
The number of times the participant responded to the stimulus by clicking 
the right key based the dominant hand used for the measure (number of 
correct responses*100)/total trials 
Mean of the fastest 
10% of 1/RT(1/S) 
The mean of the reciprocal of the fastest 10% 1/RT (seconds-1) for those 
who had a correct response to the stimulus. 1000*(mean (reciprocals of 
top 10% of the fastest response); 
Mean of the slowest 
10% of 1/RT(1/S) 
The mean of the reciprocal of the slowest 10% 1/RT (seconds-1) for those 
who had a correct response to the stimulus. 
1000*(mean (reciprocals of top 10% of the slowest response)):  
 Mean reciprocal 
correct responses 
The mean of the reciprocals of correct responses (not false, not laps) 
Mean reciprocal laps The mean of the reciprocals of responses longer than 500 milliseconds 
Mean reciprocal 
correct and laps 
 
The mean of the reciprocals of correct responses and lapses 
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Construct Outcome measure Definition 
Subjective alertness Self-reported 
sleepiness scores  
 
Sleepiness scores from 1 to 9 on Karolinska Sleepiness Scale (KSS) 
Driving performance Longitudinal velocity Longitudinal velocity of the driven vehicle or longitudinal speed 
(metres/second) 
Lateral velocity Lateral velocity of the driven vehicle (metres/second) 
Mean Lateral Lane 
Position 
Mean Lateral Lane Position of the driven vehicle with respect to the 
roadway dividing line, positive to the right. 
Longitudinal 
Acceleration due to 
the Brakes 
Longitudinal acceleration is the total acceleration due to throttle, braking 
and drag (lateral acceleration). The throttle activity refers to forward 
acceleration per second (NCSU Human Factors and Ergonomics (HFE) 
Area, 2011). Here only longitudinal acceleration due to the brakes (m/s²) 
is measured. 
Mean Driver Vehicle 
Speedometer Value 





Construct Outcome measure Definition 
Mean Steering Wheel 
Angular Rate 
Mean steering wheel angular rate (radians/second or degrees/second). The 
steering wheel rate or velocity (degrees/second) or steering wheel angular 
rate is speed of turning the steering wheel while doing steering 
movements. This variable accounts both positive and negative steering 
rates and these could average out to 0 indicating no steering activity 
(NCSU Human Factors and Ergonomics (HFE) Area, 2011). 
Minimum Time to 
Collision Vehicle 
Minimum time to collision (seconds) between the driver’s vehicle and all 
vehicles in the driver’s direction. 
Minimum Range 
Vehicle 
Minimum range (metres) between the driver’s vehicle and all vehicles in 
the driver’s direction 
Absolute Value of the 
Lateral Lane Position 
The absolute value of lateral lane position of the vehicle with respect to 
the roadway dividing line. This only shows the magnitude of lateral lane 
position and not the specific direction. 
Minimum Time to 
Collision Cross 
Traffic 
Minimum time to collision (seconds) between the driver’s vehicle and all 
cross traffic vehicles in the driver’s direction. 
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Construct Outcome measure Definition 
 Minimum Range 
Cross Traffic 
Minimum range (meters) between the driver’s vehicle and all cross traffic 
vehicles in the driver’s direction 
Minimum Time to 
Collision Pedestrian 
Minimum time to collision (seconds) between the driver’s vehicle and all 
pedestrians that are within the extents of the driver’s vehicle 
 Minimum Range 
Pedestrian 
Minimum range (meters) between the driver’s vehicle and all pedestrians 
that are within the extents of the driver’s vehicle 
Absolute Value of 
Lateral Acceleration 
Absolute value of lateral acceleration represents the magnitude of the 
abrupt lateral acceleration (m/s2) regardless of the direction (left and 
right) of lateral acceleration. 
Absolute Value of 
Steering Wheel Angle 
Absolute value of steering wheel angle (degrees). This is the absolute 
value of Steering wheel angle input (degrees) and only shows the 
magnitude of the driver’s steering wheel input and not the specific 
direction.  
SD Lateral Lane 
Position 
SD of Lateral Lane Position of the driven vehicle with respect to the 





Construct Outcome measure Definition 
Mean Steering Wheel 
Angle Input 
Mean Steering wheel angle input (degrees). This variable includes the 
direction of steering wheel input as well 
SD Steering Wheel 
Angle Input 
Standard deviation (SD) of Steering wheel angle input 
SD Driver Vehicle 
Speedometer Value 
Standard deviation (SD) of Vehicle Speedometer Value 
Total number of off 
road crashes 
The off road crash is counted when the driver steers the vehicle too far off 
the road and only counts the occurrences of crashes off the roadway 
(NCSU Human Factors and Ergonomics (HFE) Area, 2011). Here the 
events when centre point of the car exceeded the off road buffer distance 
of 1 metre were also counted as an off-road crash. 
Total number of 
collisions  
Total number of contacts with another vehicle, a barrel, a barrier or a 
collision block 
Total number of 
pedestrians hit  
The number of collisions with pedestrians 
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Construct Outcome measure Definition 
  Total number of 
speed exceedances  
Total number of instances that the vehicle exceeded the maximum posted 
speed limits of 120, 80, or 50 km/h 
  Total number of 
centreline crossings  
Total number of instances that the any portion of the driver’s vehicle 
crossed the roadway centreline.  
   Total number of 
road edge excursions  
Number of instances where any portion of the drivers’ vehicle crossed the 









Table 5.4 Primary outcomes of interest 
Construct Name of measure Specific index 
Objective 
Sleepiness 
EEG-related outcome measures Mean alpha (α; 8–13 Hz) power (mV2) 
SD of alpha (α; 8–13 Hz) power (mV2) 
Mean theta (θ; 4– 8 Hz) power (mV2) 
SD of theta (θ; 4– 8 Hz) power (mV2) 
ECG-related outcome 
measures 
Mean beat-to-beat interval (millisecond) 
SD of beat-to-beat interval (millisecond) 
Mean heart rate (beat/minute) 
Proportion of high-frequency heart rate variability (HF 0.15 to 0.40 Hz) to 
Low-frequency heart rate variability (LF 0.04 to 0.15 Hz), HF/LF 
PEBL Psychomotor Vigilance 
Task (PPVT) performance 
Percentage of lapses (%) 
Percentage of correct responses (%) 
Mean of the slowest 10% of reciprocals of reaction time (s
-1
) 





Construct Name of measure Specific index 
Subjective 
Sleepiness 
Subjective Sleepiness outcome Karolinska Sleepiness Scale (KSS) 
Driving 
performance  
Driving performance outcome 
measures 
Absolute value of lateral acceleration (meters/second
2
) 
Absolute value of steering wheel angle (degree) 
SD of lateral lane position (metre) 
Total number of collisions, 
Total number of road edge excursions,  
Total number of off-road crashes, 








Objective outcome measures 
Objective sleepiness was measured in three domains: EEG and ECG-related 
outcomes as well as PPVT-related outcome measures.  
EEG outcome measures were theta (θ; 4–8 Hz) and alpha (α; 8–13 Hz) absolute 
power (mean and SD). Absolute power refers to the total energy intensity of an 
electrode on a certain brain region at a certain frequency band
 
(Machado et al., 
2007). These two frequency bands were chosen because they have shown sensitivity 
to sleep loss in experimental studies, so that an increased activity in EEG alpha (Eoh 
et al., 2005; Gillberg et al., 2003; Lowden et al., 2009), or both alpha and theta bands 
(Åkerstedt & Gillberg, 1990; Horne, J.A & Reyner, 1996; Kecklund & Åkerstedt, 
1993; Otmani et al., 2005; Torsvall & ÅKerstedt, 1987) have been adopted as indices 
of sleepiness. Accordingly, in light and caffeine studies these two frequency bands 
have been adopted as indices of alerting effects of light/caffeine with a decrease in 
alpha and theta power (Cajochen, Christian et al., 2000; Figueiro, M.G et al., 2009). 
ECG-related outcome measures included beat-to-beat interval (mean RR), heart rate 
and the HF/LF ratio (the proportion of high-frequency heart rate variability to low-
frequency heart rate variability). Beat to beat interval is defined as variations 
between consecutive heartbeats (Tarvainen et al., 2014). A review study highlighted 
that increase in mean RR is related to driver sleepiness (Borghini et al., 2014). 
Heart rate (beat/minute) has shown a decrease during sleepy night time driving (Lal 
& Craig, 2001(a); Riemersma et al., 1977) or daytime drives (Borghini et al., 2014; 
Liang et al., 2007). LF/HF ratio calculated from RR tacho-grams refers to the 
proportion of high-frequency heart rate variability (0.15 to 0.40 Hz) to low-frequency 
heart rate (0.04 to 0.15 Hz). LF/HF heart rate variability has been found to decrease 
with increasing sleepiness (Baharav et al., 1995; Tarvainen et al., 2014). This 
attenuation has also been confirmed by some driving experiments (Liang et al., 2007; 
Michail et al., 2008). 
Driver PPVT performances were measured with 4 indices including percentage of 
lapses, percentage of correct responses, mean reciprocals of reaction times, and mean 
of the reciprocal of the slowest 10% 1/RT.  
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Percentage of lapses is traditionally indicative of reduced behavioural alertness (Loh 
et al., 2004; Sforza et al., 2004) and is defined as the ratio of responses to the 
stimulus with reaction times slower than 500 milliseconds to the total number of 
responses, multiplied by 100. Correct responses refer to reaction times between 100 
and 500 milliseconds. Percentage of correct responses represents the ratio of correct 
responses to the total number of responses multiplied by 100.  
Mean reciprocals of reaction times is traditionally known as the reaction speed 
(Lamond et al., 2008). Based on reciprocals of reaction times two more indices were 
selected: mean of the reciprocal of the slowest 10% 1/RT and mean of reciprocals of 
lapses and correct responses. Mean of the slowest 10% of reciprocals of reaction 
times (1/s) was calculated from correct responses as mean of reciprocally 
transformed top 10% of the slowest responses multiplied by 1000 (Sforza et al., 
2004). Higher values of mean of the slowest 10% of reciprocals of reaction times 
demonstrate better performance (Loh et al., 2004; Sforza et al., 2004).  
The above mentioned outcome measures are sensitive indices of PPVT to sleep loss. 
Severe sleep loss has been found to increase the number of lapses and mean 
reciprocals of reaction time (Lamond et al., 2008). Additionally, the relationship 
between number of lapses and higher crash risk rates has been repeatedly 
demonstrated (Arnedt et al., 2005). For instance, attention lapses from sleep loss 
have been correlated with both lane drifting (Jackson et al., 2013; Philip et al., 
2005(a)) and road crashes on the simulator (Dinges et al., 1997; Ting et al., 2008).  
 
Subjective outcome measure 
Subjective alertness was assessed using the Karolinska Sleepiness Scale (KSS), a 
nine-point sleepiness rating scale. This scale is one of the most commonly used 
sleepiness scales (Shahid, Shen, & Shapiro, 2010) measuring situational sleepiness. 
The KSS has been shown to be sensitive to changes of sleepiness in response to 
environmental factors, sleep loss, time of day (including circadian effects), and the 
effects of drugs (Shahid et al., 2010). The scale consists of 9 numeric ratings 
corresponding to a unique verbal description for the particular state of sleepiness 
(Åkerstedt & Gillberg, 1990) including:1 = ‘extremely alert’, 2 = ‘very alert’, 3 = 





7 = ‘sleepy, no effort to stay awake’, 8 = ‘sleepy, some effort to stay awake’, 9 = 
‘very sleepy, great effort to keep awake’ (Reyner, L. & Horne, 2002). Because of its 
nature as a measure of instantaneous sleepiness it is difficult to estimate the test-
retest reliability for the KSS due to difficulties in maintaining identical situations in 
both test and retest sessions.  Nevertheless, the KSS has shown a high reliability in 
sleep deprived subjects, such that there was no significant difference between two 
nights of sleep loss with one week wash out between them (Gillberg, Kecklund, & 
Åkerstedt, 1994). Furthermore, the KSS has demonstrated high validity against 
performance data during these two nights of sleep loss (Gillberg et al., 1994). The 
KSS has also been validated against EEG correlates of sleep and other behavioural 
variables (Åkerstedt, Kecklund, & Knutsson, 1991; Kaida et al., 2006(a)).  
 
Driving performance outcome measures 
The primary-interest driving performance outcome measures included absolute value 
of lateral acceleration, absolute value of steering wheel angle, the standard deviation 
of lateral lane position, total number of collisions, total number of road edge 
excursions, total number of off-road crashes and total number of speed exceedances.  
The absolute value of lateral acceleration is the average magnitude of abrupt lateral 
acceleration (m/s
2
) regardless of the direction (left and right) of lateral acceleration. 
Lateral lane position was defined as the distance of centre point of car from the road 
dividing line. An off-road crash was counted when the centre point of the car crossed 
the road edge by 1 metre. Additionally, all instances that any portion of the car 
crossed the road edge were accounted for as road edge excursion. The number of 
collisions were counted when the driver hit another vehicle including cross traffic 
vehicles, pedestrians, vehicles in either lane of traffic, any collisions with collision 
blocks and vehicles in the rear view mirror (NCSU Human Factors and Ergonomics 
(HFE) Area, 2011). 
The absolute value of steering wheel angle in degrees indicates the magnitude of the 
steering wheel’s input (degrees). This measure does not include the direction of 
steering wheel input. Steering wheel movements increase in amplitude when sleepy 





 (Atchley & Chan, 2011). Steering behaviour in one study was a major 
indicator of driver performance when sleepy (Forsman et al., 2013). Road edge 
excursion (lane drifting; any part of the car out of road edge) is also very sensitive to 
sleep loss (Filtness et al., 2012). Off-road crash (all four wheels off the road) 
increases with both sleep loss and time-on-task (Filtness et al., 2012). The total 
number of speed exceedance events is a metric that indicates all instances of 
exceeding the set speed limits of 120 km/h, 80 km/h or 50 km/h within the simulator 
scenarios (these limits were provided to the participants via roadside speed advisory 
signs within the scenarios). 
 
5.4 INTERVENTIONS 
Inducing the chronic sleep loss 
Two weeks prior to the experiment some small watches were attached to the 
participants’ wrist (Philips Respironics Actiwatch®- 2, Figure 5.10). This is a 43 mm 
x 23 mm x 10 mm waterproof watch (to 1 m depth for 30 minutes). This device 
includes an accelerometer to record movements (sampling rate 32 Hz) and a light 
sensor and event marker to record the lights out times (Philips Respironics).  
 
 
Figure 5.10. Philips Respironics Actiwatch®- 2, (adopted from Philips Respironics).  
 
Stimulation by Light  
Active Light (blue-green light) and Placebo Light (red light) were provided and 





commercially available product that has been independently tested for eye safety 
(CEI IEC62471). Re-Timer glasses are lens-free spectacle frames in one size of 200 
x 140 x 55 mm. These glasses comprise two LEDs per eye (0.1 watts, with a diffuser 
cover) mounted on the lower rim of the frame for each eye, approximately in the 
middle of the visual field of each eye at a distance of  approximately 12 mm from the 
corneal surface. Since point light sources at this very close distance are not 
recommended, each LED distributes an unfocused disk of light to the centre of pupil, 
subtending 20º angle of vision. Therefore, the two LEDs per eye lit two 20º diameter 
disks of light below the central or macular area when subjects view the simulator 
monitor (Wright, H. R., Lack, & Kennaway, 2004). These glasses have an on-board 
battery (i.e. wireless), with a USB port for recharging. These glasses are shown in 
Figure 5.11.  
    
  
Figure 5.11. Re-Timer light glasses with USB port for recharging, adopted from the 
official Re-Timer sleep glasses website. 
 
The illuminance can be set at a high level 506 Lux (lm/m²) with intensity 230 
µW/cm² or at a low level 315 Lux (lm/m²) illuminance and 143 µW/cm² intensity. In 
this experimental study the high level of blue-green light was administered. Using a 
reflected light method the spectral output of the high level of blue-green light was 
measured in photometric and daylight laboratory of Queensland University of 
Technology.  As it is seen in Figure 5.12 the dominant wavelength of the blue-green 





Figure 5.12. Spectral distribution of blue-green light emitted by the Re-Timer 





Some studies have reported a dose-response relationship between light intensity and 
alerting effects such that shorter wavelengths and higher intensities of light have 
more alerting effects than those of long wavelengths or low intensities (Cajochen, 
Christian et al., 2000). However, understanding of the relationships between light 
wavelength, intensity and duration that might have optimal alerting effect is still 
emerging, with new evidence that different profiles may have differential effects. 
The objective of this research was to examine the alerting effect provided by off-the-
shelf, safe, and commercially available light technologies such as Re-Timers. These 
devices were designed, with empirical support, to provide an optimal compromise 
between effective phase shifting and visual comfort, and their form factor provided 
an opportunity to assess their impact on alertness while driving. 
5.4.1 Stimulation by Caffeine  
In the Active Caffeine condition, a dose of 100 mg caffeine was administered via 
‘Stay Alert’ caffeinated chewing gum originally developed by the Walter Reed 





5.13). These gum pieces are available in 100 mg and 200 mg doses per piece, 
flavoured by arctic mint, mint, or cinnamon. The higher dose of this gum (200 mg) 
has been shown to increase the alertness among sleep-deprived participants 
(Killgore, Kamimori, & Balkin, 2011). In the current study 100-mg dose gums were 
administered. While 100 mg is not regarded as a high dose of caffeine (Denaro et al., 
1990), the American Academy of Paediatrics recommends that adolescents get no 
more than 100 mg of caffeine a day. This dose is equivalent to a regular ‘flat white’ 
or many caffeinated ‘energy drinks’, and thus represents typical caffeine intake by 
drivers when they feel sleepy. The absorption profile of caffeine from this source 
differs from that of beverage-based dosage - within 5 min of administration 
approximately 85% of the caffeine within the caffeine gum was absorbed into the 
blood circulation system (Novum, 1997). Similarly, the Walter Reed Army Institute 
of Research found a faster absorption and a faster bioavailability of caffeine in 
chewing gum than those of capsules (Kamimori et al., 2002). Overall, chewing gum 
has shown rapid absorption and is the most reliable method of administering 
caffeine.  
In this experimental study the caffeinated chewing gums were administered 15 min 
before driving to provide ample time to reach maximum blood concentrations 
(Taillard et al., 2012).  The same schedule was used for decaffeinated chewing gum 
in the Placebo Caffeine condition. Placebo Caffeine was provided by a non-
caffeinated chewing gum identical in appearance to the Active Caffeine gum and not 
distinguishable by taste. 
 




5.5 PROCEDURE AND TIMELINE 
In this study a multi-step approach was used: including study advertisement, 
screening and recruitment of participants, ambulatory monitoring of sleep-wake, 
preparing the laboratory and administration of the tests.  
Figure 5.14 shows the flowchart of the experimental study. Each step of the 
experimental study is explained below: 
 
5.5.1 Recruitment and screening 
Recruitment of participants was conducted via a three-step screening method 
including initial phone call screening and main screening session. These screening 
steps were as follows: 
 
Phone call screening 
The advertisement was undertaken by posting an approach email and flyer to 
University-based undergraduate student, postgraduate student, and staff email lists. 
The research was also advertised publically via the Centre for Accident Research and 
Road Safety’s website and via Facebook. The approach email and recruitment flyer 
are shown in Appendix G and Appendix H, respectively.  
After receiving expressions of interest, the Participant Information Sheet (Appendix 
I) was emailed to the prospective participants. Interested participants sent an email to 
the researcher with their availability for phone call screening. Using the Phone Call 
Screening Checklist (Appendix A), the researcher assessed the eligibility of 
participants by phone and gave them instructions for attending the main screening 












Main screening session 
Potential participants attended the laboratory, where their eligibility was assessed 
with the Lifestyle Appraisal Questionnaire (LAQ), Horne-Ostberg Morningness– 
Eveningness Questionnaire (MEQ), The Epworth Sleepiness Scale (ESS) and the 
screening checklist. Eligible participants were given a formal consent form to sign 
(Appendix J). It should be noted that the exclusion criteria did not rule out any 
interested participants as all respondents were mostly healthy and young adults.  
Participants then undertook a familiarization trial on the simulator using a training 
scenario for at least 5 minutes, and also completed a 5-minute trial PPVT. At the end 
of the screening session, participants were provided with a sleep-wake diary. The 
diary was specific to each person, instructing them on their Actigraphy time periods 
and test sessions, sleep and wake times and alcohol/caffeine intake requirements 
during the Actigraphy period and on the test days. A sample sleep/wake diary is 
presented in Appendix K.  In order to run the screening session smoothly, all above-
mentioned activities were followed as indicated in a Screening Checklist presented in 
Appendix K. 
 
5.5.2 Sleep deprivation protocol 
During the two weeks prior to the experiment, Actigraphic monitoring of activity and 
sleep-wake behaviour was conducted to monitor participant sleep-wake behaviour.  
Participants were required to maintain their sleep- wake time between 11 p.m. ± 30 
min and 7 a.m. ± 30 min during the first week to establish the baseline sleep-wake 
habits. Participants were instructed to text message the researcher immediately after 
waking up every day to ensure their adherence to the sleep-wake protocol.  During 
the second week (the sleep restriction week), a progressive partial bedtime restriction 
regime was adopted. From day 1 to day 4 in this week, participants gradually 
restricted their bedtime by 15 minutes per night. They did this via an earlier wake up 
time hence participants’ wake time was 6 a.m. by the fourth night of sleep restriction. 
From day 5 to day 7 the participants maintained this new sleep-wake schedule. No 
naps were allowed during these two weeks. Participants were supposed to consume 
normal caffeine (less than 2 cups of coffee per day), but no caffeine was allowed for 





bedtimes across this period. The time between 6 a.m. and 7 a.m. is shown in 15- min 
intervals. The black, yellow and red parts represent sleep, wake, and sleep restriction 
times, respectively.  
In the first test day, after 11 nights of Actigraphic monitoring, Actigraphy data were 
downloaded and the Actigram was visually inspected to ensure the compliance of 
participants with the sleep-wake protocols. Participants wore the Actiwatches again 
for the next three days and were asked to maintain their restricted bed time (7 hours 
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Figure 5.15. Time line of ambulatory sleep-wake during Actigraphy, Black:  Time in bed, Yellow: wake time during the first 11 nights,  





5.5.1 Laboratory Environmental Controls 
Ambient lighting  
The test sessions were conducted in a light and temperature controlled laboratory 
environment. Standard room lighting was provided by overhead fluorescent troffers, 
but ambient lighting during the study phase was provided by Philips Living Colours 
Generation 2 LED lamps. These lamps were used to provide dim red light 
background lighting inside the laboratory. This system is able to deliver light of 
defined spectra with control for intensity (Figure 5.16). 
 
 
Figure 5.16. Philips Living Colours Generation 2 LED (adopted from Amazon.com). 
 
A calibrated light meter (GOSSEN MAVOLUX, Model 5032B USB) was used to 
determine levels of ambient light inside the laboratory. This device is classified 
according to DIN 5032-7 and CIE 69 with initial sensitivity of 0.01 lux, allowing 
measures of extremely low light intensities and includes a photocell to measure 
general illuminance levels (Figure 5.17). 
 




Temperature and humidity were continuously monitored with HOBO tem/RH 
(UX100-003) loggers, and maintained between 20-24 
o
C. The laboratory space was 
also prepared for the study by covering mirrored internal windows with black 
acoustic foam to prevent intrusion of any noise and light. An adjustable (for height 
and lay-back) and comfortable driving seat was provided to enhance participant’s 
driving experience (KAB Controller 24-hour operator chair).  
 
5.5.2 Test session 
Before each test session the researcher prepared the lab using a “Test Session 
Checklist”. This checklist comprised of three sections - before test, during test and 
after test to run the test smoothly and on time. A sample Test Session is presented in 
Appendix M. 
During the last three days of the second week of sleep-wake monitoring (from day 5 
to day 7) the participants underwent one test session per day as follows:   
• On day 5 = Test session 1  
• On day 6 = Test session 2  
• On day 7 = Test session 3  
Each test session lasted approximately 3 hours. The timetable of one test session is 





Table 5.5 Timetable of a test session 




Arrival at laboratory, EEG and ECG electrodes placement 
9:00 am Adaptation to the darkness under a dim red light 
9:15 am Receiving the placebo caffeine (decaffeinated chewing gum) 
9:23 am Completion of a 5-min PPVT 
9: 30 am Reporting subjective sleepiness and driving on the simulator with red light Re-Timer 
10 am Reporting subjective sleepiness and completion of a 5-min PPVT 
10:05 am Presentation of either caffeinated or decaffeinated chewing gum 
10:20 am Simulated drive with either blue-green or red light Re-Timers 
10:50am Reporting subjective sleepiness and completion of a 5-min PPVT 




On the day of each test session participants woke up at 6 a.m. and arrived at the 
laboratory at 8:30 a.m. Instrumentation of participants (placement of EEG and ECG 
electrodes) was undertaken immediately upon arrival. EEG and ECG were then 
continuously recorded from 9 a.m. throughout the experiment.  Drivers were seated 
on an ergonomic and adjustable seat to reduce their movement from any discomfort 
while driving. The EEG and ECG electrodes were connected to the data recorder 
attached to the back of the head rest on the seat, and drivers were instructed not to 
make unnecessary movements.  
At 9 a.m. the overhead light system in the laboratory was switched off and the indoor 
lab area was maintained under a dim red light (< 2 lux) for the entire test period. 
Participants were seated under this dim light for a 30 min rest/adaptation period. 
There were two reasons for this adaptation period: 
1. Since the blue-green light provided by the Re-Timer device was relatively low 
intensity (in the context of intensity variation between outdoor sunlight and 
indoor light), typical background light may swamp the alerting effects of light; 
therefore, the presentation of blue-green light was preceded by an adaptation 
period to near-darkness (< 2 lux dim red light) to provide blue-green light with 
the opportunity to exert its effects. This approach was adopted by Chang et al. 
(2013) to compare the alerting effects of light after different light exposure 
histories.  They found more sustained alerting response to light when preceded 
by 1 lux exposure compared to 90 lux light exposure. 
2. The 30-min near-darkness period was intended to allow time for the autonomic 
arousal system to adapt to darkness and to the seated position. A dim red light 
was adopted because absolute darkness (without any visible light) might act as 
stressor for some participants.  
Participants were given Placebo Caffeine (decaffeinated chewing gum) at 9:15 a.m., 
15 minutes before their first drive. The reason for this 15 min interval was to treat the 
administration of Placebo Caffeine in exactly the same way as Active Caffeine. 
Participants were blind to the order of administration of caffeine, and were not 





 At 9:23 a.m. participants completed a 5-min version of the PPVT before reporting 
their subjective sleepiness on the Karolinska Sleepiness Scale. At 9:30 a.m. the EEG 
and ECG electrodes were doubled checked and participants were asked to put on the 
red-light Re-Timer glasses and to start driving. Participants began the first 30-minute 
simulated drive under Condition 4 (Placebo Caffeine and Placebo Light).   
 At 10:00 a.m. participants reported their subjective sleepiness immediately after the 
drive and undertook the PPVT. At 10:05 a.m. subjects were given either caffeinated 
gum or decaffeinated gum (depending on the counterbalanced condition assigned to 
that test session) and were asked to rest for 15 minutes.  
At 10:20 a.m. participants were asked to put on either blue-green or red light Re-
Timer glasses (depending on the counterbalanced condition assigned to that test 
session) and were asked to drive for 30 minutes on the same driving scenario as their 
first drive.  
At 10:50 a.m. participants reported their subjective sleepiness immediately after 
completing the second simulated drive and undertook a 5-min version of the PPVT.  
At 10:55 a.m. the researcher stopped the recording of the EEG and ECG and all 
electrodes were detached. Participants were reminded of all necessary instructions. 
The test session protocols were repeated for the next two days. The light exposure 
was provided only during two 30- minute drives. The PVT testing was conducted 
under ambient room light (red < 2 lux) shortly after cessation of the experimental 
light exposure in each condition. Figure 5.18 exhibits the laboratory setting and a 





Figure 5.18. The laboratory setting and a participant before switching the light 
system off (permission granted from the participant) 
 
5.6 DATA TREATMENT 
5.6.1 EEG data 
EEG data was recorded by the Compumedics Somté data recorder at 256 Hz. This 
device contains a Compact Flash Card where the recorded data is saved. Using Data 
Card Manager 3 software, EEG data were converted to Compumedics Profusion 
(Version 3) format for export in 30-second epochs. The EEG channels (central and 
occipital) were filtered with a high pass 0.3 Hz and low pass 30 Hz filters. Next, the 
EEG data were processed with Profusion 4 software. This software is used for 
reviewing, editing and reporting EEG data. The EEG data underwent Power Spectral 
Analysis (PSA) using this software. In this method, the EEG signal in each channel 
is processed using a Fast Fourier Transform to identify signal amplitude for each 
specified frequency band during each 30-s epoch, and to quantify the overall power 
spectra trends in the EEG data (Ktonas & Gosalia, 1981). The EEG and ECG data 
were also visually inspected to edit out any artefacts from head movements and 
blinking. The output containing all EEG data for the entire test session was saved in 





After identification of data in the Excel file corresponding to the first and the second 
drive periods, MATLABR2014b software (The MathWorks) was used to calculate 
four parameters of minimum, maximum, mean and the standard deviation of these 
data for each session. This process of identifying the synchronised rows of EEG data 
with two simulated drive times was undertaken to attribute alpha and theta EEG 
power indices to the corresponding driving conditions. The output of MATLAB was 
saved in another Excel sheet. These data were re-sorted by condition type before 
being copied into an SPSS file for statistical analysis.  
 
5.6.2 ECG data 
ECG data were recorded along with EEG by Compumedics Somté data at 256 Hz 
and were converted to Profusion format in 30-second epochs using Data Card 
Manager 3 software. The Profusion (version 4) software was used to filter ECG data 
at the high pass 0.3 Hz and low pass 30 Hz, and to save ECG raw data to European 
Data file (EDF) format.  Further analysis was conducted with Kubios HRV (version 
2.2) software developed by the Biosignal Analysis and Medical Imaging Group in 
the University of Eastern Finland (Biosignal analysis and medical imaging group, 
2014). Kubios HRV is specific software for studying and reporting heart rate 
variability (HRV). The software calculates values of time-domain or frequency-
domain variables of HRV. When opening an ECG EDF file with this software, the 
heart beat-to-beat intervals (RR) are identified in one-minute intervals as a default. 
These data were treated in a similar fashion to that used for EEG data, such that time 
intervals corresponding to the two driving sessions were identified.  
 
Accuracy of R-wave peak detection was assessed by visual inspection of the files, 
and were mostly correctly identified and marked in these young and healthy 
participants. A ‘low’ level of filtering only was applied to all ECG/HRV files to 
remove artefacts in the data. The Kubios HRV output report was saved in TXT 
format for further review and processing in Microsoft Excel (2010). From the time-
domain variables, mean and standard deviation of the beat-to-beat intervals and heart 
rate were reported. From the frequency domain outputs, low frequency heat rate 
variability (LF, 0.04-0.15), high frequency heat rate variability (HF, 0.15-0.4), and 
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LF/HF data were reported. These data were sorted by condition type and copied into 
SPSS file for statistical analysis. Figure 5.19 represents an EDF file opened by 




Figure 5.19. An ECG data file opened in the Kubios HRV software. The plot in 
green shows beat-to-beat intervals for the entire recording period. The section 
marked in yellow represents the sampling intervals (two driving sessions). The plot 
in blue (upper panel) shows the full ECG waveform sampled for R wave peak 
detection (peak detection marked as a red cross). 
 
5.6.3 PEBL Psychomotor Vigilance Task (PPVT) data 
PPVT data was recorded in TXT file format for every 5-min PPVT session. 
Therefore, in each test session for each participant there were three PPVT text files. 
These files were imported into a XLSX file and data were sorted from the fastest to 
slowest reaction times (RTs).  
Reaction times were transformed to reciprocals of RTs in accordance with standard 
methodology (Dinges & Kribbs, 1991). The rationale for using reciprocals of 
reaction times was that they provide normal distribution of data and highlight 
slowing in the optimum and intermediate responses and substantially hinder the 





appear at variable intervals between 2-12 seconds, there was a different number of 
RT trials completed across each 5-minute PPVT task. Therefore, the percentage of 
correct, false and lapse responses were calculated to standardised these responses. 
All calculated data were copied into a SPSS file for statistical analysis. 
 
5.6.4 Driving performance (STISIM Drive) data 
Driving performance outcome measures (25 variables) were extracted as raw data in 
a TXT file for each driving session. This report started with all commands performed 
during the scenario, and all blocks of data saved and ended with values of different 
variables, sorted in the order that had been predefined. Using MATLABR (2014b) a 
specific code was developed to calculate the mean, standard deviation, minimum and 
maximum of values of each variable for all rows of data and these secondary data 
were saved in another Excel sheet. Using this method, data for each participant were 
saved in a XLSX file containing six Excel sheets for a total of six driving sessions. In 
the next step data were sorted from condition 1 to condition 3 in another Excel sheet. 
It should be noted that the last six variables described discrete events; the total 
number of off road accidents, total number of collisions, total number of pedestrians 
hit, total number of speed exceedances, total number of centreline crossings and total 
number of road edge excursions. These data were entered to a XLSX file separately 
before copying all the data to SPSS file for statistical analysis. 
 
5.6.5 Subjective sleepiness data 
Subjective sleepiness scores were recorded three times during each test session and 
the KSS responses were extracted and entered to a XLSX file before being copied 
into an SPSS file. 
 
5.6.6 Demographic and Actigraphic data 
Demographic data including participant code, age, gender from questionnaires, as 
well as Actigraphic data such as time in bed (hours), total sleep time (hours) and 
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sleep efficiency from Actiware software were entered to SPSS for descriptive 
statistical analysis.  
 
5.7 ANALYSIS 
Statistical analysis of data was performed using Statistical Package for Social 
Sciences software (IBM SPSS version 22, (IBM)).  Demographic, Actigraphic, KSS, 
and PPVT variables were entered into one SPSS file due to the correspondence 
between the recording times of the two latter variables. Other variables such as EEG, 
ECG and the driving performance data were entered in a separate SPSS file. The data 
sets were labelled with a consistent participant identifier and with other data codes 
defined in the data dictionary. The method for data setup in SPSS for demographic, 
Actigraphic, KSS and PPVT variables is presented in Appendix N and for the EEG, 
ECG, and driving performance outcome measures in Appendix N. 
 
5.7.1 Missing data 
There were no missing values for KSS and PPVT data. The EEG recorded on the 
first test day was missing for two participants (code 301 and 311) due to technical 
problems with the data flash card. ECG data were missing for the first day (code 301 
and 311) and the second day (code 301, and 303) due to technical problems with the 
data flash card and due to a detached ECG electrode caused by excessive movement 
of the participants. Some ECG data (code 301, 313 and 317) were extreme data that 
were identified as missing data in the SPSS data file. Driving performance data were 
missing only for one participant (code 324) for two drives on the second day due to 
running the scenario with the wrong configuration file. Actigraphy data were missing 
for two participants (code 308 and 329) due to faulty Actiwatches. All missing data 
were valued as N/A in the XLSX files. Missing data in SPSS files were defined later 
with discrete values. All non-time missing data were defined as 999999.00000. For 
timed missing data such as time in bed or sleep time the missing data were defined 






5.7.2 Data analysis 
All outcome measures in this study were treated with a 2 x 3 repeated-measures, 
within-subjects Analysis of Variance (ANOVA). The first factor was “Placebo vs 
Intervention” with two levels of “Placebo (condition 4)” and “Intervention 
(Condition 1, Condition 2 or Condition 3, regardless of the type of condition)”. The 
second factor was “Intervention type” with three levels including “light and caffeine 
in combination” (Condition 1), “light alone” (Condition 2) and “caffeine alone” 
(Condition 3).  The Primary purpose of this analysis was to determine whether mean 
values of data (across all participants) after the intervention (receiving either active 
conditions of 1, 2 or 3 after the second drive) were different from receiving only the 
Placebo condition (after the first drive) and in such cases, whether or not the mean of 
these data was different across these three types of intervention (3 condition types). 
Using Mauchly’s test of sphericity the equality of variances of differences between 
variables for two main effects of “Intervention type” and “Placebo vs Intervention” 
and for their interaction “Intervention type * Placebo vs Intervention” was examined. 
The dependent variables were the outcome measures listed in Table 5.3. The p values 
less than 0.05 in Mauchly’s test were considered as violation of sphericity 
(significant differences between variances of difference between conditions). The 
violation from sphericity might lead to a lost power (an increased probability of a 
Type II error) and an incomparability of F-ratios with the tabulated values of F-ratio 
in SPSS outputs (Field, 2012). In case of violation of sphericity, the Greenhouse‐
Geisser estimate of sphericity (ε) was considered. In case of ε > 0.75 the Huynh-
Feldt correction was taken into account (Field, 2012).  
In the next step, the within-subject main effects were examined. For all non-
homogenised main effects and interactions (based on the results of Mauchly’s test of 
sphericity), the corrected F-ratios (Greenhouse-Geisser or Huynh-Feldt corrections) 
were considered. Finally, in case of any main effect of “Placebo vs Intervention” 
(significant difference between the placebo condition and interventions) a paired T-
test was conducted to track the difference between each of the three types of 
intervention and the Placebo condition. In case of any main effect of “Intervention 
type” a Post-hoc T-test was conducted to track any significant differences across the 
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three types of intervention. A detailed explanation of ANOVA has been provided in 
Section 1.1.1.  
 
5.8 ETHICAL AND TECHNICAL CONSIDERATIONS 
5.8.1 Ethical considerations 
Ethical clearance of this study was provided by the Queensland University of 
Technology (QUT) Human Research Ethics Committee (HREC; approval number 
1300000846). Participants provided written consent to participate in the experimental 
study and were assured that their participation in the project was entirely voluntary 
and if they agreed to participate, they could withdraw from participation at any time 
during the project without any comment or penalty. Participants were also provided 
with the contact details of the QUT Research Ethics Unit to reflect any concerns or 
complaints about the ethical conduct of this project. Taxi vouchers for travelling to 
and from the test sessions were provided for participants with excessive sleepiness as 
a mitigation strategy. As participants were required to spend four sessions in the 
laboratory (one screening session and three test sessions), and to wear the 
Actiwatches for two weeks, their time was compensated by $150 AUD at the end of 
the study.  
All comments and responses were treated confidentially. Any data collected as part 
of this project were stored securely as per QUT’s Management of Research Data 
policy. Participants were also informed that their names would not be identified in 
any publications resulting from this study and agreed that non-identifiable data 
collected in this project could be used as comparative data in future projects or stored 
on an open access database for secondary analysis. They were also welcomed to 
request more information on the results of this study from the research team. 
An annual progress report about ethical clearance awarded for the data collection of 
this study was submitted to QUT Human Research Ethics Committee. 
 There were some minor potential risks associated with participation in this study. 





a. Although polysomnography (EEG, ECG) instrumentation followed the same 
procedure as used in routine clinical polysomnography (i.e. sleep studies), 
there was a potential for minor discomfort from electrode placement.  
b. Participants were likely to experience some sleepiness symptoms such as 
poor concentration, sleepiness during the test sessions, and potential 
increased sleep duration for 2-3 days after the test sessions. While the degree 
of sleepiness induced by the sleep time manipulation was likely to be mild, it 
could have some impact on the participants' activities while working or 
studying. Therefore, they were advised not to engage in safety-sensitive tasks 










Chapter 6: The Results of the Experimental 
Study  
The results in this chapter are presented in accordance with the research hypotheses 
outlined in Section 1.3. A descriptive analysis of the participant characteristics is 
presented in Section 6.1. Findings of the primary analyses for the alerting effects of 
light alone, caffeine alone, and light and caffeine in combination are then presented 
in Section 6.2.  
 
6.1 DESCRIPTIVE ANALYSIS OF PARTICIPANTS 
6.1.1 Demographic characteristics of participants  
Of the 30 participants, 20 were female and 10 were male. All participants were 
between 18-25 years old. Participants scored an average of 6.4 on the Epworth 
Sleepiness Scale (all scored less than the eligibility cut-off of 10) and an average of 
8.3 on the Lifestyle Appraisal questionnaire with an eligibility cut-off of 20. 
Participants reported overall good sleep quality, with mean score of 3.6 (less than the 
eligibility cut-off of 5), and sleep efficiency of 90%, on the Pittsburgh Sleep Quality 
Index (PSQI).  Participant chronotypes were found to be mostly "intermediate” with 
an average score of 41.5 on the Morningness-Eveningness Questionnaire (MEQ). 
None of the participants were “extremely evening type”, and none were excluded on 






Table 6.1  Demographic characteristics of the participants  
 
Minimum Maximum Range Mean SD  
Age 18 25 7 23.5 2.5 
ESS 1 9 8 6.4 2.6 
MEQ 31 56 25 41.5 6.1 
LAQ 2 19 17 8.3 4.1 
PSQI 1 9 8 3.6 1.8 
Sleep efficiency (PSQI) 70 100 30 90.3 8.5 
ESS = Epworth Sleepiness Scale, MEQ = Morningness-Eveningness Questionnaire, 




6.1.2 The manipulation Check 
In order to confirm the adherence of participants to their scheduled sleep-wake times, 
some sleep-wake parameters determined by Actigraphy, such as bed time, sleep 
onset latency (time taken to fall asleep), sleep efficiency, and wake after sleep onset 
(cumulative time of awakening during sleep period) were examined. Descriptions of 
these parameters are provided in Table 6.2 for the first week, the second week, and 
the last 4 nights of the Actigraphy measurement period. 
In order to formally examine the effectiveness of the sleep deprivation regime, mean 
sleep times in the first week, the second week, and the last 4 nights of Actigraphy 




Table 6.2  Sleep-Wake parameters for the first week, second week and the last 4 nights of the Actigraphy measurement period 
 
First week Second week Last 4 nights 
Mean SD Mean SD Mean SD 
       


































Waking after Sleep Onset (min) 54.4 
 













Table 6.3 provides the mean and standard deviation (SD) of sleep times across the 
first week (baseline), second week (incremental bedtime restriction), and the last 4 
nights (experiment period) of Actigraphy. Data from two participants were missing 
due to technical problems with the Actiwatches. On average, the participants slept 
for 6:17 (h: m) per night across the first week, but in the second week they reduced 
their sleep time to 5:45 (h: m). Hence, in the last 4 nights, mean sleep time per night 
was restricted to a mean of 5:39 (h: m).  
 
Table 6.3 Mean and SD of nightly sleep times (hours: minutes) across the three 
periods of Actigraphy 
 
Sleep time Mean SD 
Sleep time for the first week 6:17 0:48 
Sleep time for the second week 5:45 1:02 
Sleep time for last 4 days 5:39 1:00 
SD=Standard deviation 
 
Table 6.4 represents the paired T-test results for the differences in mean sleep times 
during each period of the protocol. In the second week, participants slept an average 
of 32 min less than they did during the first week. This difference was significant (p 
= 0.003). In the last 4 nights participants slept an average of 40 min less than during 
the first week. This difference was also significant (p = 0.001).  
To investigate the effect of chronic sleep loss, a paired T–test analysis for KSS 
values before first drives across three days was conducted. Sleepiness levels varied 
slightly between 4.6 (rather alert) to KSS score 5.1 (neither alert nor sleepy) across 
three test days before first drives. The paired T-test of KSS scores before first drives 
in Table 6.5 shows that the mean KSS scores had a significant decrease of 0.5 point 
from the first day to the second day (p=0.033). This Table shows that there was no 
progressive sleepiness level across the three test days.  
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Table 6.4 Paired T-test results for sleep times in different periods of Actigraphy 
Pair 
Difference in sleep time 
(hours: minutes) 
95% Confidence Interval 






tailed) Mean SD Lower Upper 
Mean sleep time for the first week vs 
Mean sleep time for the second week 
0:32 0:51 0:12 0:52 3.29 27 0.003 
 
Mean sleep time for the first week vs 
Mean sleep time for last 4 nights 
0:38 0:52 0:18 0:59 3.86 27 0.001 












Table 6.5 Paired T-test results for subjective sleepiness prior to first drives on three test days  
Pair 
Difference in subjective 
sleepiness 
95% Confidence Interval 






tailed) Mean SD 
Lower Upper 
KSS first day before first drive vs KSS 
second day before first drive 
0.53 1.30 0.04 1.02 2.23 29 0.033 
 
KSS third day before first drive vs KSS 
second day before first drive 
0.16 1.14 -0.26 0.59 0.79 29 0.433 
 
KSS first day before first drive vs KSS 
third day before first drive 
0.36 1.54 -0.20 0.94 1.30 29 0.203 










6.2 ANALYSIS OF DATA 
Six specific but related primary hypotheses (see Table 1.3) were tested to examine 
the alerting effects of light, caffeine, and light and caffeine in combination.  
In order to test these hypotheses, a number of specific objective, subjective, and 
performance outcomes associated with sleepiness were selected as the primary 
dependent variable (outcomes) of interest. These variables were based on the 
findings of the narrative literature review (Chapter 2) and the systematic review 






















Table 6.6 Primary outcomes of interest 
Construct Name of measure Specific index 
Objective Sleepiness EEG-related outcome measures Mean alpha (α; 8–13 Hz) power (mV2) 
SD of alpha (α; 8–13 Hz) power (mV2) 
Mean theta (θ; 4– 8 Hz) power (mV2) 
SD of theta (θ; 4– 8 Hz) power (mV2) 
ECG-related outcome 
measures 
Mean beat-to-beat interval (millisecond) 
SD of beat-to-beat interval (millisecond) 
Mean heart rate (beat/minute) 
Proportion of high-frequency heart rate variability (HF 0.15-0.40 Hz) to Low-
frequency heart rate variability (LF 0.04-0.15 Hz), HF/LF 
PEBL Psychomotor Vigilance 
Task (PPVT) performance 
Percentage of lapses (%) 
Percentage of correct responses (%) 
Mean of the slowest 10% of reciprocals of reaction time (s
-1
) 





Construct Name of measure Specific index 
Subjective Sleepiness Subjective Sleepiness outcome Karolinska Sleepiness Scale (KSS) 
Driving performance  Driving performance outcome 
measures 
Absolute value of lateral acceleration (m/s
2
) 
Absolute value of steering wheel angle (degrees) 
SD of lateral lane position (metres) 
Total number of collisions, 
Total number of road edge excursions,  
Total number of off-road crashes, 
Total number of speed exceedances 








6.2.1 Analysis rationale 
Figure 6.1 depicts the 2 x 3 factorial design used to test the primary outcome 
measures with Analysis of Variance (ANOVA). The mean values for the outcome 
measures before the three interventions are shown along the bottom row and 
represent the Placebo condition (condition 4). Mean values for the outcome measures 
after the three types of interventions; light alone, caffeine alone, and light and 
caffeine in combination is shown along the top row.  
The main effects of two factors were examined. The first factor was “Placebo vs 
Intervention” (denoted by the vertical arrow). This factor refers to the overall effect 
of the intervention, regardless of intervention type. Three hypotheses were tested by 
analysing this factor for each of the objective, subjective and driving performance 
outcome indices. When there was a main effect of “Placebo vs Intervention” (a 
significant overall effect of the intervention), a paired T-test was conducted to test 
for significant differences between each intervention type and the corresponding 
Placebo condition. The second factor was “Intervention type” (denoted by the 
horizontal arrow). Intervention type refers to one of the three counterbalanced 
conditions of light alone, caffeine alone or the light and caffeine in combination. 
When a main effect of “Intervention type” was identified, a post-hoc T-test was 
conducted (within the ANOVA) to test for significant differences between the three 
intervention types, and to directly test the fourth and fifth hypotheses (comparison of 
relative effectiveness of light alone, caffeine alone, or light and caffeine in 
combination). In order to test the sixth hypothesis, in case of any main effects of the 













Figure 6.1. Method for conducting the 2 x 3-way ANOVA on primary outcome 
measures of interest. 
 
 
The findings of the ANOVAs are presented in Table 6.7, Table 6.9. Table 6.7 
presents the within-subjects effect, estimates of effect size and the interactions 
between the two factors for all primary outcome measures of interest. The results of 
any subsequent paired T-tests, in case of any main effect of the factor “Placebo Vs 
Intervention” (p < 0.05), are presented in Table 6.8.  This table presents the 
comparisons of the means and standard deviations of the outcome measures in the 
Placebo condition (before the three types of interventions) with the corresponding 
values after those interventions. In this table a p-value < 0.05 indicates a significant 
change between the intervention and Placebo conditions.  
In case of any main effect of the factor “Intervention Type”, a post-hoc T-test was 
conducted within the ANOVA. Table 6.9 represents the pairwise comparisons 
between outcome measures after each type of intervention. In this table any p-values 
< 0.05 were associated with a significant difference between pairs of intervention 
types. Table 6.9 also provides the overall mean difference between the outcome 
measures after the Placebo condition and after the interventions.   
Light alone Caffeine alone 






Before "Light and 
caffeine in 
combination" 































Table 6.7 Within- subjects effects of the two ANOVA factors (Placebo vs Intervention and Type of intervention) for each of the primary outcome measures 
of interest 















EEG alpha power (mV
2
) Type of intervention 2 58 1.52 0.225 0.05 0.31 
Placebo vs Intervention 1 29 2.25 0.144 0.07 0.30 
Placebo vs Intervention* Type of intervention 1.66 48.13 2.00 0.152 0.06 0.36 




Type of intervention 2 58 2.45 0.094 0.07 0.47 
Placebo vs Intervention 1 29 4.32 0.047* 0.13 0.52 
Placebo vs Intervention* Type of intervention 2 58 0.25 0.778 0.00 0.08 
EEG theta power (mV
2
) Type of intervention 1.07 
 
30.18 0.84 0.374 0.029 0.14 
Placebo vs Intervention 1 28 0.12 0.73 0.00 0.06 
Placebo vs Intervention* Type of intervention 1.27 35.69 
 
1.12 0.311 0.03 0.19 
SD of EEG Theta power  Type of intervention 2 56 0.51 0.598 0.01 0.13 
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) Placebo vs Intervention 1 28 1.85 0.184 0.06 0.26 
Placebo vs Intervention* Type of intervention 1.31 36.70 1.38 0.256 0.04 0.23 
Mean RR (milliseconds) 
 
 
Type of intervention 1.21 26.66 3.17 0.079 0.12 0.44 
Placebo vs Intervention 1 22 10.91 0.003* 0.33 0.88 
Placebo vs Intervention* Type of intervention 1.04 22.91 1.84 0.188 0.07 0.26 
SD of RR (milliseconds) 
 
Type of intervention 1.00 23.06 1.02 0.321 0.04 0.16 
Placebo vs Intervention 1 23 1.17 0.29 0.04 0.18 
Placebo vs Intervention* Type of intervention 1.00 23.02 1.09 0.307 0.04 0.17 
Mean HR (beats/minute) Type of intervention 1.66 36.56 6.02 0.008* 0.21 0.80 
Placebo vs Intervention 1 22 47.42 0.001* 0.68 1 
Placebo vs Intervention* Type of intervention 2 44 3.85 0.029* 0.14 0.66 




















Placebo vs Intervention 1 23 0.97 0.334 0.04 0.15 
Placebo vs Intervention* Type of intervention 1.01 23.44 1.35 0.256 0.05 0.20 
LF Type of intervention 2 44 1 0.376 0.04 0.21 
Placebo vs Intervention 1 22 1 0.328 0.04 0.16 
Placebo vs Intervention* Type of intervention 2 44 1 0.376 0.04 0.21 
HF Type of intervention 1 22 0.99 0.329 0.04 0.15 
Placebo vs Intervention 1 22 1.00 0.326 0.04 0.16 
Placebo vs Intervention* Type of intervention 1 22 1.00 0.328 0.04 0.16 
LF/HF Type of intervention 1.02 22.59 0.98 0.335 0.04 0.15 
 Placebo vs Intervention 1 22 0.42 0.521 0.01 0.09 
Placebo vs Intervention* Type of intervention 1.01 22.25 1.05 0.317 0.04 0.16 
KSS Type of intervention 2 58 3.51 0.036* 0.10 0.63 
Placebo vs Intervention 1 29 24.57 0.000* 0.45 0.99 
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Placebo vs Intervention* Type of intervention 2 58 1.80 0.174 0.05 0.36 
Percentage of lapses Type of intervention 2 58 3.83 0.027* 0.11 0.67 
Placebo vs Intervention 1 29 9.52 0.004* 0.24 0.84 
Placebo vs Intervention* Type of intervention 1.35 39.18 0.01 0.946 0.00 0.05 
Percentage of correct 
responses 
Type of intervention 2 58 4.06 0.022* 0.12 0.70 
Placebo vs Intervention 1 29 9.64 0.004* 0.25 0.85 
Placebo vs Intervention* Type of intervention 1.36 39.64 0.03 0.921 0.00 0.05 
Mean of the slowest 10% 
of 1/RT (1/S) 
Type of intervention 1.75 51.00 0.07 0.904 0.00 0.06 
Placebo vs Intervention 1 29 4.81 0.036* 0.14 0.56 
Placebo vs Intervention* Type of intervention 2 58 0.13 0.871 0.00 0.07 
Mean reciprocals of 
correct responses and 
lapses 
Type of intervention 1.76 51.13 5.46 0.009* 0.15 0.79 
Placebo vs Intervention 1 29 2.57 0.120 0.08 0.34 
























Type of intervention 1.65 46.40 3.94 0.033* 0.12 0.62 
Placebo vs Intervention 1 28 12.29 0.002* 0.30 0.92 
 Placebo vs Intervention* Type of intervention 1.63 45.87 1.00 0.36 0.03 0.19 
Absolute value of 
steering wheel angle 
(degree) 
Type of intervention 1.62 45.61 4.19 0.028* 0.13 0.64 
Placebo vs Intervention 1 28 16.91 0.001* 0.37 0.97 
Placebo vs Intervention* Type of intervention 1.58 44.42 1.208 0.30 0.04 0.22 
SD of lateral lane 
position (m) 
Type of intervention 1.02 29.79 0.61 0.444 0.02 0.11 
Placebo vs Intervention 1 29 0.25 0.617 0.00 0.07 
Placebo vs Intervention* Type of intervention 1.01 29.37 1.49 0.231 0.04 0.22 
Total number of 
collisions 
Type of intervention 1.58 45.82 1.10 0.326 0.03 0.21 
Placebo vs Intervention 1 29 2.08 0.160 0.06 0.28 
Placebo vs Intervention* Type of intervention 1.50 43.56 1.01 0.351 0.03 0.19 
Total number of road Type of intervention 2 58 3.72 0.030* 0.11 0.66 
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edge excursions Placebo vs Intervention 1 29 6.96 0.013* 0.19 0.72 
Placebo vs Intervention* Type of intervention 2 58 1.25 0.294 0.04 0.26 
Total number of off-road 
crash 
Type of intervention 1.34 39.12 0.33 0.632 0.01 0.09 
Placebo vs Intervention 1 29 5.70 0.024* 0.16 0.63 
Placebo vs Intervention* Type of intervention 2 58 0.90 0.410 0.03 0.19 
Total number of speed 
exceedances 
Type of intervention 2 58 3.44 0.039* 0.10 0.62 
Placebo vs Intervention 1 29 4.50 0.042* 0.13 0.53 
Placebo vs Intervention* Type of intervention 2 58 2.15 0.126 0.06 0.42 
RR = beat-to-beat interval, HR = heart rate, LF = low frequency heart rate variability, HF = high frequency heart rate variability, 












Type of intervention Placebo Intervention 
Paired differences between the Placebo 






   
95% Confidence 
Interval of the 
Difference 
Mean SD Mean SD Mean SD Lower Upper 






Light alone 4.11 4.46 3.25 3.09 0.86 2.98 -0.24 1.97 1.58 29 0.123 
Caffeine alone 3.36 3.32 2.4 2.52 0.96 2.5 0.02 1.89 2.1 29 0.044* 
Light and Caffeine 
in combination 




Light alone 849.14 107.38 1010.8 690.11 -161.73 700.28 -438.75 115.28 -1.2 26 0.241 
Caffeine alone 860 95.15 955 260.62 -95.01 225.29 -184.13 -5.89 -2.19 26 0.038* 
Light and Caffeine 
in combination 




Light alone 72.27 9.05 70.82 10.02 1.45 5.18 -0.593 3.5 1.46 26 0.156 
Caffeine alone 71.06 7.55 67.12 8 3.94 3.65 2.49 5.39 5.6 26 .0001* 
Light and Caffeine 
in combination 
69.77 7.45 65.76 7.04 4.01 3.1 2.66 5.35 6.19 22 .0001* 





Type of intervention Placebo Intervention 
Paired differences between the Placebo 





Caffeine alone 6.2 2.39 5.23 2.3 0.96 1.351 0.46 1.471 3.91 29 0.001* 
Light and Caffeine 
in combination 
5.9 2.18 4.36 2.12 1.53 1.94 0.8 2.25 4.32 29 0.001* 
Percentage of 
lapses (%) 
Light alone 24.6 26.87 18.11 21.52 6.491 19.49 -0.78 13.77 1.82 29 0.079 
Caffeine alone 21.7 25.25 15.45 21.55 6.25 13.93 1.04 11.45 2.45 29 0.02* 
Light and Caffeine 
in combination 




Light alone 73.45 27.7 80.4 21.3 -6.94 19.64 -14.28 0.39 -1.93 29 0.063 
Caffeine alone 77.3 25.61 83.48 21.53 -6.17 14.32 -11.52 -0.82 -2.36 29 0.025* 
Light and Caffeine 
in combination 
79.45 22.8 86.43 18.45 -6.97 14.82 -12.51 -1.43 -2.57 29 0.015* 
Mean of the 




Light alone 2.19 0.455 2.28 0.22 -0.09 0.49 -0.28 0.09 -1.04 29 0.307 
Caffeine alone 2.19 0.466 2.32 0.57 -0.12 0.32 -0.248 0 -2.19 29 0.036* 
Light and Caffeine 
in combination 








Light alone 2.66 0.636 2.63 0.74 0.03 0.58 -0.18 0.25 0.3 29 0.766 
Caffeine alone 2.69 0.673 2.83 0.61 -0.13 0.37 -0.27 0 -1.97 29 0.058 
Light and Caffeine 
in combination 







Type of intervention Placebo Intervention 
Paired differences between the Placebo 











Light alone 0.19 0.19 0.16 0.12 0.03 0.11 0 0.08 1.75 28 0.09 
Caffeine alone 0.17 0.13 0.12 0.08 0.05 0.08 0.02 0.08 3.34 29 0.002* 
 Light and Caffeine 
in combination 





Light alone 1.01 0.88 0.78 0.52 0.22 0.57 0 0.44 2.1 28 0.044* 
Caffeine alone 0.91 0.6 0.64 0.35 0.27 0.43 0.11 0.43 3.44 29 0.002* 
Light and Caffeine 
in combination 
1.27 1.19 0.84 0.83 0.42 0.71 0.15 0.69 3.24 29 0.003* 
SD of lateral 
lane position 
Light alone 0.57 0.2 1.03 2.53 -0.46 2.52 -1.42 0.49 -0.99 28 0.33 
Caffeine alone 0.61 0.28 0.53 0.19 0.07 0.23 -0.01 0.16 1.78 29 0.084 
Light and Caffeine 
in combination 
0.69 0.35 0.55 0.18 0.14 0.25 0.04 0.23 3.05 29 0.005* 
Total number of 
collisions 
Light alone 3.7 8.58 0 0 3.7 8.58 0.49 6.9 2.36 29 0.025* 
Caffeine alone 3.66 13.81 2.03 5.18 1.63 12.84 -3.16 6.43 0.69 29 0.492 
Light and Caffeine 
in combination 
4.03 9.32 4.13 8.36 -0.1 10.331 -3.95 3.75 -0.05 29 0.958 
Total number of 
road edge 
Light alone 20.56 32.94 17 23.51 3.56 16.61 -2.63 9.77 1.17 29 0.249 





Type of intervention Placebo Intervention 
Paired differences between the Placebo 





excursions Light and Caffeine 
in combination 
25 33.99 16.66 20.21 8.33 19.47 1.06 15.6 2.34 29 0.026* 
Total number of 
off-road crash 
Light alone 18 36.42 16.13 26.9 1.86 15.54 -3.93 7.66 0.65 29 0.516 
Caffeine alone 18.1 29.99 11.23 15.94 6.86 17.67 0.26 13.46 2.12 29 0.042* 
Light and Caffeine 
in combination 
14.56 21.13 10.6 15.72 3.96 12.11 -0.55 8.491 1.79 29 0.083 
Total number of 
speed 
exceedances 
Light alone 13.06 9.221 10.56 8.33 2.5 4.78 0.71 4.28 2.86 29 0.008* 
Caffeine alone 10.6 6.371 8.6 5.6 2 5.43 -0.02 4.02 2.01 29 0.053 
Light and Caffeine 
in combination 
9.56 8.228 9.3 7.26 0.26 6.02 -1.98 2.51 0.24 29 0.81 
RR = beat-to-beat interval, HR = heart rate,  
SD = Standard deviation, DF = Degree of freedom 





Table 6.9 Pairwise comparisons of outcome measures of sleepiness for the two factors “Type of intervention” and “Placebo vs Intervention” 











SD of EEG alpha power (mV
2
) 
Type of intervention 
1 2 0.05 1 -1.07 1.19 
 3 0.85 0.12 -0.16 1.87 
2 3 0.79 0.252 -0.33 1.92 
Placebo vs Intervention 
1 2 1.08 0.047* 0.01 2.14 
Mean RR (millisecond) 
Type of intervention 
1 2 45.76 0.001* 17.14 74.38 
 3 -13.27 1 -91.26 64.70 
2 3 -59.04 0.14 -131.66 13.57 
Placebo vs Intervention 
1 2 -61.05 0.003* -99.37 -22.73 
Mean HR (beats/minute) 
Type of intervention 
1 2 -3.85 0.001* -6.10 -1.59 
 3 -0.86 1 -3.83 2.10 
2 3 2.98 0.138 -0.67 6.64 
Placebo vs Intervention 
1 2 3.49 0.001* 2.44 4.54 
LF/HF 
Type of intervention 
1 2 -.526 0.027* -1.00 -0.05 
 3 -1.19 0.706 -3.73 1.34 
2 3 -0.67 1 -3.51 2.17 
Placebo vs Intervention 
1 2 -0.33 0.521 -1.40 0.73 
KSS Type of intervention 
1 2 -0.65 0.025* -1.34 0.04 
 3 -0.58 0.051* -1.31 0.14 
2 3 0.06 0.789 -0.56 0.69 
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Placebo vs Intervention 
1 2 1.13 0.001* 0.66 1.60 
Percentage of lapses (%) 
Type of intervention 
1 2 -5.60 0.044* -11 -0.11 
 3 -2.82 0.65 -8.5 2.85 
2 3 2.78 0.291 -1.3 6.91 
Placebo vs Intervention 
1 2 6.54 0.004* 2.21 10.88 
Percentage of correct responses (%) 
Type of intervention 
1 2 6.01 0.041* 0.2 11.82 
 3 2.55 0.825 -3.3 8.38 
2 3 -3.46 0.16 -7.8 0.90 
Placebo vs Intervention 
1 2 -6.70 0.004* -11 -2.28 
Mean of the slowest 10% of 1/RT(1/S) 
Type of intervention 
1 2 0.01 1 -0.08 0.11 
 3 -0.00 1 -0.13 0.12 
2 3 -0.02 1 -0.17 0.13 
Placebo vs Intervention 
1 2 -.12 0.036* -0.24 -0.00 
Mean reciprocals of correct responses 
and lapses 
Type of intervention 
1 2 .20 0.028* 0.02 0.39 
 3 0.09 0.242 -0 0.21 
2 3 -0.11 0.206 -0.3 0.04 
Placebo vs Intervention 
1 2 -0.09 0.12 -0.21 0.02 
Absolute value of lateral acceleration Type of intervention 1 2 0.02 0.689 -0.02 0.07 
   3 0.05 0.083 -0.00 0.11 
















 Placebo vs Intervention 1 2 .054 0.002* 0.02 0.08 
Absolute value of steering wheel angle 
(degree) 
Type of intervention 
1 2 0.17 0.119 -0.04 0.38 
 3 0.3 0.023* 0.045 0.54 
2 3 0.12 0.095 -0.02 0.27 
Placebo vs Intervention 
1 2 .309 0* 0.15 0.46 
SD of lateral lane position 
Type of intervention 
1 2 -0.17 1 -0.8 0.44 
 3 0.05 0.32 -0.02 0.14 
2 3 0.23 0.996 -0.36 0.83 
Placebo vs Intervention 
1 2 -0.07 0.618 -0.4 0.24 
Total number of collisions 
Type of intervention 
1 2 2.23 0.098 -0.29 4.76 
 3 1.23 1 -2.96 5.42 
2 3 -1 1 -5.43 3.43 
Placebo vs Intervention 
1 2 1.74 0.16 -0.73 4.21 
Total number of road edge excursions 
Type of intervention 
1 2 2.05 0.344 -2.30 6.40 
 3 6.36 0.024* 0.92 11.81 
2 3 4.31 0.074 -0.43 9.07 
Placebo vs Intervention 
1 2 6.70 0.013* 1.50 11.89 
Total number of off-road crash 
Type of intervention 
1 2 -4.48 1 -22.13 13.16 
 3 -2.08 1 -16.03 11.87 
2 3 2.4 1 -6.39 11.19 
Placebo vs Intervention 
1 2 4.23 0.024* 0.61 7.85 
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Total number of speed exceedances 
Type of intervention 
1 2 -2.38 0.031* -4.52 -0.23 
 3 -0.16 0.858 -2.05 1.72 
2 3 2.21 0.046* 0.03 4.39 
Placebo vs Intervention 
1 2 1.58 0.042* 0.05 3.11 
  
      
1 = Light and caffeine in combination, 2 = Light alone, 3 = Caffeine alone, RR = beat-to-beat interval, HR = heart rate,  
SD =Standard deviation,  










6.2.2 Hypothesis 1: Light (condition 2) has an alerting effect relative to the 
Placebo condition (condition 4) 
Main effect of light alone on objective outcome measures of sleepiness 
Findings from the 2 x 3 ANOVA (Table 6.7) showed that there was a main effect of 
the factor “Placebo Vs Intervention” on three primary outcomes: the standard 
deviation of EEG alpha power (F1, 29 = 4.324, p = 0.047, partial η
2 
= 0.130, power = 
0.520), the ECG-based outcomes of mean RR (F1, 22 = 10.91, p = 0.003, partial η
2 
= 
0.33, power = 0.88), and mean HR (F1, 22 = 47.42, p = 0.001, partial η
2 
= 0.68, power 
= 1). These effects represent a medium effect size on the standard deviation of EEG 
alpha power, and large effect sizes on both mean RR and mean HR based on effect 
size conventions for partial η2 (Watson et al., 2015). Subsequent paired T-tests 
showed that the mean differences in the standard deviation of EEG alpha power 
(0.86), mean RR (-161.73 milliseconds) and mean HR (1.45 beats/minute) between 
light alone and the Placebo condition were not significant (p = 0.123, p = 0.241, p = 
0.156, respectively). Therefore, light alone had no alerting effect on either EEG or 
ECG-related sleepiness outcome measures. 
For the PPVT-related sleepiness outcome measures there was a main effect of the 
factor “Placebo vs Intervention” (Table 6.7) for the percentage of lapses (F1, 29 = 
9.524, p = 0.004, partial η2 = 0.242, power = 0.847), percentage of correct responses 
(F1, 29  =  9.642, p = 0.004, partial η
2 
= 0.250, power = 0.851), and mean of the 
slowest 10% of 1/RTs (F1, 29 = 4.819, p = 0.036, partial η
2 
= 0.142, power = 0.564). 
These are associated with a medium effect size on all PPVT outcome measures 
(Watson et al., 2015). However, the paired T-test showed that light alone did not 
significantly improve any of these outcome measures when compared with the 
Placebo condition (p = 0.079, p = 0.063, p = 0.307, respectively).  
Overall, when compared with the Placebo condition, none of objective sleepiness 
outcome measures changed under light alone (condition 2). Therefore, these data do 





Main effect of light alone on subjective outcome of sleepiness 
There was a large effect of the factor “Placebo vs Intervention” (Watson et al., 2015) 
on subjective sleepiness, measured by Karolinska Sleepiness Scale (KSS; Table 6.7), 
when compared with the Placebo condition (F1, 29 = 24.578, p = 0.001, partial η
2 
= 
0.459, power = 0.998). With regards to the specific effect of light alone, the paired T-
test revealed that the mean sleepiness scores decreased significantly by 0.9 score 
points from a KSS score of 6.2 (‘some signs of sleepiness’) in the Placebo condition 
to a KSS score of 5.3 (‘neither alert nor sleepy’) after receiving the light alone (t29 = 
3.91, p = 0.009). These results support the hypothesis of an alerting effect of light 
alone on subjective sleepiness. 
 
Main effect of the light on the driving performance outcome measures of 
sleepiness 
The analysis described in Table 6.7 showed the main effect of the factor “Placebo vs 
Intervention” on some driving performance outcome measures including the absolute 
value of lateral acceleration  (F1, 28 = 12.29, p = 0.002, partial η
2 
= 0.30, power = 
0.92), the absolute value of steering wheel angle (F1, 28 = 16.91, p = 0.001, partial η
2 
= 0.37, power = 0.97), total number of road edge excursions (F1, 29 = 6.96, p = 0.013, 
partial η2 = 0.19, power = 0.72), total number of off-road crashes (F1, 29 = 5.70, p = 
0.024, partial η2 = 0.16, power = 0.63), and the total number of speed exceedances 
(F1, 29 = 4.50, p = 0.042, partial η
2 
= 0.13, power = 0.53). The effect sizes suggest a 
large effect of intervention on the absolute value of lateral acceleration and the 
absolute value of steering wheel angle, and a medium effect of intervention on the 
latter three variables.  
The paired T-test showed that the absolute value of lateral acceleration dropped from 




This drop of 0.03 m/s
2 
was not significant after receiving light only 
when compared with the Placebo condition (p = 0.09). The absolute value of steering 
wheel angle had a significant drop of 0.22 degrees from 1.01 degrees in the Placebo 
condition to 0.78 degrees after receiving light alone (t28 = 2.10, p = 0.044). The total 
number of speed exceedances (Table 6.7) showed a significant change after the 
intervention (F1, 29 = 4.508, p = 0.04, partial η
2 
= 0.135, power = 0.537). Regarding 





2.5 speed exceedances, from a mean of 13.06 under the Placebo condition to 10.56 
after receiving the light alone (t29 = 2.86, p = 0.008). These findings partly support 
the hypothesis of an alerting effects of light alone on driving performance outcome 
measures, in that light alone improved some but not all driving performance outcome 
measures.  
Taking the effects of light alone on all primary outcome measures of interest into 
account, these data partly support the hypothesis of an alerting effect of the light, in 
that light alone could improve subjective sleepiness and two driving performance 
outcome measures.  
 
6.2.3 Hypothesis 2: Caffeine (condition 3) has an alerting effect compared to the 
Placebo condition (condition 4) 
Main effect of caffeine on the objective outcomes of sleepiness 
Of all the EEG-based outcome measures (Table 6.7), a medium effect of the 
“Intervention” was found only for the SD of EEG alpha power when compared to the 
Placebo condition (F1, 29 = 4.324, p = 0.047, partial η
2 
= 0.130, power = 0.520). The 
paired T-test revealed that the SD of EEG alpha power dropped significantly by 0.96 
mV
2
 from 3.36 mV
2 
in the Placebo condition to 2.40 mV
2
 after caffeine alone (t29 = 
2.103, p = 0.044).  
Of the ECG-based outcome measures, the factor “Placebo vs Intervention” had a 
large effect for change in the mean beat-to-beat intervals (mean RR) (F1, 22 = 10.91, p 
= 0.003, partial η2 = 0.33, power = 0.88).  The Paired T-test revealed that mean RR 
increased significantly by 95 milliseconds, from a mean of 860 milliseconds in the 
Placebo condition to 955 milliseconds after caffeine alone (t29 = 2.19, p = 0.038). A 
large effect of the factor “Placebo vs Intervention” was also observed for change in 
mean heart rate (F1, 22 = 47.42, p = 0.001, partial η
2 
= 0.68, power = 1). The paired T-
test showed that the mean HR had a significant decrease of 3.94 (beats/min), from 
71.06 beats/min in the Placebo condition to 67.12 beats/min after receiving caffeine 
alone (t29 = 5.6, p = 0.001).  In general, caffeine alone did not improve either the 
EEG or the ECG-related sleepiness outcome measures.  
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Of all the PPVT outcome measures, an overall medium effect (Watson et al., 2015) 
of the “Intervention” was found (Table 6.7) for all three outcome measures; the 
percentage of lapses (F1, 29 = 9.524,  p = 0.004, partial η
2 
= 0.242, power = 0.847), the 
percentage of correct responses (F1, 29 = 9.642, p = 0.004, partial η
2 
= 0.250, power = 
0.851), and the mean of the slowest 10% of 1/RTs as opposed to the Placebo 
condition (F1, 29 =  4.819, p = 0.036, partial η
2 
= 0.142, power = 0.564). The paired T-
test revealed that caffeine alone decreased the percentage of lapses to 15.4% (down 
from 21.7% under the placebo condition), a drop of 6.25% (t29 = 2.45, p = 0.02), and 
increased the percentage of correct responses by 6.17%, from 77.3% under the 
Placebo condition to 83.48%, (t29 = 2.36, p = 0.025). The paired T-test also showed 
that caffeine alone resulted in a rise of 0.12 (s
-1
) in the mean of the slowest 10% of 
1/RTs from 2.19 (s
-1
) in the Placebo condition to 2.32 (s
-1
) after the intervention (t29 = 
2.19, p = 0.036).  These results show that caffeine alone considerably improved the 
majority of PPVT-related sleepiness outcome measures. 
Overall, taking all sleepiness outcome measures in to account, these data partly 
support the hypothesis of an alerting effect of caffeine alone on the objective 
sleepiness outcome measures. 
 
Main effect of caffeine alone on the subjective outcome measures of 
sleepiness 
Subjective sleepiness scores had a significant decrease of 0.966 points from a KSS 
score of 6.2 (‘some signs of sleepiness’) in the Placebo condition to a KSS score of 
5.2 (‘neither alert nor sleepy’) after receiving caffeine alone (t29 = 3.91, p = 0.001). 
These findings support the hypothesis of the alerting effect of caffeine alone on 
subjective sleepiness. 
 
Main effect of caffeine alone on the driving performance outcome measures 
There were large effects of the factor “Placebo vs Intervention” (Table 6.7) for 
differences in the absolute value of lateral acceleration and the absolute value of 
steering wheel angle, and a medium effect for differences in the total number of road 
edge excursions (F1, 29 = 6.967, p = 0.013, partial η
2 
= 0.194, power = 0.723) and the 
total number of off road crashes (F1, 29 = 5.709, p = 0.024, partial η
2 





0.637). The total number of off-road crashes was defined as all instances in which 
the centre of the car exceeded the off-road buffer distance of 0.99 m.    





 in the Placebo condition to 0.12 m/s
2
 after receiving caffeine alone t (29) = 
3.34, p = 0.002.  Caffeine alone also significantly reduced the steering wheel angle 
by 0.27 degrees, from 0.91 degrees in the Placebo condition to 0.64 degrees, t (29) = 
3.44, p = .002. A significant decreased of 8.2 excursions was observed in the total 
number of road edge excursions, dropping from 18.5 excursions in the Placebo 
condition down to 10.36 excursions, t (29) = 2.69, p = .012. The paired T-test also 
revealed that the total number of off-road crashes decreased by 6.8 crashes, from 
18.1 crashes in the Placebo condition to 11.23 after receiving caffeine alone t (29) = 
2.12, p = .042.  
There was also a medium effect of the factor “Placebo vs Intervention” for 
differences in the total number of speed exceedances (F1, 29 = 4.50, p = 0.042, partial 
η2 = 0.13, power = 0.53). Caffeine alone resulted in a reduction of 2 exceedances, 
from 10.6 cases in the Placebo condition to 8.6 cases (t29 = 2.01, p = 0.053).  
However, this effect was not significant. These findings imply that caffeine had an 
alerting effect on the driving performance outcome measures, in that caffeine alone 
reduced the lateral acceleration, the steering wheel angle, total number of road edge 
excursions and off-road accidents.  
In summary, these findings partly support the hypothesis for an alerting effect of 
caffeine alone when compared to the Placebo condition. This is because alerting 
effects of caffeine alone were found for some objective sleepiness outcomes, for 





6.2.4 Hypothesis 3: Light and caffeine in combination (condition 1) has an 
alerting effect compared to the Placebo condition (condition 4) 
Main effect of light and caffeine in combination on the objective sleepiness 
outcome measures 
There was main effect of the factor “Placebo vs Intervention” on EEG and ECG-
related outcome measures with a medium effect for differences in the SD of EEG 
alpha power, and large effects for differences in both mean RR, and mean HR (Table 
6.7). The paired T-test showed that the SD of EEG alpha power did not change after 
receiving light and caffeine in combination when compared with the Placebo 
condition (p = 0.165). However, mean RR had a significant rise of 52.7 milliseconds 
from 877.2 milliseconds in the Placebo condition to 930 milliseconds after 
administering light and caffeine in combination (t24 = -5.88, p = 0.001). Light and 
caffeine in combination significantly decreased mean HR by 4.1 beats/min, from 
69.77 beats/min in the Placebo condition to 65.76 beats/min (t24 = 6.19, p = 0.001). 
For the PPVT outcome measures, the main effect of the factor “Placebo vs 
Intervention” was observed for differences in the percentage of lapses and percentage 
of correct responses. The paired T-test revealed that both percentage of lapses and 
percentage of correct responses changed after the light and caffeine in combination, 
with the percentage of correct responses being 6.97% more (t29 = 2.57, p = 0.015), 
and the percentage of lapses being 6.8% less than the Placebo condition (t29 = 2.68, p 
= 0.012). 
These findings suggest that light and caffeine in combination could improve some 
PPVT-related sleepiness outcome measures. 
Overall, the findings partly support the hypothesis of an alerting effect of light and 
caffeine in combination on objective sleepiness outcome measures.  
 
Main effect of light and caffeine in combination on the subjective outcome of 
sleepiness 
The paired T-test found that subjective sleepiness decreased from a mean KSS score 
of 5.9 (‘some signs of sleepiness’) in the Placebo condition to a mean KSS score of 





= 0.001). This supports the hypothesis of an alerting effect of light and caffeine in 
combination on subjective sleepiness.  
 
Main effect of light and caffeine in combination on the driving performance 
outcome measures of sleepiness 
The ANOVA results in Table 6.7 suggest large effects of the factor “Placebo vs 
Intervention” for differences in mean steering wheel angular rate (changes in steering 
wheel angle per second) (F1, 29 = 2771.36, p = 0.001, partial η
2 
= 0.99, power = 1.00), 
the absolute value of lateral acceleration, and the absolute value of steering wheel 
angle.  The factor “Placebo vs Intervention” had a medium effect on the total number 
of road edge excursions (see Section 6.2.3). A significant drop of 0.07 m/s
2
 was 
found in the absolute value of lateral acceleration from 0.23 m/s
2
 in the Placebo 
condition to 0.16 m/s
2
 after providing light and caffeine in combination (t29 = 2.99, p 
= 0.006).  Light and caffeine in combination resulted in a significant drop of 0.42 
degrees in the absolute value of steering wheel angle, from 1.27 degrees in the 
Placebo condition to 0.84 degrees after the intervention (t29 = 3.241, p = 0.003). The 
total number of road edge excursions also dropped from 25 cases in the Placebo 
condition to 20.2 cases after receiving the light and caffeine in combination, a 
reduction of 8.3 cases (t29 = 2.34, p = 0.026). Based on these results, the hypothesis 
of alerting effects of light and caffeine in combination on driving performance 
outcome measures is partly supported.   
Overall, these findings partly support the alerting effects of light and caffeine in 
combination when compared to the Placebo condition.   
 
6.2.5 Hypothesis 4: Light and caffeine in combination (condition 1) has a 
greater alerting effect than either light or caffeine alone 
Comparison of alerting effect of light and caffeine in combination with 
either light alone or caffeine alone on objective outcomes of sleepiness 
Based on the main effect of the factor “Placebo vs Intervention” on the standard 
deviation of EEG alpha power, the paired T-test suggested a significant difference in 
the standard deviation of EEG alpha power after receiving caffeine alone as opposed 
to the Placebo condition. The results of the 2 x 3 ANOVA (Table 6.7) showed that 
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there was no main effect of the factor “Intervention type” on the standard deviation 
of EEG alpha power (p = 0.094). This suggests no significant difference between the 
standard deviation of EEG alpha power after caffeine alone or after the other two 
types of interventions (light alone and light and caffeine in combination). Figure 6.2 
presents the comparison of mean values of the standard deviation of EEG alpha 
power in the Placebo condition and the three types of intervention. 
 
 
Figure 6.2. Comparison of the standard deviation of EEG alpha power in the Placebo 
condition and the three types of intervention,  *significant difference between the 
intervention and the Placebo condition 
 
Based on the paired T-test both interventions of caffeine alone and light and caffeine 
in combination caused a significant rise in mean RR when compared with the 
Placebo conditions. The ANOVA (Table 6.7) did not suggest any within-subjects 
main effect of the factor “Intervention type” on this variable, however the Post-hoc 
T-test (Table 6.9) revealed that after receiving light and caffeine in combination, 
mean RR was 45 milliseconds more than after light only. Taking the more 
conservative within-subjects effect into account, the findings show no significant 
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alone or light alone (p = 0.079). Figure 6.3 presents the differences in mean RR 
between the Placebo condition and the three types of intervention. 
 
 
Figure 6.3. Differences between mean RR in the Placebo condition and the three 
types of intervention, *significant difference between the intervention and the 
Placebo condition 
 
The paired T-test revealed that the mean heart rate (Mean HR) significantly 
decreased after both interventions of caffeine alone and light and caffeine in 
combination by almost 4 beats/second as opposed to the Placebo conditions. The 
results of the ANOVA (Table 6.7) revealed a medium effect (Watson et al., 2015) of 
the “Intervention type” on this variable (F1.66, 36.56 = 6.02, p = 0.008, partial η
2 
= 0.21, 
power = 0.80). According to the post-hoc T-test, the mean heart rate after light and 
caffeine in combination was 3.8 beats/min less than that of light alone (95% CI -6.10 
to -1.59, p = 0.001). Figure 6.4 shows the differences of mean HR between the 




















Figure 6.4. Differences in mean HRs between the Placebo condition and the three 
types of intervention, *significant difference between the intervention and the 
Placebo condition 
 
Compared to the Placebo condition, both intervention types of caffeine alone and 
light and caffeine in combination resulted in a drop of more than 7% and 6% in the 
percentage of lapses, respectively. Based on the findings of the ANOVA (Table 6.7) 
there was also a medium effect (Watson et al., 2015) of the “Intervention type” on 
the percentage of lapses (F2, 58 = 3.831, p = 0.027, partial η
2 
= 0.117, power = 0.673). 
The post-hoc T-test (Table 6.9) suggested that the percentage of lapses after 
receiving the light and caffeine in combination was 5.6% less than that of light alone 
(95% CI -11 to -0.113, p = 0.044). Figure 6.5 presents the differences of the 























Figure 6.5. The differences between the percentage of lapses in the Placebo condition 
and the three types of intervention, *significant difference between the intervention 
and the Placebo condition 
 
The paired T-test revealed that compared to the Placebo condition, both interventions 
of caffeine alone and light and caffeine in combination significantly increased the 
percentage of correct responses by at least 6% and 7%, respectively. The analysis 
described in Table 6.7 showed that there was a small effect (Watson et al., 2015) of 
the “Intervention type” for differences in the percentage of correct responses (F2, 58 =  
4.064, p = 0.022, partial η2 = 0.123, power = 0.701). Based on the post-hoc T-test 
(Table 6.9) the percentage of correct responses under the condition of the light and 
caffeine in combination was 6.05% greater than that of light alone (95% CI 0.2 to 
11.22, p = 0.041). Figure 6.6 shows the differences between the percentage of correct 
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Figure 6.6. The differences between the percentage of correct responses in the 
Placebo condition and the three types of intervention, *significant difference between 
the intervention and the Placebo condition 
 
Of the three interventions types only caffeine alone could significantly increase the 
mean of the reciprocal of the slowest 10% RTs as opposed to the Placebo conditions. 
However, the ANOVA (Table 6.7) did not suggest any main effect of the 
“Intervention type” on this variable (F1.759, 51.001 = 0.079, p = 0.904, partial η
2 
= 0.003, 
power = 0.601). The differences between the mean of the reciprocal of the slowest 
10% RTs in the Placebo condition and the three types of interventions are presented 
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Figure 6.7. The differences between mean of the reciprocal of the slowest 10% RTs 
(s
-1
) in the Placebo condition and the three types of intervention, *significant 
difference between the intervention and the Placebo condition 
 
According to results of the ANOVA (Table 6.7) there was no main effect of the 
factor “Placebo vs Intervention” on mean reciprocals of correct responses and lapses 
(p = 0.12), Nevertheless, there was a medium effect (Watson et al., 2015) of the 
“Intervention type” on this variable (F1.763, 51.132 = 5.464, p = 0.009, partial η
2 
= 0.159, 
power = 0.793). The post-hoc T-test (Table 6.9) showed that the mean reciprocals of 
correct responses and lapses with light and caffeine in combination was 0.206 s
-1
 
greater than for light alone (95% CI 0.02-0.395, p = 0.028). Figure 6.6 shows the 
differences between the mean reciprocals of correct responses and lapses in the 
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Figure 6.8. The differences between the mean reciprocals of correct responses and 
lapses in the Placebo condition and the three types of intervention, *significant 
difference between the intervention and the Placebo condition 
 
These results suggest that PPVT outcome measures improved after administering 
light and caffeine in combination more than with light alone. There was no 
difference between the effect of light and caffeine in combination and caffeine alone 
on PPVT.  
Overall these data partly support the hypothesis of a greater alerting effect of light 
and caffeine in combination on objective sleepiness outcomes, when compared with 
either light alone or caffeine alone.  
 
Comparison of alerting effect of light and caffeine in combination with 
either light alone or caffeine alone on subjective outcome of sleepiness 
The paired T-test showed that both light alone and caffeine alone reduced subjective 
sleepiness from a KSS mean rating of 6 (‘some signs of sleepiness’) to a rating of 5 
(‘neither alert nor sleepy’), while light and caffeine in combination decreased 
sleepiness ratings by 2 points to a rating of 4 (‘rather alert’). The ANOVA (Table 
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type” on subjective sleepiness (F2, 58 = 3.513, p = 0.036, partial η
2 
= 0.108, power = 
0.633). The post-hoc T-test revealed that light and caffeine in combination 
significantly reduced sleepiness scores by 0.65 points more than light alone (95% CI 
-1.348 to 0.048, p = 0.025), and by 0.58 points more than caffeine alone (95% CI -
1.312 to 0.145; p = 0.051). Figure 6.9 represents the differences between mean 
subjective sleepiness with the Placebo condition and the three types of interventions. 
 
 
Figure 6.9. The differences between the mean KSS in the Placebo condition and the 
three types of intervention, *significant difference between the intervention and the 
Placebo condition 
 
These results support the hypothesis that light and caffeine in combination has a 
greater alerting effect on subjective sleepiness than either light alone or caffeine 
alone. 
  
Comparison of alerting effect of light and caffeine in combination with 
either light alone or caffeine alone on the driving performance 
outcome measures 
Based on the 2-way ANOVA (Table 6.7) there was a small within-subjects effect 



















acceleration (F1.65, 46.40 = 3.94,  p = 0.033, partial η
2 
= 0.12, power = 0.62). However, 
the Post-hoc T-test (Table 6.9) did not show any significant differences in this 
variable between light and caffeine in combination and either light alone (p = 0.689) 
or caffeine alone (p = 0.083). These data suggest no advantage of the three 
intervention types together. Figure 6.11 shows the differences in the absolute value 




Figure 6.10 The differences of the absolute value of lateral acceleration (m/s
2
) 
between the Placebo condition and the three types of intervention,*significant 
difference between the intervention and the Placebo condition 
 
 
The 2-way ANOVA (Table 6.7) highlighted that there was a medium effect of the 
“Intervention type” on the absolute value of steering wheel angle (F1.629, 45.618 = 
4.198, p = 0.028, partial η2 = 0.13, power = 0.649). The Post-hoc T-test revealed that 
the absolute value of steering wheel angle after administering light and caffeine in 
combination was almost 0.3 degrees more than that of caffeine alone (95% CI 0.045 
to 0.549, p = 0.023), but not more than with light alone (p = 0.119).  These data 
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light and caffeine in combination, but not more than light alone. Figure 6.11 shows 
the differences in the absolute value of steering wheel angle with the Placebo 
condition and the three types of intervention. In this figure the smaller values are 




Figure 6.11. The differences the absolute value of steering wheel angle with the 
Placebo condition and the three types of intervention,*significant difference between 
the intervention and the Placebo condition 
 
The paired T-test showed that the number of road edge excursions dropped 
significantly with both intervention types of light and caffeine in combination and 
caffeine alone when compared to the Placebo conditions. There was a medium effect 
of the “Intervention type” (Table 6.7) on the total number of road edge excursions 
(F2, 58 = 3.721, p = 0.03, partial η
2 
= 0.114, power = 0.66). The Post-hoc T-test (Table 
6.9) suggested that with light and caffeine in combination the number of road edge 
excursions was 6 cases more than with caffeine alone (95% CI 0.92 to 11.813, p = 
0.024). There was no significant difference in this variable between light and 
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caffeine alone (p = 0.07). These findings show that caffeine alone had a greater 
alerting effect than did light and caffeine in combination, and an effect equal to that 
of light alone. Figure 6.12 represents the differences in the total number of road edge 
excursions with the Placebo condition and the three types of intervention. 
 
 
Figure 6.12. The differences of the total number of road edge excursions under the 
Placebo condition and the three types of intervention, *significant difference between 
the intervention and the Placebo condition 
 
When compared with the Placebo condition, only caffeine alone reduced the total 
number of off-road crashes significantly (by about 7 crashes). Nevertheless, there 
was no main effect of the “Intervention type” (Table 6.7) on the total number of off-
road crashes (F1.349, 39.125 = 0.334, p = 0.632, partial η
2 
= 0.011, power = 0.092).  
Based on the results of the Post-hoc T-test (Table 6.9), light and caffeine in 
combination did not significantly change this variable when compared to either light 
alone (p = 1.00), or to caffeine alone (p = 1.00). This suggests no advantage of light 
and caffeine in combination over either light alone or caffeine alone. Figure 6.13 
represents the differences of the total number of off-road crashes under the Placebo 
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Figure 6.13. The differences of the total number of off- road crashes under the 
Placebo condition and the three types of intervention, *significant difference between 
the intervention and the Placebo condition 
 
The paired T-test showed that, of the three intervention types, only the administration 
of light alone significantly reduced the number of speed exceedances when compared 
to the Placebo condition. The effect of caffeine alone (p = 0.053), as well as light and 
caffeine in combination (p = 0.81), were statistically insignificant. Based on the 
results of the ANOVA (Table 6.7) there was a small effect (Watson et al., 2015) of 
the factor “Intervention type” on the total number of speed exceedances (F2, 58 = 
3.444, p = 0.039, partial η2 = 0.106, power = 0.624).  A further Post-hoc T-test 
showed that the number of speed exceedances after administering light alone was 
about 2.3 cases more than after light and caffeine in combination (95% CI -4.528 to -
0.239, p = 0.031) and 2.2 cases more than after caffeine alone (95% CI 0.039 to 
4.394, p = 0.046). However, this does not mean a lower alerting effect of light alone. 
As seen in Figure 6.14, even though the number of speed exceedances after receiving 
light alone is more than those of the other two interventions, the drop in this variable 
from the Placebo condition is greater with light alone when compared with the other 
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number of speed exceedances than that of either caffeine alone or light and caffeine 
in combination. Figure 6.14 shows the differences in the total number of speed 
exceedances with the Placebo condition and the three types of intervention, with 
smaller values presenting a greater alerting effect. 
 
Figure 6.14. The differences of the total number of speed exceedances under the 
Placebo condition and the three types of intervention, *significant difference between 
the intervention and the Placebo condition 
 
The results of the ANOVA did not support the hypothesis of greater effectiveness of 
light and caffeine in combination on driving performance outcome measures when 
compared with either light alone or caffeine alone. Taking all the findings together, 
these data partly support the hypothesis of the greater alerting effect of light and 
caffeine in combination than either light alone or caffeine alone.  
 
6.2.6 Hypothesis 5: Light alone has a greater alerting effect than caffeine alone 
The findings revealed that of all outcome measures, some EEG and ECG related 
measures remained unchanged by light alone but were impaired after consumption of 
caffeine. The majority of PPVT outcomes improved with caffeine alone, but 
remained unchanged after receiving light alone. A greater number of driving 
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Therefore, these data do not support the hypothesis of a greater alerting effect of light 
alone than caffeine alone (see Table 6.10 for summary).
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Table 6.10 Summary of main effects of the two factors “Placebo vs Intervention” and “Intervention type” on primary-interest outcome measures 
Construct Outcome 
Main effect 




The paired T-test (Table 6.7) 
Main effect of the factor 
“Intervention type” 
(Table 6.7) 









(p = 0.047, 
η2 = 0.13)   




No main effect (p = 
0.225) 
light and caffeine in 
combination = Light alone 





(p = 0.003, 
η2 = 0.33) 
Light and caffeine in combination caused 
an increase of 52.77 milliseconds (6%) 
No main effect (p = 
0.079) 
light and caffeine in 
combination = Light alone 
= Caffeine alone 





(p = 0.001, 
η2 = 0.68) 
Light and caffeine in combination caused a 
decrease of 4.1beats/min (5%) 
*Main effect 
(p = 0.008, η2 = 0.21)  
Light alone > light and 
caffeine in combination 
2-1 = 3.85 beats/min (p = 
0.001)   
Light alone = Caffeine 
alone 











The paired T-test (Table 6.7) 
Main effect of the factor 
“Intervention type” 
(Table 6.7) 






(p = 0.004, 
η2 = 0.24) 
Light and caffeine in combination, 7% 
decrease 
*Main effect (p =0.027, 
η2 = 0.117) 
 
light and caffeine in 
combination > Light, 1-2= 
-5.605 (p = 0.044), 
light and caffeine in 
combination = Caffeine 
alone (p = 0.65), 
Light alone= Caffeine 
alone (p = 0.291), 





(p = 0.004, 
η2 = 0.25) 
light and caffeine in combination, 7% 
increase 
Main effect (p = 0.022, 
partial η2 = 0.123) 
light and caffeine in 
combination > Light 
alone, 1-2 = 6.015 (p = 
0.041) 









The paired T-test (Table 6.7) 
Main effect of the factor 
“Intervention type” 
(Table 6.7) 
The post-hoc T-test  
(Table 6.9) 
light and caffeine in 
combination = Caffeine (p 
= 0.825), 
Light alone = Caffeine 
alone (p = 0.16), 
Mean of the 





(p = 0.036, 
η2 = 0.14) 
Caffeine alone caused a 0.12/s increase 
(5%) 
No main effect (p = 
0.904) 
light and caffeine in 
combination = Light alone 








effect (p = 
0.12, η2 = 
0.08) 
 Main effect (p = 0.009, 
partial η2 = 0.159) 
light and caffeine in 
combination > Light 
alone, 1-2 = 0.206 (p = 
0.028), 
Combination of light and 











The paired T-test (Table 6.7) 
Main effect of the factor 
“Intervention type” 
(Table 6.7) 
The post-hoc T-test  
(Table 6.9) 
(p = 0.242), 
Light alone = Caffeine 
alone (p = 0.206), 
Subjective 
sleepiness 
KSS Main effect 
(p = 0.001, 
η2 = 0.45) 
Light and caffeine in combination caused a 
decrease of 1.533 score in sleepiness rating 
Main effect (p = 0.036, 
η2 = 0.108) 
light and caffeine in 
combination > Light 
alone, 1
*
-2 = -0.650 (p = 
0.025), 
Light and caffeine in 
combination > Caffeine 
alone, 1-3= -0.583 (p = 
0.051), 
Light alone = Caffeine 
alone (p = 0.789), 
   Light alone, a decrease of 0.9 score  









The paired T-test (Table 6.7) 
Main effect of the factor 
“Intervention type” 
(Table 6.7) 











(p = 0.002, 
η2 = 0.30) 
Caffeine alone, a decrease of 0.05 (m/s
2
) 
Light and Caffeine in combination, a 




Main effect (p = 0.033, 
η2 = 0.12) 
No difference was 
detectable; light and 
caffeine in combination = 
Light alone = Caffeine 
alone 




(p = 0.001, 
η2 = 0.37) 
Light and caffeine in combination caused a 
decrease of 0.42 degrees (33%)  
Main effect (p = 0.028, 
partial η2 = 0.13) 
Light and caffeine in 
combination > Caffeine 
alone, 1-3 = 0.297 (p = 
0.023), 
Light and caffeine in 
combination = Light alone 
= Caffeine alone (p = 
0.119), 
Light alone = Caffeine 
Light alone caused a decrease of 0.22 
degrees (22%) 
Caffeine alone caused a decrease of 0.27 











The paired T-test (Table 6.7) 
Main effect of the factor 
“Intervention type” 
(Table 6.7) 
The post-hoc T-test  
(Table 6.9) 
alone (p = 0.095), 




(p = 0.013, 
η2 = 0.19) 
Light and caffeine in combination cause a 
decrease of 8.3 cases (33%) 
Main effect (p = 0.03, 
partial η2 = 0.114) 
Light and caffeine in 
combination > Caffeine 
alone, 1-3 = 6.36 (p = 
0.024), 
 
  Caffeine alone cause a decrease of 8.2 
excursions (30%) 
  
Total number of 
off-road crash 
Main effect 
(p = 0.024, 
η2 = 0.16) 
Caffeine alone caused a decrease of 6.8 
crashes (37%)  
No main effect (p = 
0.632) 
Light and caffeine in 
combination = Light alone 









The paired T-test (Table 6.7) 
Main effect of the factor 
“Intervention type” 
(Table 6.7) 
The post-hoc T-test  
(Table 6.9) 






(p = 0.04, η2 
= 0.13) 
Light alone caused a decrease of 2.5 
exceedances compared to Placebo (19%)  
Main effect (p = 0.039, 
partial η2 = 0.106) 
 
 
Light alone> light and 
caffeine in combination, 
1-2= -2.383 (p=0.031) 
Light alone> Caffeine 
alone, 2-3= 2.217 
(p=0.046) 
Light and caffeine in 
combination = Caffeine 
alone, p=0.85 
RR= beat-to-beat interval, HR= heart rate, SD=Standard deviation,  
*1=condition 1 (light and caffeine in combination), 2= condition 2 (light alone), 3= condition 3 (caffeine alone) 





6.2.7 Hypothesis 6: Administration of any intervention has an alerting effect 
compared to the Placebo condition 
To test this hypothesis, the main effect of the factor “Placebo vs Intervention” on the 
objective, subjective and the driving performance outcome measures were examined 
(Table 6.7). In case of any main effect, a post-hoc T-test was performed to determine 
the significant differences between the intervention and the Placebo condition (Table 
6.9). As previously mentioned, in this analysis the ‘intervention’ refers to the overall 
or combined effect of the three intervention types. Of EEG and ECG-related outcome 
measures there was a main effect of the factor “Placebo vs Intervention” (Table 6.7) 
only on the standard deviation of EEG alpha power, and on the mean RR and the 
mean HR.  The post-hoc T-test (Table 6.9) suggested that after the intervention the 
standard deviation of EEG alpha power was 1.081 (mV
2
) less than in the Placebo 
condition (95% CI 0.018 to 2.144, p = 0.047, Bonferroni adjusted), the mean RR was 
61 milliseconds higher than the Placebo condition (95% CI 99.37 to 22.73, p = 0.003, 
Bonferroni adjusted) and the mean HR decreased by 3.5 beats/min as opposed to the 
Placebo condition (95% CI 2.44 to 4.54, p = 0.001, Bonferroni adjusted). These 
changes in the three variables indicated increased sleepiness. Therefore, the EEG and 
the ECG-related outcome measures were not improved by the administration of the 
intervention and in some cases even degraded.  
The 2-way ANOVA (Table 6.7) revealed that all PPVT-related outcome measures 
were significantly changed by the intervention, except for the mean reciprocals of 
correct responses and lapses (p = 0.120). The Post-hoc T-test (Table 6.9) revealed 
that after the intervention the percentage of lapses had a decrease of 6.54% (95% CI 
2.21 to 10.88, p = 0.004), the percentage of correct responses had an increase of 
6.7% (95% CI -11 to -2.28, p = 0.004) and the mean slowest 10% of 1/RTs had an 
increase of 0.124 (95% CI -0.2 to -0.008, p = 0.036) compared to the Placebo 
condition. These results partly support the hypothesis of improved PPVT-related 
outcome measures after the intervention.  
Overall, these data partly support an overall alerting effect from the intervention on 




The findings of the ANOVA reflected in Table 6.7 showed that after the intervention 
KSS ratings decreased by an average of 1.133 points (95% CI 0.666 to 1.601, p = 
0.001). This supports the hypothesis of an alerting effect of the intervention on 
subjective sleepiness when compared with the Placebo condition.  
The results of the ANOVA (Table 6.7) showed a main effect of the factor “Placebo 
vs Intervention” on all driving performance outcome measures, except for the two 
variables of the standard deviation of lateral lane position (p = 0.617) and the total 
number of collisions (p = 0.160). The post-hoc T-test (Table 6.9) suggested that, 
when compared to the Placebo condition, the absolute value of lateral acceleration 
had a significant drop of 0.54 m/s
2
 (95% CI 0.02 to 0.08, p = 0.002), the absolute 
value of steering wheel angle had a significant drop of 0.309 degrees (95% CI 0.155 
to 0.462, p = 0.001), the number of speed exceedances had a decrease of 1.58 
exceedances (95% CI 0.058 to 3.119, p = 0.042), the number of road edge excursions 
had a drop of 6.7 cases (95% CI 1.509 to 11.891, p = 0.013) and the total number of 
off-road crashes had a drop of 4.233 crashes (95% CI 0.61 to 7.857, p = 0.024) after 
the intervention. Therefore, these data partly support the hypothesis of an alerting 
effect of the intervention on driving performance outcome measures when compared 
to the Placebo condition.  
Taking all data together, these results partly support the hypothesis of an alerting 









Chapter 7: Discussion  
An overview of the whole program of research is provided in Section 7.1. The results 
are summarised in Section 7.1.3, followed by an interpretation of the findings in 
Section 7.2. The findings of the experimental study are compared and contrasted 
against findings from the reviewed literature in Section 7.3, followed by a 
description of the contribution of this research to existing knowledge in Section 7.4. 
Finally, some considerations are presented in Section 7.5.   
 
7.1 OVERVIEW OF THE WHOLE PROGRAM OF RESEARCH 
7.1.1 Purpose/scope 
The purpose of this experimental study was to investigate the effects of light 
(provided at a pragmatic dose and via a commercially-available delivery system) on 
young drivers’ alertness and performance, and to compare these effects to those 
provided by caffeine, after chronic partial sleep deprivation in a simulated driving 
experiment.  
 
7.1.2 Rationale for selecting the outcomes  
In the experimental study a multi-level approach to the measurement of driver 
sleepiness was taken. Sleepiness was measured by objective, subjective, and driving 
performance outcome measures. The rationale for measuring the objective outcomes 
of brain activity, heart rate variability, and psychomotor performance outcomes, 
stemmed from the findings of the narrative review suggesting that the influence of 
sleepiness upon performance commences at an earlier point than the driver’s own 
perception of that moment. Psychomotor vigilance is a critical component of drivers’ 
cognitive performance, and the PVT remains a standardized and sensitive probe in 
sleep and circadian research. The systematic review pointed out that PVT reaction 
times could slow by 45% after one week chronic sleep loss in young drivers (Rupp et 
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al., 2004), and the use of the PVT allows some comparisons with previous studies. 
The outcome of subjective sleepiness was also of importance in that, even after a 
perception of increased sleepiness and impaired performance, young drivers mostly 
carry on their drive (and in some cases to the point of a crash). Additionally, the 
literature showed that there is a paucity of data regarding variation in the KSS in 
response to light during daytime hours (Hommes & Giménez, 2015). Finally, based 
on the systematic review, driving performance in the simulator was measured by 
outcomes identified as particularly sensitive to sleepiness and/or critical for safe 
driving, such as the standard deviation of lateral position and inappropriate line 
crossings, the steering wheel angle, and speed. 
 
7.1.3 The results of this program of research  
The findings of the primary narrative review (Chapter 2) revealed that the 
homeostatic and circadian sleep drives are the two primary regulators of sleepiness, 
but their influence can be shaped by other contributing factors such as the presence 
of sleep disorders, time-on-task fatigue, consumption of drugs and medicines, and 
other sources of inter-individual differences. The primary narrative review also 
showed that young drivers are overrepresented in sleep-related crashes, and are more 
vulnerable to the devastating consequences of sleep loss. In order to have a better 
understanding of the effects of sleep loss on young drivers a systematic review 
(Chapter 3) was conducted. The systematic review revealed that between 2004 and 
2014 only 10 studies were published on the effects of sleep loss on young drivers’ 
performance. There were no standard outcome metrics or randomised control trial 
interventions for the problem of sleepy driving identified. The systematic review also 
found that about half the studies adopted samples of fewer than 15 participants, 
predominantly included only male drivers. Half of them were conducted during night 
time with acute sleep loss, and only one-fifth of studies adopted a chronic sleep 
deprivation paradigm. An equal number of studies objectively monitored and 
quantified the sleep manipulation by Actigraphy or by measuring wake EEG during 
their experiment. The majority of studies were undertaken on some sort of driving 
simulator. These properties have impacted the quality of evidence in this field and 





The process of developing the GRADE criteria for rating the quality of papers found 
that the most important degrading factor for the quality of papers was the risk of bias 
(mostly because of some flaws in the implementation of the study, such as 
inadequate monitoring of sleepiness during the test period and practice effects on the 
outcome measures used). The GRADE rating analysis revealed that this limited 
evidence on the effect of sleep loss on young drivers’ performance was not a reliable 
source of information. The available evidence suffered from very low quality studies 
(0 < OGS < 1) for reaction time outcomes, and from low quality studies (1 < OGS < 
2) for the standard deviation of lateral position. There is no high-quality evidence 
currently available on young drivers’ performance after sleep loss. 
In order to understand the effects of light and caffeine on young drivers’ performance 
a second narrative review was performed (Chapter 4). The literature revealed that 
short wavelengths of light such as blue or green light have greater alerting effects 
than those of longer wavelengths such as yellow or white light of equivalent 
intensity. In parallel, caffeinated chewing gums have higher absorption rates than 
other forms of caffeine and even low doses of caffeine have alerting effects. 
However, the review showed that few studies have examined the alerting effects of 
either light or caffeine in the driving context. There were some specific gaps in the 
available literature; most studies have been conducted during the night time, and 
there was no clear evidence for an alerting effect of light and caffeine on young 
adults’ objective and subjective sleepiness, or upon their driving performance, after 
chronic sleep loss during the daytime. These ‘gaps’ in the current literature were 
convincing enough to conduct an experimental driving study during the daytime 
hours (when young drivers typically experience mild sleepiness in their routine life 
and more often drive). The combined findings of the primary and secondary narrative 
reviews and the systematic review framed the structure of the experimental study 
including the study design, sample characteristics, outcomes and measurement tools. 
The experimental study (Chapter 5: and Chapter 6:) found that neither light, not 
caffeine alone, nor the combination of light and caffeine together improved the 
drivers’ sleepiness outcomes on all objective, subjective, psychomotor performance, 
and driving performance measures. The data suggested that light and caffeine in 
combination could improve psychomotor performance (PPVT) outcomes to a greater 
extent than could light alone, but not to a greater extent than caffeine alone. Both 
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light and caffeine alone seemed to improve subjective sleepiness, while light and 
caffeine in combination had a greater alerting effect, with the drivers reporting 
themselves to be rather alert. Of the other primary outcomes, light alone improved 
speed exceedance and steering wheel angle indices, while caffeine alone or 
combined with light improved a broader range of outcomes including percentage of 
lapses, correct responses, steering wheel angle, and the total number of road edge 
excursions. However, these findings did not suggest any advantage for the 
combination light and caffeine over light alone, or over caffeine alone, in improving 
driving performance outcomes. Table 6.11 presents a summary of findings of the 





Table 6.11 Summary of findings of the experimental study and their overall support for the six primary hypotheses 
 
Hypothesis Description 
Support of the hypothesis by objective, subjective and driving performance 
outcome measures of interest 
Overall support for 
the hypothesis  
Hypothesis 1 Light (condition 2) has 
an alerting effect 
relative to the Placebo 
condition (condition 4) 
Objective sleepiness outcomes 
a. EEG outcomes: Did not support 
b. ECG outcomes: Did not support 
c. PPVT outcomes: Did not support 
Subjective sleepiness (KSS): Supported 
Driving performance outcomes: Partly supported 
A decrease in the absolute value of steering wheel angle and speed exceedances.  
Partly supported 
Hypothesis 2 Caffeine (condition 3) 
has an alerting effect 
compared to the Placebo 
condition (condition 4) 
Objective sleepiness outcomes 
a. EEG outcomes: Did not support (even standard deviation of EEG alpha 
power decreased) 
b. ECG outcomes: Did not support (even mean RR increased and mean HR 
decreased) 
c. PPVT outcomes: Partly supported by reducing the percentage of lapses 
and increasing the percentage of correct responses and mean of the 
slowest 10% of 1/RTs.  
Subjective sleepiness (KSS): Supported 





Support of the hypothesis by objective, subjective and driving performance 
outcome measures of interest 
Overall support for 
the hypothesis  
value of lateral acceleration, the absolute value of steering wheel angle, total 
number of road edge excursions and total number of off-road crashes. 
Hypothesis 3 Light and caffeine in 
combination (condition 
1) has an alerting effect 
compared to the Placebo 
condition (condition 4) 
Objective sleepiness outcomes 
a. EEG outcomes: Did not support 
b. ECG outcomes: Did not support (even mean RR increased and mean HR 
decreased) 
c. PPVT outcomes: Partly supported by reducing the percentage of lapses 
and increasing the percentage of correct responses  
 
d. Subjective sleepiness (KSS): Supported 
 
Driving performance outcomes: Partly supported 
A decrease in the absolute value of lateral acceleration, the absolute value of 
steering wheel angle and total number of road edge excursions.  
Partly supported 
Hypothesis 4 Light and caffeine in 
combination (condition 
1) has a greater alerting 
effect than either light or 
caffeine alone 
Objective sleepiness outcomes 
a. EEG outcomes: Did not support 
e. ECG outcomes: Did not support (even mean HR was less than light 
alone) 
b. PPVT outcomes: Partly supported  







Support of the hypothesis by objective, subjective and driving performance 
outcome measures of interest 
Overall support for 
the hypothesis  
correct responses was more than that of light alone, the mean reciprocals 
of correct responses and lapses was larger than that of light alone. 
Subjective sleepiness (KSS): Supported 
Driving performance outcomes: Did not support 
(Even the absolute value of steering wheel angle and the number of road edge 
excursions were both more than those of caffeine alone). 
Hypothesis 5 Light alone has a greater 
alerting effect than 
caffeine alone 
Objective sleepiness outcomes  
a. EEG outcomes: Did not support 
b. ECG outcomes: Did not support 
c. PPVT outcomes: Did not support (the majority of PPVT outcomes 
improved by caffeine alone) 
Subjective sleepiness (KSS): Did not support 
Driving performance outcomes Driving performance outcomes: Did not 
support 
A decrease in the absolute value of lateral acceleration, total number of road edge 
excursions and total number of off-road crashes occurred by caffeine alone, but 
not after receiving light alone. 
Did not support 
Hypothesis 6 Administration of any 
intervention has an 
Objective sleepiness outcomes 






Support of the hypothesis by objective, subjective and driving performance 
outcome measures of interest 
Overall support for 
the hypothesis  
alerting effect compared 
to the Placebo condition 
power decreased) 
b. ECG outcomes: Did not support (even mean RR increased and mean HR 
decreased) 
c. PPVT outcomes: Partly Supported 
All PPVT outcomes improved after the intervention except for the mean 
reciprocals of correct responses and lapses with no change. 
Subjective sleepiness (KSS): Supported 
Driving performance outcomes: Partly Supported 
All driving performance outcomes improved after the intervention except for the 
two variables of the standard deviation of lateral lane position and the total 








7.2 INTERPRETATION OF THE FINDINGS  
In this experimental study participants’ sleep-wake times were manipulated, and a 
chronic mild sleep loss was successfully induced.  
A one-hour sleep loss was induced to simulate the sleep loss that is normally 
experienced by non-professional drivers and to have a more conservative estimate of 
the net effect of this limitation and potential benefits of interventional conditions. 
Based on the joint consensus statement of the American Academy of Sleep Medicine 
(AASM) and Sleep Research Society (ARS)  sleep restricted to less than 7 hours per 
night is regarded as insufficient (Panel et al., 2015). This is a mild degree of sleep 
loss, consistent with that which might have result in mild levels of impairment and 
consequently the lower levels of improvements in sleepiness after administering the 
three conditions. Nevertheless, even a mild degree of sleepiness is not acceptable 
when driving. This degree of sleep restriction was enough to induce a subjective 
sleepiness level of 6, with effects observed on sensitive measures of specific aspects 
of neurocognitive function relevant to safe driving. A recent study shows that a 
rating of ‘6’ or more on the KSS,  is associated with impaired simulator driving 
performance and with increased real-world crash risk (Åkerstedt, Anund, Axelsson, 
& Kecklund, 2014). The one-hour sleep deprivation in this study did not induce 
progressive subjective sleepiness. This means that participants had the same 
subjective sleepiness at the beginning of each test day, and that the level of 
sleepiness did not vary considerably before administering the three conditions across 
the three test days.  
As for the first hypothesis, the non-significant change in the objective sleepiness 
outcome measures after receiving light alone implies that the alerting effects of light 
were not sufficient to improve these outcomes. On the other hand, light alone did 
significantly improve the drivers’ subjective sleepiness. This difference was 
sufficient to shift mean KSS scores from a value corresponding to “some signs of 
sleepiness” to value corresponding to “neither alert nor sleepy”. One implication of 
this finding is a discrepancy or misalignment between subjective and objective 
sleepiness. This could mean that under such lighting condition drivers could perceive 
improved alertness and would keep driving, without any improvement in their  
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Light alone improved some driving performance outcome measures such as the 
absolute value of steering wheel angle and the total number of speed exceedances. 
Light alone decreased the absolute value of steering wheel angle by 0.2 degrees from 
1.01 degrees in the Placebo condition to 0.78 degrees. These absolute values seem to 
be very small. However, as the simulator had a sensitive steering wheel, drivers were 
able to adjust the vehicle’s lane position by small movements of the steering wheel.  
Therefore, the 0.2 degree corresponds to an attenuation of more than 20% in the 
magnitude of steering movements, and reflects better steering wheel control. Having 
a medium effect, light alone reduced the number of speed exceedances from 13 cases 
in the Placebo condition to 10.5 cases. This drop of 2 cases represents a one-fifth 
(19%) drop in speeding. However, more than 10 cases of speed exceedance 
remained. Overall, the light did not improve the drivers’ alertness consistently across 
all levels of subjective sleepiness, objective sleepiness, and objective driving 
performance. Therefore, the first hypothesis is partly supported and provision of light 
alone could not be regarded as a reliable stimulant in the context of increased 
sleepiness.  
The provision of caffeine did not improve any EEG-related outcome measures except 
for a decrease in the standard deviation of alpha power by 0.96 mV
2
 from 3.3 mV
2
. 
This is almost 30% attenuation in alpha power variability representing a medium 
effect of caffeine. Based on the classification of sleep onset period by Hori et al. 
(2001), increased alpha and theta EEG activity represent early stages of sleepiness. 
Therefore, this change represents less instability in alpha power and could be a sign 
of increased alertness. In contrast, caffeine alone did not improve ECG-related 
outcome measures, and did not prevent increasing mean heart beat-to-beat interval, 
and decreasing mean heart rate. Mean RR after consumption of caffeine rose by an 
average of 95 milliseconds (a decrease in mean heart rate by 4 beats/min). Since 
slower mean beat-to-beat intervals have been reported to reflect increased alertness 
(Rodriguez-Ibañez, García-Gonzalez, de la Cruz, Fernández-Chimeno, & Ramos-
Castro, 2012), the increased mean RR and decreased HR in this study could be 
interpreted as increased sleepiness. However, that interpretation is contradicted by 
the parallel findings that caffeine alone improved the majority of PPVT outcome 
measures. Caffeine reduced the percentage of PPVT lapses and increased the 





slowest 10% reciprocal of reaction times by 0.12/s. Given that higher values of mean 
of the slowest 10% of reciprocals of reaction times reflect higher reaction speeds 
(Loh et al., 2004; Sforza et al., 2004), these findings all imply that caffeine is able to 
decrease the proportion of slow reaction times and increase the reaction speed 
significantly. In spite of the medium effect of the intervention on above-mentioned 
three variables, lapses were still observed at a rate of 15% after consumption of 
caffeine.  
Caffeine was also associated with a modest improvement in subjective sleepiness 
scores, shifting mean KSS scores from a value corresponding to “some signs of 
sleepiness” to value corresponding to “neither alert nor sleepy”. This means that after 
consumption of caffeine, the feeling of sleepiness could disappear. 
Caffeine was found to decrease the absolute value of steering wheel angle by 0.27 
degrees, the number of the road edge excursions by more than 8 cases, and the 
number of off-road crashes by almost 7 cases. These correspond to 30%, 30%, and 
37% decreases in these outcome measures, respectively. These performance-based 
metrics have been associated with sleepiness-related road crash (either in simulator 
or on-road), and changes of these magnitudes may represent significantly reduced 
crash risk. These data together partly support the second hypothesis of an alerting 
effect of caffeine as opposed to the Placebo condition.  
The combination of light and caffeine did not change any EEG-related outcomes. 
However, this condition had differential effects on ECG-derived outcomes. The 
mean beat-to-beat interval (mean RR) rose by 52 milliseconds (4 beats/min drop). 
These changes represent a change of 5%, a large effect of the intervention on these 
variables. Since the increase in mean RR (Borghini et al., 2014) or decrease in mean 
HR (Borghini et al., 2014; Liang et al., 2007) imply increased sleepiness, these 
findings suggest that the combination of light and caffeine could not improve these 
outcomes. Instead, these two outcomes degraded due to increased sleepiness.  
The combination of light and caffeine seemed to improve the PPVT outcomes, 
increasing the percentage of correct responses and decreasing the percentage of 
lapses by about 7%. These changes suggest a medium effect of the intervention and 
significant improvement in reaction times under the combination of light and 
caffeine as opposed to the Placebo condition.  
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The combination of light and caffeine had a large effect on subjective sleepiness 
score by improving the KSS scores by 1.5 points from KSS value 6 (‘some signs of 
sleepiness’) in the Placebo condition to a value of 4 (‘rather alert’) after the 
intervention. This intervention could make sleepy drivers feel rather alert. One 
implication is that the administering light and caffeine in combination would give a 
sense of security to drivers regarding their sleepiness, and that they would continue 
driving in that context.  
Of the driving performance outcome measures, there was a large effect of the 
combination of light and caffeine on the absolute value of lateral acceleration and the 
absolute value of the steering wheel angle with substantial decreases of 0.07 m/s
2
 and 
0.42 degrees (33%), respectively. These changes imply that drivers decreased the 
frequency of their abrupt lateral deviations and magnitude of their steering wheel 
movements. There were also eight (33%) fewer occurrences of road edge excursions 
with the combination of light and caffeine when compared with the Placebo 
condition. These findings indicate a significant improvement in driver performance.  
Overall, the combination of light and caffeine did not significantly improve EEG and 
ECG-based outcomes of sleepiness, but did provide potentially considerable 
improvements in subjective alertness, PPVT, and driving performance outcomes of 
sleepiness. Therefore, the third hypothesis predicting the alerting effect of light and 
caffeine in combination is partly supported. 
It is obvious that these three interventions do not exert their alerting effects on all 
levels of driver’s sleepiness. There were no improvements in EEG or ECG-related 
outcome measures but some PPVT and driving performance benefits. It is unlikely 
that the unchanged EEG-based outcomes are due to poor sensitivity of EEG to 
sleepiness. There might be a mismatch between broader cortical EEG (including the 
specific recording positions) and the sensory-motor cortex functions associated with 
driving. Additionally, EEG and ECG-based outcome measures were each averaged 
over 30 min driving time. This averaging might have masked instantaneous changes 
of these variables at critical time points of driving. Therefore, there might be a need 
to analyse these data using different time bases (e.g. the point of roadway 





The comparison of these three intervention types also revealed that they affect 
outcome measures in different ways. For example, EEG-derived outcomes of mean 
RR and mean HR did not change in response to light alone but were impaired with 
both caffeine alone and light and caffeine in combination. Conversely, PPVT 
outcomes measures did not change with light alone but improved with both caffeine 
alone and light and caffeine in combination. This implies that caffeine might exert its 
alerting effects on different pathways of alertness when compared with light alone.   
The comparison of relative effectiveness of the three intervention types revealed no 
significant differences in EEG and ECG-based indices across these interventions. 
Having a small effect of receiving light and caffeine in combination, the percentage 
of lapses was 5.6% less, and the percentage of correct responses was 6% more than 
those with light only. However, light and caffeine in combination did not improve 
these metrics to a greater extent than did caffeine alone. Additionally, data showed a 
small effect of type of intervention on subjective sleepiness with lower sleepiness 
levels after light and caffeine in combination than after either light alone or caffeine 
alone. Data from the driving performance outcomes showed that with a medium 
effect of type of intervention, after light and caffeine in combination the absolute 
value of steering wheel angle was 0.3 degree greater than that of caffeine alone. The 
intervention type had a small effect on the number of road edge excursions, with the 
road edge excursions after light and caffeine in combination occurring more often 
than those observed after caffeine alone. These results show a greater alerting effect 
of caffeine than the light and caffeine in combination on the latter two variables.  
Overall, data partly supported hypothesis 4, predicting the advantage of light and 
caffeine in combination over the other two interventions.  
The findings for the objective, subjective and driving performance outcomes did not 
support hypothesis 5, the prediction of a higher alerting effect of light relative to 
caffeine. 
In spite of decreasing subjective sleepiness and improving the majority of driving 
performance outcome measures there was some deterioration in ECG-based outcome 
measures such as mean RR and Mean HR after administering an intervention (small 
to medium effects). These data partly supported hypothesis 6 that predicted a greater 
alerting effect of making an intervention when compared with the Placebo condition. 
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One important finding of the experimental study was the mismatch between 
subjective and objective sleepiness under all the three interventional conditions. The 
reasons for this discrepancy need to be studied further under another research 
paradigm.  One reason for this discrepancy could be that it is not easy to have insight 
into the human physiological performance, to recognise cues of sleepiness associated 
with performance decline, nor to calibrate performance against subjective 
experience. The correspondence of each level of subjective sleepiness with drivers’ 
objective performance is not well understood. The data from the current 
experimental study show that there were no strong associations between subjective 
sleepiness, PPVT performance and driving performance on the simulator. The 
potential discrepancy between subjective sleepiness and objective sleepiness may 
need to be taken into account when developing advertisements or similar road safety 
strategies against driver sleepiness. In advertisements it may be crucial to tell people 
not to rely on their own perception of sleepiness because subjective sleepiness may 
not reflect their real level of deteriorated performance. Instead, it could be reinforced 
that if drivers are not getting enough sleep (normally less than 8 hours), it will be 
more dangerous to drive. Literature suggests young drivers do not stop driving when 
they feel sleepy. This group of drivers may often have to drive while sleepy (when 
they stay up late or wake up earlier) for work, or because they have chosen to 
sacrifice sleep for socialization. Therefore, telling them not to drive when not having 
had enough sleep may not be effective. Advertisement or education-based methods 
have not yet been shown to be effective and should be developed and evaluated. This 
misalignment also has implications for current road safety strategies and justifies the 
need for prioritising the problem of sleepy driving, perhaps increasing the use of 
rumble strips, road side rest stops, and sleepiness-warning technologies inside 
vehicles. Using Actigraphy to give the drivers some feedback of their general level 
of sleepiness might be worth considering as a possible road safety strategy. 
Findings of both the systematic review and the experimental study have some 
implications for our understanding of the mainstream bio-mathematical models of 
sleep-wake regulation, the neuroscience of sleepiness, and the neurocognitive 
substrates of driving. The systematic review showed some inconsistencies in the 
responses from different sleepiness outcome measures to sleep loss at different times 





driving performance outcomes, examined at 10 a.m. with low circadian sleepiness, 
do not respond to the three interventional conditions consistently. With regards to the 
bio-mathematical models, a very recent study reported that human cognition, 
including alertness and reaction time (which are particularly important for driving), 
are differentially sensitive to different processes of human sleep-wake regulation 
with inhibitory control being sensitive to the circadian processes and selective visual 
attention being modulated by sleep inertia (Burke, Tina M, Scheer, Ronda, Czeisler, 
& Wright, 2015). Therefore, it is highly likely for measures such as PPVT or driving 
performance to either remain unchanged or to degrade to different extents due to 
sleep loss alone (if primarily driven by the homeostatic drive for sleepiness) and 
hence, to differentially improve after light or caffeine in the current experimental 
study. Therefore, it may be crucial to run forced de-synchrony studies in driving 
paradigms to examine the sensitivity of a broad range of objective, subjective and 
driving performance outcome measures of sleepiness due to different 
circadian/homeostatic balance. The differentiated responses of outcomes to sleep loss 
and light/caffeine could be related to the neuroscience of sleepiness, and in fact be 
consistent with the involvement of different brain areas and pathways that subserve 
the different tasks involved during driving (Inc. reaction time, decision making, 
hazard perception and attitude). These skills might have different sensitivity to 
different types of sleepiness. The fact that no PPVT and driving performance 
outcomes failed after light/caffeine confirms the different sensitivity of these 
outcomes to sleep loss (homeostatic drive for sleep). There were strong changes in 
some outcomes showing their greater sensitivity to sleep loss and greater 
improvement after light/caffeine intervention. Changes of this magnitude are 
important in road safety because they could result in lower crash rates. It should be 
noted that there are other factors such as peer pressure, pressure of work, and 
increased distraction that could be included in the sleep deprived driving paradigm 
which would produce different outcome responses.   
 Different driving skills are balanced to meet the demands of various driving 
environments. For example, the predominant skills required for driving on a long 
rural highway (e.g. vigilance and control) might vary from those required in complex 
urban traffic (e.g. hazard perception). In the current experimental study, the driving 
scenario was a combination of straight highway, urbanised residential areas, and 
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curved sections. However, the specific responses of outcome measures were not 
analysed for each section. The specific sensitivity of outcome measures to sleep loss 
and light/caffeine interventions across a variety of driving contexts need to be 
examined.  
There are some considerations associated with implementation of the Re-Timer and 
caffeinated chewing gum technologies into on-road mitigation strategies. Caffeinated 
gums were initially developed in a military environment and are now commercially 
available. There is no evidence available on the potential harm of these gums or their 
potential effectiveness on crash rates. Caffeine is currently habitually consumed by 
many drivers. It is not often regarded as a health intervention, and there are currently 
no government-driven rules or standardised timings and dosages of its consumption 
as a mitigation strategy for drivers’ sleepiness. Given that some people cannot 
tolerate caffeine and some simply do not like its taste, it is also not known whether 
promoting caffeine as a countermeasure for drivers’ sleepiness is an effective public 
health strategy. Therefore, the usability of caffeinated chewing gums needs to be 
examined.  
The exposure to light might exert some minor side effects in some people such as 
discomfort, minor eye strain and a slight glare/headache. Some people might feel 
“weird” or stimulated exposure to light. It should be noted that risks associated with 
light are mostly attributed to light therapy methods in which bright light in high 
illuminances of more than 2500 lux is used for long times to treat people with 
depression (Terman & Terman, 1999). In this experiment the Re-Timer glasses, with 
small diodes in their frames, were adopted to produce a blue-green light with 
illuminance of 560 lux. This device was used in the study for 120 min by each 
participant (four times of 30 min). None of the above-mentioned side effects were 
reported by the participants. It should also be emphasised that if wearing the glasses 
degraded the drivers’ performance in some way, their performance was still better 
than under the Placebo condition. It remains necessary to test a range of potential 
side effects of these glasses, and to test alternative sources of light, either mounted 
inside the dashboard (Okamoto et al., 2014) or provided in road side rest stops (e.g. 





colour perception of drivers, particularly during night time drives. Finally, their 
shape, design or price may have some hinder their usability in the real world.  
Given the above-mentioned considerations, a complimentary study has been 
developed (HREC approval number: 1500000298) to examine the usability of the 
Re-Timer glasses and their feasibility as a countermeasure for drivers’ sleepiness.     
 
7.3 COMPARISON OF THE FINDINGS WITH THE LITERATURE  
In this study monochromatic blue-green light (500 nm dominant wavelengths, 
illuminance 506 Lux, irradiance 230µW/cm
2
, duration 30 min) and low dose of 
caffeine (100 mg) were administered.  
The findings of this study are difficult to compare directly to the available evidence 
due to major differences in methodologies, time of day, outcomes, sleep deprivation 
and the characteristics of the light or caffeine (described in the systematic review 
Chapter 3:). Therefore, only the directions of changes in outcomes have been 
compared to those described in previous studies.  
No differences in the EEG-based outcomes were observed while receiving the light 
alone or caffeine alone, except for a decrease in the variability of alpha EEG power 
after caffeine consumption. This single index could be an indicator of improved 
alertness conferred by the caffeine alone but not the light alone. Contrary to the 
findings from night time studies showing decreased alpha and theta EEG activity in 
response to the provision of light (An et al., 2009; Cajochen, Christian et al., 2000; 
Figueiro, M.G et al., 2009; Phipps-Nelson et al., 2009), findings from previous 
daytime studies are mostly consistent with the results of this study. For instance, 
Badia et al. (1991) did not find any significant difference in the log power density of 
alpha and theta EEG bands during daytime exposure to high levels of bright white 
light. An et al. (2009) found that exposure to either blue or red light during the 
daytime did not attenuate alpha EEG power significantly. Some other daylight 
studies, however, have shown some changes in EEG activity. Okamoto et al. (2014) 
reported that during the daytime EEG alpha power was lower under blue light, as 
opposed to darkness. There may be methodological reasons for the inconsistency 
between the current findings and those reported by Okamoto et al. (2014). In their 
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study participants were partially sleep deprived during one night, for 1.5 hours in the 
early morning, while in the current study participants experienced half of that sleep 
restriction (45 minutes).  
In the current study there were significant increases in mean cardiac beat-to-beat 
interval (mean RR), and reciprocal decreases in mean heart rate (mean HR) in 
response to both caffeine alone, and light and caffeine in combination. Since mean 
RR typically increases during the transition from wake to sleep during the sleep onset 
period (Boudreau et al., 2013; Trinder, John et al., 2001), the increase in this variable 
could be attributed to increased sleepiness after these two interventions. The changes 
in these two autonomic indices could also be the result of caffeine withdrawal before 
the experiment.  
In this experimental study mean RR and mean HR both remained unchanged under 
light alone. It can be implied that although the light could not improve sleepiness, it 
could at least potentially prevent the progression of sleepiness.   
Rüger et al. (2006), also did not find any changes in heart rate after 4 h exposure to 
5000 lux bright light during the daytime, while they reported an increase in heart rate 
after exposure to night time light in the same level and duration.  In another daytime 
study, there was no significant differences in ECG-derived indices such as mean HR, 
percentage of successive RR intervals differing more than 50 milliseconds, LF HRV, 
HF HRV and LF/HF HRV between the Placebo condition and either 100 mg caffeine 
or 200 mg caffeine conditions (Rauh, Burkert, Siepmann, & Mueck-Weymann, 
2006).  Figueiro et al. (2009) found an increased mean RR after night time exposure 
to 40 lux of blue light. Since the circadian drive for sleep is known to increase mean 
HR (Boudreau et al., 2013; Trinder, John et al., 2001), the aggravating of ECG-
derived sleepiness outcomes during night time but not daytime, could be attributed to 
the contribution of the circadian drive to sleepiness at night.   
Regarding PVT performance, the findings of the current study revealed that the 
combination of light and caffeine decreased the percentage of lapses and increased 
the percentage of correct responses as opposed to the Placebo condition. Light 
however, did not result in any change any of these outcomes when compared with 
the Placebo condition. Even though caffeine significantly improved these two 





the values of these two variables after receiving caffeine alone when compared to 
light alone (no change across these two intervention types).   
The studies reviewed previously (Chapter 4:) confirm these findings by reporting 
either ineffectiveness of light or no special advantage of caffeine over light. For 
instance, Phipps-Nelson et al. (2009) found no main effect for light on percentage of 
PVT lapses. They even reported an increased percentage of lapses during their night 
time study, probably due to an increased circadian sleepiness component. Hartley et 
al. (2013) did find an immediate effect after the 30 min administration of night time 
light or caffeine, but did find a delayed response 5 h after these interventions, with 
fewer lapses after caffeine than after the Placebo condition or after light alone. When 
compared with 100 mg caffeine in the current study, the high dose of caffeine 
(capsules of 200 mg) in the Hartley et al. (2013)study might have exerted a greater 
alerting effect. Additionally, the follow-up measurement of these outcomes after 5 h 
revealed some improvements which were not observed immediately. However, it 
should be noted here that a 5 h delay in improved alertness is not consistent with the 
intent to use caffeine as an acute alerting agent to combat sleepiness while driving. 
Significant improvements in subjective sleepiness were observed after all three 
conditions when compared with the Placebo condition, with light and caffeine in 
combination having greater improving effect than either light alone or caffeine alone. 
The effect of light alone was equivalent to that of caffeine alone. This finding is 
comparable to those of some previous studies. Hartley et al. (2013) found that 
caffeine was more effective than light in improving sleepiness ratings. As before, one 
explanation for the higher effectiveness of caffeine for subjective sleepiness could be 
the higher dose of caffeine (200 mg) provided by Hartley et al. (2013) than was 
provided in the current study. Two other studies by Cajochen et al. (2000) and Ruger 
et al. (2006) also support these results, with the former reporting a rapid 
improvement in subjective sleepiness after bright light (9100 lux) provided at night 
compared with l00 lux and 3 lux lights, and the latter reporting an equal 
improvement in subjective sleepiness after bright light (5000 lux) in both the daytime 
and at night. The high levels of light used in the study of Cajochen et al. (2000), and 
long-time exposure to the light (4 h) in the study of Ruger et al. (2006) provided a 
greater photon ‘dose’ than in the current study. Conversely, some studies did not find 
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any changes in subjective sleepiness after exposure to light. In a study by Figueiro et 
al. (2009), an alternative exposure to 45 min of blue light (40 lux and 10 lux) and 45 
min darkness during the night resulted in neither increase nor decrease in the 
subjective sleepiness. Other studies recorded subjective sleepiness for longer periods 
across the night time hours and reported that sleepiness either degraded across the 
night after exposure to blue light (1.12-1.15 lux for 6 h) (Phipps-Nelson et al., 2009), 
or remained unchanged up to 1 h after 6.5 h exposure to blue light (12.1 µW/cm
2
) 
and then degraded (Lockley et al., 2006). This could be due to the progressive 
predominance of the circadian pressure for sleep during night time hours, especially 
across the circadian temperature nadir.  
Of the driving performance outcomes, the steering wheel angle was found to be the 
index most sensitive to the light and the caffeine interventions used in the current 
study. All interventions of the combination of light and caffeine, caffeine alone, and 
light alone, resulted in significantly decreased steering wheel angle compared to the 
Placebo condition, with the combination of light and caffeine having a considerably 
greater effect than light alone. This finding is consistent with the findings of Forsman 
et al. (2013). They examined more than 80 objective driving performance outcomes 
among sleep-deprived drivers. After principal component analysis they concluded 
that of all these driving performance outcomes, two dominant groups of variables, 
steering wheel variability and lateral lane position variability, were the most 
sensitive to driver sleepiness. Further, these two indices were, more than any other 
outcome measure, directly predictive of line crossings, off-road accidents, and hitting 
adjacent cars.  
In the current study, the total number of road edge excursions reduced after receiving 
caffeine alone and to a greater extent after light and caffeine in combination when 
compared to the Placebo condition. The total number of off-road crash (when the 
centre of the car crossed the road edge line by 0.99 m) reduced after administering 
caffeine alone. The total number of speed exceedances only reduced after receiving 
light alone. Additionally, unlike the findings of Forsman et al. (2013), no overall 
effect of the “Intervention” was observed on the standard deviation of lateral position 





Findings of Taillard et al. (2012) and Hartley et al. (2013) are partly consistent with 
these results. In the study conducted by Taillard et al. (2012), the road edge 
excursion (inappropriate line crossing) decreased with both blue light (7.4 µw/cm
2
) 
and caffeine (2*200 mg) as opposed to the Placebo condition. The decrease in the 
number of road edge excursions by light alone in their study could be attributed to 
the long exposure time (4 h) to blue light. Hartley et al. (2013) observed an overall 
effect of the intervention (bright light alone 10000 lux, caffeine 200 mg, or 
combination of them) on off-road crash (when the centre of the car crossed the edge 
of the lane). The latter authors also found a smaller speed deviation (as the mean sum 
of differences between speed of the vehicle and speed limit) with light alone (10000 
lux) than the Placebo condition in the first 2 h (at 3 a.m.).  
The ineffectiveness of the light in this experimental study is in line with the findings 
of some other studies. For instance, Phipps-Nelson (2009) did not find any overall 
effect of the ‘Intervention” on the standard deviation of lateral lane position. This 
variable worsened over the night with blue light (2000 µW/cm
2
). However, Taillard 
et al. (2012) found an overall effect of the “Intervention” on this variable. They 
reported that both blue light (7.4µW/cm
2
) and caffeine (2*200 mg) decreased the 
mean standard deviation of lateral lane position as opposed to the Placebo condition. 
Hartley et al. (2013) also found some delayed decreases in the standard deviation of 
lateral position 2 h post-administration of the light and caffeine in combination when 
compared with the Placebo condition. 
One reason for not observing the change in the standard deviation of lateral lane 
position in the current study was the fact that in the driving scenario a four-lane 
highway was simulated with two ongoing lanes on the left side. Since all ongoing 
cars were moving in the adjacent lane, there was no need to overtake any car 
(Section 5.3.2; the STISIM Drive simulator). The other reason for not finding any 
changes in this variable is that unlike the Hartley et al. (2013) study, in this 
experimental study the driving performance data were only measured when the light 
was administered. There may have been some alerting effects of the interventions at 
some point after administration. Additionally, administering higher doses of caffeine 
(Hartley et al. (2013); 200 mg and Taillard et al. (2012); 400 mg) and the presence of 
higher levels of sleep restriction at night in these two studies (4-6 hours) might have 
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resulted in the significant improvement in the standard deviation of lateral lane 
position. An important point to note is the role of the circadian rhythm of sleepiness 
resulting in different levels of sleepiness at different times of day (Phillips, 2015). 
Timing of exposure to light and caffeine changes the phase of circadian rhythm. In 
one study examining the response of the circadian rhythm to 3 h exposure to 9000 
lux full-spectrum light it was observed that the circadian rhythm was relatively 
unresponsive to light when exposure was centred 6 h after minimum core body 
temperature (light exposure happened around 10-11 a.m.), but there was a large 
phase-delay in circadian rhythm when the light was centred 2 h before body 
temperature minimum (Minors, Waterhouse, & Wirz-Justice, 1991). Caffeine has 
also been found to phase shift human circadian rhythm. In one study administering 
2.9 mg/kg caffeine 3 h before habitual bedtime resulted in 1 h phase delay in 
circadian rhythm (Burke, Tina M., 2011). These findings imply that the timing of 
administering the three types of intervention (light, caffeine and light and caffeine 
combination) might have different effects on circadian rhythm and hence the level of 
sleepiness. In this experimental study the implications of the circadian drive on 
sleepiness were considered. The test time was set at the peak time of alertness in the 
day around 10 a.m. A very recent report (Wright, K. P. et al., 2015) suggests a 
strongly differential sensitivity of specific aspects of sleepiness (and associated 
measures) under variation in circadian and homeostatic loads. 
Another point is that caffeine curfew and withdrawal prior to testing (an aspect of the 
study methodology) might impact the driver’s performance before the administration 
of the light/caffeine. Even though no withdrawal effects of caffeine have been 
reported in some studies (Bonnet, Michael H & Arand, 1992), in some cases an 
overnight caffeine withdrawal resulted in greater sleepiness, deteriorated mental 
alertness, and increased simple and choice reaction times in the afternoon. 
Administering 250 mg caffeine improved these measures in consumers of more than 
40 mg/day (medium-high consumers) but did not affect measures in non-consumers 
of caffeine (Rogers, Peter J., Heatherley, Mullings, & Smith, 2013). This raises the 
possibility that the observed alerting effects of caffeine could be partly due to a 
withdrawal effect. In other words, deterioration of sleepiness indicators, such as 
driving performance and PVT outcomes, prior and during the first drive might be due 





a result, the improvements in sleepiness outcomes during and after the second drive 
might be because of caffeine withdrawal reversal (the consumption of caffeine in the 
form of the Active gum) and the differential impacts associated with individual 
variation in use, metabolism and tolerance of caffeine, and not because of a more 
specific alerting effect of caffeine. Comparisons of findings for the objective, 
subjective sleepiness and driving performance outcome measures in the current study 
with the literature are presented in Table 6.12 and Table 6.13  respectively. 
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7.4 CONTRIBUTION OF THIS PROGRAM OF RESEARCH TO THE 
EXISTING KNOWLEDGE 
The current program of research has added some novel findings to existing 
knowledge as follows: 
1. As part of this program a systematic review was conducted for the first time 
on the effects of sleepiness on young driver’s performance. The systematic 
review revealed the paucity of this information with a very limited number of 
available papers on this subject (only 10 papers). Studies of chronic sleep loss 
on daytime sleepiness of young drivers are particularly rare.  
2. For the first time some important methodological characteristics of papers on 
young drivers’ sleepiness were identified that could degrade or upgrade the 
quality of papers for certain outcome measures. These characteristics fit in 
some broader classes of the GRADE criteria such as risk of bias and 
imprecision.  
3. This program introduced a novel approach in the field of road safety for 
rating the quality of papers for their outcome measures by developing specific 
GRADE rating criteria for drivers’ sleepiness. In this method papers with a 
medium quality for one outcome measure might be identified as a low-quality 
paper for another outcome measure and vice versa.  
4. Considering the sample sizes, for the first time in the field of road safety, a 
new algorithm was introduced to identify the overall GRADE Score (OGS) 
for the quality of the whole body of evidence for a certain outcome measure.  
5. For the first time different ranges of Overall GRADE Scores were assigned to 
different GRADE quality levels from very low quality level to high quality 
level.  
6. The existing knowledge about the alerting effects of light and caffeine on 
sleep-deprived drivers mostly stems from two relevant studies (Hartley et al., 
2013; Taillard et al., 2012). Both these studies were undertaken at night after 
a single night of sleep deprivation, provided high doses of caffeine or long 
exposure to light, and examined limited outcomes. Additionally, Hartley et al. 
(2013) assessed the effects of white light rather than blue light. This current 
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experimental study was the first to take into account the high sensitivity of 
young drivers to sleep loss and subsequently targeted only young drivers.  
7. This program benefitted from an innovative experimental study in that it 
addressed the need for a chronic restriction paradigm to better reflect young 
adult sleep deprivation. The type of sleepiness induced in this study was a 
chronic mild sleep deprivation (1 h) which young drivers frequently suffer 
from and had not been previously studied. Additionally, early morning wake-
up was chosen to induce sleepiness, since this type of sleep deprivation 
deteriorates sleepiness outcomes to a greater extent than does wakefulness 
extended into the evening (Darwent et al., 2010). The sleep deprivation was a 
naturalistic home-based sleep loss mapped onto the drivers’ real sleep 
paradigm although this form of sleep loss causes some noise on the effect and 
makes it harder to control some contributors to sleepiness.   
8. The experimental study took a multi-model design by comparing the effects 
of the three interventional conditions on different outcomes of sleepiness in 
all objective, subjective, and driving performance levels. The existence of 
misalignment between subjective and objective sleepiness outcome measures 
confirmed the need to measure all levels of sleepiness and not be restricted to 
limited numbers of driving performance outcome measures.  
9. This study was conducted during the daytime, and at the same time each day. 
This aspect limited the variation in the circadian drive for sleepiness, while 
previous studies have not distinguished the homeostatic drive from the 
circadian drive.  
10. In this study a constant level of blue light and a low dose of caffeinated 
chewing gum were administered for the first time in a driving paradigm to 
evaluate the alerting effects of commercially available light and caffeine 
technologies. This makes it feasible to test these technologies in the real 
world. These two forms of light and caffeine have not been used together 
before.  
11. The driving performance measures were specific to the three newly 





majority of the driving outcomes have not been studied in chronically sleep 
deprived young drivers before, such as the absolute value of lateral 
acceleration, LF, HF and LF/HF components of heart rate variability, the 
absolute value of steering wheel angle and the total number of off-road 
crashes. This approach provided an opportunity to observe some novel results 
- for example, the absolute value of steering wheel angle was the most 
sensitive outcome measure to manipulations of light and caffeine and 
significantly improved with all the three types of intervention.  
 
7.5 CONSIDERATIONS  
There are some considerations to be taken into account when interpreting the 
outcomes of this experimental study, associated with both the recruitment process 
and the conducting of the testing. 
Assessment of participant age, health status, taking medicines or illicit drugs, 
habitual consumption of alcohol or caffeine and driving experience (holding a valid 
driver’s licence) was based on self-reported data, largely due to ethical 
considerations. There might have been some deviations from the inclusion criteria. 
However, the within-participant study design was highly likely to eliminate the effect 
of inter-individual differences. 
Even though participants were instructed to refrain from consumption of alcohol 
totally and adhere to a 9 h caffeine curfew during the last three days, there was no 
monitoring tool, such as blood testing, to strictly control for alcohol or caffeine use. 
This might have affected the sleepiness levels caused by partial sleep deprivation.  
The current study was conducted on the driving simulator not on real roads due to 
technical difficulties in collecting EEG data during on-road driving, and the need to 
provide a controlled light environment during the daytime. Driving simulators have 
been criticized for inducing fatigue more quickly than observed during on-road 
experiments (Philip et al., 2005(b)). Therefore, there is a need for further on-road 
research (with relevant contextual or motivational stimuli underlying this effect) to 
verify the effect of this level of blue light and this dose of caffeine in the real world.  
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It possible that light emitted from the STISIM Drive display screen masked some 
alerting effects of the blue-green light. To minimise the interference of light emitted 
by the simulator screen, all computer displays were covered by neutral density grey 
filters. These filters reduce the brightness of light emitted from display screens 
without affecting objects’ colours in the graphics shown by the simulator.  
Given the difference in pupil diameter and its response to the light among people 
(Feigl et al., 2012), the actual light levels received by retina might have been 
different across participants in this study. This aspect is rarely controlled for in sleep 
circadian studies (Zele et al., 2011). 
In this study the distance between the simulator screen and participants’ eyes varied 
between the participants due to the immobile steering wheel of the simulator. In fact, 
participants had to adjust their distance from the screen by moving the chair back and 
forth to be able to control the steering wheel properly. This variation might have 
affected their visual input. The within-participant design was intended to mitigate 
this difference.  
In the current study the measurements of objective and driving performance 
outcomes of sleepiness were conducted concurrently with the administration of the 
light, while other measures were made immediately after 30 min exposure to the 
light. This granularity in the timing of measurement might not have captured some 
possible alerting effects.  
The duration of simulated driving time in the current study was limited to 30 min for 
two reasons; firstly, caffeine seems to reach its minimum level in the blood in an 
average 30 min (Blanchard & Sawers, 1983; O'connell & Zurzola, 1984). Secondly, 
time-on-task effect or fatigue from driving is highly likely to emerge after 30 min 
driving (Van der Hulst et al., 2001). It remains quite possible that a longer driving 
time could reveal greater alerting effects of light and caffeine.  
The presentation of the Placebo condition first could have had a systematic effect on 
the results, such as a false positive impact from the interventions in the case of 
presence of any practice effect on the driving task. The practice effect could result in 
false improvements in driving performance and PVT outcomes. To minimize 





road sceneries were counterbalanced across the three test days. Additionally, within 
each test day, and in order to minimize the learning effect between the first drive and 
second drive on the same scenario, a random selection of immobile and mobile cars, 
pedestrians and buildings was included in the scenario. Therefore, the drivers would 
not be able to remember the exact sequence of events in the second play of the same 
scenario. The driving task did not include any predictable events such as the sudden 
appearance of objects, cars, or pedestrians in the scenario. As for the PVT, the red 
dot appeared in the intervals of 2 to 12 seconds and drivers could not anticipate the 
time of appearance of the red dot. There is no strong evidence of learning effects on 
the PVT including use of this test in very similar paradigms (Cluydts et al., 2002; 
Jackson et al., 2013; Lim & Dinges, 2008; Ting et al., 2008; Van Dongen & Dinges, 
2005). The three conditions were also counterbalanced across three days so any 
possible learning effect would be distributed across the conditions.” 
With regards to effect of light, one might expect that withdrawal effect of light 
(adaptation to darkness) might also have increased sleepiness and have deteriorated 
performance prior to testing by interrupting the natural process of exposure to light 
and modulation of circadian alerting effect of light. There is no evidence that low 
levels of dim red light makes drivers sleepy. Instead, it may ‘unmask’ incipient 
sleepiness. The relationships between prior light exposure and the effects of light are 
likely to be complex, but are currently unknown. 
There are some new questions raised from this research that need to be answered by 
further research, as follows: 
1. What are the delayed effects of light, caffeine or combination of light and 
caffeine on all levels of sleepiness after administering these countermeasures?   
2. What are the effects of light, caffeine or combination of light and caffeine on 
all levels of sleepiness in different times of day?  
3. What is the best intensity of blue light with the most alerting effect and least 
glaring effect? 
4. What is the optimal wavelength of blue light with the greatest alerting effect 
and least interference with colours and contrast in the driving environment 
(including road signals, and the headlights of upcoming cars at night)?  
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5. What are the lasting (washout) periods for the alerting effects of light and 
caffeine or light and caffeine in combination? 
6. Are the Re-timer glasses feasible for use in the real world? 
 
7.6 LIMITATIONS 
In this study no baseline measurement of outcomes without sleep loss was 
conducted. Therefore it was not possible to monitor the changes of outcomes after 
sleep loss compared to normal sleep. Additionally, based on the systematic review in 
this program of research, data and evidence on the values of different objective 
sleepiness and driving performance outcomes in normal conditions and after sleep 
loss, particularly after mild sleep loss, are not available to provide a robust 





















Chapter 8: Conclusion 
An overall conclusion of this research is provided in Section 8.1.  In Section 8.2 the 
remaining gaps in the knowledge are provided, followed by some future studies 
recommended in Section 8.3. Finally, some methodological pieces of advice are 
included in Section 8.4. 
 
8.1 CONCLUSION OF THIS PROGRAM OF RESEARCH 
The blue-green light and caffeine when administered alone or in combination have 
some alerting effects on various outcome measures of sleepiness. The data partly 
support the overall effect of the “Intervention” when compared with the Placebo 
condition. Therefore, the greater alerting effects of light alone, caffeine alone or the 
combination of them compared to the Placebo condition are partly supported. Data 
are also partly in agreement with the hypothesis of the greater alerting effect of light 
and caffeine in combination than either light alone or caffeine alone, but do not 
support the hypothesis that light alone has greater benefits than caffeine alone.  
 
8.2 REMAINING GAPS IN THE KNOWLEDGE 
This program of research provided some answers about the effectiveness of light and 
caffeine alone or combined together on daytime sleepiness from sleep loss 
(homeostatic sleep drive). However, there are still some major gaps remaining in the 
current knowledge, as follows.  
1. The pathways for effects of sleep loss on driver sleepiness in objective, 
subjective and driving performance levels are not fully determined. 
Accordingly, the most sensitive outcome measures of driver’s sleepiness are 
not identified.  
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2. The effects of homeostatic and circadian drives on young driver’s sleepiness 
are not fully understood and distinguished.  
3. The effectiveness of light and caffeine alone or combined together in relation 
to sleep homeostatic (different types and doses of sleep loss) and circadian 
factors (different times of day) is largely unknown.  
4. This program of research did not intend to compute a new alertness model by 
including light and caffeine in the current sleep-wake regulation models. 
Therefore, fitting light and caffeine in current available models remains to be 
done.  
5. This program of research adopted a pragmatic approach by using the 
available technologies (the Re-timers and caffeinated chewing gums) to 
provide constant light and caffeine doses. Therefore, optimal light properties 
(e.g. intensity, wavelength) or caffeine doses to exert the highest alerting 
effects are not still known. New light devices and/or caffeine modalities are 
likely to emerge, each with different properties. 
6. Since in this experimental study a caffeine curfew was adopted for habitual 
caffeine users, it is not known whether the alerting effects of caffeine are due 
to stimulating properties of caffeine itself or from its paradoxical 
physiological effects from caffeine withdrawal.  
7. The usability of the Re-timer glasses in the real world remains to be studied, 
particularly in terms of driver eye comfort and willingness of drivers to use 
them. 
8. The interaction of light with the surrounding environment for driver safety, 
particularly for night time drives is not known. 
9. Since there is no consensus on washout periods for light or caffeine in the 
driving context, the delayed effects of light, caffeine or combination of light 
and caffeine on all levels of sleepiness after administering these 
countermeasures is not well understood.  
10. Light and caffeine exert their alerting effects on different levels of driver 





11. The effects of combinations of light with other countermeasures such as naps 
or exercise on young drivers’ chronic sleepiness indices are not known. 
12. There is a lack of data on sleepy driving and alerting effects of light, caffeine 
or other countermeasures in on-road driving experiments. 
13. Potential risks from light such as eye strain, headache, nausea and feeling 
'wired' have been mostly observed in light therapy studies. In the current 
experimental study none of these effects were observed. However, there is no 
data available for these side effects in the sleepy driving studies.  
 
8.3 RECOMMENDED FUTHER RESEARCH   
1. High-quality evidence such as randomized control trials (RTCs), large-scale 
studies or strong experimental designs must be undertaken to provide reliable 
data for behaviour of sleepy young drivers, the pathways involved, and the 
most sensitive outcome measures of driver sleepiness.  
2. The contribution of circadian and homeostatic drives to driver sleepiness 
should be taken into account in developing the RTCs and large scale studies 
by adopting different types and doses of sleep loss at different times of day. 
One possible approach is to include sleep deprivation and light/caffeine 
interventions into modified constant routine protocols to examine the effect 
of time of day on the alerting effects of the light and caffeine alone in sleepy 
drivers. This would involve adopting a sleep laboratory protocol to monitor 
the sleep-wake regimes precisely, at the cost of naturalistic evaluation.  
3. Caffeine-based and light-based RCTs or large scale studies need to be 
conducted to provide high-quality evidence of the alerting effects of these 
stimulants on young driver chronic sleepiness.  
4. The effects of caffeine withdrawal on driver sleepiness should be 
distinguished from the adverse effects of sleep loss.  
5. Combination of light or caffeine with other countermeasures such as naps or 
exercise should be studied in the sleepy driving context and those findings 
must be verified in on-road experiments.  
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8.4 METHODOLOGICAL SUGGESTIONS FOR THE FUTURE STUDIES 
Based on the methodology utilised in this experimental study the following 
considerations are suggested for future similar studies: 
1. It is suggested that the baseline measurements without sleep deprivation are 
conducted to monitor the changes of outcomes after sleep loss compared to 
normal sleep. These measurements would permit comparisons of the alerting 
effects of counterbalanced conditions after sleep loss with baseline alertness 
without sleep loss. 
2. Recording of objective outcome measures such as EEG and ECG-related 
outcomes could be more closely synchronized with the sampling by the 
driving simulator. This would facilitate instantaneous measurement around 
critical events such as crashes. 
3. Follow-up measurements should be recorded for at least several hours after 
the interventions to track any delayed responses to alerting effects of light, 
caffeine or other countermeasures for sleepiness.  
4. EEG and ECG-derived variables could be averaged across shorter time 
epochs to track short-term changes in those variables, particularly around 
critical events such as crashes, road edge excursions, line crossings and speed 
exceedances. 
5. The illuminance and irradiance of the confounding light emitted from the 
simulator displays should be measured, even after using light filters, to 
determine the possible share of this light at the eye level or in the retina.  
6. To retain a constant distance between participants’ eyes and the desktop 
simulator screen (STISIM Drive) a potential approach would be to mount the 
simulator screen on an adjustable table with sliding parts to adjust the 
steering wheel and gas pedal distances and set a constant distance of 
simulator screen for all participants.  
7. In case of using higher illuminances a diffuse light to avoid glare and 





8. In order to study the confounding effects of caffeine withdrawal on driver 
sleepiness, there is a need to conduct a pilot study without sleep deprivation. 
The drivers’ sleepiness after caffeine withdrawal (without sleep loss) should 
be measured before caffeine treatment and compared with those values after 
caffeine treatment. Otherwise, a washout period of a minimum four days is 
suggested to eliminate any carryover effects and withdrawal effects of 
caffeine (Sondermeijer, van Marle, Kamen, & Krum, 2002). 
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Phone call screening questionnaire  
Inclusion criteria 
1. How old are you?  
                Less than 18 years                     18-24 years                25 years or more        
2. Are you holding a driver’s licence? 
  Yes                       No 
3.   Do you have any physical restrictions to drive?     
 Yes                       No 
Exclusion Criteria 
4. Are you a professional driver? 
Yes                       No 
5. Have you been doing shift work during last month? 
Yes                       No 
6. Have you travelled to different time zones in the last month? 
Yes                       No 
7. Do you usually go to sleep after 12am (midnight)? 
Yes                       No 
8. Do you have any acute illness particularly neurological diseases such as 
dementia, cardiovascular diseases, balance problem, or mental disease? 
Yes                       No 
9. Do you have any eye or optic nerve diseases that affect your normal vision 
and are a problem for driving? 
Yes                       No 
10. Do you usually drink more than 2 standard alcoholic drinks per day? (One 
standard drink contains 10 grams of alcohol) 
Yes                       No 
11. Are you taking prescription medications such as melatonin, Antihistamines, 
Antidepressants, barbiturates, methaqualone and diazepam? 
Yes                       No 
12. Are you taking illicit drugs s such as opium, heroin, cocaine, Marijuana, 
Hashish, amphetamine, amphetamine-type stimulants and ecstasy? 
Yes                       No 
13. Are you a caffeine avoider (do not consume caffeine)? 





14. Are you a heavy caffeine user (e.g. drink more than 3 caffeinated drinks per 
day)? 
Yes                       No 
Screening result 
Is this prospective participant likely to be eligible for this study? 






























(All comments and responses will be treated confidentially) 
Participant name: 
Date:  
Part A: Inclusion and exclusion criteria 
Inclusion criteria 
1. How old are you?  
                Less than 18 years                     18-24 years                25 years or more        
2. Are you holding a driver’s licence? 
  Yes                       No 
3.   Do you have any physical restrictions to drive?     
 Yes                       No 
Exclusion Criteria 
4. Are you a professional driver? 
Yes                       No 
5. Have you been doing shift work during past month? 
Yes                       No 
6. Have you travelled to different time zones in the last month? 
Yes                       No 
7. If yes where did you go and when? 
 
8. Do you have any of these diseases? 
9. Neurological diseases such as dementia, 
a. Cardiovascular diseases,  
b. Balance problem, 
c. Major mental disease 
Yes                       No 
10. If yes which one? 
11. Do you have any eye or optic nerve diseases that affect your normal vision 
and are a problem for driving? 
Yes                       No 





13. Do you usually take more than 2 standard alcoholic drinks per day? (One 
standard drink contains 10 grams of alcohol) 
Yes                       No 
14. If yes what type of drink and how much per day? 
15. Have you been taking one or more than one of these illicit drugs? 
a. Opiates (Naturally extracted or semi synthetic drugs) such as opium, 
morphine,  codeine and heroin 
b. Opioids (wholly synthetic products) such as methadone, pethidine 
and fentanyl. 
c. Sedative-hypnotics such as Methaqualone 
d. Stimulants such as cocaine hydrochloride and crack cocaine, 
amphetamine and amphetamine-type stimulants (ATS), MDA (3,4-
methylenedioxy-amphetamine) and MDMA (3,4-methylenedioxy-
methamphetaime or ecstasy) 
e. Cannabis such as Marijuana and Hashish 
16. Have you been taking prescription medications? 
o Beta blockers, melatonin, or melatonin agonists 
o Psychoactive medications such as: 
 Cocaine  
 Antihistamines,  
 Antidepressants,  
 Anxiolytics, anticonvulsants such as barbiturates, non-
barbiturate depressants (Methaqualone) and 
benzodiazepines (diazepam or Valium)  
              Yes                       No 
17. Are you a caffeine avoider (do not consume caffeine)? 
Yes                       No 
18. Are you a heavy caffeine user (e.g. drink more than 3 caffeinated drinks per 
day)? 












Part B: Questionnaires scores 
Questionnaire Score Exclusion criteria Comments 
Lifestyle Appraisal Questionnaire 
score 
 -  
Pittsburg sleep quality index    PSQI TOTAL > 5 
(poor sleep quality) 
OR TMPHSE less 
than 85 
 






 Scores between 16 





Is this prospective participant eligible for this study? 




















Lifestyle Appraisal Questionnaire (LAQ) 
Scoring the LAQ 
Items in Part 1 are scored for level of risk. For most items, risks range from 0 (little 
or no risk) to 4 (high risk) whilst some are dichotomous. Part I is scored by adding 
up the level of risk. The total possible score on Part I is 73. Higher scores are 
assumed to be associated with higher risks of disease and lower quality of life. In 
Part 11, a four point Likert scale ranging from 0 (almost never) to 3 (almost always) 
was used to assess the person’s cognitive appraisal of life pressures and demands. 
Items are added directly and high scores indicate higher perceived levels of stress. 
The total possible score for Part I1 is 75. 
 
Please circle the appropriate number 
1. (a) Have you ever regularly smoked cigarettes? 
No 0                             Yes 1 
(b) Do you presently smoke cigarettes? 
No 0                           Yes 3 
* If you presently smoke – answer Questions 2 & 3. If not - go to Q. 4. 
2. How frequently do you smoke? 
Only socially (once a week or less) I 
Once or twice a day 2 
Up to 10 a day 3 
More than 10 a day 4 
3. Have you ever attempted to give up smoking? 
Never 1                Yes, but have not been successful 2 
4. Systolic blood pressure (mmHg) ......... Syst. 
Less than 130 0 
130 - 139 1 
140 - 149 2 
150 - 159 3 
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160 + 4 
5. Diastolic blood pressure (mmHg) ...... Diast. 
Less than 80    0 
80 - 84           1 
85 - 89           2 
90 – 95          3 
95 +              4 
6. Body Mass Index 
Height (without shoes) ......      cm 
Weight (light clothes/no shoes ...      kilos 
Less than 20    1                            
 20 – 24            0 
7. Do you drink alcohol? 
No, or up to 2 drinks per day 0 
3 - 4 drinks per day           I 
5 - 8 drinks per day          2 
9 - 15 drinks per day         3 
More than 16 drinks per day       4 
8. Do you take any drugs or medication other than tea, coffee, alcohol and nicotine 
(eg. Sleeping tablets, anti-anxiety drugs such as Valium, anti-depressants, 
hallucinogens, barbiturates, pain-killers, etc.)? 
No   0        
Only once or twice a year    1 
Once or twice a month       2 
Once or twice a week       3 
Every day                        4 
9. Does anyone in your immediate family (father, mother, brother, sister) have a 
history of: 
 Heart disease   No 1    Yes 1 
Cancer     No   0       Yes 1 
High blood pressure   No    0      Yes 1 
10. How often do you exercise or go for a walk? (For at least 15 minutes each time) 





About once a week 1 
About once a month 2 
Not at all 3 
11. How frequently do you participate in an activity or recreation you enjoy (eg. 
gardening, reading, hobbies, sport etc.)? 
Every day 0 
Once a week 1 
Once a month 2 
Not at all 3 
12. How often do you do any relaxation exercises? 
At least once a week 0 
About once a month 1 
Not at all 3 
13. How frequently do you eat a meal that is composed of a mixture of vegetables, 
fruit, bread, and lean meat? 
Once every 6 months 2 
At least once a day    0 
14. How often do you eat fatty or sweet foods (such as fat on meat, pies, fried foods, 
cheeses, full cream products, chocolate etc.)? 
Once or twice a week          0 
About once a day                      1 
A few times each day            2 
At least 4 times a day               3 
15. Do you have close friends and family to help you with problems? 
Often available                           1 
Sometimes available                 2 
Rarely or never available            3 
16. How often do you give and receive affection? 
Always available            0 
Frequently each day        0 
Occasionally each day    1 
Rarely or never              4 
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17. In the last 6 months, how many major stressful events have you experienced 
(such as any experiences that cause upset or create pressure, eg. loss of a loved one, 
divorce, financial crisis, illness, robbery, loss of employment, accident etc.)? 
None     0 
1 - 2             1 
3 - 6           2 
7-12             3 
More than 12        4 
18. Do you, at present suffer from any chronic disease or illness (such as cancer, 
heart disease, asthma, diabetes, arthritis, etc.)? 
No              0 
Yes          2 
If yes please list the disease(s) ...... 
19. Do you suffer from physical symptoms (such as headache, backache, poor 
appetite, dizziness, sleep disturbance, loss of sexual interest, nausea, fatigue etc.)? 
Not at all               0 
A few times a year             1 
Once or twice a month           2 
Once or twice a week         3 
Every day            4 
If yes, please list these symptoms 
 
20. How often do you have a good night sleep? 
Most nights     0 
About every second night        1 
About once a week           2 
Rarely         3 
21. Do you drink tea or coffee? 
No, or up to 3 cups per day 0 
4 - 8 cups per day           I 
9 - 12 cups per day           2 
13 - 20 cups per day          3 








































































 Appendix G  
Approach email 
Participate in a research study looking into the effects of light on human sleepiness 
and alertness 
 
Dear QUT staff and students, 
 
My name is Shamsi Shekari Soleimanloo from the Centre for Accident Research and 
Road Safety – Queensland (CARRS-Q). I am doing a PhD into the effects of light on 
human sleepiness and alertness under supervision of Associate Professor Simon 
Smith. Sleepiness is a major contributor of road crashes, and conducting research in 
this area is important to help us understand how to combat driver sleepiness. 
 
We are seeking people aged 18-25 years old to take part in our study. The study will 
require you to be involved for two weeks, and the requirements are as follows. 
Week 1- During the first week you can: 
Sleep for 8 hours each night; however 
Sleep must occur between 11pm and 7am. 
Week 2- During the second week you will be required to: 
Gradually reduce your sleep time by 1 hour (i.e. 15 mins less for 4 nights, resulting 
in the final sleep time of 11pm to 6am); 
attend 3 consecutive testing sessions at the Institute of Health and Biomedical 
Innovation, QUT, Kelvin Grove (60 Musk Avenue, Q-Block – IHBI). These sessions 
will take a total of 9 hours, and involve: 
Chewing either caffeinated or decaffeinated chewing gum; 
Wearing special light-emitting glasses that emit either blue or red light;  
Simulated driving tests; and 
Computerised reaction time test 
Moreover, you may experience sleepiness symptoms such as poor concentration, 
head nodding during few days prior to testing, sleepiness during testing sessions, and 
potential increased sleep duration for 2-3 days after completion of the study. To 
compensate you for your time, we will provide you with $150 and taxi vouchers for 
travel to and from the laboratory. 
Please view the attached recruitment flyer for further details on the study and how to 
participate. Should you wish to participate or have any questions, please contact us 






Please note that this study has been approved by the QUT Human Research Ethics 
Committee (approval number (1300000846). 
 
 Many thanks for your consideration 
  
Principal Researcher: 
Shamsi Shekari Soleimanloo 
PhD Student  
Centre for Accident Research and Road Safety- Queensland 
Queensland University of Technology 
Phone: 3138 0137 
Email: s.shekarisoleimanloo@qut.edu.au 
 
Associate Researcher:  
Associate Professor Simon Smith 
Principal Research Fellow 
Centre for Accident Research and Road Safety- Queensland 
Queensland University of Technology 
















Participant Recruitment Flyer 
 
PARTICIPATE IN RESEARCH 
Information for Prospective Participants 
The following research activity has been reviewed via QUT arrangements for the conduct of 
research involving human participation. 
If you choose to participate, you will be provided with more detailed participant information, 
including who you can contact if you have any concerns. 
Effects of light on human sleepiness and alertness: A simulated driving experiment 
Research team contacts 
Principal 
Researcher: 
Mrs Shamsi Shekari Soleimanloo 
Associate 
Researcher: 
Associate Professor Simon Smith 
Centre for Accident Research & Road Safety – Queensland (CARRS-Q) – Queensland 
University of Technology (QUT) 
What is the purpose of the research? 
The purpose of this project is to assess the impact of mild sleepiness on young drivers’ alertness and 
performance, and to assess the nature and magnitude of the alerting effects of light on drivers’ 
sleepiness and performance while driving. 
Are you looking for people like me? 
The research team is looking for people aged 18-25 years, who hold a driver’s licence with no 
physical restrictions to drive, and normal vision (including normal vision while using spectacles and 
or contact lenses). 
You are not eligible for this study: 
 If you are a professional driver, shift worker or have travelled overseas in the past month. 
 If you usually go to sleep after 12am (midnight). 
 If you have any significant health problems, particularly if you suffer from vestibular and/or 
psychiatric diseases. 
 If you have any eye or optic nerve diseases affecting your normal vision, such as retinopathy, 
colour vision that is incompatible with driving, and diseases of the optic nerve or ocular media.  
 If you take prescription medication or illicit drugs  
 If you do not consume caffeine or are a heavy caffeine user (e.g. drink more than 3 caffeinated 
drinks per day). 
 If you consume more than 2 standard alcoholic drinks per day (a standard drink contains 10 
grams of alcohol). 
 
What will you ask me to do? 
If you are interested in this study please send an email to the researcher.  The researcher will email 
you a Participant Information Package to let you know about the nature of this research and the 
inclusion criteria. If you are still interested in participating in this study after consideration of the 
information provided in the Participant Information Package, we request you contact the research 





confirm you meet the initial inclusion criteria (as mentioned above), and a time will be arranged for 
you to attend the screening session in a laboratory at the Institute of Health & Biomedical Innovation 
(IHBI), QUT, Kelvin Grove.  
 
During this session the researcher will complete a battery of questionnaires. If you meet the eligibility 
criteria, you will be given an Actiwatch (a small wrist-watch device that records your activity levels 
and allows us to monitor your sleep) and advised of when you need to wear the Actiwatch, as well as 
when the subsequent testing sessions will take place. You will be required to wear the Actiwatch for 
two weeks prior to the commencement of your testing sessions. During the first week, you will be 
asked to sleep between 11pm and 7am each night. At the start of the second week, you will be asked 
to reduce your sleep by 15 minutes for 4 nights, resulting in sleep loss of an hour (thus sleeping 
between 11pm and 6am). In the final three days of the second week, you will be asked to attend three 
testing sessions in the laboratory at IHBI (one testing session per day). Each testing session will take 
about 3 hours (i.e. approximately 8:10am to 11am). 
 
During the testing sessions sensors will be stuck on your scalp, using a non-toxic sticky gel, to 
measure your brain waves and on your chest to measure your heart rate. You will also be required to 
chew either caffeinated or decaffeinated chewing gum. Your eyes will also be exposed to either blue 
or red light through special light-emitting glasses. In addition, you will undertake computerised tests, 
including a simulated driving test and a reaction time test. In total, the 3 testing sessions will take up 
about 9 hours of your time across the 3 days. 
 
Are there any risks for me in taking part? 
There are some minor risks associated with your participation in this project. You might find the 
study tiring, feel sleepy or uncomfortable from the electrodes. You may experience minor eye strain, 
a headache, nausea or feel stimulated from exposure to low-level lights. Moreover, you may 
experience sleepiness symptoms such as poor concentration, head nodding during few days prior to 
testing, sleepiness during testing sessions, and potential increased sleep duration for 2-3 days after 
completion of the study.
 
While the degree of sleepiness induced by the sleep time manipulation is 
likely to be mild, you may feel excessive sleepiness
 
while working or studying. Therefore, you should 
not engage in safety-sensitive tasks such as driving. If you experience these symptoms please let us 
know.  
If you feel stressed, very sleepy or very tired we will discuss some mitigation strategies with you. To 
minimize the risks of driving while sleepy, we will provide taxi vouchers for your transportation to 
and from the test sessions. It should be noted that if you do agree to participate, you can withdraw 
from participation at any time during the project without comment or penalty. 
Are there any benefits for me in taking part? 
It is not expected that this project will benefit you directly. However, it may benefit others in the 
future.  We expect that the results of this study will lead to better understanding of the problem of 
sleepy driving, and potentiality for light as an effective countermeasure. 
Will I be compensated for my time? 
As you will be required to spend four sessions in the laboratory (one screening session and three test 
sessions), and to wear an Actiwatch for two weeks, we would like to compensate you for your time. If 
the screening session excludes you from the study, you will receive $20 to compensate you for your 
time. If you are recruited, you will receive $150 at the end of the study. Taxi vouchers for 
transportation to and from the laboratory will also be provided. 
I am interested – what should I do next? 
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If you would like to participate in this study, please contact one of the research team members for 
details of the next step. 
 Ms Shamsi Shekari Soleimanloo Phone: 3138 0137                  
s.shekarisoleimanloo@qut.edu.au 
             Associate Professor Simon Smith                 Phone: 3138 4908                   
simon.smith@qut.edu.au  
You will be provided with further information to ensure that your decision and consent to participate 
is fully informed. 
Thank You! 



























Participant Information Sheet  
 
 
RESEARCH TEAM  
Description 
Sleep loss in the main cause of driver sleepiness. Young drivers are particularly 
vulnerable to sleep deprivation, so they are at a greater risk when it comes to sleep-
related crashes and fatalities. It is not known exactly why sleepiness causes such a 
problem for driving and how to reduce sleepy driving. Bright light has been shown to 
have some alerting and stimulating effects, similar to caffeine, which is better known 
for its alerting effect. The purpose of this project is to assess the impact of mild 
sleepiness on young drivers’ alertness and performance, and to assess the alerting 
effects of light and caffeine on sleepiness and driving performance  
This project is being undertaken by PhD student Ms Shamsi Shekari Soleimanloo 
from CARRS-Q under the supervision of Associate Professor Simon Smith, Dr 
Melanie White and Dr Veronica Garcia Hansen. The research team is looking for 
people aged 18-25 years, who hold a driver’s licence with no physical restrictions to 
 
PARTICIPANT INFORMATION FOR QUT RESEARCH PROJECT 
Effects of light on human sleepiness and alertness: A simulated driving experiment 
QUT Ethics Approval Number 1300000846 
Principal 
Researcher: 
Ms Shamsi Shekari SoleimanlooPhD student 
Associate 
Researchers: 
Associate Professor Simon Smith Principal Research Fellow and Primary 
Supervisor 
 
 Centre for Accident Research & Road Safety – Queensland 
(CARRS-Q) 
 Dr Melanie White Senior Lecturer and Associate Supervisor 
  School of Psychology and Counselling, Faculty of Health 
 Dr Veronica Garcia Hansen Senior Lecturer and Associate Supervisor 
  School of Design, Creative Industries Faculty 
 Queensland University of Technology (QUT) 
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drive, and normal vision (including normal vision while using spectacles and or 
contact lenses). 
You are not eligible for this study: 
If you are a professional driver, shift worker or have travelled overseas in the past 
month. 
If you usually go to sleep after 12am (midnight), 
If you have any significant health problems, particularly if you suffer from vestibular 
and/or psychiatric diseases, 
If you have any eye or optic nerve diseases affecting your normal vision, such as 
retinopathy, colour vision that is incompatible with driving, and diseases of the optic 
nerve or ocular media, 
If you take prescription medication or illicit drugs, 
If you do not consume caffeine or are a heavy caffeine user (e.g. drink more than 3 
caffeinated drinks per day), 
If you consume more than 2 standard alcoholic drinks per day (a standard drink 
contains 10 grams of alcohol; see Figure 1). 
 
Participation 
Participation in this study comprises three parts: (1) Recruitment and Screening 
session, (2) Actigraphy, and (3) Testing sessions in the lab  
 
Recruitment and Screening session 
This Participant Information Sheet and Consent Form is part of the Participant 
Information Package. This package also includes a questionnaire battery including 
the Pittsburgh Sleep Quality Questionnaire, the Epworth Sleepiness Scale, and the 
Horne-Ostberg Morningness–Eveningness Questionnaire. The questionnaire battery 
informs you of the types of questions you will be asked in the screening session, and 
allows the research team to assess your habitual sleep patterns and daytime 
sleepiness. 
If you are still interested in participating in this study after consideration of the 
information provided in the Participant Information Package, we request you contact 
the research team by email or phone to advise them of your interest to the screening 
call. You will then be contacted by phone to confirm you meet the initial inclusion 
criteria (as mentioned above), and a time will be arranged for you to attend the main 
screening session. 
The main screening session will take place in the desktop driving simulator 
laboratory (Room Q.629) at the Institute of Health & Biomedical Innovation (IHBI), 
QUT Kelvin Grove campus. During the screening session, the researcher will explain 
the study to you, obtain your written consent to participate in the study, and complete 
a battery of questionnaires. If you meet the eligibility criteria, you will be given an 





allows us to monitor your sleep; see Figure 2) and advised of when you need to wear 
the Actiwatches, as well as when your subsequent testing sessions will take place. 
 
Actigraphy 
You will be required to wear the Actiwatches for two weeks prior to the 
commencement of your testing sessions. During the first week, you will be asked to 
sleep between 11pm and 7am each night. At the start of the second week, you will be 
asked to reduce your sleep by 15 minutes for 4 nights, resulting in sleep loss of an 
hour (thus sleeping between 11pm and 6am). The e Actiwatches is a waterproof 
device and must be worn day and night during this period, including when 
showering, bathing and swimming. In the final three days of the second week, whilst 
still wearing the Actiwatches, you will be asked to attend three testing sessions in the 
desktop driving simulator laboratory at IHBI. Your scheduled sleep-wake timeline 
over two weeks of Actigraphy has been shown in Figure3. 
 
Testing sessions in the lab 
As mentioned, in the final three days of the second week of the study, you will be 
asked to attend three testing sessions in the laboratory at IHBI (one testing session 
per day). On each test day you will be required to wake up at 6am and arrive at the 
laboratory at 8:30am. Each testing session will take about 3 hours (i.e. approximately 
8:30am to 11:15am). In total, the 3 testing sessions will take up about 9 hours of your 
time across the 3 days.  
During the testing sessions sensors will be stuck on your scalp, using a non-toxic 
sticky gel, to measure your brain waves and on your chest to measure your heart rate. 
During the sessions you will be sitting in a quiet and dim lit environment. You will 
be required to chew either caffeinated or decaffeinated chewing gum, which will be 
undistinguishable to you. You will also be required to wear special light-emitting 
glasses (Re-Timer glasses; see Figure 4). This device will direct a low-level green-
blue or red light onto your eyes. In addition, you will undertake computerized tests, 
including a simulated driving test and a reaction time test. The computerized driving 
test requires you to drive on a simulated road for about half an hour allowing 
assessment of your driving performance. The PEBLE psychomotor vigilance task is a 
simple computerized reaction time task, re-specified to measure your sleepiness and 
arousal. During this test a stimulus appears on the computer screen and you are 
required to respond as quickly as possible by pressing the spacebar. Additionally, 
you will be asked to rank your perceived level of sleepiness. Importantly, we ask you 
to refrain from consuming caffeine or taking naps on the three test-session days.  
Your participation in this project is entirely voluntary. If you do agree to participate, 
you can withdraw from participation at any time during the project without comment 
or penalty. Your decision to participate will in no way impact upon your current or 





It is not expected that this project will benefit you directly. However, it may benefit 
others in the future. We expect that the results of this study will lead to better 
understanding of the problem of sleepy driving, and potentiality of light as an 
effective countermeasure.
 
As you will be required to spend four sessions in the 
laboratory (one screening session and three test sessions), and to wear an Actiwatch 
for two weeks, we would like to compensate you for your time. If the screening 
session excludes you from the study, you will receive $20 to compensate you for 
your time. If you are recruited, you will receive $150 at the end of the study. Taxi 
vouchers for transportation to and from the laboratory will also be provided. 
 
Risks 
There are some minor risks associated with your participation in this project. You 
might find the study tiring, feel sleepy or uncomfortable from the electrodes. You 
may experience minor eye strain, a headache, nausea or feel stimulated from 
exposure to low-level lights. Moreover, you may experience sleepiness symptoms 
such as poor concentration, head nodding during the day prior to testing, sleepiness 
during testing sessions, and potential increased sleep duration for 2-3 days after 
completion of the study.
 
While the degree of sleepiness induced by the sleep time 
manipulation is likely to be mild, you may feel excessive sleepiness
 
while working or 
studying. Therefore, you should not engage in safety-sensitive tasks such as driving. 
If you experience these symptoms please let us know.  
If you feel stressed, very sleepy or very tired we will discuss some mitigation 
strategies with you. To minimize the risks of driving while sleepy, we will provide 
taxi vouchers for your transportation to and from the test sessions. It should be noted 
that if you do agree to participate, you can withdraw from participation at any time 
during the project without comment or penalty. 
 
Privacy and confidentiality 
All comments and responses will be treated confidentially.  The names of individual 
persons are not required in any of the responses, and you will not be identified in any 
publications resulted from this study. Any data collected as part of this project will 
be stored securely as per QUT’s Management of research data policy. 
Please note that non-identifiable data collected in this project may be used as 
comparative data in future projects or stored on an open access database for 
secondary analysis.  
After completion of the study, you will be advised of the type of gum you received 
during each session. You will also be advised of some sleepiness mitigation 
strategies after each test session and for use over the few days upon completion of 
the study. Additionally, for more information on the results of this study, you may 
request this information from the research team. 
 
Consent to Participate 
We would like to ask you to sign a written consent form (enclosed) to confirm your 






Questions / further information about the project 
If have any questions or require further information please contact one of the 





















Concerns / complaints regarding the conduct of the project 
QUT is committed to research integrity and the ethical conduct of research projects.  
However, if you do have any concerns or complaints about the ethical conduct of the 
project you may contact the QUT Research Ethics Unit on 3138 5123 or email 
ethicscontact@qut.edu.au. The QUT Research Ethics Unit is not connected with the 
research project and can facilitate a resolution to your concern in an impartial 
manner. 












































































CONSENT FORM FOR QUT RESEARCH PROJECT 
  
Effects of light on human sleepiness and alertness: A simulated driving experiment 
QUT Ethics Approval Number 1300000846 
 
RESEARCH TEAM CONTACTS 
Ms Shamsi Shekari  
Soleimanloo Dr Simon Smith 
Dr Melanie White Dr Veronica  
Garcia Hansen 
3138 0183 3138 4908 




STATEMENT OF CONSENT 
By signing below, you are indicating that you: 
 Have read and understood the information document regarding this project. 
 Have had any questions answered to your satisfaction. 
 Understand that if you have any additional questions you can contact the 
research team. 
 Understand that you are free to withdraw at any time, without comment or 
penalty. 
 Understand that you can contact the Research Ethics Unit on 3138 5123 or 
email ethicscontact@qut.edu.au if you have concerns about the ethical conduct 
of the project. 
 Understand that non-identifiable data collected in this project may be used as 
comparative data in future projects. 














Study day Date sleep time (pm) Wake time (am) First test session Second test session Third test session Alcohol intake Coffee intake Breakfast intake 
1 11/09/2014 11 7:00       
2 12/09/2014 11 7:00       
3 13/09/2014 11 7:00       
4 14/09/2014 11 7:00       
5 15/09/2014 11 7:00       
6 16/09/2014 11 7:00       
7 17/09/2014 11 7:00       
8 18/09/2014 11 6:45       
9 19/09/2014 11 6:30       
10 20/09/2014 11 6:15       
11 21/09/2014 11 6:00       
12 22/09/2014 11 6:00 8:30 am        
13 23/09/2014 11 6:00   8:30:00 am      




Screening Session Checklist 
Participant name:  
 
Preparation 
Screening Session Checklist Items Yes No Comments 
Has the time and venue of screening session been communicated 
with the participant? 
  
 
Is there ample time allotted for the screening to ensure that all agenda 
items can be sufficiently discussed?   
 
 
Has the inclusion-Exclusion checklist been prepared?    
Has the battery of questionnaires been prepared? 
  
 
Has standard drink chart been prepared?    
Has the power point slide for sleep-wake monitoring been prepared? 
  
 
Has the The Actiwatches been charged and set up one day before 
screening session?   
 
Has simulator training file been prepared?    
Has reaction time test been prepared for training?    
Has a folder for participant handouts been prepared? 
  
 
Has $20 been put in an envelope? 
  
 
Has a partial payment receipt been prepared?    
Has the participant consent form been prepared?    
Has the “Participant Actigraphy and Wakeup Message Sheet” been 
prepared?   
 
Has participant sleep wake diary been prepared? 
  
 











Has a taxi voucher been prepared for the participant?    
Has the lab environment been prepared and cleaned? 
  
 
Have some cold water, instant coffee and biscuits been prepared?    
Has the note for lab door “Participant Screening in Progress, Please 




Screening Session Checklist Items Yes No Comments 
Is the participant at ease and comfortable within the screening 
setting?   
 
Has the participant been provided with an opportunity to ask 
questions during screening session?   
 
 
Have the objectives of screening session been restated using 
PowerPoint slides?    
 
Has Part A in “Inclusion-Exclusion Checklist for Screening Session” 
been filled out? 
  
 
Have the battery of questionnaires been filled out? 
  
 
Has Part B in “Inclusion-Exclusion Checklist for Screening Session” 
been filled out? 
  
 
Is the participant eligible for the study? 
  
 
If participant is not eligible, have you given them $20? 
  
 
If participant is eligible, have the PowerPoint slides been explained 
to them?   
 
Has participant signed “the participant consent form”?    
Has participant been trained on how to drive on the simulator?    
Has participant been trained on how to do reaction time test?    
Has the participant been provided with a fully charged Actigraph? 
  
 
Has “Actigraph important notes” been explained to the participant? 
  
 
Has the “Participant Actigraphy and Wakeup Message Sheet” been 





Has start time of Actigraphy been specified for participant? 
  
 
Has the participant’s sleep wake diary scheduled based on 
Actigraphy start time?   
 
Has the commuting method of participant been asked?    
Conclusion 
Screening Session Checklist Items Yes No Comments 
Has a copy of table of sleep-wake diary been given to the participant? 
  
 
Has a copy of important notes about Actigraph been given to the 
participant?   
 
Has a copy of PowerPoint slides been given to the participant? 
  
 
Has a copy of participant consent form been given to the participant?    
Has participant signed partial payment receipt?    
Has the Actiwatch been given to the participant? 
  
 
Have the start time of Actigraphy and test sessions were finalized 
with the participant?   
 
Is the time of texting to the participants for testing their wakefulness 
been finalized with the participant?  
  
 
If participant needs taxi for test sessions, has a taxi voucher been 
given to the participant?   
 


















Test Session Checklist 
Participant name:  
Preparation 
Test Session Checklist Items 
Ye
s No Comments 




Has the participant been advised on washing their heir with only 
shampoo not conditioner? 
  
 
Has the Karolinska Sleepiness Scale been prepared?    
Has the KSS recording sheet been prepared?    
Has a total/withdraw payment receipt been prepared?    
Has the notice “Study in progress, please do not disturb” been 
prepared?   
 
Have batteries of Somte data recorder been fully charged?    
Have all material for EEG and ECG setup been prepared? 
  
 
Have red-light and blue-green- light Re-Timer glasses been charged? 
  
 








Has $150 been put in an envelope? 
  
 
Have the scenario and configuration files been prepared?    




Has PEBLE PPVT test been prepared? 
  
 
Has neutral filter been installed on the simulator screen?    
Has a taxi voucher been prepared for the participant?    
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Has the lab environment been prepared and cleaned? 
  
 
Have some cold water, instant coffee and biscuits been prepared?    
Have randomized scenario and test condition been specified for this 
test session?   
 
 
Has a folder to save participant Actigraphic data been specified?    




Has a folder to save participant PEBLE PPVT data been specified?    
Has a folder to save participant simulator data been specified?    
Has a table to save participant KSS data been prepared?    




Has the interventional conditions for participant been 
counterbalanced? 
   
Has the road scenarios for test sessions been counterbalanced?    
Execution 
Test Session Checklist Items 
Ye
s No Comments 








Have data from participant the Actiwatch been copied to a specific 
folder in the Actiware? 
  
 
Is the participant at ease and comfortable within the Test setting? 
  
 
Have EEG and ECG electrodes been setup on the participant by 9 
am?    
 
 
Have EEG and ECG recording been started straightaway after setup?    
Have the lights been off and Philip Living Colour lights been 
adjusted to red light at 9 am?    
 
Has participant been asked to seat on a chair for 30 min (until 9:30) 







Has the participant been given a decaffeinated chewing gum after 15 
min adaptation to darkness (at 9:15 am)?   
 
Has first round of PEBLE PPVT been recorded after 20min of 
darkness for 5min (at 9:20 am)?   
 
Have EEG and ECG been double checked to continue recording at 
the beginning of driving (at 9:30 am)? 
  
 
Has participant put on red-light Re-Timer glasses before simulated 
drive (at 9:30 am)?   
 
Has KSS level been asked from participant immediately before 
driving test (at 9:30 am)? 
  
 
Has participant driven on the randomized scenario for 30 min (from 
9:30 to 10 am)? 
  
 
Has KSS level been recorded immediately after first drive (at 10 
am)?   
 
Has second PEBLE PPVT been recorded after first drive for 5 min 
(at 10 am)?   
 
Has caffeinated or decaffeinated chewing gum pills been given to the 
participant based on the specific randomized test condition for this 
test session (at 10:05 am)? 
  
 
Has the participant worn red-light or blue-green-light Re-timer 
glasses after 15 min of chewing gum based on the specific 
randomized test condition for this test session (at 10:20am)?    
 
Has the participant driven their second driving scenario for 30 
minutes (from 10:20 to 10:50 am)?   
 




Has third PEBLE PPVT been recorded after second drive for 5 min 
(at 10:55 am)? 
  
 
Has EEG and ECG recording been stopped after PEBLE PPVT test 
(at 11 am)? 
  
 
Has EEG and ECG electrodes been removed from participant?    
Has participants head and skin been cleaned after test?    
Conclusion 
Test Session Checklist Items 
Ye
s No Comments 
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Has participant been provided with some refreshment? 
  
 
Has coffee, alcohol and meal intake been restated for the participant? 
  
 
Has taxi voucher been provided for participant (if required)?    
Has participant signed complete payment receipt (in the last session)?    
Have EEG and ECG data been transferred to data manager and a 
backup file been copied to the hard drive?   
 
Have PEBLE PPVT data been stored and backup file been copied to 
hard drive?   
 
Have the simulator data been saved in the simulator data file and a 
backup file been copied to the hard drive?  
  
 
Has KSS data been stored in a file in hard drive? 
  
 








Have all preparation steps for the next test day been taken based on 










Data setup in SPSS for demographic, Actigraphic, KSS and PPVT data 
Since the study design was a within subject repeated measures design, data were 
sorted in SPSS as below: 
First codes of participants were entered in the SPSS in the order of 301 to 330. The 
demographic and Actigraphic data had only one measure and entered in separated 
columns for each participant code. As for KSS and PPVT data, first values of these 
data were named and labelled in the “Variable View” of SPSS. The name comprised 
three elements of name of variable, Condition Type (1, 2 or 3) and the time of 
recording KSS (1= before first drive, 2= after first drive and 3= after second drive). 
For example KSS 23 was assigned to the KSS variable measured with the 
Intervention Type 2 (light only) and after the second drive. Since the KSS and PPVT 
variables were recorded three times every test session, there were 9 records for the 
KSS and for every variable derived from PPVT for each participant in the SPSS file. 
All variables of the KSS and PPVT were entered in separate columns after 
demographic and Actigraphic data. This form of setting up the data made it possible 
to perform the repetitive measures, within-participants ANOVA analysis. Table N1 













Table N 1Naming and labelling of KSS scores in SPSS 
Order of data in 
SPSS 
Name of KSS record Label of KSS record 
1 KSS11 KSS, Condition 1, before first drive 
2 KSS12 KSS, Condition 1, after first drive 
3 KSS13 KSS, Condition 1, after second drive 
4 KSS21 KSS, Condition 2, before first drive 
5 KSS22 KSS, Condition 2, after first drive 
6 KSS23 KSS, Condition 2, after second drive 
7 KSS31 KSS, Condition 3, before first drive 
8 KSS32 KSS, Condition 3, after first drive 




















Data setup in SPSS for the EEG, ECG, and driving performance outcome 
measures 
For the EEG, ECG and driving performance outcomes, there was an average of 30-
min data for each variable, each Intervention Type and each drive (30 min). Since in 
every test session there were two drives, a total number of 6 values for each variable 
for each participant were entered in consecutive columns in the SPSS. The name of 
each variable comprised three elements as follows: 
 Name of variable 
 Intervention Type (1, 2 or 3); values of Condition 1 were presented before 
Condition 2 and those of Condition 2 before condition 3. 
 Timing of recording the variable; before receiving the intervention (first 
drive) or after receiving the intervention (second drive), with the number 1 
representing the first drive.  
To clarify the naming and setting the data in SPSS, data for the standard deviation of 













Table O1: Naming and labelling of SD Lateral Lane position 
Order of  
data  
Name of variable Label of variable 
1 SDLATLANPOS11 SD of lateral lane position, Condition1, after 
first drive 
2 SDLATLANPOS12 SD of lateral lane position, Condition1, after 
second drive 
3 SDLATLANPOS21 SD of lateral lane position, Condition2, after 
first drive 
4 SDLATLANPOS22 SD of lateral lane position,  Condition 2, after 
second drive 
5 SDLATLANPOS31 SD of lateral lane position,  Condition 3, after 
first drive 
6 SDLATLANPOS32 SD of lateral lane position,  Condition 3, after 
second drive 
 
 
 
